activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177455	CHEMBL678608	Inhibition of Fibroblast growth factor receptor 3	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	64.0	CHEMBL2742	Homo sapiens	Activity	%	64.0
	177455	CHEMBL678608	Inhibition of Fibroblast growth factor receptor 3	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	64.0	CHEMBL2742	Homo sapiens	Activity	%	64.0
	178768	CHEMBL678608	Inhibition of Fibroblast growth factor receptor 3	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	79.0	CHEMBL2742	Homo sapiens	Activity	%	79.0
	182515	CHEMBL678608	Inhibition of Fibroblast growth factor receptor 3	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	83.0	CHEMBL2742	Homo sapiens	Activity	%	83.0
	915775	CHEMBL678609	Inhibition of Fibroblast growth factor receptor 3 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	58.0	CHEMBL2742	Homo sapiens	Activity	%	58.0
	931236	CHEMBL678609	Inhibition of Fibroblast growth factor receptor 3 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	61.0	CHEMBL2742	Homo sapiens	Activity	%	61.0
	1611784	CHEMBL881229	Inhibitory activity against Fibroblast growth factor receptor 3	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccc(O)cc12		CHEMBL26559	=	IC50	nM	400.0	CHEMBL2742	Homo sapiens	IC50	uM	0.4
	1611791	CHEMBL881229	Inhibitory activity against Fibroblast growth factor receptor 3	B	Cc1c2cc[n+](C)cc2c(C)c2c1[nH]c1ccc(O)cc12		CHEMBL16699	=	IC50	nM	500.0	CHEMBL2742	Homo sapiens	IC50	uM	0.5
	1611817	CHEMBL881229	Inhibitory activity against Fibroblast growth factor receptor 3	B	CCN(CC)CCCNc1nccc2c(C)c3c(c(C)c12)c1cc(O)ccc1n3C		CHEMBL55137	=	IC50	nM	1400.0	CHEMBL2742	Homo sapiens	IC50	uM	1.4
Not Active	1650738	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1650739	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1650740	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2742	Homo sapiens	Kd		
	1650741	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	300.0	CHEMBL2742	Homo sapiens	Kd	uM	0.3
Not Active	1650742	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1650743	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1650744	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1650745	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1650746	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL2742	Homo sapiens	Kd		
	1651709	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL2742	Homo sapiens	Kd	uM	0.11
Not Active	1651710	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651711	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651712	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651713	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651714	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651715	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651716	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1651717	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2742	Homo sapiens	Kd		
	1651718	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	240.0	CHEMBL2742	Homo sapiens	Kd	uM	0.24
Not Active	1651719	CHEMBL860801	Average Binding Constant for FGFR3; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL2742	Homo sapiens	Kd		
Not Active	1658685	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL2742	Homo sapiens	Activity		
	1723183	CHEMBL860211	Inhibition of FGFR3	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	nM	1900.0
	1723185	CHEMBL860211	Inhibition of FGFR3	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	nM	1900.0
	1723186	CHEMBL860211	Inhibition of FGFR3	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	nM	1900.0
	1723187	CHEMBL860211	Inhibition of FGFR3	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	nM	1900.0
	1723188	CHEMBL860211	Inhibition of FGFR3	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	nM	1900.0
	1723189	CHEMBL860211	Inhibition of FGFR3	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	nM	1900.0
Not Determined	1728712	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1728755	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1728798	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1728841	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1728884	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1728937	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1728980	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729023	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729066	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729109	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729152	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729195	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729238	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729281	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729327	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729370	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729413	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729456	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729499	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729542	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729600	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Determined	1729643	CHEMBL860304	Inhibitory activity against FGFR3 at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL2742	Homo sapiens	Activity		
	1734193	CHEMBL862474	Residual activity at human FGFR3 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	121.0	CHEMBL2742	Homo sapiens	Activity	%	121.0
	1744470	CHEMBL867312	Inhibition of FGFR3	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	1900.0	CHEMBL2742	Homo sapiens	Ki	uM	1.9
	1769393	CHEMBL910913	Inhibition of FGFR3	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	uM	1.0
	1790047	CHEMBL855308	Percentage activity of human FGFR3 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	76.0	CHEMBL2742	Homo sapiens	Activity	%	76.0
	1824549	CHEMBL914313	Inhibition of FGFR3	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2742	Homo sapiens	Ki	uM	10.0
	1824720	CHEMBL914313	Inhibition of FGFR3	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL2742	Homo sapiens	Ki	uM	10.0
	1824796	CHEMBL914313	Inhibition of FGFR3	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2742	Homo sapiens	Ki	uM	10.0
	1968057	CHEMBL895278	Inhibition of FGFR3	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	>	IC50	nM	6000.0	CHEMBL2742	Homo sapiens	IC50	uM	6.0
	1996181	CHEMBL899841	Inhibition of FGFR3 K650E mutant at 10 uM	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	<	Inhibition	%	30.0	CHEMBL2742	Homo sapiens	Inhibition	%	30.0
	2025140	CHEMBL886967	Inhibition of human FGFR3 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	84.0	CHEMBL2742	Homo sapiens	Inhibition	%	84.0
	2025312	CHEMBL886967	Inhibition of human FGFR3 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	75.0	CHEMBL2742	Homo sapiens	Inhibition	%	75.0
	2025313	CHEMBL886967	Inhibition of human FGFR3 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	117.0	CHEMBL2742	Homo sapiens	Inhibition	%	117.0
	2025314	CHEMBL886967	Inhibition of human FGFR3 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	114.0	CHEMBL2742	Homo sapiens	Inhibition	%	114.0
	2051620	CHEMBL941758	Inhibition of FGFR3	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	1863.0	CHEMBL2742	Homo sapiens	Ki	uM	1.863
	2081791	CHEMBL928814	Inhibition of FGFR3 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2742	Homo sapiens	Inhibition	%	20.0
	2132655	CHEMBL921279	Inhibition of FGFR3	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	2147263	CHEMBL921853	Activity of human FGFR3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	86.0	CHEMBL2742	Homo sapiens	Activity	%	86.0
	2153738	CHEMBL924596	Inhibition of FGFR3 at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	Inhibition	%	50.0
	2153773	CHEMBL924596	Inhibition of FGFR3 at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	Inhibition	%	50.0
Not Active	2170355	CHEMBL930310	Activity at FGFR3 at 10 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL2742	Homo sapiens	Activity		
	2206904	CHEMBL974015	Inhibition of FGFR3	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
	2206955	CHEMBL974015	Inhibition of FGFR3	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL2742	Homo sapiens	EC50	uM	1.0
	2206960	CHEMBL990564	Inhibition of FGFR3 by cellular assay	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	EC50	nM	30.0	CHEMBL2742	Homo sapiens	EC50	nM	30.0
	2206991	CHEMBL974015	Inhibition of FGFR3	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	2250297	CHEMBL1009184	Inhibition of FGFR3	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	3.0	CHEMBL2742	Homo sapiens	IC50	nM	3.0
	2251213	CHEMBL1009911	Inhibition of FGFR3	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	2470221	CHEMBL983623	Inhibition of FGFR3 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	2470222	CHEMBL983624	Inhibition of FGFR3 G697C mutant at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	2476621	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	11.1	CHEMBL2742	Homo sapiens	Activity	%	11.1
Not Evaluated	2476824	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2478663	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2742	Homo sapiens	Activity		
	2478866	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	8.1	CHEMBL2742	Homo sapiens	Activity	%	8.1
Not Evaluated	2479721	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2742	Homo sapiens	Activity		
Active	2480720	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2742	Homo sapiens	Activity		
	2511582	CHEMBL972540	Inhibition of FGFR3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	uM	0.018
	2511954	CHEMBL969676	Inhibition of human FGFR3 at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	40.0	CHEMBL2742	Homo sapiens	Activity	%	40.0
Not Evaluated	2577342	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2577545	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2742	Homo sapiens	Activity		
	2593547	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	4.3	CHEMBL2742	Homo sapiens	Activity	%	4.3
Not Evaluated	2593750	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2594016	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2594959	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2595162	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2595228	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2596359	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2597628	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2742	Homo sapiens	Activity		
Not Evaluated	2597831	CHEMBL1035885	Binding affinity to human FGFR3 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2742	Homo sapiens	Activity		
	2603070	CHEMBL1023865	Inhibition of FGFR3	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	2613483	CHEMBL1031525	Inhibition of FGFR3	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
Active	2719511	CHEMBL1058293	Inhibition of FGFR3 expressed in mouse BA/F3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1[nH]cnc2ncnc1-2		CHEMBL563577		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	2721608	CHEMBL1057437	Inhibition of FGFR3 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	2907187	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907188	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907189	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907190	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907191	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907192	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907193	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	230.0	CHEMBL2742	Homo sapiens	Kd	nM	230.0
	2907194	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907195	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907196	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907197	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907198	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907199	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907200	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907201	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907202	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907203	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907204	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	740.0	CHEMBL2742	Homo sapiens	Kd	nM	740.0
	2907205	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907206	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	510.0	CHEMBL2742	Homo sapiens	Kd	nM	510.0
	2907207	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907208	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907209	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907210	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1200.0	CHEMBL2742	Homo sapiens	Kd	nM	1200.0
	2907211	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907212	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1700.0	CHEMBL2742	Homo sapiens	Kd	nM	1700.0
	2907213	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907214	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907215	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907216	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907217	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907218	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907219	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	88.0	CHEMBL2742	Homo sapiens	Kd	nM	88.0
	2907220	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	560.0	CHEMBL2742	Homo sapiens	Kd	nM	560.0
	2907221	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	290.0	CHEMBL2742	Homo sapiens	Kd	nM	290.0
	2907222	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	860.0	CHEMBL2742	Homo sapiens	Kd	nM	860.0
	2907223	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907224	CHEMBL1063711	Binding constant for FGFR3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1600.0	CHEMBL2742	Homo sapiens	Kd	nM	1600.0
	2907225	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907226	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907227	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907228	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907229	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907230	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907231	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	370.0	CHEMBL2742	Homo sapiens	Kd	nM	370.0
	2907232	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907233	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907234	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907235	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907236	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907237	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907238	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907239	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907240	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907241	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907242	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	620.0	CHEMBL2742	Homo sapiens	Kd	nM	620.0
	2907243	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907244	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	690.0	CHEMBL2742	Homo sapiens	Kd	nM	690.0
	2907245	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907246	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907247	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907248	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1300.0	CHEMBL2742	Homo sapiens	Kd	nM	1300.0
	2907249	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907250	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907251	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907252	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907253	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907254	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907255	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907256	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	5900.0	CHEMBL2742	Homo sapiens	Kd	nM	5900.0
	2907257	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	310.0	CHEMBL2742	Homo sapiens	Kd	nM	310.0
	2907258	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	380.0	CHEMBL2742	Homo sapiens	Kd	nM	380.0
	2907259	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1400.0	CHEMBL2742	Homo sapiens	Kd	nM	1400.0
	2907260	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	820.0	CHEMBL2742	Homo sapiens	Kd	nM	820.0
	2907261	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	2907262	CHEMBL1062841	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	6900.0	CHEMBL2742	Homo sapiens	Kd	nM	6900.0
	2921336	CHEMBL1053729	Inhibition of FGFR3 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	2924054	CHEMBL1041537	Inhibition of FGFR3 by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	2924055	CHEMBL1041537	Inhibition of FGFR3 by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	2928475	CHEMBL1049973	Binding affinity to FGFR3 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	89.0	CHEMBL2742	Homo sapiens	Activity	%	89.0
	2938505	CHEMBL1041360	Inhibition of FGFR3 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	8.0	CHEMBL2742	Homo sapiens	INH	%	8.0
	3006319	CHEMBL1038370	Inhibition of FGFR3	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989	>	IC50	nM	7000.0	CHEMBL2742	Homo sapiens	IC50	uM	7.0
	3006320	CHEMBL1038370	Inhibition of FGFR3	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887	>	IC50	nM	7000.0	CHEMBL2742	Homo sapiens	IC50	uM	7.0
	3006321	CHEMBL1038370	Inhibition of FGFR3	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922	>	IC50	nM	7000.0	CHEMBL2742	Homo sapiens	IC50	uM	7.0
	3006322	CHEMBL1038370	Inhibition of FGFR3	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601	>	IC50	nM	7000.0	CHEMBL2742	Homo sapiens	IC50	uM	7.0
	3052611	CHEMBL1037587	Residual activity of FGFR3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL2742	Homo sapiens	Residual activity	%	88.0
	3053920	CHEMBL1045130	Residual activity of FGFR3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	46.0	CHEMBL2742	Homo sapiens	Residual activity	%	46.0
	3054172	CHEMBL1040640	Residual activity of FGFR3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	95.0	CHEMBL2742	Homo sapiens	Residual activity	%	95.0
	3055459	CHEMBL1037587	Residual activity of FGFR3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	90.0	CHEMBL2742	Homo sapiens	Residual activity	%	90.0
	3055711	CHEMBL1045130	Residual activity of FGFR3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	171.0	CHEMBL2742	Homo sapiens	Residual activity	%	171.0
	3057016	CHEMBL1040640	Residual activity of FGFR3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	104.0	CHEMBL2742	Homo sapiens	Residual activity	%	104.0
	3058336	CHEMBL1037587	Residual activity of FGFR3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL2742	Homo sapiens	Residual activity	%	98.0
	3058588	CHEMBL1045130	Residual activity of FGFR3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	169.0	CHEMBL2742	Homo sapiens	Residual activity	%	169.0
	3062467	CHEMBL1037150	Binding affinity to human FGFR3 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	85.0	CHEMBL2742	Homo sapiens	Activity	%	85.0
	3063602	CHEMBL1074868	Binding affinity to human FGFR3 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	43.0	CHEMBL2742	Homo sapiens	Activity	%	43.0
	3063692	CHEMBL1047844	Binding affinity to human FGFR3 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	3065871	CHEMBL1069303	Inhibition of FGFR3 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	4.0	CHEMBL2742	Homo sapiens	INH	%	4.0
	3066937	CHEMBL1069303	Inhibition of FGFR3 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	32.0	CHEMBL2742	Homo sapiens	INH	%	32.0
	3072934	CHEMBL1040640	Residual activity of FGFR3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	100.0	CHEMBL2742	Homo sapiens	Residual activity	%	100.0
	3084436	CHEMBL1073299	Inhibition of FGFR3	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	3213812	CHEMBL1108399	Inhibition of FGFR3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL2742	Homo sapiens	INH	%	3.0
	3213813	CHEMBL1108400	Inhibition of FGFR3 K650E mutant at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	9.0	CHEMBL2742	Homo sapiens	INH	%	9.0
	3213814	CHEMBL1108401	Inhibition of FGFR3 K650M mutant at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL2742	Homo sapiens	INH	%	4.0
	3224821	CHEMBL1099658	Inhibition of FGFR3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3224822	CHEMBL1099659	Inhibition of FGFR3 K650E (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3225071	CHEMBL1099658	Inhibition of FGFR3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3225072	CHEMBL1099659	Inhibition of FGFR3 K650E (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3308355	CHEMBL1119639	Inhibition of FGFR3 at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829	=	Inhibition	%	100.0	CHEMBL2742	Homo sapiens	INH	%	100.0
	3308356	CHEMBL1119639	Inhibition of FGFR3 at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337	=	Inhibition	%	100.0	CHEMBL2742	Homo sapiens	INH	%	100.0
	3315892	CHEMBL1120238	Inhibition of FGFR3K	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	3331943	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3331944	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3333358	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3333359	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3334763	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3334764	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3336183	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3336184	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3337530	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3337531	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3337780	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3337781	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3339114	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3339115	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3340416	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3340417	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3340711	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3340712	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3342127	CHEMBL1169233	Inhibition of FGFR3 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3342128	CHEMBL1169234	Inhibition of FGFR3 G697C mutant at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	3358578	CHEMBL1174423	Inhibition of FGFR3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.3	CHEMBL2742	Homo sapiens	INH	%	0.3
	3358579	CHEMBL1174424	Inhibition of FGFR3 G697C mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.05	CHEMBL2742	Homo sapiens	INH	%	0.05
	3359020	CHEMBL1174423	Inhibition of FGFR3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.15	CHEMBL2742	Homo sapiens	INH	%	0.15
	3359021	CHEMBL1174424	Inhibition of FGFR3 G697C mutant at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.15	CHEMBL2742	Homo sapiens	INH	%	0.15
	3400016	CHEMBL1217213	Inhibition of human FGFR3 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	100.0	CHEMBL2742	Homo sapiens	INH	%	100.0
	3419122	CHEMBL1228790	Inhibition of FGFR3 at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	83.0	CHEMBL2742	Homo sapiens	INH	%	83.0
	3441501	CHEMBL1244084	Inhibition of human FGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	108.0	CHEMBL2742	Homo sapiens	IC50	nmol/L	108.0
	3443398	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	63.0	CHEMBL2742	Homo sapiens	INH	%	63.0
	3443399	CHEMBL1244432	Inhibition of FGFR3 K650E mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	60.0	CHEMBL2742	Homo sapiens	INH	%	60.0
	3443615	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	91.0	CHEMBL2742	Homo sapiens	INH	%	91.0
	3443616	CHEMBL1244432	Inhibition of FGFR3 K650E mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	85.0	CHEMBL2742	Homo sapiens	INH	%	85.0
	3444770	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	29.0	CHEMBL2742	Homo sapiens	INH	%	29.0
	3444771	CHEMBL1244432	Inhibition of FGFR3 K650E mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	16.0	CHEMBL2742	Homo sapiens	INH	%	16.0
	3445118	CHEMBL1244840	Binding affinity to FGFR3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	580.0	CHEMBL2742	Homo sapiens	Kd	nM	580.0
	3445119	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	730.0	CHEMBL2742	Homo sapiens	Kd	nM	730.0
	3445394	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	9.0	CHEMBL2742	Homo sapiens	INH	%	9.0
	3445395	CHEMBL1244432	Inhibition of FGFR3 K650E mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	2.0	CHEMBL2742	Homo sapiens	INH	%	2.0
	3445611	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	26.0	CHEMBL2742	Homo sapiens	INH	%	26.0
	3445612	CHEMBL1244432	Inhibition of FGFR3 K650E mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	22.0	CHEMBL2742	Homo sapiens	INH	%	22.0
	3445820	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	40.0	CHEMBL2742	Homo sapiens	INH	%	40.0
	3446010	CHEMBL1244431	Inhibition of FGFR3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	25.0	CHEMBL2742	Homo sapiens	INH	%	25.0
	3448008	CHEMBL1249764	Inhibition of human FGFR3 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	7.0	CHEMBL2742	Homo sapiens	INH	%	7.0
	3448084	CHEMBL1249764	Inhibition of human FGFR3 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	27.0	CHEMBL2742	Homo sapiens	INH	%	27.0
	3448436	CHEMBL1244840	Binding affinity to FGFR3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3448437	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3448756	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3448928	CHEMBL1244840	Binding affinity to FGFR3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1700.0	CHEMBL2742	Homo sapiens	Kd	nM	1700.0
	3449174	CHEMBL1244840	Binding affinity to FGFR3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	290.0	CHEMBL2742	Homo sapiens	Kd	nM	290.0
	3449434	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1400.0	CHEMBL2742	Homo sapiens	Kd	nM	1400.0
	3449435	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	5900.0	CHEMBL2742	Homo sapiens	Kd	nM	5900.0
	3449671	CHEMBL1244840	Binding affinity to FGFR3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3449672	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3450082	CHEMBL1244840	Binding affinity to FGFR3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3451004	CHEMBL1244840	Binding affinity to FGFR3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3451005	CHEMBL1244841	Binding affinity to FGFR3 G697C mutant	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	uM	10.0
	3463231	CHEMBL1252419	Inhibition of FGFR3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	-1.0	CHEMBL2742	Homo sapiens	INH	%	-1.0
	3463232	CHEMBL1252420	Inhibition of FGFR3 K650E mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	8.0	CHEMBL2742	Homo sapiens	INH	%	8.0
	3463450	CHEMBL1252419	Inhibition of FGFR3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	23.0	CHEMBL2742	Homo sapiens	INH	%	23.0
	3463451	CHEMBL1252420	Inhibition of FGFR3 K650E mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL2742	Homo sapiens	INH	%	12.0
	3463994	CHEMBL1252419	Inhibition of FGFR3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	43.0	CHEMBL2742	Homo sapiens	INH	%	43.0
	3463995	CHEMBL1252420	Inhibition of FGFR3 K650E mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	38.0	CHEMBL2742	Homo sapiens	INH	%	38.0
	5120414	CHEMBL1645966	Inhibition of human FGFR3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	109.0	CHEMBL2742	Homo sapiens	INH	%	109.0
	5152480	CHEMBL1656525	Inhibition of FGFR3 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	5152505	CHEMBL1656525	Inhibition of FGFR3 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	5243707	CHEMBL1685670	Inhibition of FGFR3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	27.0	CHEMBL2742	Homo sapiens	INH	%	27.0
	5243815	CHEMBL1685919	Inhibition of FGFR3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	-3.0	CHEMBL2742	Homo sapiens	INH	%	-3.0
	5243928	CHEMBL1685670	Inhibition of FGFR3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	17.0	CHEMBL2742	Homo sapiens	INH	%	17.0
	5244036	CHEMBL1685919	Inhibition of FGFR3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	1.0	CHEMBL2742	Homo sapiens	INH	%	1.0
	5244909	CHEMBL1685670	Inhibition of FGFR3 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	72.0	CHEMBL2742	Homo sapiens	INH	%	72.0
	5245017	CHEMBL1685919	Inhibition of FGFR3 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	26.0	CHEMBL2742	Homo sapiens	INH	%	26.0
	5245168	CHEMBL1685670	Inhibition of FGFR3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	53.0	CHEMBL2742	Homo sapiens	INH	%	53.0
	5245998	CHEMBL1685919	Inhibition of FGFR3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	19.0	CHEMBL2742	Homo sapiens	INH	%	19.0
	5249804	CHEMBL1687336	inhibition of FGFR3 at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	0.1	CHEMBL2742	Homo sapiens	INH	%	0.1
	5249854	CHEMBL1687363	inhibition of FGFR3	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	IC50	nM	21.5	CHEMBL2742	Homo sapiens	IC50	nM	21.5
Active	6155966	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(I)nc3[nH]cnc23)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1		CHEMBL1760286		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155967	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(NCCN3CCOCC3)nc3[nH]cnc23)[C@@H](O)[C@@H]1O		CHEMBL1760295		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155968	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	COc1ccc(CCNc2nc(NC[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)c3nc[nH]c3n2)cc1OC		CHEMBL1760294		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155969	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(NCCc3ccccc3)nc3[nH]cnc23)[C@@H](O)[C@@H]1O		CHEMBL1760293		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155970	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(NCCN3CCOCC3)c3nc[nH]c3n2)[C@@H](O)[C@@H]1O		CHEMBL1760292		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155971	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	COc1ccc(CCNc2nc(NC[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)nc3[nH]cnc23)cc1OC		CHEMBL1760291		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155972	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(NCCc3ccccc3)c3nc[nH]c3n2)[C@@H](O)[C@@H]1O		CHEMBL1760290		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155973	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(NCCc3ccccc3)c3nc[nH]c3n2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1		CHEMBL1760289		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155974	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	OC[C@H]1O[C@@H](CNc2nc(NCCc3ccccc3)nc3[nH]cnc23)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1		CHEMBL1760288		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	6155975	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	Ic1nc(NCCN2CCOCC2)c2nc[nH]c2n1		CHEMBL1760287		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	6155976	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	Nc1ncc2ncn(C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		CHEMBL1760296		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	6155977	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	CCN(CC)CCCNc1nc(Nc2ccccc2)c2ncn(C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		CHEMBL1760301		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	6155978	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	Nc1nc(Nc2ccccc2)c2ncn(C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		CHEMBL1760300		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	6155979	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	CCN(CC)CCCNc1nc(N)c2ncn(C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		CHEMBL1760299		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	6155980	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	Nc1nc(N)c2ncn(C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		CHEMBL1760298		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	6155981	CHEMBL1764158	Inhibition of FGFR3 at 50 uM	B	Nc1ncnc2c1ncn2C[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1760297		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	6167563	CHEMBL1769036	Binding affinity to human Fgfr3 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	6167579	CHEMBL1769053	Binding affinity to human Fgfr3 assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	97.0	CHEMBL2742	Homo sapiens	Activity	%	97.0
	6196677	CHEMBL1776847	Inhibition of human FGFR3	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2F)n[nH]1		CHEMBL1774056	=	IC50	nM	115.0	CHEMBL2742	Homo sapiens	IC50	uM	0.115
	6212360	CHEMBL1785930	Inhibition of FGFR3 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	=	IC50	nM	4600.0	CHEMBL2742	Homo sapiens	IC50	uM	4.6
	6219894	CHEMBL1785582	Inhibition of human FGFR3 using poly[Glu:Tyr] peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	10.5	CHEMBL2742	Homo sapiens	IC50	nM	10.5
	6265546	CHEMBL1798255	Inhibition of FGFR3 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2742	Homo sapiens	INH	%	65.0
	6265650	CHEMBL1798255	Inhibition of FGFR3 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	Inhibition	%	100.0	CHEMBL2742	Homo sapiens	INH	%	100.0
	6281544	CHEMBL1804197	Inhibition of human FGFR3	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	50.0	CHEMBL2742	Homo sapiens	IC50	nM	50.0
	6340023	CHEMBL1826928	Activity of FGFR3 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	89.0	CHEMBL2742	Homo sapiens	Activity	%	89.0
	6341060	CHEMBL1828229	Activity of FGFR3 G697C mutant kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	6386432	CHEMBL1838073	Inhibition of FGFR3 K650E mutant-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	52.2	CHEMBL2742	Homo sapiens	IC50	nM	52.2
	6386433	CHEMBL1838072	Inhibition of FGFR3 juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	0.7	CHEMBL2742	Homo sapiens	IC50	nM	0.7
	6386434	CHEMBL1838071	Inhibition of FGFR3-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2.0	CHEMBL2742	Homo sapiens	IC50	nM	2.0
	6386436	CHEMBL1838069	Inhibition of FGFR3 S249C mutant expressed in HEK293 cells assessed as inhibition of autophosphorylation of tyrosine residue after 40 mins by ELISA assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	5.0	CHEMBL2742	Homo sapiens	IC50	nM	5.0
	6386437	CHEMBL1838068	Inhibition of FGFR3 K650E mutant expressed in HEK293 cells assessed as inhibition of autophosphorylation of tyrosine residue after 40 mins by ELISA assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	5.0	CHEMBL2742	Homo sapiens	IC50	nM	5.0
	6386464	CHEMBL1837844	Inhibition of recombinant FGFR3 K650E mutant	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	4.9	CHEMBL2742	Homo sapiens	IC50	uM	0.0049
	6386465	CHEMBL1837843	Inhibition of recombinant FGFR3	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	uM	0.001
	6387456	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3cccc(CN(C)C)c3)ncn2)c1Cl		CHEMBL1834663	=	IC50	nM	19.0	CHEMBL2742	Homo sapiens	IC50	nM	19.0
	6387457	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3cccc(CN4CCN(C)CC4)c3)ncn2)c1Cl		CHEMBL1834662	=	IC50	nM	20.0	CHEMBL2742	Homo sapiens	IC50	nM	20.0
	6387458	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	CCN1CCC(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1834661	=	IC50	nM	7.0	CHEMBL2742	Homo sapiens	IC50	nM	7.0
	6387459	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(CCCN(C)C)cc3)ncn2)c1Cl		CHEMBL1834660	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
	6387460	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl		CHEMBL1834659	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
	6387461	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3cccc(N4CCN(C)CC4)c3)ncn2)c1Cl		CHEMBL1834658	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
	6387462	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	5.0	CHEMBL2742	Homo sapiens	IC50	nM	5.0
	6387463	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1ccc(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1Cl		CHEMBL1834656	=	IC50	nM	54.0	CHEMBL2742	Homo sapiens	IC50	nM	54.0
	6387464	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1ccc(Cl)c(NC(=O)Nc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1Cl		CHEMBL1834655	=	IC50	nM	51.0	CHEMBL2742	Homo sapiens	IC50	nM	51.0
	6387465	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1ccc(Cl)c(NC(=O)Nc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1		CHEMBL1834654	=	IC50	nM	840.0	CHEMBL2742	Homo sapiens	IC50	nM	840.0
	6387466	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	CCN(C(=O)Nc1cc(OC)cc(OC)c1Cl)c1cc(Nc2ccc(N3CCN(C)CC3)cc2)ncn1		CHEMBL1833981	=	IC50	nM	115.0	CHEMBL2742	Homo sapiens	IC50	nM	115.0
	6387467	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(Cl)c(OC)c1		CHEMBL1834653	=	IC50	nM	66.0	CHEMBL2742	Homo sapiens	IC50	nM	66.0
	6387468	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(NC(=O)N(C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(Cl)c(OC)c1		CHEMBL1834603	=	IC50	nM	125.0	CHEMBL2742	Homo sapiens	IC50	nM	125.0
	6387469	CHEMBL1837639	Inhibition of GST-fusion FGFR3 K650E mutant using [gamma33P]ATP as substrate after 10 mins by scintillation counting	B	COc1cc(NC(=O)N(C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc(OC)c1		CHEMBL1834602	=	IC50	nM	505.0	CHEMBL2742	Homo sapiens	IC50	nM	505.0
	7567176	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	23.0	CHEMBL2742	Homo sapiens	Kd	nM	23.0
	7567177	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	35.0	CHEMBL2742	Homo sapiens	Kd	nM	35.0
	7567635	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7567636	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7568106	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7568107	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7568574	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	5200.0	CHEMBL2742	Homo sapiens	Kd	nM	5200.0
	7568575	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7569006	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	290.0	CHEMBL2742	Homo sapiens	Kd	nM	290.0
	7569007	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1400.0	CHEMBL2742	Homo sapiens	Kd	nM	1400.0
	7569149	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7569150	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7569609	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2700.0	CHEMBL2742	Homo sapiens	Kd	nM	2700.0
	7569610	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	3500.0	CHEMBL2742	Homo sapiens	Kd	nM	3500.0
	7570081	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7570082	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7571125	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7571126	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7571582	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3900.0	CHEMBL2742	Homo sapiens	Kd	nM	3900.0
	7571583	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7572058	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1100.0	CHEMBL2742	Homo sapiens	Kd	nM	1100.0
	7572059	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1600.0	CHEMBL2742	Homo sapiens	Kd	nM	1600.0
	7572079	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7572080	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7572495	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	95.0	CHEMBL2742	Homo sapiens	Kd	nM	95.0
	7572496	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	120.0	CHEMBL2742	Homo sapiens	Kd	nM	120.0
	7573106	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	93.0	CHEMBL2742	Homo sapiens	Kd	nM	93.0
	7573107	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	140.0	CHEMBL2742	Homo sapiens	Kd	nM	140.0
	7573563	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7573564	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7574066	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1700.0	CHEMBL2742	Homo sapiens	Kd	nM	1700.0
	7574067	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7574474	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7574475	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7575084	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7575085	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7575574	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7575575	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7576039	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7576040	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7576447	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	360.0	CHEMBL2742	Homo sapiens	Kd	nM	360.0
	7576448	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	760.0	CHEMBL2742	Homo sapiens	Kd	nM	760.0
	7577058	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7577075	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	910.0	CHEMBL2742	Homo sapiens	Kd	nM	910.0
	7577076	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1600.0	CHEMBL2742	Homo sapiens	Kd	nM	1600.0
	7577553	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1200.0	CHEMBL2742	Homo sapiens	Kd	nM	1200.0
	7577554	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	280.0	CHEMBL2742	Homo sapiens	Kd	nM	280.0
	7578023	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	660.0	CHEMBL2742	Homo sapiens	Kd	nM	660.0
	7578024	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	770.0	CHEMBL2742	Homo sapiens	Kd	nM	770.0
	7578428	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1600.0	CHEMBL2742	Homo sapiens	Kd	nM	1600.0
	7578429	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	6900.0	CHEMBL2742	Homo sapiens	Kd	nM	6900.0
	7578624	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7578625	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7578999	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7579448	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7579449	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7579922	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7579923	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7580391	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7580392	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7580794	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	860.0	CHEMBL2742	Homo sapiens	Kd	nM	860.0
	7580795	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	820.0	CHEMBL2742	Homo sapiens	Kd	nM	820.0
	7580982	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7580983	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7581367	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7581368	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7581812	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7581813	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7582283	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7582284	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7582747	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	56.0	CHEMBL2742	Homo sapiens	Kd	nM	56.0
	7582748	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	67.0	CHEMBL2742	Homo sapiens	Kd	nM	67.0
	7583147	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7583148	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7583328	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7583329	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7583725	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7583726	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7584170	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7584171	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7584641	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7584642	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7585103	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7585104	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7585658	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7585659	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7586066	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	160.0	CHEMBL2742	Homo sapiens	Kd	nM	160.0
	7586067	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	150.0	CHEMBL2742	Homo sapiens	Kd	nM	150.0
	7586512	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7586513	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7586983	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7586984	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7587619	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	210.0	CHEMBL2742	Homo sapiens	Kd	nM	210.0
	7587620	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	210.0	CHEMBL2742	Homo sapiens	Kd	nM	210.0
	7588038	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	580.0	CHEMBL2742	Homo sapiens	Kd	nM	580.0
	7588039	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	730.0	CHEMBL2742	Homo sapiens	Kd	nM	730.0
	7588491	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7588492	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7588971	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7588972	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7589584	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7589585	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7590008	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	230.0	CHEMBL2742	Homo sapiens	Kd	nM	230.0
	7590009	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	370.0	CHEMBL2742	Homo sapiens	Kd	nM	370.0
	7590475	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7590476	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7590507	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7590508	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7590958	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7590959	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7591557	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3900.0	CHEMBL2742	Homo sapiens	Kd	nM	3900.0
	7591558	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3000.0	CHEMBL2742	Homo sapiens	Kd	nM	3000.0
	7591979	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7591980	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7592482	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1200.0	CHEMBL2742	Homo sapiens	Kd	nM	1200.0
	7592483	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1300.0	CHEMBL2742	Homo sapiens	Kd	nM	1300.0
	7592935	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7592936	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7593524	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7593525	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7593989	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7593990	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7594462	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7594463	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7594914	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	4200.0	CHEMBL2742	Homo sapiens	Kd	nM	4200.0
	7594915	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	5900.0	CHEMBL2742	Homo sapiens	Kd	nM	5900.0
	7595494	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7595495	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7595968	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7595969	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7596439	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	740.0	CHEMBL2742	Homo sapiens	Kd	nM	740.0
	7596440	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	620.0	CHEMBL2742	Homo sapiens	Kd	nM	620.0
	7596886	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	88.0	CHEMBL2742	Homo sapiens	Kd	nM	88.0
	7596887	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	310.0	CHEMBL2742	Homo sapiens	Kd	nM	310.0
	7597022	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7597023	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7597475	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7597476	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7597948	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7597949	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2742	Homo sapiens	Kd	nM	10000.0
	7598418	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	48.0	CHEMBL2742	Homo sapiens	Kd	nM	48.0
	7598419	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	46.0	CHEMBL2742	Homo sapiens	Kd	nM	46.0
	7598860	CHEMBL1908479	Binding constant for FGFR3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	560.0	CHEMBL2742	Homo sapiens	Kd	nM	560.0
	7598861	CHEMBL1908480	Binding constant for FGFR3(G697C) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	380.0	CHEMBL2742	Homo sapiens	Kd	nM	380.0
	7943734	CHEMBL1921577	Inhibition of FGFR3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	14.71	CHEMBL2742	Homo sapiens	IC50	nM	14.71
	7943774	CHEMBL1921431	Inhibition of FGFR3 at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	7956221	CHEMBL1924840	Inhibition of N-terminus flag-tagged FGFR3 expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	7959769	CHEMBL1932859	Inhibition of FGFR3	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2742	Homo sapiens	IC50	uM	30.0
	7959770	CHEMBL1932859	Inhibition of FGFR3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2742	Homo sapiens	IC50	uM	30.0
	8013068	CHEMBL1947855	Inhibition of FGFR3 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	8013069	CHEMBL1947856	Inhibition of FGFR3 kinase domain using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	8047119	CHEMBL1958945	Inhibition of FGFR3 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	8059501	CHEMBL1958980	Inhibition of FGFR3	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	400.0	CHEMBL2742	Homo sapiens	Ki	uM	0.4
	8061557	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.85	CHEMBL2742	Homo sapiens	Inhibition	%	-2.85
	8061664	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.39	CHEMBL2742	Homo sapiens	Inhibition	%	4.39
	8061888	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.24	CHEMBL2742	Homo sapiens	Inhibition	%	0.24
	8062079	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	11.21	CHEMBL2742	Homo sapiens	Inhibition	%	11.21
	8062419	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	5.11	CHEMBL2742	Homo sapiens	Inhibition	%	5.11
	8062581	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.79	CHEMBL2742	Homo sapiens	Inhibition	%	1.79
	8062903	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.64	CHEMBL2742	Homo sapiens	Inhibition	%	0.64
	8063035	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.23	CHEMBL2742	Homo sapiens	Inhibition	%	0.23
	8063259	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	5.11	CHEMBL2742	Homo sapiens	Inhibition	%	5.11
	8063426	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.57	CHEMBL2742	Homo sapiens	Inhibition	%	2.57
	8063758	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.79	CHEMBL2742	Homo sapiens	Inhibition	%	2.79
	8063940	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	47.75	CHEMBL2742	Homo sapiens	Inhibition	%	47.75
	8064279	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.94	CHEMBL2742	Homo sapiens	Inhibition	%	1.94
	8064489	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.96	CHEMBL2742	Homo sapiens	Inhibition	%	-0.96
	8064851	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.32	CHEMBL2742	Homo sapiens	Inhibition	%	2.32
	8065017	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.12	CHEMBL2742	Homo sapiens	Inhibition	%	4.12
	8065357	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.9	CHEMBL2742	Homo sapiens	Inhibition	%	1.9
	8065532	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.74	CHEMBL2742	Homo sapiens	Inhibition	%	4.74
	8065756	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	7.93	CHEMBL2742	Homo sapiens	Inhibition	%	7.93
	8065871	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.5	CHEMBL2742	Homo sapiens	Inhibition	%	2.5
	8066081	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.96	CHEMBL2742	Homo sapiens	Inhibition	%	2.96
	8066441	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	13.2	CHEMBL2742	Homo sapiens	Inhibition	%	13.2
	8066607	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.8	CHEMBL2742	Homo sapiens	Inhibition	%	1.8
	8066831	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.95	CHEMBL2742	Homo sapiens	Inhibition	%	0.95
	8066955	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.36	CHEMBL2742	Homo sapiens	Inhibition	%	4.36
	8067354	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.85	CHEMBL2742	Homo sapiens	Inhibition	%	4.85
	8067475	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.54	CHEMBL2742	Homo sapiens	Inhibition	%	3.54
	8067685	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.24	CHEMBL2742	Homo sapiens	Inhibition	%	-0.24
	8067909	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.1	CHEMBL2742	Homo sapiens	Inhibition	%	2.1
	8068044	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	4.0	CHEMBL2742	Homo sapiens	Inhibition	%	4.0
	8068432	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.72	CHEMBL2742	Homo sapiens	Inhibition	%	2.72
	8068557	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.66	CHEMBL2742	Homo sapiens	Inhibition	%	2.66
	8068781	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.58	CHEMBL2742	Homo sapiens	Inhibition	%	1.58
	8068955	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.38	CHEMBL2742	Homo sapiens	Inhibition	%	4.38
	8069080	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.68	CHEMBL2742	Homo sapiens	Inhibition	%	5.68
	8069304	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.66	CHEMBL2742	Homo sapiens	Inhibition	%	2.66
	8069375	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	20.49	CHEMBL2742	Homo sapiens	Inhibition	%	20.49
	8069599	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	4.93	CHEMBL2742	Homo sapiens	Inhibition	%	4.93
	8069760	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	4.48	CHEMBL2742	Homo sapiens	Inhibition	%	4.48
	8070110	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.77	CHEMBL2742	Homo sapiens	Inhibition	%	2.77
	8070282	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.62	CHEMBL2742	Homo sapiens	Inhibition	%	4.62
	8070631	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.55	CHEMBL2742	Homo sapiens	Inhibition	%	3.55
	8070929	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	14.99	CHEMBL2742	Homo sapiens	Inhibition	%	14.99
	8071086	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.47	CHEMBL2742	Homo sapiens	Inhibition	%	1.47
	8071436	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.61	CHEMBL2742	Homo sapiens	Inhibition	%	1.61
	8071609	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.2	CHEMBL2742	Homo sapiens	Inhibition	%	5.2
	8071958	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.81	CHEMBL2742	Homo sapiens	Inhibition	%	1.81
	8072272	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.57	CHEMBL2742	Homo sapiens	Inhibition	%	0.57
	8072429	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.97	CHEMBL2742	Homo sapiens	Inhibition	%	0.97
	8072653	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	5.75	CHEMBL2742	Homo sapiens	Inhibition	%	5.75
	8072778	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.89	CHEMBL2742	Homo sapiens	Inhibition	%	4.89
	8072945	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.29	CHEMBL2742	Homo sapiens	Inhibition	%	6.29
	8073169	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	7.26	CHEMBL2742	Homo sapiens	Inhibition	%	7.26
	8073294	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	5.73	CHEMBL2742	Homo sapiens	Inhibition	%	5.73
	8073637	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.04	CHEMBL2742	Homo sapiens	Inhibition	%	4.04
	8073870	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.54	CHEMBL2742	Homo sapiens	Inhibition	%	1.54
	8074246	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.54	CHEMBL2742	Homo sapiens	Inhibition	%	3.54
	8074376	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.53	CHEMBL2742	Homo sapiens	Inhibition	%	1.53
	8074757	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.66	CHEMBL2742	Homo sapiens	Inhibition	%	3.66
	8074884	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	11.54	CHEMBL2742	Homo sapiens	Inhibition	%	11.54
	8075108	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.3	CHEMBL2742	Homo sapiens	Inhibition	%	0.3
	8075219	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	26.51	CHEMBL2742	Homo sapiens	Inhibition	%	26.51
	8075456	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.14	CHEMBL2742	Homo sapiens	Inhibition	%	-2.14
	8075821	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	6.79	CHEMBL2742	Homo sapiens	Inhibition	%	6.79
	8075963	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	8.98	CHEMBL2742	Homo sapiens	Inhibition	%	8.98
	8076187	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.12	CHEMBL2742	Homo sapiens	Inhibition	%	0.12
	8076335	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.8	CHEMBL2742	Homo sapiens	Inhibition	%	3.8
	8076693	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.87	CHEMBL2742	Homo sapiens	Inhibition	%	0.87
	8076795	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.86	CHEMBL2742	Homo sapiens	Inhibition	%	0.86
	8077019	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.18	CHEMBL2742	Homo sapiens	Inhibition	%	2.18
	8077042	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.76	CHEMBL2742	Homo sapiens	Inhibition	%	-0.76
	8077266	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.56	CHEMBL2742	Homo sapiens	Inhibition	%	-1.56
	8077394	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	24.82	CHEMBL2742	Homo sapiens	Inhibition	%	24.82
	8077769	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	3.58	CHEMBL2742	Homo sapiens	Inhibition	%	3.58
	8077912	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.83	CHEMBL2742	Homo sapiens	Inhibition	%	2.83
	8078275	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	1.11	CHEMBL2742	Homo sapiens	Inhibition	%	1.11
	8078601	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	3.1	CHEMBL2742	Homo sapiens	Inhibition	%	3.1
	8078851	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.33	CHEMBL2742	Homo sapiens	Inhibition	%	-0.33
	8078967	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.6	CHEMBL2742	Homo sapiens	Inhibition	%	2.6
	8079191	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.98	CHEMBL2742	Homo sapiens	Inhibition	%	3.98
	8079349	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.92	CHEMBL2742	Homo sapiens	Inhibition	%	0.92
	8079491	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.85	CHEMBL2742	Homo sapiens	Inhibition	%	2.85
	8079715	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.41	CHEMBL2742	Homo sapiens	Inhibition	%	3.41
	8079854	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.58	CHEMBL2742	Homo sapiens	Inhibition	%	8.58
	8080183	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.75	CHEMBL2742	Homo sapiens	Inhibition	%	2.75
	8080435	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.1	CHEMBL2742	Homo sapiens	Inhibition	%	0.1
	8080774	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.63	CHEMBL2742	Homo sapiens	Inhibition	%	1.63
	8080938	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	6.57	CHEMBL2742	Homo sapiens	Inhibition	%	6.57
	8081297	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.82	CHEMBL2742	Homo sapiens	Inhibition	%	2.82
	8081441	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.99	CHEMBL2742	Homo sapiens	Inhibition	%	3.99
	8081768	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.37	CHEMBL2742	Homo sapiens	Inhibition	%	4.37
	8082020	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	10.81	CHEMBL2742	Homo sapiens	Inhibition	%	10.81
	8082357	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.3	CHEMBL2742	Homo sapiens	Inhibition	%	2.3
	8082530	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.25	CHEMBL2742	Homo sapiens	Inhibition	%	-3.25
	8082877	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.29	CHEMBL2742	Homo sapiens	Inhibition	%	3.29
	8083033	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.74	CHEMBL2742	Homo sapiens	Inhibition	%	1.74
	8083257	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.75	CHEMBL2742	Homo sapiens	Inhibition	%	4.75
	8083356	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	21.31	CHEMBL2742	Homo sapiens	Inhibition	%	21.31
	8083610	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.79	CHEMBL2742	Homo sapiens	Inhibition	%	-2.79
	8083944	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.51	CHEMBL2742	Homo sapiens	Inhibition	%	3.51
	8084129	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.53	CHEMBL2742	Homo sapiens	Inhibition	%	-1.53
	8084353	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	26.11	CHEMBL2742	Homo sapiens	Inhibition	%	26.11
	8084471	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.04	CHEMBL2742	Homo sapiens	Inhibition	%	3.04
	8084856	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.37	CHEMBL2742	Homo sapiens	Inhibition	%	5.37
	8084954	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.56	CHEMBL2742	Homo sapiens	Inhibition	%	1.56
	8085178	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.41	CHEMBL2742	Homo sapiens	Inhibition	%	2.41
	8085210	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.23	CHEMBL2742	Homo sapiens	Inhibition	%	-2.23
	8085434	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.23	CHEMBL2742	Homo sapiens	Inhibition	%	-3.23
	8085542	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.31	CHEMBL2742	Homo sapiens	Inhibition	%	4.31
	8085955	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	70.68	CHEMBL2742	Homo sapiens	Inhibition	%	70.68
	8086070	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.39	CHEMBL2742	Homo sapiens	Inhibition	%	4.39
	8086294	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.14	CHEMBL2742	Homo sapiens	Inhibition	%	4.14
	8086456	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.48	CHEMBL2742	Homo sapiens	Inhibition	%	1.48
	8086779	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.49	CHEMBL2742	Homo sapiens	Inhibition	%	0.49
	8086990	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.62	CHEMBL2742	Homo sapiens	Inhibition	%	5.62
	8087148	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.62	CHEMBL2742	Homo sapiens	Inhibition	%	6.62
	8087372	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.42	CHEMBL2742	Homo sapiens	Inhibition	%	2.42
	8087486	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	54.72	CHEMBL2742	Homo sapiens	Inhibition	%	54.72
	8087848	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.58	CHEMBL2742	Homo sapiens	Inhibition	%	2.58
	8087990	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	12.34	CHEMBL2742	Homo sapiens	Inhibition	%	12.34
	8088214	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.38	CHEMBL2742	Homo sapiens	Inhibition	%	7.38
	8088362	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.12	CHEMBL2742	Homo sapiens	Inhibition	%	-0.12
	8088714	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.87	CHEMBL2742	Homo sapiens	Inhibition	%	6.87
	8088807	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.45	CHEMBL2742	Homo sapiens	Inhibition	%	2.45
	8089031	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.35	CHEMBL2742	Homo sapiens	Inhibition	%	2.35
	8089159	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.52	CHEMBL2742	Homo sapiens	Inhibition	%	0.52
	8089531	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.36	CHEMBL2742	Homo sapiens	Inhibition	%	3.36
	8089651	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.5	CHEMBL2742	Homo sapiens	Inhibition	%	2.5
	8090055	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.74	CHEMBL2742	Homo sapiens	Inhibition	%	1.74
	8090220	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	7.88	CHEMBL2742	Homo sapiens	Inhibition	%	7.88
	8090611	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.35	CHEMBL2742	Homo sapiens	Inhibition	%	6.35
	8090750	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.74	CHEMBL2742	Homo sapiens	Inhibition	%	5.74
	8091179	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.56	CHEMBL2742	Homo sapiens	Inhibition	%	4.56
	8091316	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.39	CHEMBL2742	Homo sapiens	Inhibition	%	1.39
	8091695	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.89	CHEMBL2742	Homo sapiens	Inhibition	%	2.89
	8091811	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	6.19	CHEMBL2742	Homo sapiens	Inhibition	%	6.19
	8092035	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	13.12	CHEMBL2742	Homo sapiens	Inhibition	%	13.12
	8092172	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.57	CHEMBL2742	Homo sapiens	Inhibition	%	-1.57
	8092547	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.0	CHEMBL2742	Homo sapiens	Inhibition	%	6.0
	8092695	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	8.3	CHEMBL2742	Homo sapiens	Inhibition	%	8.3
	8093048	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	24.27	CHEMBL2742	Homo sapiens	Inhibition	%	24.27
	8093360	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.01	CHEMBL2742	Homo sapiens	Inhibition	%	2.01
	8093500	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.96	CHEMBL2742	Homo sapiens	Inhibition	%	0.96
	8093863	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%		CHEMBL2742	Homo sapiens	Inhibition	%	
	8093983	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	6.65	CHEMBL2742	Homo sapiens	Inhibition	%	6.65
	8094207	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	32.38	CHEMBL2742	Homo sapiens	Inhibition	%	32.38
	8094387	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.36	CHEMBL2742	Homo sapiens	Inhibition	%	-0.36
	8094562	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.19	CHEMBL2742	Homo sapiens	Inhibition	%	3.19
	8094786	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.85	CHEMBL2742	Homo sapiens	Inhibition	%	7.85
	8094942	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.45	CHEMBL2742	Homo sapiens	Inhibition	%	4.45
	8095082	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.87	CHEMBL2742	Homo sapiens	Inhibition	%	3.87
	8095306	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	23.29	CHEMBL2742	Homo sapiens	Inhibition	%	23.29
	8095509	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.89	CHEMBL2742	Homo sapiens	Inhibition	%	3.89
	8095650	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.92	CHEMBL2742	Homo sapiens	Inhibition	%	6.92
	8095874	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.81	CHEMBL2742	Homo sapiens	Inhibition	%	6.81
	8096022	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.3	CHEMBL2742	Homo sapiens	Inhibition	%	3.3
	8096363	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.99	CHEMBL2742	Homo sapiens	Inhibition	%	6.99
	8096502	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-4.55	CHEMBL2742	Homo sapiens	Inhibition	%	-4.55
	8096882	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.34	CHEMBL2742	Homo sapiens	Inhibition	%	6.34
	8097029	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.4	CHEMBL2742	Homo sapiens	Inhibition	%	0.4
	8097253	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	6.81	CHEMBL2742	Homo sapiens	Inhibition	%	6.81
	8097340	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.59	CHEMBL2742	Homo sapiens	Inhibition	%	4.59
	8097560	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.53	CHEMBL2742	Homo sapiens	Inhibition	%	1.53
	8097710	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.33	CHEMBL2742	Homo sapiens	Inhibition	%	-1.33
	8097934	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.5	CHEMBL2742	Homo sapiens	Inhibition	%	-0.5
	8098067	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.47	CHEMBL2742	Homo sapiens	Inhibition	%	-1.47
	8098411	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.31	CHEMBL2742	Homo sapiens	Inhibition	%	-1.31
	8098591	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.17	CHEMBL2742	Homo sapiens	Inhibition	%	3.17
	8099000	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.24	CHEMBL2742	Homo sapiens	Inhibition	%	3.24
	8099144	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.11	CHEMBL2742	Homo sapiens	Inhibition	%	5.11
	8099510	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.58	CHEMBL2742	Homo sapiens	Inhibition	%	2.58
	8099704	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.76	CHEMBL2742	Homo sapiens	Inhibition	%	1.76
	8100075	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.56	CHEMBL2742	Homo sapiens	Inhibition	%	9.56
	8100221	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.13	CHEMBL2742	Homo sapiens	Inhibition	%	3.13
	8100561	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.98	CHEMBL2742	Homo sapiens	Inhibition	%	7.98
	8100701	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.22	CHEMBL2742	Homo sapiens	Inhibition	%	-0.22
	8100925	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.23	CHEMBL2742	Homo sapiens	Inhibition	%	3.23
	8101085	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	7.66	CHEMBL2742	Homo sapiens	Inhibition	%	7.66
	8101451	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.69	CHEMBL2742	Homo sapiens	Inhibition	%	1.69
	8101636	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.57	CHEMBL2742	Homo sapiens	Inhibition	%	1.57
	8101889	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.63	CHEMBL2742	Homo sapiens	Inhibition	%	4.63
	8102268	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-3.38	CHEMBL2742	Homo sapiens	Inhibition	%	-3.38
	8102399	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	11.9	CHEMBL2742	Homo sapiens	Inhibition	%	11.9
	8102743	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.24	CHEMBL2742	Homo sapiens	Inhibition	%	0.24
	8102921	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.01	CHEMBL2742	Homo sapiens	Inhibition	%	2.01
	8103145	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	7.69	CHEMBL2742	Homo sapiens	Inhibition	%	7.69
	8103341	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	9.04	CHEMBL2742	Homo sapiens	Inhibition	%	9.04
	8103479	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.99	CHEMBL2742	Homo sapiens	Inhibition	%	3.99
	8103703	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	4.22	CHEMBL2742	Homo sapiens	Inhibition	%	4.22
	8103853	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.41	CHEMBL2742	Homo sapiens	Inhibition	%	6.41
	8104038	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.06	CHEMBL2742	Homo sapiens	Inhibition	%	1.06
	8104410	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.72	CHEMBL2742	Homo sapiens	Inhibition	%	6.72
	8104556	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.63	CHEMBL2742	Homo sapiens	Inhibition	%	-0.63
	8104780	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	10.1	CHEMBL2742	Homo sapiens	Inhibition	%	10.1
	8104894	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.14	CHEMBL2742	Homo sapiens	Inhibition	%	3.14
	8105258	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.88	CHEMBL2742	Homo sapiens	Inhibition	%	0.88
	8105424	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	7.43	CHEMBL2742	Homo sapiens	Inhibition	%	7.43
	8105786	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	16.62	CHEMBL2742	Homo sapiens	Inhibition	%	16.62
	8106066	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.66	CHEMBL2742	Homo sapiens	Inhibition	%	4.66
	8106231	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	8.05	CHEMBL2742	Homo sapiens	Inhibition	%	8.05
	8106611	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	4.68	CHEMBL2742	Homo sapiens	Inhibition	%	4.68
	8106740	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	18.39	CHEMBL2742	Homo sapiens	Inhibition	%	18.39
	8106964	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	59.51	CHEMBL2742	Homo sapiens	Inhibition	%	59.51
	8107085	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.88	CHEMBL2742	Homo sapiens	Inhibition	%	-0.88
	8107481	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.69	CHEMBL2742	Homo sapiens	Inhibition	%	1.69
	8107682	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.32	CHEMBL2742	Homo sapiens	Inhibition	%	3.32
	8108041	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	9.81	CHEMBL2742	Homo sapiens	Inhibition	%	9.81
	8108199	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.02	CHEMBL2742	Homo sapiens	Inhibition	%	2.02
	8108374	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.97	CHEMBL2742	Homo sapiens	Inhibition	%	2.97
	8108598	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.72	CHEMBL2742	Homo sapiens	Inhibition	%	2.72
	8108745	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	11.16	CHEMBL2742	Homo sapiens	Inhibition	%	11.16
	8109111	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.41	CHEMBL2742	Homo sapiens	Inhibition	%	0.41
	8109225	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.22	CHEMBL2742	Homo sapiens	Inhibition	%	5.22
	8109449	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.67	CHEMBL2742	Homo sapiens	Inhibition	%	5.67
	8109579	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.04	CHEMBL2742	Homo sapiens	Inhibition	%	-0.04
	8109750	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.86	CHEMBL2742	Homo sapiens	Inhibition	%	4.86
	8109974	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.86	CHEMBL2742	Homo sapiens	Inhibition	%	9.86
	8110106	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.91	CHEMBL2742	Homo sapiens	Inhibition	%	1.91
	8110385	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.53	CHEMBL2742	Homo sapiens	Inhibition	%	5.53
	8110551	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.5	CHEMBL2742	Homo sapiens	Inhibition	%	-1.5
	8110775	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.97	CHEMBL2742	Homo sapiens	Inhibition	%	-0.97
	8110933	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-4.55	CHEMBL2742	Homo sapiens	Inhibition	%	-4.55
	8111280	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.09	CHEMBL2742	Homo sapiens	Inhibition	%	3.09
	8111407	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.39	CHEMBL2742	Homo sapiens	Inhibition	%	0.39
	8111631	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-3.24	CHEMBL2742	Homo sapiens	Inhibition	%	-3.24
	8111797	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.38	CHEMBL2742	Homo sapiens	Inhibition	%	2.38
	8112002	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.68	CHEMBL2742	Homo sapiens	Inhibition	%	6.68
	8112363	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.89	CHEMBL2742	Homo sapiens	Inhibition	%	1.89
	8112531	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.23	CHEMBL2742	Homo sapiens	Inhibition	%	7.23
	8112927	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.09	CHEMBL2742	Homo sapiens	Inhibition	%	2.09
	8113079	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.71	CHEMBL2742	Homo sapiens	Inhibition	%	8.71
	8113439	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.24	CHEMBL2742	Homo sapiens	Inhibition	%	6.24
	8113787	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.68	CHEMBL2742	Homo sapiens	Inhibition	%	6.68
	8113903	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.2	CHEMBL2742	Homo sapiens	Inhibition	%	-1.2
	8114303	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	9.13	CHEMBL2742	Homo sapiens	Inhibition	%	9.13
	8114435	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	10.2	CHEMBL2742	Homo sapiens	Inhibition	%	10.2
	8114711	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.11	CHEMBL2742	Homo sapiens	Inhibition	%	4.11
	8115101	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.93	CHEMBL2742	Homo sapiens	Inhibition	%	6.93
	8115266	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-3.83	CHEMBL2742	Homo sapiens	Inhibition	%	-3.83
	8115610	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	6.95	CHEMBL2742	Homo sapiens	Inhibition	%	6.95
	8115967	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.67	CHEMBL2742	Homo sapiens	Inhibition	%	0.67
	8116126	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	4.13	CHEMBL2742	Homo sapiens	Inhibition	%	4.13
	8116329	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.17	CHEMBL2742	Homo sapiens	Inhibition	%	4.17
	8116553	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.92	CHEMBL2742	Homo sapiens	Inhibition	%	7.92
	8116687	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.0	CHEMBL2742	Homo sapiens	Inhibition	%	2.0
	8116859	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.12	CHEMBL2742	Homo sapiens	Inhibition	%	6.12
	8117083	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	23.31	CHEMBL2742	Homo sapiens	Inhibition	%	23.31
	8117254	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.53	CHEMBL2742	Homo sapiens	Inhibition	%	3.53
	8117412	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.79	CHEMBL2742	Homo sapiens	Inhibition	%	7.79
	8117636	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.95	CHEMBL2742	Homo sapiens	Inhibition	%	3.95
	8117766	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.05	CHEMBL2742	Homo sapiens	Inhibition	%	2.05
	8118128	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.74	CHEMBL2742	Homo sapiens	Inhibition	%	0.74
	8118244	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.28	CHEMBL2742	Homo sapiens	Inhibition	%	-1.28
	8118468	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.11	CHEMBL2742	Homo sapiens	Inhibition	%	5.11
	8118640	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	10.66	CHEMBL2742	Homo sapiens	Inhibition	%	10.66
	8118776	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.53	CHEMBL2742	Homo sapiens	Inhibition	%	5.53
	8119000	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.9	CHEMBL2742	Homo sapiens	Inhibition	%	5.9
	8119047	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.7	CHEMBL2742	Homo sapiens	Inhibition	%	4.7
	8119271	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.37	CHEMBL2742	Homo sapiens	Inhibition	%	2.37
	8119430	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	34.29	CHEMBL2742	Homo sapiens	Inhibition	%	34.29
	8119597	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.4	CHEMBL2742	Homo sapiens	Inhibition	%	-1.4
	8119821	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.39	CHEMBL2742	Homo sapiens	Inhibition	%	-2.39
	8119940	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.17	CHEMBL2742	Homo sapiens	Inhibition	%	2.17
	8120303	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.98	CHEMBL2742	Homo sapiens	Inhibition	%	-1.98
	8120463	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	5.3	CHEMBL2742	Homo sapiens	Inhibition	%	5.3
	8120888	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.73	CHEMBL2742	Homo sapiens	Inhibition	%	2.73
	8121016	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.14	CHEMBL2742	Homo sapiens	Inhibition	%	1.14
	8121412	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.73	CHEMBL2742	Homo sapiens	Inhibition	%	1.73
	8121579	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	6.3	CHEMBL2742	Homo sapiens	Inhibition	%	6.3
	8121966	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.69	CHEMBL2742	Homo sapiens	Inhibition	%	5.69
	8122087	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.98	CHEMBL2742	Homo sapiens	Inhibition	%	4.98
	8122311	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.4	CHEMBL2742	Homo sapiens	Inhibition	%	1.4
	8122449	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.67	CHEMBL2742	Homo sapiens	Inhibition	%	2.67
	8122793	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.87	CHEMBL2742	Homo sapiens	Inhibition	%	6.87
	8122960	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	13.75	CHEMBL2742	Homo sapiens	Inhibition	%	13.75
	8123326	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	6.21	CHEMBL2742	Homo sapiens	Inhibition	%	6.21
	8123604	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.03	CHEMBL2742	Homo sapiens	Inhibition	%	1.03
	8123754	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.91	CHEMBL2742	Homo sapiens	Inhibition	%	2.91
	8124145	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.58	CHEMBL2742	Homo sapiens	Inhibition	%	-3.58
	8124264	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.26	CHEMBL2742	Homo sapiens	Inhibition	%	4.26
	8124488	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.93	CHEMBL2742	Homo sapiens	Inhibition	%	0.93
	8124627	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.0	CHEMBL2742	Homo sapiens	Inhibition	%	1.0
	8124792	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.4	CHEMBL2742	Homo sapiens	Inhibition	%	0.4
	8125016	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.43	CHEMBL2742	Homo sapiens	Inhibition	%	0.43
	8125217	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.97	CHEMBL2742	Homo sapiens	Inhibition	%	7.97
	8125347	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.91	CHEMBL2742	Homo sapiens	Inhibition	%	3.91
	8125571	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.05	CHEMBL2742	Homo sapiens	Inhibition	%	0.05
	8125739	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.73	CHEMBL2742	Homo sapiens	Inhibition	%	0.73
	8125903	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	19.23	CHEMBL2742	Homo sapiens	Inhibition	%	19.23
	8126127	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.59	CHEMBL2742	Homo sapiens	Inhibition	%	-0.59
	8126291	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.87	CHEMBL2742	Homo sapiens	Inhibition	%	4.87
	8126630	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	17.9	CHEMBL2742	Homo sapiens	Inhibition	%	17.9
	8126766	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	17.15	CHEMBL2742	Homo sapiens	Inhibition	%	17.15
	8127112	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.61	CHEMBL2742	Homo sapiens	Inhibition	%	7.61
	8127279	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	14.77	CHEMBL2742	Homo sapiens	Inhibition	%	14.77
	8127503	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	52.85	CHEMBL2742	Homo sapiens	Inhibition	%	52.85
	8127645	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	18.25	CHEMBL2742	Homo sapiens	Inhibition	%	18.25
	8127933	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.25	CHEMBL2742	Homo sapiens	Inhibition	%	3.25
	8128085	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	7.58	CHEMBL2742	Homo sapiens	Inhibition	%	7.58
	8128309	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.74	CHEMBL2742	Homo sapiens	Inhibition	%	3.74
	8128476	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.63	CHEMBL2742	Homo sapiens	Inhibition	%	3.63
	8128819	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	10.92	CHEMBL2742	Homo sapiens	Inhibition	%	10.92
	8128956	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.22	CHEMBL2742	Homo sapiens	Inhibition	%	1.22
	8129351	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.69	CHEMBL2742	Homo sapiens	Inhibition	%	-1.69
	8129540	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.0	CHEMBL2742	Homo sapiens	Inhibition	%	5.0
	8129903	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.8	CHEMBL2742	Homo sapiens	Inhibition	%	1.8
	8130064	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.73	CHEMBL2742	Homo sapiens	Inhibition	%	3.73
	8130460	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.01	CHEMBL2742	Homo sapiens	Inhibition	%	2.01
	8130620	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.66	CHEMBL2742	Homo sapiens	Inhibition	%	2.66
	8130960	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.42	CHEMBL2742	Homo sapiens	Inhibition	%	2.42
	8131099	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	56.67	CHEMBL2742	Homo sapiens	Inhibition	%	56.67
	8131323	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.4	CHEMBL2742	Homo sapiens	Inhibition	%	6.4
	8131443	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.27	CHEMBL2742	Homo sapiens	Inhibition	%	5.27
	8131834	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	77.27	CHEMBL2742	Homo sapiens	Inhibition	%	77.27
	8131975	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	7.97	CHEMBL2742	Homo sapiens	Inhibition	%	7.97
	8132261	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.03	CHEMBL2742	Homo sapiens	Inhibition	%	3.03
	8132632	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.19	CHEMBL2742	Homo sapiens	Inhibition	%	3.19
	8132800	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.84	CHEMBL2742	Homo sapiens	Inhibition	%	0.84
	8133145	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.71	CHEMBL2742	Homo sapiens	Inhibition	%	-0.71
	8133283	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	14.53	CHEMBL2742	Homo sapiens	Inhibition	%	14.53
	8133507	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-1.19	CHEMBL2742	Homo sapiens	Inhibition	%	-1.19
	8133679	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.19	CHEMBL2742	Homo sapiens	Inhibition	%	-0.19
	8133859	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.9	CHEMBL2742	Homo sapiens	Inhibition	%	4.9
	8134231	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.11	CHEMBL2742	Homo sapiens	Inhibition	%	-0.11
	8134391	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.58	CHEMBL2742	Homo sapiens	Inhibition	%	2.58
	8134615	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.69	CHEMBL2742	Homo sapiens	Inhibition	%	2.69
	8134799	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.57	CHEMBL2742	Homo sapiens	Inhibition	%	1.57
	8134959	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.35	CHEMBL2742	Homo sapiens	Inhibition	%	5.35
	8135298	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.73	CHEMBL2742	Homo sapiens	Inhibition	%	2.73
	8135663	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.02	CHEMBL2742	Homo sapiens	Inhibition	%	8.02
	8135784	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.38	CHEMBL2742	Homo sapiens	Inhibition	%	4.38
	8136008	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.03	CHEMBL2742	Homo sapiens	Inhibition	%	5.03
	8136176	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.59	CHEMBL2742	Homo sapiens	Inhibition	%	4.59
	8136320	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	34.42	CHEMBL2742	Homo sapiens	Inhibition	%	34.42
	8136544	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.95	CHEMBL2742	Homo sapiens	Inhibition	%	6.95
	8136610	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.36	CHEMBL2742	Homo sapiens	Inhibition	%	-0.36
	8136969	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.17	CHEMBL2742	Homo sapiens	Inhibition	%	2.17
	8137132	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.98	CHEMBL2742	Homo sapiens	Inhibition	%	1.98
	8137356	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.74	CHEMBL2742	Homo sapiens	Inhibition	%	0.74
	8137476	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.67	CHEMBL2742	Homo sapiens	Inhibition	%	-0.67
	8137848	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.89	CHEMBL2742	Homo sapiens	Inhibition	%	1.89
	8138014	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.94	CHEMBL2742	Homo sapiens	Inhibition	%	-2.94
	8138193	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.11	CHEMBL2742	Homo sapiens	Inhibition	%	5.11
	8138417	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.91	CHEMBL2742	Homo sapiens	Inhibition	%	4.91
	8138565	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.94	CHEMBL2742	Homo sapiens	Inhibition	%	-2.94
	8138947	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.14	CHEMBL2742	Homo sapiens	Inhibition	%	5.14
	8139132	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	25.54	CHEMBL2742	Homo sapiens	Inhibition	%	25.54
	8139291	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.34	CHEMBL2742	Homo sapiens	Inhibition	%	5.34
	8139515	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.82	CHEMBL2742	Homo sapiens	Inhibition	%	4.82
	8139629	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.77	CHEMBL2742	Homo sapiens	Inhibition	%	4.77
	8139994	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.06	CHEMBL2742	Homo sapiens	Inhibition	%	8.06
	8140341	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	10.41	CHEMBL2742	Homo sapiens	Inhibition	%	10.41
	8140500	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.11	CHEMBL2742	Homo sapiens	Inhibition	%	5.11
	8140867	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.41	CHEMBL2742	Homo sapiens	Inhibition	%	9.41
	8140945	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.8	CHEMBL2742	Homo sapiens	Inhibition	%	-2.8
	8141169	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.52	CHEMBL2742	Homo sapiens	Inhibition	%	3.52
	8141299	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	14.11	CHEMBL2742	Homo sapiens	Inhibition	%	14.11
	8141683	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	8.88	CHEMBL2742	Homo sapiens	Inhibition	%	8.88
	8141802	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.67	CHEMBL2742	Homo sapiens	Inhibition	%	-2.67
	8142026	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.86	CHEMBL2742	Homo sapiens	Inhibition	%	-3.86
	8142187	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.94	CHEMBL2742	Homo sapiens	Inhibition	%	3.94
	8142355	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.6	CHEMBL2742	Homo sapiens	Inhibition	%	-1.6
	8142755	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.35	CHEMBL2742	Homo sapiens	Inhibition	%	4.35
	8142904	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.95	CHEMBL2742	Homo sapiens	Inhibition	%	-4.95
	8143283	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.12	CHEMBL2742	Homo sapiens	Inhibition	%	3.12
	8143470	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.43	CHEMBL2742	Homo sapiens	Inhibition	%	6.43
	8143853	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.84	CHEMBL2742	Homo sapiens	Inhibition	%	7.84
	8143967	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.71	CHEMBL2742	Homo sapiens	Inhibition	%	5.71
	8144191	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.3	CHEMBL2742	Homo sapiens	Inhibition	%	0.3
	8144330	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.32	CHEMBL2742	Homo sapiens	Inhibition	%	7.32
	8144684	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.63	CHEMBL2742	Homo sapiens	Inhibition	%	8.63
	8144837	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.56	CHEMBL2742	Homo sapiens	Inhibition	%	4.56
	8145198	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.36	CHEMBL2742	Homo sapiens	Inhibition	%	7.36
	8145511	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.84	CHEMBL2742	Homo sapiens	Inhibition	%	0.84
	8145635	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.13	CHEMBL2742	Homo sapiens	Inhibition	%	1.13
	8145859	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.83	CHEMBL2742	Homo sapiens	Inhibition	%	3.83
	8146020	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.14	CHEMBL2742	Homo sapiens	Inhibition	%	0.14
	8146364	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.1	CHEMBL2742	Homo sapiens	Inhibition	%	2.1
	8146524	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	12.58	CHEMBL2742	Homo sapiens	Inhibition	%	12.58
	8146691	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.95	CHEMBL2742	Homo sapiens	Inhibition	%	-0.95
	8146915	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.66	CHEMBL2742	Homo sapiens	Inhibition	%	0.66
	8147084	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.04	CHEMBL2742	Homo sapiens	Inhibition	%	6.04
	8147226	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.57	CHEMBL2742	Homo sapiens	Inhibition	%	-3.57
	8147450	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.31	CHEMBL2742	Homo sapiens	Inhibition	%	1.31
	8147603	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.49	CHEMBL2742	Homo sapiens	Inhibition	%	4.49
	8147790	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.73	CHEMBL2742	Homo sapiens	Inhibition	%	5.73
	8148014	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.03	CHEMBL2742	Homo sapiens	Inhibition	%	8.03
	8148172	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	6.97	CHEMBL2742	Homo sapiens	Inhibition	%	6.97
	8148510	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.62	CHEMBL2742	Homo sapiens	Inhibition	%	1.62
	8148649	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.32	CHEMBL2742	Homo sapiens	Inhibition	%	3.32
	8148873	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.86	CHEMBL2742	Homo sapiens	Inhibition	%	2.86
	8149011	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	11.02	CHEMBL2742	Homo sapiens	Inhibition	%	11.02
	8149170	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.99	CHEMBL2742	Homo sapiens	Inhibition	%	3.99
	8149394	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.19	CHEMBL2742	Homo sapiens	Inhibition	%	-1.19
	8149528	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.93	CHEMBL2742	Homo sapiens	Inhibition	%	6.93
	8149850	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.97	CHEMBL2742	Homo sapiens	Inhibition	%	2.97
	8150199	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.92	CHEMBL2742	Homo sapiens	Inhibition	%	-0.92
	8150359	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	5.59	CHEMBL2742	Homo sapiens	Inhibition	%	5.59
	8150703	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.77	CHEMBL2742	Homo sapiens	Inhibition	%	2.77
	8150868	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.66	CHEMBL2742	Homo sapiens	Inhibition	%	0.66
	8151255	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-5.18	CHEMBL2742	Homo sapiens	Inhibition	%	-5.18
	8151432	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.41	CHEMBL2742	Homo sapiens	Inhibition	%	4.41
	8151794	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.97	CHEMBL2742	Homo sapiens	Inhibition	%	2.97
	8151948	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.6	CHEMBL2742	Homo sapiens	Inhibition	%	2.6
	8152172	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.58	CHEMBL2742	Homo sapiens	Inhibition	%	4.58
	8152360	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.51	CHEMBL2742	Homo sapiens	Inhibition	%	5.51
	8152518	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.27	CHEMBL2742	Homo sapiens	Inhibition	%	7.27
	8152856	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	17.35	CHEMBL2742	Homo sapiens	Inhibition	%	17.35
	8153219	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.81	CHEMBL2742	Homo sapiens	Inhibition	%	3.81
	8153356	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.64	CHEMBL2742	Homo sapiens	Inhibition	%	6.64
	8153737	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.34	CHEMBL2742	Homo sapiens	Inhibition	%	-0.34
	8153870	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.0	CHEMBL2742	Homo sapiens	Inhibition	%	2.0
	8154094	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.02	CHEMBL2742	Homo sapiens	Inhibition	%	5.02
	8154191	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.24	CHEMBL2742	Homo sapiens	Inhibition	%	2.24
	8154541	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	7.51	CHEMBL2742	Homo sapiens	Inhibition	%	7.51
	8154700	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.87	CHEMBL2742	Homo sapiens	Inhibition	%	1.87
	8154924	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%		CHEMBL2742	Homo sapiens	Inhibition	%	
	8155044	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.44	CHEMBL2742	Homo sapiens	Inhibition	%	0.44
	8155220	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.61	CHEMBL2742	Homo sapiens	Inhibition	%	2.61
	8155444	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	6.31	CHEMBL2742	Homo sapiens	Inhibition	%	6.31
	8155605	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.28	CHEMBL2742	Homo sapiens	Inhibition	%	0.28
	8155783	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	6.71	CHEMBL2742	Homo sapiens	Inhibition	%	6.71
	8156007	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	11.03	CHEMBL2742	Homo sapiens	Inhibition	%	11.03
	8156145	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.18	CHEMBL2742	Homo sapiens	Inhibition	%	2.18
	8156357	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.62	CHEMBL2742	Homo sapiens	Inhibition	%	5.62
	8156731	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	59.99	CHEMBL2742	Homo sapiens	Inhibition	%	59.99
	8156874	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.08	CHEMBL2742	Homo sapiens	Inhibition	%	7.08
	8157098	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	11.19	CHEMBL2742	Homo sapiens	Inhibition	%	11.19
	8157218	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.62	CHEMBL2742	Homo sapiens	Inhibition	%	5.62
	8157583	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.25	CHEMBL2742	Homo sapiens	Inhibition	%	3.25
	8157713	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	6.31	CHEMBL2742	Homo sapiens	Inhibition	%	6.31
	8157937	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.26	CHEMBL2742	Homo sapiens	Inhibition	%	5.26
	8158098	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.98	CHEMBL2742	Homo sapiens	Inhibition	%	0.98
	8158348	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.07	CHEMBL2742	Homo sapiens	Inhibition	%	6.07
	8158506	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.97	CHEMBL2742	Homo sapiens	Inhibition	%	6.97
	8158730	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.11	CHEMBL2742	Homo sapiens	Inhibition	%	4.11
	8158899	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.51	CHEMBL2742	Homo sapiens	Inhibition	%	3.51
	8159258	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.89	CHEMBL2742	Homo sapiens	Inhibition	%	5.89
	8159378	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.77	CHEMBL2742	Homo sapiens	Inhibition	%	3.77
	8159602	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.37	CHEMBL2742	Homo sapiens	Inhibition	%	1.37
	8159733	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	13.37	CHEMBL2742	Homo sapiens	Inhibition	%	13.37
	8160098	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.25	CHEMBL2742	Homo sapiens	Inhibition	%	1.25
	8160235	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.63	CHEMBL2742	Homo sapiens	Inhibition	%	3.63
	8160609	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.35	CHEMBL2742	Homo sapiens	Inhibition	%	-0.35
	8160679	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.42	CHEMBL2742	Homo sapiens	Inhibition	%	5.42
	8160903	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.53	CHEMBL2742	Homo sapiens	Inhibition	%	5.53
	8161053	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	6.19	CHEMBL2742	Homo sapiens	Inhibition	%	6.19
	8161420	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.39	CHEMBL2742	Homo sapiens	Inhibition	%	6.39
	8161545	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	8.47	CHEMBL2742	Homo sapiens	Inhibition	%	8.47
	8161769	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.9	CHEMBL2742	Homo sapiens	Inhibition	%	2.9
	8161907	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.79	CHEMBL2742	Homo sapiens	Inhibition	%	4.79
	8162261	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.74	CHEMBL2742	Homo sapiens	Inhibition	%	3.74
	8162421	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.95	CHEMBL2742	Homo sapiens	Inhibition	%	-0.95
	8162674	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.72	CHEMBL2742	Homo sapiens	Inhibition	%	3.72
	8163046	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%		CHEMBL2742	Homo sapiens	Inhibition	%	
	8163215	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.02	CHEMBL2742	Homo sapiens	Inhibition	%	2.02
	8163573	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.62	CHEMBL2742	Homo sapiens	Inhibition	%	6.62
	8163920	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.47	CHEMBL2742	Homo sapiens	Inhibition	%	1.47
	8164054	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	5.86	CHEMBL2742	Homo sapiens	Inhibition	%	5.86
	8164418	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.59	CHEMBL2742	Homo sapiens	Inhibition	%	1.59
	8164573	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.45	CHEMBL2742	Homo sapiens	Inhibition	%	6.45
	8164941	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.39	CHEMBL2742	Homo sapiens	Inhibition	%	1.39
	8165235	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.55	CHEMBL2742	Homo sapiens	Inhibition	%	7.55
	8165376	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	10.27	CHEMBL2742	Homo sapiens	Inhibition	%	10.27
	8165743	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	15.73	CHEMBL2742	Homo sapiens	Inhibition	%	15.73
	8166093	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.97	CHEMBL2742	Homo sapiens	Inhibition	%	2.97
	8166231	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.19	CHEMBL2742	Homo sapiens	Inhibition	%	8.19
	8166585	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.28	CHEMBL2742	Homo sapiens	Inhibition	%	4.28
	8166910	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	30.51	CHEMBL2742	Homo sapiens	Inhibition	%	30.51
	8166998	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.58	CHEMBL2742	Homo sapiens	Inhibition	%	2.58
	8167222	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.36	CHEMBL2742	Homo sapiens	Inhibition	%	3.36
	8167363	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	64.99	CHEMBL2742	Homo sapiens	Inhibition	%	64.99
	8167527	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.84	CHEMBL2742	Homo sapiens	Inhibition	%	5.84
	8167751	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.55	CHEMBL2742	Homo sapiens	Inhibition	%	4.55
	8167884	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.35	CHEMBL2742	Homo sapiens	Inhibition	%	7.35
	8168232	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.3	CHEMBL2742	Homo sapiens	Inhibition	%	4.3
	8168373	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.56	CHEMBL2742	Homo sapiens	Inhibition	%	4.56
	8168597	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.45	CHEMBL2742	Homo sapiens	Inhibition	%	5.45
	8168733	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.55	CHEMBL2742	Homo sapiens	Inhibition	%	1.55
	8168897	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	9.72	CHEMBL2742	Homo sapiens	Inhibition	%	9.72
	8169121	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	17.21	CHEMBL2742	Homo sapiens	Inhibition	%	17.21
	8169263	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.11	CHEMBL2742	Homo sapiens	Inhibition	%	6.11
	8169567	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.61	CHEMBL2742	Homo sapiens	Inhibition	%	4.61
	8169701	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.47	CHEMBL2742	Homo sapiens	Inhibition	%	5.47
	8169925	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	7.1	CHEMBL2742	Homo sapiens	Inhibition	%	7.1
	8170070	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	10.75	CHEMBL2742	Homo sapiens	Inhibition	%	10.75
	8170419	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.97	CHEMBL2742	Homo sapiens	Inhibition	%	3.97
	8170559	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.88	CHEMBL2742	Homo sapiens	Inhibition	%	8.88
	8170783	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.17	CHEMBL2742	Homo sapiens	Inhibition	%	1.17
	8170918	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.69	CHEMBL2742	Homo sapiens	Inhibition	%	5.69
	8171115	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.55	CHEMBL2742	Homo sapiens	Inhibition	%	-0.55
	8171339	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	8.22	CHEMBL2742	Homo sapiens	Inhibition	%	8.22
	8171556	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.9	CHEMBL2742	Homo sapiens	Inhibition	%	1.9
	8171697	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	9.36	CHEMBL2742	Homo sapiens	Inhibition	%	9.36
	8172074	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.54	CHEMBL2742	Homo sapiens	Inhibition	%	0.54
	8172206	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.83	CHEMBL2742	Homo sapiens	Inhibition	%	5.83
	8172430	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	Inhibition	%	10.0
	8172558	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	14.71	CHEMBL2742	Homo sapiens	Inhibition	%	14.71
	8172924	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.13	CHEMBL2742	Homo sapiens	Inhibition	%	7.13
	8173060	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.12	CHEMBL2742	Homo sapiens	Inhibition	%	-0.12
	8173449	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.39	CHEMBL2742	Homo sapiens	Inhibition	%	7.39
	8173590	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.97	CHEMBL2742	Homo sapiens	Inhibition	%	5.97
	8173901	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.41	CHEMBL2742	Homo sapiens	Inhibition	%	6.41
	8174257	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.59	CHEMBL2742	Homo sapiens	Inhibition	%	6.59
	8174405	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	52.81	CHEMBL2742	Homo sapiens	Inhibition	%	52.81
	8174629	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.92	CHEMBL2742	Homo sapiens	Inhibition	%	4.92
	8174751	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.33	CHEMBL2742	Homo sapiens	Inhibition	%	3.33
	8175118	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.22	CHEMBL2742	Homo sapiens	Inhibition	%	-1.22
	8175254	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.5	CHEMBL2742	Homo sapiens	Inhibition	%	7.5
	8175510	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.96	CHEMBL2742	Homo sapiens	Inhibition	%	7.96
	8175734	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	22.01	CHEMBL2742	Homo sapiens	Inhibition	%	22.01
	8175897	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.96	CHEMBL2742	Homo sapiens	Inhibition	%	3.96
	8176050	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.81	CHEMBL2742	Homo sapiens	Inhibition	%	7.81
	8176274	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.59	CHEMBL2742	Homo sapiens	Inhibition	%	9.59
	8176423	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.4	CHEMBL2742	Homo sapiens	Inhibition	%	-0.4
	8176779	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	33.03	CHEMBL2742	Homo sapiens	Inhibition	%	33.03
	8176909	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.79	CHEMBL2742	Homo sapiens	Inhibition	%	1.79
	8177275	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.74	CHEMBL2742	Homo sapiens	Inhibition	%	3.74
	8177413	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.44	CHEMBL2742	Homo sapiens	Inhibition	%	0.44
	8177637	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	7.7	CHEMBL2742	Homo sapiens	Inhibition	%	7.7
	8177801	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	11.94	CHEMBL2742	Homo sapiens	Inhibition	%	11.94
	8177941	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	9.43	CHEMBL2742	Homo sapiens	Inhibition	%	9.43
	8178165	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	8.18	CHEMBL2742	Homo sapiens	Inhibition	%	8.18
	8178253	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.55	CHEMBL2742	Homo sapiens	Inhibition	%	7.55
	8178477	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.3	CHEMBL2742	Homo sapiens	Inhibition	%	5.3
	8178604	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.87	CHEMBL2742	Homo sapiens	Inhibition	%	4.87
	8178977	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	9.43	CHEMBL2742	Homo sapiens	Inhibition	%	9.43
	8179100	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.87	CHEMBL2742	Homo sapiens	Inhibition	%	4.87
	8179468	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.61	CHEMBL2742	Homo sapiens	Inhibition	%	4.61
	8179605	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.25	CHEMBL2742	Homo sapiens	Inhibition	%	6.25
	8179829	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.56	CHEMBL2742	Homo sapiens	Inhibition	%	3.56
	8180086	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.57	CHEMBL2742	Homo sapiens	Inhibition	%	5.57
	8180240	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	11.4	CHEMBL2742	Homo sapiens	Inhibition	%	11.4
	8180620	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.14	CHEMBL2742	Homo sapiens	Inhibition	%	6.14
	8180768	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	7.1	CHEMBL2742	Homo sapiens	Inhibition	%	7.1
	8181125	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	6.01	CHEMBL2742	Homo sapiens	Inhibition	%	6.01
	8181256	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.74	CHEMBL2742	Homo sapiens	Inhibition	%	4.74
	8181480	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.94	CHEMBL2742	Homo sapiens	Inhibition	%	0.94
	8181620	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.92	CHEMBL2742	Homo sapiens	Inhibition	%	2.92
	8181983	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	15.19	CHEMBL2742	Homo sapiens	Inhibition	%	15.19
	8182146	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.15	CHEMBL2742	Homo sapiens	Inhibition	%	8.15
	8182510	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.52	CHEMBL2742	Homo sapiens	Inhibition	%	6.52
	8182826	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.64	CHEMBL2742	Homo sapiens	Inhibition	%	5.64
	8182948	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.59	CHEMBL2742	Homo sapiens	Inhibition	%	6.59
	8183321	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	28.73	CHEMBL2742	Homo sapiens	Inhibition	%	28.73
	8183450	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.14	CHEMBL2742	Homo sapiens	Inhibition	%	4.14
	8183674	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.49	CHEMBL2742	Homo sapiens	Inhibition	%	6.49
	8183816	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	8.12	CHEMBL2742	Homo sapiens	Inhibition	%	8.12
	8184176	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.41	CHEMBL2742	Homo sapiens	Inhibition	%	2.41
	8184442	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.99	CHEMBL2742	Homo sapiens	Inhibition	%	4.99
	8184589	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.0	CHEMBL2742	Homo sapiens	Inhibition	%	-1.0
	8184970	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.66	CHEMBL2742	Homo sapiens	Inhibition	%	4.66
	8185119	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	29.56	CHEMBL2742	Homo sapiens	Inhibition	%	29.56
	8185343	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.88	CHEMBL2742	Homo sapiens	Inhibition	%	0.88
	8185474	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	11.04	CHEMBL2742	Homo sapiens	Inhibition	%	11.04
	8185829	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	21.0	CHEMBL2742	Homo sapiens	Inhibition	%	21.0
	8185968	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.47	CHEMBL2742	Homo sapiens	Inhibition	%	6.47
	8186333	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.17	CHEMBL2742	Homo sapiens	Inhibition	%	5.17
	8186497	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.37	CHEMBL2742	Homo sapiens	Inhibition	%	11.37
	8186721	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.71	CHEMBL2742	Homo sapiens	Inhibition	%	8.71
	8186860	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.25	CHEMBL2742	Homo sapiens	Inhibition	%	4.25
	8187182	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.56	CHEMBL2742	Homo sapiens	Inhibition	%	4.56
	8187306	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.78	CHEMBL2742	Homo sapiens	Inhibition	%	6.78
	8187530	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.66	CHEMBL2742	Homo sapiens	Inhibition	%	5.66
	8187678	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	70.02	CHEMBL2742	Homo sapiens	Inhibition	%	70.02
	8188031	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.94	CHEMBL2742	Homo sapiens	Inhibition	%	6.94
	8188174	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.81	CHEMBL2742	Homo sapiens	Inhibition	%	5.81
	8188533	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.85	CHEMBL2742	Homo sapiens	Inhibition	%	1.85
	8188807	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.54	CHEMBL2742	Homo sapiens	Inhibition	%	6.54
	8188955	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%		CHEMBL2742	Homo sapiens	Inhibition	%	
	8189179	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.62	CHEMBL2742	Homo sapiens	Inhibition	%	1.62
	8189335	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	13.5	CHEMBL2742	Homo sapiens	Inhibition	%	13.5
	8189708	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.49	CHEMBL2742	Homo sapiens	Inhibition	%	0.49
	8189840	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.79	CHEMBL2742	Homo sapiens	Inhibition	%	5.79
	8190196	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	8.55	CHEMBL2742	Homo sapiens	Inhibition	%	8.55
	8190336	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.96	CHEMBL2742	Homo sapiens	Inhibition	%	5.96
	8190560	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	7.6	CHEMBL2742	Homo sapiens	Inhibition	%	7.6
	8190697	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.65	CHEMBL2742	Homo sapiens	Inhibition	%	7.65
	8191085	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.26	CHEMBL2742	Homo sapiens	Inhibition	%	8.26
	8191223	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.17	CHEMBL2742	Homo sapiens	Inhibition	%	6.17
	8191543	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.79	CHEMBL2742	Homo sapiens	Inhibition	%	4.79
	8191889	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.19	CHEMBL2742	Homo sapiens	Inhibition	%	6.19
	8192038	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.74	CHEMBL2742	Homo sapiens	Inhibition	%	6.74
	8192391	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.91	CHEMBL2742	Homo sapiens	Inhibition	%	2.91
	8192535	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	12.99	CHEMBL2742	Homo sapiens	Inhibition	%	12.99
	8192759	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.04	CHEMBL2742	Homo sapiens	Inhibition	%	6.04
	8192895	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.08	CHEMBL2742	Homo sapiens	Inhibition	%	4.08
	8193167	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.34	CHEMBL2742	Homo sapiens	Inhibition	%	3.34
	8193536	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.76	CHEMBL2742	Homo sapiens	Inhibition	%	7.76
	8193693	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	8.3	CHEMBL2742	Homo sapiens	Inhibition	%	8.3
	8194066	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.34	CHEMBL2742	Homo sapiens	Inhibition	%	0.34
	8194197	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.33	CHEMBL2742	Homo sapiens	Inhibition	%	3.33
	8194421	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.03	CHEMBL2742	Homo sapiens	Inhibition	%	6.03
	8194552	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	14.01	CHEMBL2742	Homo sapiens	Inhibition	%	14.01
	8194919	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.17	CHEMBL2742	Homo sapiens	Inhibition	%	6.17
	8195052	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.57	CHEMBL2742	Homo sapiens	Inhibition	%	7.57
	8195276	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.67	CHEMBL2742	Homo sapiens	Inhibition	%	5.67
	8195440	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	9.26	CHEMBL2742	Homo sapiens	Inhibition	%	9.26
	8195579	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.98	CHEMBL2742	Homo sapiens	Inhibition	%	5.98
	8195803	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.26	CHEMBL2742	Homo sapiens	Inhibition	%	6.26
	8195901	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.88	CHEMBL2742	Homo sapiens	Inhibition	%	4.88
	8196242	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.51	CHEMBL2742	Homo sapiens	Inhibition	%	4.51
	8196392	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	9.45	CHEMBL2742	Homo sapiens	Inhibition	%	9.45
	8196616	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	6.27	CHEMBL2742	Homo sapiens	Inhibition	%	6.27
	8196744	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.29	CHEMBL2742	Homo sapiens	Inhibition	%	5.29
	8197109	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.39	CHEMBL2742	Homo sapiens	Inhibition	%	4.39
	8197246	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.13	CHEMBL2742	Homo sapiens	Inhibition	%	1.13
	8197470	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.09	CHEMBL2742	Homo sapiens	Inhibition	%	2.09
	8197521	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.84	CHEMBL2742	Homo sapiens	Inhibition	%	4.84
	8197745	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.54	CHEMBL2742	Homo sapiens	Inhibition	%	2.54
	8197885	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.37	CHEMBL2742	Homo sapiens	Inhibition	%	4.37
	8198042	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	21.02	CHEMBL2742	Homo sapiens	Inhibition	%	21.02
	8198266	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.38	CHEMBL2742	Homo sapiens	Inhibition	%	2.38
	8198404	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.31	CHEMBL2742	Homo sapiens	Inhibition	%	-0.31
	8198758	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	10.2	CHEMBL2742	Homo sapiens	Inhibition	%	10.2
	8198889	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.07	CHEMBL2742	Homo sapiens	Inhibition	%	8.07
	8199113	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	11.58	CHEMBL2742	Homo sapiens	Inhibition	%	11.58
	8199261	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.84	CHEMBL2742	Homo sapiens	Inhibition	%	7.84
	8199619	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.99	CHEMBL2742	Homo sapiens	Inhibition	%	4.99
	8199782	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	19.15	CHEMBL2742	Homo sapiens	Inhibition	%	19.15
	8200144	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	7.28	CHEMBL2742	Homo sapiens	Inhibition	%	7.28
	8200248	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.89	CHEMBL2742	Homo sapiens	Inhibition	%	7.89
	8200472	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.85	CHEMBL2742	Homo sapiens	Inhibition	%	4.85
	8200587	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.34	CHEMBL2742	Homo sapiens	Inhibition	%	5.34
	8200961	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	8.54	CHEMBL2742	Homo sapiens	Inhibition	%	8.54
	8201091	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.72	CHEMBL2742	Homo sapiens	Inhibition	%	1.72
	8201315	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	12.42	CHEMBL2742	Homo sapiens	Inhibition	%	12.42
	8201450	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.04	CHEMBL2742	Homo sapiens	Inhibition	%	2.04
	8201807	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.3	CHEMBL2742	Homo sapiens	Inhibition	%	1.3
	8202086	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.79	CHEMBL2742	Homo sapiens	Inhibition	%	4.79
	8202226	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	13.16	CHEMBL2742	Homo sapiens	Inhibition	%	13.16
	8202617	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.09	CHEMBL2742	Homo sapiens	Inhibition	%	0.09
	8202742	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.33	CHEMBL2742	Homo sapiens	Inhibition	%	4.33
	8203096	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.7	CHEMBL2742	Homo sapiens	Inhibition	%	7.7
	8203451	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	35.48	CHEMBL2742	Homo sapiens	Inhibition	%	35.48
	8203597	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.44	CHEMBL2742	Homo sapiens	Inhibition	%	11.44
	8203955	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.8	CHEMBL2742	Homo sapiens	Inhibition	%	3.8
	8204121	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	7.81	CHEMBL2742	Homo sapiens	Inhibition	%	7.81
	8204345	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	7.63	CHEMBL2742	Homo sapiens	Inhibition	%	7.63
	8204482	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	8.93	CHEMBL2742	Homo sapiens	Inhibition	%	8.93
	8204811	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	6.0	CHEMBL2742	Homo sapiens	Inhibition	%	6.0
	8204926	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.91	CHEMBL2742	Homo sapiens	Inhibition	%	5.91
	8205150	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	18.98	CHEMBL2742	Homo sapiens	Inhibition	%	18.98
	8205299	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.59	CHEMBL2742	Homo sapiens	Inhibition	%	6.59
	8205659	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.0	CHEMBL2742	Homo sapiens	Inhibition	%	5.0
	8205798	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.76	CHEMBL2742	Homo sapiens	Inhibition	%	2.76
	8206154	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	3.02	CHEMBL2742	Homo sapiens	Inhibition	%	3.02
	8206430	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.38	CHEMBL2742	Homo sapiens	Inhibition	%	3.38
	8206573	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.11	CHEMBL2742	Homo sapiens	Inhibition	%	-0.11
	8206797	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.45	CHEMBL2742	Homo sapiens	Inhibition	%	1.45
	8206977	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.01	CHEMBL2742	Homo sapiens	Inhibition	%	6.01
	8207103	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%		CHEMBL2742	Homo sapiens	Inhibition	%	
	8207327	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.38	CHEMBL2742	Homo sapiens	Inhibition	%	4.38
	8207457	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.46	CHEMBL2742	Homo sapiens	Inhibition	%	9.46
	8207813	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	70.13	CHEMBL2742	Homo sapiens	Inhibition	%	70.13
	8207958	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.61	CHEMBL2742	Homo sapiens	Inhibition	%	3.61
	8208182	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.83	CHEMBL2742	Homo sapiens	Inhibition	%	1.83
	8208314	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.17	CHEMBL2742	Homo sapiens	Inhibition	%	8.17
	8208704	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	9.54	CHEMBL2742	Homo sapiens	Inhibition	%	9.54
	8208837	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	25.78	CHEMBL2742	Homo sapiens	Inhibition	%	25.78
	8209166	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	29.34	CHEMBL2742	Homo sapiens	Inhibition	%	29.34
	8209506	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.15	CHEMBL2742	Homo sapiens	Inhibition	%	5.15
	8209656	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.95	CHEMBL2742	Homo sapiens	Inhibition	%	10.95
	8210016	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	10.87	CHEMBL2742	Homo sapiens	Inhibition	%	10.87
	8210157	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.17	CHEMBL2742	Homo sapiens	Inhibition	%	2.17
	8210381	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.92	CHEMBL2742	Homo sapiens	Inhibition	%	3.92
	8210517	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.64	CHEMBL2742	Homo sapiens	Inhibition	%	-1.64
	8210776	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.78	CHEMBL2742	Homo sapiens	Inhibition	%	1.78
	8211144	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.13	CHEMBL2742	Homo sapiens	Inhibition	%	6.13
	8211314	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.96	CHEMBL2742	Homo sapiens	Inhibition	%	3.96
	8211661	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	8.26	CHEMBL2742	Homo sapiens	Inhibition	%	8.26
	8211790	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.23	CHEMBL2742	Homo sapiens	Inhibition	%	8.23
	8212014	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.52	CHEMBL2742	Homo sapiens	Inhibition	%	12.52
	8212146	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.37	CHEMBL2742	Homo sapiens	Inhibition	%	8.37
	8212511	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.83	CHEMBL2742	Homo sapiens	Inhibition	%	4.83
	8212644	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.23	CHEMBL2742	Homo sapiens	Inhibition	%	5.23
	8213038	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	22.76	CHEMBL2742	Homo sapiens	Inhibition	%	22.76
	8213167	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.58	CHEMBL2742	Homo sapiens	Inhibition	%	7.58
	8213391	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.03	CHEMBL2742	Homo sapiens	Inhibition	%	8.03
	8213495	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	65.45	CHEMBL2742	Homo sapiens	Inhibition	%	65.45
	8213832	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.97	CHEMBL2742	Homo sapiens	Inhibition	%	4.97
	8213979	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.47	CHEMBL2742	Homo sapiens	Inhibition	%	3.47
	8214203	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.72	CHEMBL2742	Homo sapiens	Inhibition	%	5.72
	8214340	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	9.47	CHEMBL2742	Homo sapiens	Inhibition	%	9.47
	8214698	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	3.55	CHEMBL2742	Homo sapiens	Inhibition	%	3.55
	8214850	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.77	CHEMBL2742	Homo sapiens	Inhibition	%	-1.77
	8215101	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.81	CHEMBL2742	Homo sapiens	Inhibition	%	-1.81
	8215478	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	13.87	CHEMBL2742	Homo sapiens	Inhibition	%	13.87
	8215642	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.33	CHEMBL2742	Homo sapiens	Inhibition	%	5.33
	8215985	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.06	CHEMBL2742	Homo sapiens	Inhibition	%	1.06
	8216328	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.08	CHEMBL2742	Homo sapiens	Inhibition	%	5.08
	8216464	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	13.02	CHEMBL2742	Homo sapiens	Inhibition	%	13.02
	8216826	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.2	CHEMBL2742	Homo sapiens	Inhibition	%	3.2
	8216960	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.23	CHEMBL2742	Homo sapiens	Inhibition	%	6.23
	8217184	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.22	CHEMBL2742	Homo sapiens	Inhibition	%	6.22
	8217358	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.41	CHEMBL2742	Homo sapiens	Inhibition	%	4.41
	8217713	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	9.71	CHEMBL2742	Homo sapiens	Inhibition	%	9.71
	8217814	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.31	CHEMBL2742	Homo sapiens	Inhibition	%	1.31
	8218038	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.66	CHEMBL2742	Homo sapiens	Inhibition	%	2.66
	8218153	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.89	CHEMBL2742	Homo sapiens	Inhibition	%	5.89
	8218504	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	6.47	CHEMBL2742	Homo sapiens	Inhibition	%	6.47
	8218647	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%		CHEMBL2742	Homo sapiens	Inhibition	%	
	8219002	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	18.43	CHEMBL2742	Homo sapiens	Inhibition	%	18.43
	8219162	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.61	CHEMBL2742	Homo sapiens	Inhibition	%	3.61
	8219386	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.31	CHEMBL2742	Homo sapiens	Inhibition	%	5.31
	8219412	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.29	CHEMBL2742	Homo sapiens	Inhibition	%	4.29
	8219636	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.08	CHEMBL2742	Homo sapiens	Inhibition	%	2.08
	8219797	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.98	CHEMBL2742	Homo sapiens	Inhibition	%	6.98
	8219966	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.1	CHEMBL2742	Homo sapiens	Inhibition	%	3.1
	8220190	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.23	CHEMBL2742	Homo sapiens	Inhibition	%	6.23
	8220319	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.63	CHEMBL2742	Homo sapiens	Inhibition	%	3.63
	8220657	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.54	CHEMBL2742	Homo sapiens	Inhibition	%	3.54
	8220795	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	10.34	CHEMBL2742	Homo sapiens	Inhibition	%	10.34
	8221019	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	30.93	CHEMBL2742	Homo sapiens	Inhibition	%	30.93
	8221155	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.46	CHEMBL2742	Homo sapiens	Inhibition	%	1.46
	8221512	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.65	CHEMBL2742	Homo sapiens	Inhibition	%	4.65
	8221677	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.9	CHEMBL2742	Homo sapiens	Inhibition	%	4.9
	8222032	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	24.07	CHEMBL2742	Homo sapiens	Inhibition	%	24.07
	8222354	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	19.97	CHEMBL2742	Homo sapiens	Inhibition	%	19.97
	8222488	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.69	CHEMBL2742	Homo sapiens	Inhibition	%	4.69
	8222830	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	9.95	CHEMBL2742	Homo sapiens	Inhibition	%	9.95
	8222974	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	10.03	CHEMBL2742	Homo sapiens	Inhibition	%	10.03
	8223198	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	63.8	CHEMBL2742	Homo sapiens	Inhibition	%	63.8
	8223327	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	7.91	CHEMBL2742	Homo sapiens	Inhibition	%	7.91
	8223712	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.29	CHEMBL2742	Homo sapiens	Inhibition	%	2.29
	8223962	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.02	CHEMBL2742	Homo sapiens	Inhibition	%	4.02
	8224124	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.72	CHEMBL2742	Homo sapiens	Inhibition	%	6.72
	8224518	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.83	CHEMBL2742	Homo sapiens	Inhibition	%	1.83
	8224653	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.12	CHEMBL2742	Homo sapiens	Inhibition	%	6.12
	8224877	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.57	CHEMBL2742	Homo sapiens	Inhibition	%	5.57
	8224991	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.2	CHEMBL2742	Homo sapiens	Inhibition	%	9.2
	8225349	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.15	CHEMBL2742	Homo sapiens	Inhibition	%	9.15
	8225487	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.3	CHEMBL2742	Homo sapiens	Inhibition	%	-1.3
	8225711	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.46	CHEMBL2742	Homo sapiens	Inhibition	%	4.46
	8225846	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.48	CHEMBL2742	Homo sapiens	Inhibition	%	8.48
	8226004	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.33	CHEMBL2742	Homo sapiens	Inhibition	%	3.33
	8226228	CHEMBL1962293	GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.36	CHEMBL2742	Homo sapiens	Inhibition	%	2.36
	8226353	CHEMBL1962292	GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.34	CHEMBL2742	Homo sapiens	Inhibition	%	5.34
inactive	9682452	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682453	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682454	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682455	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
active	9682456	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	316.23	CHEMBL2742	Homo sapiens	pKi		6.5
inactive	9682457	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682458	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
active	9682459	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	63.1	CHEMBL2742	Homo sapiens	pKi		7.2
inactive	9682460	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682461	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682462	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682463	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682464	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682465	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682466	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682467	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682468	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682469	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682470	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682471	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9682472	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682473	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
inactive	9682474	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682475	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682476	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682477	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682478	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9682479	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682480	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682481	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9682482	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682483	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682484	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682485	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682486	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682487	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682488	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682489	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	63.1	CHEMBL2742	Homo sapiens	pKi		7.2
inactive	9682490	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682491	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682492	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9682493	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
active	9682494	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9682495	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682496	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682497	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682498	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682499	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682500	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	316.23	CHEMBL2742	Homo sapiens	pKi		6.5
inactive	9682501	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9682502	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682503	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
inactive	9682504	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9682505	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9682506	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	100.0	CHEMBL2742	Homo sapiens	pKi		7.0
inactive	9686467	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686468	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686469	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686470	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686471	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686472	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686473	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686474	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686475	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686476	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686477	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686478	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686479	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
inactive	9686480	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686481	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
inactive	9686482	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686483	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	63.1	CHEMBL2742	Homo sapiens	pKi		7.2
inactive	9686484	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686485	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686486	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686487	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1977619	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
active	9686488	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9686489	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686490	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686491	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
active	9686492	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	12.59	CHEMBL2742	Homo sapiens	pKi		7.9
inactive	9686493	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686494	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686495	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
active	9686496	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
inactive	9686497	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686498	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686499	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686500	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686501	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686502	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686503	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686504	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686505	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	50.12	CHEMBL2742	Homo sapiens	pKi		7.3
active	9686506	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
inactive	9686507	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686508	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686509	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686510	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686511	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686512	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686513	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686514	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686515	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686516	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686517	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686518	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686519	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686520	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686521	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686522	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9686523	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
active	9686524	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
inactive	9686525	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686526	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686527	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686528	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686529	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686530	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686531	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686532	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686533	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686534	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686535	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
inactive	9686536	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686537	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686538	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686539	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686540	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686541	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686542	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686543	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686544	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686545	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
active	9686546	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9686547	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686548	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	3.162	CHEMBL2742	Homo sapiens	pKi		8.5
inactive	9686549	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686550	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686551	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686552	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
inactive	9686553	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686554	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
active	9686555	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
active	9686556	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
inactive	9686557	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686558	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686559	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686560	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	2.512	CHEMBL2742	Homo sapiens	pKi		8.6
inactive	9686561	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686562	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686563	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686564	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	10.0	CHEMBL2742	Homo sapiens	pKi		8.0
inactive	9686565	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686566	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686567	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686568	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686569	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686570	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686571	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686572	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686573	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	<	Ki	nM	5011.87	CHEMBL2742	Homo sapiens	pKi		5.3
inactive	9686574	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686575	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686576	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686577	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686578	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686579	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	15.85	CHEMBL2742	Homo sapiens	pKi		7.8
inactive	9686580	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686581	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686582	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686583	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686584	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686585	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686586	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
inactive	9686587	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686588	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686589	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686590	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
inactive	9686591	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686592	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686593	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686594	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	25.12	CHEMBL2742	Homo sapiens	pKi		7.6
inactive	9686595	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686596	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686597	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686598	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686599	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686600	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686601	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686602	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
active	9686603	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9686604	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686605	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686606	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686607	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686608	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686609	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686610	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686611	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686612	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686613	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686614	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686615	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686616	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686617	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	10000.0	CHEMBL2742	Homo sapiens	pKi		5.0
inactive	9686618	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686619	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686620	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686621	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
active	9686622	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9686623	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686624	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686625	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686626	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
active	9686627	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
inactive	9686628	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686629	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686630	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
inactive	9686631	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686632	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686633	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686634	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686635	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686636	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686637	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
inactive	9686638	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686639	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686640	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686641	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686642	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686643	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686644	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686645	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686646	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686647	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686648	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	125.89	CHEMBL2742	Homo sapiens	pKi		6.9
inactive	9686649	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686650	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
inactive	9686651	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686652	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686653	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686654	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
active	9686655	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9686656	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686657	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
active	9686658	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
inactive	9686659	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686660	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686661	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686662	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686663	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686664	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686665	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686666	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686667	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9686668	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686669	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686670	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	5.012	CHEMBL2742	Homo sapiens	pKi		8.3
inactive	9686671	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686672	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686673	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686674	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686675	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686676	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686677	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	316.23	CHEMBL2742	Homo sapiens	pKi		6.5
active	9686678	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
active	9686679	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
inactive	9686680	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686681	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
inactive	9686682	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686683	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686684	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686685	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
inactive	9686686	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686687	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686688	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686689	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686690	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686691	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686692	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]cnc2ccc(Br)cc12		CHEMBL562488	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9686693	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686694	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686695	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686696	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686697	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686698	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9686699	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
inactive	9686700	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686701	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686702	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9686703	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690663	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690664	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690665	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690666	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690667	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690668	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9690669	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690670	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	79.43	CHEMBL2742	Homo sapiens	pKi		7.1
inactive	9690671	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690672	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690673	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690674	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690675	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690676	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690677	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690678	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690679	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9690680	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690681	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	316.23	CHEMBL2742	Homo sapiens	pKi		6.5
active	9690682	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
inactive	9690683	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
active	9690684	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	630.96	CHEMBL2742	Homo sapiens	pKi		6.2
inactive	9690685	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690686	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690687	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690688	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
inactive	9690689	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690690	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
inactive	9690691	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690692	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
inactive	9690693	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9690694	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690695	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690696	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690697	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690698	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690699	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690700	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690701	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
active	9690702	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	630.96	CHEMBL2742	Homo sapiens	pKi		6.2
active	9690703	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	630.96	CHEMBL2742	Homo sapiens	pKi		6.2
inactive	9690704	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690705	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
inactive	9690706	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690707	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690708	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690709	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690710	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690711	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690712	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9690713	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690714	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690715	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690716	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	316.23	CHEMBL2742	Homo sapiens	pKi		6.5
inactive	9690717	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690718	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690719	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690720	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690721	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	50.12	CHEMBL2742	Homo sapiens	pKi		7.3
inactive	9690722	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690723	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690724	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
active	9690725	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
inactive	9690726	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690727	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690728	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690729	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690730	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690731	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690732	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690733	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690734	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690735	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9690736	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690737	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690738	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690739	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690740	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	15.85	CHEMBL2742	Homo sapiens	pKi		7.8
inactive	9690741	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690742	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9690743	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690744	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690745	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
inactive	9690746	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690747	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690748	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690749	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690750	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690751	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690752	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
active	9690753	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	12.59	CHEMBL2742	Homo sapiens	pKi		7.9
active	9690754	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	398.11	CHEMBL2742	Homo sapiens	pKi		6.4
inactive	9690755	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690756	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690757	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
active	9690758	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	630.96	CHEMBL2742	Homo sapiens	pKi		6.2
inactive	9690759	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
inactive	9690760	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690761	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690762	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690763	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	15.85	CHEMBL2742	Homo sapiens	pKi		7.8
inactive	9690764	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690765	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690766	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690767	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	25.12	CHEMBL2742	Homo sapiens	pKi		7.6
inactive	9690768	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690769	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690770	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690771	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690772	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690773	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690774	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690775	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	158.49	CHEMBL2742	Homo sapiens	pKi		6.8
active	9690776	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
inactive	9690777	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690778	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690779	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690780	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690781	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690782	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690783	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690784	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690785	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690786	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690787	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9690788	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690789	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690790	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690791	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690792	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9690793	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690794	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690795	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690796	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690797	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690798	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690799	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690800	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690801	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690802	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690803	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690804	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690805	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690806	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690807	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690808	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690809	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690810	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690811	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690812	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690813	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690814	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690815	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690816	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9690817	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690818	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690819	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9690820	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690821	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690822	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690823	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690824	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690825	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690826	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690827	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690828	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690829	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690830	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690831	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690832	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690833	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690834	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	100.0	CHEMBL2742	Homo sapiens	pKi		7.0
inactive	9690835	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690836	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690837	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690838	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690839	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690840	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	630.96	CHEMBL2742	Homo sapiens	pKi		6.2
inactive	9690841	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690842	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690843	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690844	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690845	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690846	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690847	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690848	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690849	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690850	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690851	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	19.95	CHEMBL2742	Homo sapiens	pKi		7.7
inactive	9690852	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690853	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690854	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690855	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690856	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690857	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	630.96	CHEMBL2742	Homo sapiens	pKi		6.2
inactive	9690858	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690859	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690860	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690861	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
inactive	9690862	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690863	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690864	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690865	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690866	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690867	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3162.28	CHEMBL2742	Homo sapiens	pKi		5.5
inactive	9690868	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690869	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690870	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690871	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690872	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690873	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	7.943	CHEMBL2742	Homo sapiens	pKi		8.1
inactive	9690874	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690875	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9690876	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690877	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690878	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690879	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690880	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690881	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690882	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	251.19	CHEMBL2742	Homo sapiens	pKi		6.6
inactive	9690883	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690884	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690885	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690886	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690887	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690888	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	25.12	CHEMBL2742	Homo sapiens	pKi		7.6
inactive	9690889	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690890	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690891	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690892	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9690893	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	79.43	CHEMBL2742	Homo sapiens	pKi		7.1
inactive	9690894	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690895	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690896	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690897	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690898	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9690899	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694843	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	794.33	CHEMBL2742	Homo sapiens	pKi		6.1
inactive	9694844	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9694845	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694846	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694847	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694848	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
active	9694849	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	63.1	CHEMBL2742	Homo sapiens	pKi		7.2
inactive	9694850	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694851	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694852	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
inactive	9694853	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694854	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694855	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694856	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694857	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694858	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694859	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694860	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9694861	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694862	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	199.53	CHEMBL2742	Homo sapiens	pKi		6.7
inactive	9694863	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694864	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694865	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	398.11	CHEMBL2742	Homo sapiens	pKi		6.4
inactive	9694866	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694867	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694868	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694869	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694870	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694871	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694872	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694873	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
inactive	9694874	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694875	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694876	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694877	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694878	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694879	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694880	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694881	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	398.11	CHEMBL2742	Homo sapiens	pKi		6.4
inactive	9694882	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694883	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694884	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	398.11	CHEMBL2742	Homo sapiens	pKi		6.4
active	9694885	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	31.62	CHEMBL2742	Homo sapiens	pKi		7.5
inactive	9694886	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694887	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694888	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694889	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694890	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694891	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694892	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694893	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694894	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694895	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694896	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	79.43	CHEMBL2742	Homo sapiens	pKi		7.1
active	9694897	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	50.12	CHEMBL2742	Homo sapiens	pKi		7.3
inactive	9694898	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694899	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	3.981	CHEMBL2742	Homo sapiens	pKi		8.4
active	9694900	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	100.0	CHEMBL2742	Homo sapiens	pKi		7.0
inactive	9694901	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694902	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1584.89	CHEMBL2742	Homo sapiens	pKi		5.8
inactive	9694903	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694904	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694905	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694906	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694907	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694908	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
inactive	9694909	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694910	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694911	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694912	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694913	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	19952.62	CHEMBL2742	Homo sapiens	pKi		4.7
inactive	9694914	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694915	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694916	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694917	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
active	9694918	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	100.0	CHEMBL2742	Homo sapiens	pKi		7.0
inactive	9694919	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694920	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694921	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694922	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694923	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694924	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694925	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694926	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694927	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
inactive	9694928	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694929	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694930	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694931	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1258.93	CHEMBL2742	Homo sapiens	pKi		5.9
active	9694932	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1000.0	CHEMBL2742	Homo sapiens	pKi		6.0
inactive	9694933	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694934	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	63.1	CHEMBL2742	Homo sapiens	pKi		7.2
inactive	9694935	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694936	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694937	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694938	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694939	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694940	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694941	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694942	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694943	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694944	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	63.1	CHEMBL2742	Homo sapiens	pKi		7.2
inactive	9694945	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694946	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694947	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694948	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	31.62	CHEMBL2742	Homo sapiens	pKi		7.5
inactive	9694949	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694950	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694951	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694952	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694953	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694954	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694955	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694956	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694957	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694958	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694959	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694960	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694961	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	25.12	CHEMBL2742	Homo sapiens	pKi		7.6
inactive	9694962	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694963	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694964	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694965	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694966	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694967	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	39.81	CHEMBL2742	Homo sapiens	pKi		7.4
inactive	9694968	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694969	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694970	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	5.012	CHEMBL2742	Homo sapiens	pKi		8.3
inactive	9694971	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
inactive	9694972	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694973	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	501.19	CHEMBL2742	Homo sapiens	pKi		6.3
active	9694974	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	1.585	CHEMBL2742	Homo sapiens	pKi		8.8
inactive	9694975	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
active	9694976	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	25.12	CHEMBL2742	Homo sapiens	pKi		7.6
inactive	9694977	CHEMBL1963828	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	1995.26	CHEMBL2742	Homo sapiens	pKi		5.7
	10838584	CHEMBL2014207	Inhibition of FGFR3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL2742	Homo sapiens	INH	%	1.0
	10838585	CHEMBL2014425	Inhibition of FGFR3 K650E mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	3.0	CHEMBL2742	Homo sapiens	INH	%	3.0
	10838586	CHEMBL2014426	Inhibition of FGFR3 K650M mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	10843857	CHEMBL2016111	Inhibition of human FGFR3 using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	89.0	CHEMBL2742	Homo sapiens	IC50	nM	89.0
	10850675	CHEMBL2019795	Inhibition of human FGFR3 at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	10867522	CHEMBL2027412	Inhibition of FGFR3 at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	20.0	CHEMBL2742	Homo sapiens	INH	%	20.0
	10949911	CHEMBL2049403	Inhibition of FGFR3 using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	10978470	CHEMBL2066237	Inhibition of human recombinant FGFR3 using ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 90 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL2742	Homo sapiens	Activity	%	80.0
	10984742	CHEMBL2072038	Inhibition of human FGFR3 at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	12036445	CHEMBL2150416	Inhibition of FGFR3 after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	12046306	CHEMBL2156636	Inhibition of FGFR3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	15.7	CHEMBL2742	Homo sapiens	INH	%	15.7
	12074634	CHEMBL2161196	Inhibition of FGFR3 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	12173611	CHEMBL2213550	Inhibition of FGFR3 G697C mutant assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	12173612	CHEMBL2213551	Inhibition of FGFR3 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	12175200	CHEMBL2210726	Inhibition of FGFR3	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	86.0	CHEMBL2742	Homo sapiens	IC50	nM	86.0
	12191214	CHEMBL2215708	Inhibition of FGFR3 by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	=	IC50	nM	4200.0	CHEMBL2742	Homo sapiens	IC50	nM	4200.0
	12195396	CHEMBL2210919	Inhibition of recombinant FGFR3 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	1400.0	CHEMBL2742	Homo sapiens	Ki	nM	1400.0
	12195614	CHEMBL2212863	Inhibition of human recombinant FGFR3 using Ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 90 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	92.9	CHEMBL2742	Homo sapiens	Activity	%	92.9
	12205239	CHEMBL2217233	Inhibition of FGFR3	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	11.9	CHEMBL2742	Homo sapiens	IC50	nM	11.9
	12208614	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	111.0	CHEMBL2742	Homo sapiens	Residual Activity	%	111.0
	12208615	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12208616	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	100.0	CHEMBL2742	Homo sapiens	Residual Activity	%	100.0
	12208617	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	83.0	CHEMBL2742	Homo sapiens	Residual Activity	%	83.0
	12208618	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	14.0	CHEMBL2742	Homo sapiens	Residual Activity	%	14.0
	12208619	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	74.0	CHEMBL2742	Homo sapiens	Residual Activity	%	74.0
	12208620	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	23.0	CHEMBL2742	Homo sapiens	Residual Activity	%	23.0
	12208621	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	97.0	CHEMBL2742	Homo sapiens	Residual Activity	%	97.0
	12208622	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	125.0	CHEMBL2742	Homo sapiens	Residual Activity	%	125.0
	12208623	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	119.0	CHEMBL2742	Homo sapiens	Residual Activity	%	119.0
	12208624	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	123.0	CHEMBL2742	Homo sapiens	Residual Activity	%	123.0
	12208625	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	25.0	CHEMBL2742	Homo sapiens	Residual Activity	%	25.0
	12208626	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	94.0	CHEMBL2742	Homo sapiens	Residual Activity	%	94.0
	12208627	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	107.0	CHEMBL2742	Homo sapiens	Residual Activity	%	107.0
	12208628	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12208629	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	57.0	CHEMBL2742	Homo sapiens	Residual Activity	%	57.0
	12208630	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	109.0	CHEMBL2742	Homo sapiens	Residual Activity	%	109.0
	12208631	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	96.0	CHEMBL2742	Homo sapiens	Residual Activity	%	96.0
	12208632	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL2742	Homo sapiens	Residual Activity	%	110.0
	12208633	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	103.0	CHEMBL2742	Homo sapiens	Residual Activity	%	103.0
	12208634	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	107.0	CHEMBL2742	Homo sapiens	Residual Activity	%	107.0
	12208635	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	73.0	CHEMBL2742	Homo sapiens	Residual Activity	%	73.0
	12208636	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	107.0	CHEMBL2742	Homo sapiens	Residual Activity	%	107.0
	12208637	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	85.0	CHEMBL2742	Homo sapiens	Residual Activity	%	85.0
	12208638	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	20.0	CHEMBL2742	Homo sapiens	Residual Activity	%	20.0
	12208639	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	67.0	CHEMBL2742	Homo sapiens	Residual Activity	%	67.0
	12208640	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208641	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	66.0	CHEMBL2742	Homo sapiens	Residual Activity	%	66.0
	12208642	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12208643	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	28.0	CHEMBL2742	Homo sapiens	Residual Activity	%	28.0
	12208644	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208645	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL2742	Homo sapiens	Residual Activity	%	101.0
	12208646	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	101.0	CHEMBL2742	Homo sapiens	Residual Activity	%	101.0
	12208647	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12208648	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	67.0	CHEMBL2742	Homo sapiens	Residual Activity	%	67.0
	12208649	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	107.0	CHEMBL2742	Homo sapiens	Residual Activity	%	107.0
	12208650	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	129.0	CHEMBL2742	Homo sapiens	Residual Activity	%	129.0
	12208651	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	65.0	CHEMBL2742	Homo sapiens	Residual Activity	%	65.0
	12208652	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208653	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	128.0	CHEMBL2742	Homo sapiens	Residual Activity	%	128.0
	12208654	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	53.0	CHEMBL2742	Homo sapiens	Residual Activity	%	53.0
	12208655	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	7.0	CHEMBL2742	Homo sapiens	Residual Activity	%	7.0
	12208656	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	58.0	CHEMBL2742	Homo sapiens	Residual Activity	%	58.0
	12208657	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	121.0	CHEMBL2742	Homo sapiens	Residual Activity	%	121.0
	12208658	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	121.0	CHEMBL2742	Homo sapiens	Residual Activity	%	121.0
	12208659	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	68.0	CHEMBL2742	Homo sapiens	Residual Activity	%	68.0
	12208660	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	132.0	CHEMBL2742	Homo sapiens	Residual Activity	%	132.0
	12208661	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	109.0	CHEMBL2742	Homo sapiens	Residual Activity	%	109.0
	12208662	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	13.0	CHEMBL2742	Homo sapiens	Residual Activity	%	13.0
	12208663	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	7.0	CHEMBL2742	Homo sapiens	Residual Activity	%	7.0
	12208664	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	9.0	CHEMBL2742	Homo sapiens	Residual Activity	%	9.0
	12208665	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12208666	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	122.0	CHEMBL2742	Homo sapiens	Residual Activity	%	122.0
	12208667	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	124.0	CHEMBL2742	Homo sapiens	Residual Activity	%	124.0
	12208668	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	83.0	CHEMBL2742	Homo sapiens	Residual Activity	%	83.0
	12208669	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	78.0	CHEMBL2742	Homo sapiens	Residual Activity	%	78.0
	12208670	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	59.0	CHEMBL2742	Homo sapiens	Residual Activity	%	59.0
	12208671	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	73.0	CHEMBL2742	Homo sapiens	Residual Activity	%	73.0
	12208672	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	62.0	CHEMBL2742	Homo sapiens	Residual Activity	%	62.0
	12208673	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	19.0	CHEMBL2742	Homo sapiens	Residual Activity	%	19.0
	12208674	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12208675	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12208676	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	136.0	CHEMBL2742	Homo sapiens	Residual Activity	%	136.0
	12208677	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	64.0	CHEMBL2742	Homo sapiens	Residual Activity	%	64.0
	12208678	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12208679	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	110.0	CHEMBL2742	Homo sapiens	Residual Activity	%	110.0
	12208680	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12208681	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	54.0	CHEMBL2742	Homo sapiens	Residual Activity	%	54.0
	12208682	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	95.0	CHEMBL2742	Homo sapiens	Residual Activity	%	95.0
	12208683	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	91.0	CHEMBL2742	Homo sapiens	Residual Activity	%	91.0
	12208684	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	29.0	CHEMBL2742	Homo sapiens	Residual Activity	%	29.0
	12208685	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL2742	Homo sapiens	Residual Activity	%	100.0
	12208686	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	34.0	CHEMBL2742	Homo sapiens	Residual Activity	%	34.0
	12208687	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	42.0	CHEMBL2742	Homo sapiens	Residual Activity	%	42.0
	12208688	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12208689	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL2742	Homo sapiens	Residual Activity	%	1.0
	12208690	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12208691	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL2742	Homo sapiens	Residual Activity	%	-1.0
	12208692	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	58.0	CHEMBL2742	Homo sapiens	Residual Activity	%	58.0
	12208693	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	4.0	CHEMBL2742	Homo sapiens	Residual Activity	%	4.0
	12208694	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	88.0	CHEMBL2742	Homo sapiens	Residual Activity	%	88.0
	12208695	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12208696	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12208697	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	122.0	CHEMBL2742	Homo sapiens	Residual Activity	%	122.0
	12208698	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	78.0	CHEMBL2742	Homo sapiens	Residual Activity	%	78.0
	12208699	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208700	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	84.0	CHEMBL2742	Homo sapiens	Residual Activity	%	84.0
	12208701	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	2.0	CHEMBL2742	Homo sapiens	Residual Activity	%	2.0
	12208702	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12208703	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12208704	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL2742	Homo sapiens	Residual Activity	%	4.0
	12208705	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12208706	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	105.0	CHEMBL2742	Homo sapiens	Residual Activity	%	105.0
	12208707	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12208708	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	110.0	CHEMBL2742	Homo sapiens	Residual Activity	%	110.0
	12208709	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	118.0	CHEMBL2742	Homo sapiens	Residual Activity	%	118.0
	12208710	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	118.0	CHEMBL2742	Homo sapiens	Residual Activity	%	118.0
	12208711	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12208712	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	41.0	CHEMBL2742	Homo sapiens	Residual Activity	%	41.0
	12208713	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL2742	Homo sapiens	Residual Activity	%	2.0
	12208714	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208715	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	92.0	CHEMBL2742	Homo sapiens	Residual Activity	%	92.0
	12208716	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	109.0	CHEMBL2742	Homo sapiens	Residual Activity	%	109.0
	12208717	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12208718	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	100.0	CHEMBL2742	Homo sapiens	Residual Activity	%	100.0
	12208719	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12208720	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	119.0	CHEMBL2742	Homo sapiens	Residual Activity	%	119.0
	12208721	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	87.0	CHEMBL2742	Homo sapiens	Residual Activity	%	87.0
	12208722	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208723	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12208724	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12208725	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12208726	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	132.0	CHEMBL2742	Homo sapiens	Residual Activity	%	132.0
	12208727	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	126.0	CHEMBL2742	Homo sapiens	Residual Activity	%	126.0
	12208728	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	15.0	CHEMBL2742	Homo sapiens	Residual Activity	%	15.0
	12208729	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	89.0	CHEMBL2742	Homo sapiens	Residual Activity	%	89.0
	12208730	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	83.0	CHEMBL2742	Homo sapiens	Residual Activity	%	83.0
	12208731	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12208732	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	95.0	CHEMBL2742	Homo sapiens	Residual Activity	%	95.0
	12208733	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	53.0	CHEMBL2742	Homo sapiens	Residual Activity	%	53.0
	12208734	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	59.0	CHEMBL2742	Homo sapiens	Residual Activity	%	59.0
	12208735	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12208736	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	23.0	CHEMBL2742	Homo sapiens	Residual Activity	%	23.0
	12208737	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12208738	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	56.0	CHEMBL2742	Homo sapiens	Residual Activity	%	56.0
	12208739	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	137.0	CHEMBL2742	Homo sapiens	Residual Activity	%	137.0
	12208740	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12208741	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2742	Homo sapiens	Residual Activity	%	0.0
	12208742	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	109.0	CHEMBL2742	Homo sapiens	Residual Activity	%	109.0
	12208743	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12208744	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	40.0	CHEMBL2742	Homo sapiens	Residual Activity	%	40.0
	12208745	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12208746	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	9.0	CHEMBL2742	Homo sapiens	Residual Activity	%	9.0
	12208747	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	20.0	CHEMBL2742	Homo sapiens	Residual Activity	%	20.0
	12208748	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	103.0	CHEMBL2742	Homo sapiens	Residual Activity	%	103.0
	12208749	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	4.0	CHEMBL2742	Homo sapiens	Residual Activity	%	4.0
	12208750	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	54.0	CHEMBL2742	Homo sapiens	Residual Activity	%	54.0
	12208751	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	77.0	CHEMBL2742	Homo sapiens	Residual Activity	%	77.0
	12208752	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12208753	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	80.0	CHEMBL2742	Homo sapiens	Residual Activity	%	80.0
	12208754	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	92.0	CHEMBL2742	Homo sapiens	Residual Activity	%	92.0
	12208755	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	29.0	CHEMBL2742	Homo sapiens	Residual Activity	%	29.0
	12208756	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	73.0	CHEMBL2742	Homo sapiens	Residual Activity	%	73.0
	12208757	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208758	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	22.0	CHEMBL2742	Homo sapiens	Residual Activity	%	22.0
	12208759	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	94.0	CHEMBL2742	Homo sapiens	Residual Activity	%	94.0
	12208760	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	87.0	CHEMBL2742	Homo sapiens	Residual Activity	%	87.0
	12208761	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	124.0	CHEMBL2742	Homo sapiens	Residual Activity	%	124.0
	12208762	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	14.0	CHEMBL2742	Homo sapiens	Residual Activity	%	14.0
	12208763	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12208764	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	92.0	CHEMBL2742	Homo sapiens	Residual Activity	%	92.0
	12208765	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12208766	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12208767	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	33.0	CHEMBL2742	Homo sapiens	Residual Activity	%	33.0
	12208768	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	88.0	CHEMBL2742	Homo sapiens	Residual Activity	%	88.0
	12208769	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	18.0	CHEMBL2742	Homo sapiens	Residual Activity	%	18.0
	12250765	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	126.0	CHEMBL2742	Homo sapiens	Residual Activity	%	126.0
	12250766	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	27.0	CHEMBL2742	Homo sapiens	Residual Activity	%	27.0
	12250767	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250768	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12250769	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12250770	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	76.0	CHEMBL2742	Homo sapiens	Residual Activity	%	76.0
	12250771	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	17.0	CHEMBL2742	Homo sapiens	Residual Activity	%	17.0
	12250772	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250773	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	79.0	CHEMBL2742	Homo sapiens	Residual Activity	%	79.0
	12250774	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12250775	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	86.0	CHEMBL2742	Homo sapiens	Residual Activity	%	86.0
	12250776	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	85.0	CHEMBL2742	Homo sapiens	Residual Activity	%	85.0
	12250777	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	118.0	CHEMBL2742	Homo sapiens	Residual Activity	%	118.0
	12250778	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	83.0	CHEMBL2742	Homo sapiens	Residual Activity	%	83.0
	12250779	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	96.0	CHEMBL2742	Homo sapiens	Residual Activity	%	96.0
	12250780	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	85.0	CHEMBL2742	Homo sapiens	Residual Activity	%	85.0
	12250781	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	105.0	CHEMBL2742	Homo sapiens	Residual Activity	%	105.0
	12250782	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12250783	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250784	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	94.0	CHEMBL2742	Homo sapiens	Residual Activity	%	94.0
	12250785	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250786	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12250787	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250788	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL2742	Homo sapiens	Residual Activity	%	105.0
	12250789	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250790	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	92.0	CHEMBL2742	Homo sapiens	Residual Activity	%	92.0
	12250791	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	70.0	CHEMBL2742	Homo sapiens	Residual Activity	%	70.0
	12250792	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	109.0	CHEMBL2742	Homo sapiens	Residual Activity	%	109.0
	12250793	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	115.0	CHEMBL2742	Homo sapiens	Residual Activity	%	115.0
	12250794	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	98.0	CHEMBL2742	Homo sapiens	Residual Activity	%	98.0
	12250795	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	118.0	CHEMBL2742	Homo sapiens	Residual Activity	%	118.0
	12250796	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	59.0	CHEMBL2742	Homo sapiens	Residual Activity	%	59.0
	12250797	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	115.0	CHEMBL2742	Homo sapiens	Residual Activity	%	115.0
	12250798	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	123.0	CHEMBL2742	Homo sapiens	Residual Activity	%	123.0
	12250799	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250800	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	117.0	CHEMBL2742	Homo sapiens	Residual Activity	%	117.0
	12250801	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	111.0	CHEMBL2742	Homo sapiens	Residual Activity	%	111.0
	12250802	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	97.0	CHEMBL2742	Homo sapiens	Residual Activity	%	97.0
	12250803	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	110.0	CHEMBL2742	Homo sapiens	Residual Activity	%	110.0
	12250804	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	86.0	CHEMBL2742	Homo sapiens	Residual Activity	%	86.0
	12250805	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	110.0	CHEMBL2742	Homo sapiens	Residual Activity	%	110.0
	12250806	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	98.0	CHEMBL2742	Homo sapiens	Residual Activity	%	98.0
	12250807	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12250808	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	46.0	CHEMBL2742	Homo sapiens	Residual Activity	%	46.0
	12250809	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12250810	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	123.0	CHEMBL2742	Homo sapiens	Residual Activity	%	123.0
	12250811	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12250812	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	80.0	CHEMBL2742	Homo sapiens	Residual Activity	%	80.0
	12250813	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	125.0	CHEMBL2742	Homo sapiens	Residual Activity	%	125.0
	12250814	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250815	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	63.0	CHEMBL2742	Homo sapiens	Residual Activity	%	63.0
	12250816	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	41.0	CHEMBL2742	Homo sapiens	Residual Activity	%	41.0
	12250817	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	19.0	CHEMBL2742	Homo sapiens	Residual Activity	%	19.0
	12250818	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12250819	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	117.0	CHEMBL2742	Homo sapiens	Residual Activity	%	117.0
	12250820	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	93.0	CHEMBL2742	Homo sapiens	Residual Activity	%	93.0
	12250821	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	122.0	CHEMBL2742	Homo sapiens	Residual Activity	%	122.0
	12250822	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	123.0	CHEMBL2742	Homo sapiens	Residual Activity	%	123.0
	12250823	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL2742	Homo sapiens	Residual Activity	%	98.0
	12250824	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL2742	Homo sapiens	Residual Activity	%	101.0
	12250825	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	96.0	CHEMBL2742	Homo sapiens	Residual Activity	%	96.0
	12250826	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	34.0	CHEMBL2742	Homo sapiens	Residual Activity	%	34.0
	12250827	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12250828	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250829	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	127.0	CHEMBL2742	Homo sapiens	Residual Activity	%	127.0
	12250830	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	89.0	CHEMBL2742	Homo sapiens	Residual Activity	%	89.0
	12250831	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250832	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	122.0	CHEMBL2742	Homo sapiens	Residual Activity	%	122.0
	12250833	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	96.0	CHEMBL2742	Homo sapiens	Residual Activity	%	96.0
	12250834	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	78.0	CHEMBL2742	Homo sapiens	Residual Activity	%	78.0
	12250835	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	85.0	CHEMBL2742	Homo sapiens	Residual Activity	%	85.0
	12250836	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	83.0	CHEMBL2742	Homo sapiens	Residual Activity	%	83.0
	12250837	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	94.0	CHEMBL2742	Homo sapiens	Residual Activity	%	94.0
	12250838	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	97.0	CHEMBL2742	Homo sapiens	Residual Activity	%	97.0
	12250839	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12250840	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	74.0	CHEMBL2742	Homo sapiens	Residual Activity	%	74.0
	12250841	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	111.0	CHEMBL2742	Homo sapiens	Residual Activity	%	111.0
	12250842	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	8.0	CHEMBL2742	Homo sapiens	Residual Activity	%	8.0
	12250843	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	117.0	CHEMBL2742	Homo sapiens	Residual Activity	%	117.0
	12250844	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL2742	Homo sapiens	Residual Activity	%	3.0
	12250845	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	92.0	CHEMBL2742	Homo sapiens	Residual Activity	%	92.0
	12250846	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	29.0	CHEMBL2742	Homo sapiens	Residual Activity	%	29.0
	12250847	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250848	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL2742	Homo sapiens	Residual Activity	%	96.0
	12250849	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250850	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	117.0	CHEMBL2742	Homo sapiens	Residual Activity	%	117.0
	12250851	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	105.0	CHEMBL2742	Homo sapiens	Residual Activity	%	105.0
	12250852	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	115.0	CHEMBL2742	Homo sapiens	Residual Activity	%	115.0
	12250853	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250854	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	20.0	CHEMBL2742	Homo sapiens	Residual Activity	%	20.0
	12250855	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	129.0	CHEMBL2742	Homo sapiens	Residual Activity	%	129.0
	12250856	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12250857	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	34.0	CHEMBL2742	Homo sapiens	Residual Activity	%	34.0
	12250858	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	114.0	CHEMBL2742	Homo sapiens	Residual Activity	%	114.0
	12250859	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	123.0	CHEMBL2742	Homo sapiens	Residual Activity	%	123.0
	12250860	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12250861	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	121.0	CHEMBL2742	Homo sapiens	Residual Activity	%	121.0
	12250862	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	118.0	CHEMBL2742	Homo sapiens	Residual Activity	%	118.0
	12250863	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	107.0	CHEMBL2742	Homo sapiens	Residual Activity	%	107.0
	12250864	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	97.0	CHEMBL2742	Homo sapiens	Residual Activity	%	97.0
	12250865	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	76.0	CHEMBL2742	Homo sapiens	Residual Activity	%	76.0
	12250866	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	17.0	CHEMBL2742	Homo sapiens	Residual Activity	%	17.0
	12250867	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	100.0	CHEMBL2742	Homo sapiens	Residual Activity	%	100.0
	12250868	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	82.0	CHEMBL2742	Homo sapiens	Residual Activity	%	82.0
	12250869	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	125.0	CHEMBL2742	Homo sapiens	Residual Activity	%	125.0
	12250870	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	111.0	CHEMBL2742	Homo sapiens	Residual Activity	%	111.0
	12250871	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250872	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	96.0	CHEMBL2742	Homo sapiens	Residual Activity	%	96.0
	12250873	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	139.0	CHEMBL2742	Homo sapiens	Residual Activity	%	139.0
	12250874	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	127.0	CHEMBL2742	Homo sapiens	Residual Activity	%	127.0
	12250875	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	109.0	CHEMBL2742	Homo sapiens	Residual Activity	%	109.0
	12250876	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	121.0	CHEMBL2742	Homo sapiens	Residual Activity	%	121.0
	12250877	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250878	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	105.0	CHEMBL2742	Homo sapiens	Residual Activity	%	105.0
	12250879	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	129.0	CHEMBL2742	Homo sapiens	Residual Activity	%	129.0
	12250880	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	135.0	CHEMBL2742	Homo sapiens	Residual Activity	%	135.0
	12250881	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	81.0	CHEMBL2742	Homo sapiens	Residual Activity	%	81.0
	12250882	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	125.0	CHEMBL2742	Homo sapiens	Residual Activity	%	125.0
	12250883	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	120.0	CHEMBL2742	Homo sapiens	Residual Activity	%	120.0
	12250884	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	132.0	CHEMBL2742	Homo sapiens	Residual Activity	%	132.0
	12250885	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12250886	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12250887	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12250888	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	106.0	CHEMBL2742	Homo sapiens	Residual Activity	%	106.0
	12250889	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	22.0	CHEMBL2742	Homo sapiens	Residual Activity	%	22.0
	12250890	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	124.0	CHEMBL2742	Homo sapiens	Residual Activity	%	124.0
	12250891	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	98.0	CHEMBL2742	Homo sapiens	Residual Activity	%	98.0
	12250892	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	132.0	CHEMBL2742	Homo sapiens	Residual Activity	%	132.0
	12250893	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	98.0	CHEMBL2742	Homo sapiens	Residual Activity	%	98.0
	12250894	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL2742	Homo sapiens	Residual Activity	%	3.0
	12250895	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	103.0	CHEMBL2742	Homo sapiens	Residual Activity	%	103.0
	12250896	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250897	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	72.0	CHEMBL2742	Homo sapiens	Residual Activity	%	72.0
	12250898	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12250899	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	53.0	CHEMBL2742	Homo sapiens	Residual Activity	%	53.0
	12250900	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL2742	Homo sapiens	Residual Activity	%	92.0
	12250901	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	123.0	CHEMBL2742	Homo sapiens	Residual Activity	%	123.0
	12250902	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	49.0	CHEMBL2742	Homo sapiens	Residual Activity	%	49.0
	12250903	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	59.0	CHEMBL2742	Homo sapiens	Residual Activity	%	59.0
	12250904	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250905	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	102.0	CHEMBL2742	Homo sapiens	Residual Activity	%	102.0
	12250906	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	108.0	CHEMBL2742	Homo sapiens	Residual Activity	%	108.0
	12250907	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	98.0	CHEMBL2742	Homo sapiens	Residual Activity	%	98.0
	12250908	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	90.0	CHEMBL2742	Homo sapiens	Residual Activity	%	90.0
	12250909	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	116.0	CHEMBL2742	Homo sapiens	Residual Activity	%	116.0
	12250910	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250911	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	84.0	CHEMBL2742	Homo sapiens	Residual Activity	%	84.0
	12250912	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	112.0	CHEMBL2742	Homo sapiens	Residual Activity	%	112.0
	12250913	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	113.0	CHEMBL2742	Homo sapiens	Residual Activity	%	113.0
	12250914	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	88.0	CHEMBL2742	Homo sapiens	Residual Activity	%	88.0
	12250915	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	61.0	CHEMBL2742	Homo sapiens	Residual Activity	%	61.0
	12250916	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	103.0	CHEMBL2742	Homo sapiens	Residual Activity	%	103.0
	12250917	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	95.0	CHEMBL2742	Homo sapiens	Residual Activity	%	95.0
	12250918	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	104.0	CHEMBL2742	Homo sapiens	Residual Activity	%	104.0
	12250919	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	121.0	CHEMBL2742	Homo sapiens	Residual Activity	%	121.0
	12250920	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	54.0	CHEMBL2742	Homo sapiens	Residual Activity	%	54.0
	12250921	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	121.0	CHEMBL2742	Homo sapiens	Residual Activity	%	121.0
	12250922	CHEMBL2219066	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	38.0	CHEMBL2742	Homo sapiens	Residual Activity	%	38.0
	12250923	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	99.0	CHEMBL2742	Homo sapiens	Residual Activity	%	99.0
	12250924	CHEMBL2219067	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	4.0	CHEMBL2742	Homo sapiens	Residual Activity	%	4.0
	12626721	CHEMBL2316995	Inhibition of FGFR3 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL2742	Homo sapiens	INH	%	95.0
	12650029	CHEMBL2327558	Inhibition of FGFR3 (unknown origin) relative to control	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	=	Inhibition	%	60.0	CHEMBL2742	Homo sapiens	INH	%	60.0
	12693266	CHEMBL2343950	Inhibition of FGFR3 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	12718789	CHEMBL2350675	Inhibition of FGFR3 (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	25.0	CHEMBL2742	Homo sapiens	IC50	nM	25.0
	12718813	CHEMBL2350697	Inhibition of FGFR3 (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	44.0	CHEMBL2742	Homo sapiens	INH	%	44.0
	12718836	CHEMBL2350989	Inhibition of FGFR3 (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	65.0	CHEMBL2742	Homo sapiens	INH	%	65.0
	12728083	CHEMBL2351298	Inhibition of FGFR3 (unknown origin) incubated for 5 mins prior to ATP addition measured after 10 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	12728833	CHEMBL2352906	Inhibition of FGFR3 K650E mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	92.0	CHEMBL2742	Homo sapiens	Activity	%	92.0
	12728834	CHEMBL2352907	Inhibition of FGFR3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	90.0	CHEMBL2742	Homo sapiens	Activity	%	90.0
	12729078	CHEMBL2352256	Inhibition of FGFR3 K650E mutant (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL2742	Homo sapiens	Activity	%	96.0
	12729079	CHEMBL2352257	Inhibition of FGFR3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL2742	Homo sapiens	Activity	%	95.0
	12729959	CHEMBL2352195	Inhibition of FGFR3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	91.0	CHEMBL2742	Homo sapiens	Activity	%	91.0
	12730221	CHEMBL2352906	Inhibition of FGFR3 K650E mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL2742	Homo sapiens	Activity	%	92.0
	12730222	CHEMBL2352907	Inhibition of FGFR3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	89.0	CHEMBL2742	Homo sapiens	Activity	%	89.0
Not Active	13335988	CHEMBL2394044	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	13335989	CHEMBL2394044	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	13336050	CHEMBL2394068	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	13336051	CHEMBL2394068	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	13336052	CHEMBL2394068	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	13365768	CHEMBL2406314	Inhibition of TEL-fused FGFR3 (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	13367219	CHEMBL2406340	Inhibition of FGFR3 (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	430.0	CHEMBL2742	Homo sapiens	IC50	uM	0.43
	13375863	CHEMBL2405125	Inhibition of FGFR3 K650E mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL2742	Homo sapiens	INH	%	2.0
	13375864	CHEMBL2405128	Inhibition of FGFR3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-3.0	CHEMBL2742	Homo sapiens	INH	%	-3.0
	13419616	CHEMBL2422078	Inhibition of FGFR3 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	13419617	CHEMBL2422078	Inhibition of FGFR3 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	7.0	CHEMBL2742	Homo sapiens	INH	%	7.0
	13419618	CHEMBL2422078	Inhibition of FGFR3 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	7.0	CHEMBL2742	Homo sapiens	INH	%	7.0
	13439846	CHEMBL2427147	Competitive binding affinity to FGFR3 G697C mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13442357	CHEMBL2427789	Competitive binding affinity to FGFR3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13445383	CHEMBL2427147	Competitive binding affinity to FGFR3 G697C mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13445492	CHEMBL2427789	Competitive binding affinity to FGFR3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	74.0	CHEMBL2742	Homo sapiens	INH	%	74.0
	13445679	CHEMBL2427147	Competitive binding affinity to FGFR3 G697C mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13448547	CHEMBL2427789	Competitive binding affinity to FGFR3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13448683	CHEMBL2427789	Competitive binding affinity to FGFR3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13451478	CHEMBL2427789	Competitive binding affinity to FGFR3 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13451666	CHEMBL2427147	Competitive binding affinity to FGFR3 G697C mutant (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13454663	CHEMBL2427789	Competitive binding affinity to FGFR3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	13840829	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1		CHEMBL3091590	=	Inhibition	%	3.0	CHEMBL2742	Homo sapiens	INH	%	3.0
	13840830	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1		CHEMBL3091590	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840831	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1		CHEMBL3091590	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840856	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1		CHEMBL3091589	=	Inhibition	%	12.0	CHEMBL2742	Homo sapiens	INH	%	12.0
	13840857	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1		CHEMBL3091589	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840858	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1		CHEMBL3091589	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840883	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL3091588	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840884	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL3091588	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840885	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL3091588	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840910	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1		CHEMBL3091587	=	Inhibition	%	16.0	CHEMBL2742	Homo sapiens	INH	%	16.0
	13840911	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1		CHEMBL3091587	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840912	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1		CHEMBL3091587	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840937	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O		CHEMBL3091603	=	Inhibition	%	6.0	CHEMBL2742	Homo sapiens	INH	%	6.0
	13840938	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O		CHEMBL3091603	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840939	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O		CHEMBL3091603	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840964	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1		CHEMBL3091602	=	Inhibition	%	9.0	CHEMBL2742	Homo sapiens	INH	%	9.0
	13840965	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1		CHEMBL3091602	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840966	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1		CHEMBL3091602	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840991	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Inhibition	%	16.0	CHEMBL2742	Homo sapiens	INH	%	16.0
	13840992	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13840993	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13841889	CHEMBL3095517	Inhibition of FGFR3 (unknown origin) at 75 uM relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13841890	CHEMBL3095518	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13841891	CHEMBL3095519	Inhibition of FGFR3 (unknown origin) at 0.5 uM relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13872145	CHEMBL3101770	Inhibition of human FGFR3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	126.0	CHEMBL2742	Homo sapiens	Activity	%	126.0
	13948213	CHEMBL3132620	Inhibition of FGFR3 (unknown origin) using biotinylated poly-Glu-Tyr (4:1) as substrate preincubated for 5 mins measured after 12 hrs	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	280.0	CHEMBL2742	Homo sapiens	IC50	nmol/L	280.0
	13953377	CHEMBL3130936	Inhibition of human FGFR3 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	79.0	CHEMBL2742	Homo sapiens	Activity	%	79.0
	13954728	CHEMBL3130936	Inhibition of human FGFR3 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	80.0	CHEMBL2742	Homo sapiens	Activity	%	80.0
	13954762	CHEMBL3130936	Inhibition of human FGFR3 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	62.0	CHEMBL2742	Homo sapiens	Activity	%	62.0
	13965707	CHEMBL3135919	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	27.5	CHEMBL2742	Homo sapiens	INH	%	27.5
	13966085	CHEMBL3137073	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	63.5	CHEMBL2742	Homo sapiens	INH	%	63.5
	13973987	CHEMBL3135887	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	5.5	CHEMBL2742	Homo sapiens	INH	%	5.5
	13974078	CHEMBL3134916	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13974169	CHEMBL3136506	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	43.5	CHEMBL2742	Homo sapiens	INH	%	43.5
	13974260	CHEMBL3136116	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	30.5	CHEMBL2742	Homo sapiens	INH	%	30.5
	13974998	CHEMBL3135294	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	95.0	CHEMBL2742	Homo sapiens	INH	%	95.0
	13975089	CHEMBL3136861	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	3.5	CHEMBL2742	Homo sapiens	INH	%	3.5
	13975180	CHEMBL3135634	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13975271	CHEMBL3137154	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13975914	CHEMBL3136281	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	0.5	CHEMBL2742	Homo sapiens	INH	%	0.5
	13976007	CHEMBL3136432	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	13976098	CHEMBL3136769	Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	27.0	CHEMBL2742	Homo sapiens	INH	%	27.0
	14582499	CHEMBL3242351	Inhibition of human FGFR3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	111.5	CHEMBL2742	Homo sapiens	Activity	%	111.5
	14659355	CHEMBL3267566	Inhibition of FGFR3 (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	8.0	CHEMBL2742	Homo sapiens	INH	%	8.0
	14659356	CHEMBL3267566	Inhibition of FGFR3 (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	1.0	CHEMBL2742	Homo sapiens	INH	%	1.0
	14713698	CHEMBL3296763	Binding affinity to FGFR3 (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	89.0	CHEMBL2742	Homo sapiens	Ki	uM	0.089
	14713744	CHEMBL3296852	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	91.0	CHEMBL2742	Homo sapiens	INH	%	91.0
Not Determined	14713756	CHEMBL3296763	Binding affinity to FGFR3 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL2742	Homo sapiens	Ki		
	15009785	CHEMBL3361648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	3.5	CHEMBL2742	Homo sapiens	INH	%	3.5
	15018594	CHEMBL3362258	Inhibition of FGFR3 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	12.9	CHEMBL2742	Homo sapiens	INH	%	12.9
	15091093	CHEMBL3381536	Inhibition of human recombinant FGFR3 kinase using Ulight-CAGAGAIETDKEYYTVKD substrate assessed as remaining enzyme activity at 1 uM after 90 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	82.0	CHEMBL2742	Homo sapiens	Activity	%	82.0
	15112135	CHEMBL3388147	Inhibition of FGFR3 (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	>	IC50	nM	5741.0	CHEMBL2742	Homo sapiens	IC50	nM	5741.0
	15149983	CHEMBL3395928	Inhibition of FGFR3 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149984	CHEMBL3395928	Inhibition of FGFR3 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149985	CHEMBL3395928	Inhibition of FGFR3 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149986	CHEMBL3395928	Inhibition of FGFR3 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149987	CHEMBL3395928	Inhibition of FGFR3 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149988	CHEMBL3395929	Inhibition of FGFR3 K650E (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149989	CHEMBL3395929	Inhibition of FGFR3 K650E (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149990	CHEMBL3395929	Inhibition of FGFR3 K650E (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149991	CHEMBL3395929	Inhibition of FGFR3 K650E (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15149992	CHEMBL3395929	Inhibition of FGFR3 K650E (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	15165347	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3c[nH]c4cccc(Br)c34)[nH]c2n1		CHEMBL3401370	=	IC50	nM	18360.0	CHEMBL2742	Homo sapiens	IC50	uM	18.36
	15165348	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3c[nH]c4ccccc34)[nH]c2n1		CHEMBL3401369	=	IC50	nM	19640.0	CHEMBL2742	Homo sapiens	IC50	uM	19.64
	15165349	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3ccc(C)cc3C)[nH]c2n1		CHEMBL3401368	=	IC50	nM	19580.0	CHEMBL2742	Homo sapiens	IC50	uM	19.58
	15165350	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cccc(-c2nc3c(O)nc(NC(C)=O)nc3[nH]2)c1OC		CHEMBL3401367	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165351	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	COc1ccccc1-c1nc2c(O)nc(NC(C)=O)nc2[nH]1		CHEMBL3401366	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165352	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3ccccc3)[nH]c2n1		CHEMBL3401365	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165353	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3c[nH]c4cccc(Br)c34)[nH]c2n1		CHEMBL3401364	=	IC50	nM	19830.0	CHEMBL2742	Homo sapiens	IC50	uM	19.83
	15165354	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3c[nH]c4ccccc34)[nH]c2n1		CHEMBL3401363	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165355	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	Cc1ccc(-c2nc3c(O)nc(N)nc3[nH]2)c(C)c1		CHEMBL3401362	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165356	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cccc(-c2nc3c(O)nc(N)nc3[nH]2)c1OC		CHEMBL3401361	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165357	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	COc1ccccc1-c1nc2c(O)nc(N)nc2[nH]1		CHEMBL3401360	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165358	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3ccccc3)[nH]c2n1		CHEMBL3401359	>	IC50	nM	20000.0	CHEMBL2742	Homo sapiens	IC50	uM	20.0
	15165359	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	290.0	CHEMBL2742	Homo sapiens	IC50	uM	0.29
	15165360	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	CN1CCN(c2ccc(-c3nc4c(N5CCN(CC(=O)Nc6nccs6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3401358	=	IC50	nM	71.0	CHEMBL2742	Homo sapiens	IC50	uM	0.071
	15165361	CHEMBL3404250	Inhibition of FGFR3 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	27.0	CHEMBL2742	Homo sapiens	IC50	uM	0.027
	15165393	CHEMBL3404246	Inhibition of FGFR3 (unknown origin)	B	CN1CCN(c2ccc(-c3nc4c(N5CCN(CC(=O)Nc6nccs6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3401358	=	IC50	nM	20.0	CHEMBL2742	Homo sapiens	IC50	nM	20.0
	15193440	CHEMBL3411886	Inhibition of human FGFR3	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	108.0	CHEMBL2742	Homo sapiens	IC50	nM	108.0
	15600666	CHEMBL3578766	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 10 um after 3 days by cell titer-Glo luminescent cell viability assay	B	Cn1nc(-c2ccccc2)c2c(C(F)(F)F)cc(-c3ccc(C(=O)O)cc3)nc21		CHEMBL3578249	=	Inhibition	%	40.0	CHEMBL2742	Homo sapiens	INH	%	40.0
	15600667	CHEMBL3578766	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 10 um after 3 days by cell titer-Glo luminescent cell viability assay	B	O=c1[nH]c2ccc(-c3cc(C(F)(F)F)c4c(-c5ccccc5)n[nH]c4n3)cc2[nH]1		CHEMBL3578248	=	Inhibition	%	19.0	CHEMBL2742	Homo sapiens	INH	%	19.0
	15600668	CHEMBL3578766	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 10 um after 3 days by cell titer-Glo luminescent cell viability assay	B	O=C(c1cccc(-c2cc(C(F)F)c3c(-c4ccccc4)n[nH]c3n2)c1)N1CCCC1		CHEMBL3578247	=	Inhibition	%	90.5	CHEMBL2742	Homo sapiens	INH	%	90.5
	15600669	CHEMBL3578766	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 10 um after 3 days by cell titer-Glo luminescent cell viability assay	B	Cn1nc(-c2ccccc2)c2c(C(F)(F)F)cc(-c3cccc(C(N)=O)c3)nc21		CHEMBL3578246	=	Inhibition	%	41.1	CHEMBL2742	Homo sapiens	INH	%	41.1
	15600670	CHEMBL3578621	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 1 um after 3 days by cell titer-Glo luminescent cell viability assay	B	Cn1nc(-c2ccccc2)c2c(C(F)(F)F)cc(-c3ccc(C(=O)O)cc3)nc21		CHEMBL3578249	=	Inhibition	%	17.0	CHEMBL2742	Homo sapiens	INH	%	17.0
	15600671	CHEMBL3578621	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 1 um after 3 days by cell titer-Glo luminescent cell viability assay	B	O=c1[nH]c2ccc(-c3cc(C(F)(F)F)c4c(-c5ccccc5)n[nH]c4n3)cc2[nH]1	Outside typical range	CHEMBL3578248	=	Inhibition	%	-11.0	CHEMBL2742	Homo sapiens	INH	%	-11.0
	15600672	CHEMBL3578621	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 1 um after 3 days by cell titer-Glo luminescent cell viability assay	B	O=C(c1cccc(-c2cc(C(F)F)c3c(-c4ccccc4)n[nH]c3n2)c1)N1CCCC1		CHEMBL3578247	=	Inhibition	%	26.9	CHEMBL2742	Homo sapiens	INH	%	26.9
	15600673	CHEMBL3578621	Antagonist activity against FGFR3 Ser249Cys mutant in human TCC97-7 cells cultured in serum-supplemented medium assessed as reduction in ATP content at 1 um after 3 days by cell titer-Glo luminescent cell viability assay	B	Cn1nc(-c2ccccc2)c2c(C(F)(F)F)cc(-c3cccc(C(N)=O)c3)nc21		CHEMBL3578246	=	Inhibition	%	10.9	CHEMBL2742	Homo sapiens	INH	%	10.9
	15616275	CHEMBL3583123	Inhibition of Tel-fused FGFR3 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	5000.0	CHEMBL2742	Homo sapiens	IC50	uM	5.0
	15616276	CHEMBL3583123	Inhibition of Tel-fused FGFR3 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	4900.0	CHEMBL2742	Homo sapiens	IC50	uM	4.9
	15616277	CHEMBL3583123	Inhibition of Tel-fused FGFR3 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1		CHEMBL3582439	=	IC50	nM	9500.0	CHEMBL2742	Homo sapiens	IC50	uM	9.5
	15616278	CHEMBL3583123	Inhibition of Tel-fused FGFR3 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	3900.0	CHEMBL2742	Homo sapiens	IC50	uM	3.9
	15723387	CHEMBL3619998	Inhibition of FGFR3 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
Not Active	15723388	CHEMBL3619998	Inhibition of FGFR3 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	15723436	CHEMBL3620028	Inhibition of FGFR3 (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10.3	CHEMBL2742	Homo sapiens	IC50	nM	10.3
	15755881	CHEMBL3630658	Inhibition of FGFR3 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	54.0	CHEMBL2742	Homo sapiens	Activity	%	54.0
	15756985	CHEMBL3630498	Inhibition of FGFR3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	72.27	CHEMBL2742	Homo sapiens	INH	%	72.27
	15757738	CHEMBL3630498	Inhibition of FGFR3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	51.25	CHEMBL2742	Homo sapiens	INH	%	51.25
	15758717	CHEMBL3630498	Inhibition of FGFR3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	8.78	CHEMBL2742	Homo sapiens	INH	%	8.78
273876	16305103	CHEMBL3707723	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	15.59	CHEMBL2742	Homo sapiens	IC50	nM	15.59
273843	16340912	CHEMBL3707723	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	=	IC50	nM	8998.0	CHEMBL2742	Homo sapiens	IC50	nM	8998.0
	16413449	CHEMBL3743695	Inhibition of FGFR3 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16417160	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	16417161	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	16417162	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	16417163	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	16417164	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	3.0	CHEMBL2742	Homo sapiens	INH	%	3.0
	16417165	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	9.0	CHEMBL2742	Homo sapiens	INH	%	9.0
	16417166	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	4.0	CHEMBL2742	Homo sapiens	INH	%	4.0
	16417167	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	7.0	CHEMBL2742	Homo sapiens	INH	%	7.0
	16417168	CHEMBL3750648	Inhibition of FGFR3 (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	7.0	CHEMBL2742	Homo sapiens	INH	%	7.0
	16421911	CHEMBL3750393	Inhibition of FGFR3 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16421965	CHEMBL3749784	Inhibition of FGFR3 K650E mutant (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16425408	CHEMBL3749851	Inhibition of FGFR3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.8	CHEMBL2742	Homo sapiens	INH	%	1.8
	16429055	CHEMBL3750793	Inhibition of FGFR3 (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	5.0	CHEMBL2742	Homo sapiens	INH	%	5.0
	16431834	CHEMBL3748188	Inhibition of human FGFR3 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	5000.0	CHEMBL2742	Homo sapiens	IC50	uM	5.0
	16450843	CHEMBL3762699	Inhibition of FGFR3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	18.4	CHEMBL2742	Homo sapiens	INH	%	18.4
	16450844	CHEMBL3762700	Inhibition of FGFR3 K650E mutant (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	38.8	CHEMBL2742	Homo sapiens	INH	%	38.8
	16465831	CHEMBL3767844	Inhibition of human FGFR3 at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	14.89	CHEMBL2742	Homo sapiens	INH	%	14.89
	16485726	CHEMBL3771575	Inhibition of human recombinant FGFR3 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	16495995	CHEMBL3779690	Inhibition of N-terminal His6-tagged recombinant human FGFR3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-9.0	CHEMBL2742	Homo sapiens	Activity	%	-9.0
	16508182	CHEMBL3779690	Inhibition of N-terminal His6-tagged recombinant human FGFR3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	2.0	CHEMBL2742	Homo sapiens	Activity	%	2.0
	16509159	CHEMBL3779690	Inhibition of N-terminal His6-tagged recombinant human FGFR3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	3.0	CHEMBL2742	Homo sapiens	Activity	%	3.0
Not Active	16514125	CHEMBL3782173	Inhibition of partial length human FGFR3 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	16540783	CHEMBL3789986	Inhibition of FGFR3 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16540784	CHEMBL3789986	Inhibition of FGFR3 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16540785	CHEMBL3789986	Inhibition of FGFR3 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16540786	CHEMBL3789986	Inhibition of FGFR3 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16540787	CHEMBL3789987	Inhibition of FGFR3-K650E mutant (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16540788	CHEMBL3789987	Inhibition of FGFR3-K650E mutant (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16540789	CHEMBL3789987	Inhibition of FGFR3-K650E mutant (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	2500.0	CHEMBL2742	Homo sapiens	IC50	uM	2.5
	16540790	CHEMBL3789987	Inhibition of FGFR3-K650E mutant (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	16575580	CHEMBL3802392	Inhibition of human FGFR3 at 10 uM measured after 40 mins by scintillation counting	B	CNC(=O)c1cc(Oc2ccc3nc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)sc3c2)ccn1		CHEMBL3797601	<	Inhibition	%	40.0	CHEMBL2742	Homo sapiens	INH	%	40.0
	16580858	CHEMBL3804521	Inhibition of recombinant FGFR3 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	=	IC50	nM	5.0	CHEMBL2742	Homo sapiens	IC50	nM	5.0
	16580859	CHEMBL3804521	Inhibition of recombinant FGFR3 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	5.6	CHEMBL2742	Homo sapiens	IC50	nM	5.6
	16580871	CHEMBL3804530	Inhibition of FGFR3 in human RT112 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	<	IC50	nM	0.2	CHEMBL2742	Homo sapiens	IC50	nM	0.2
	16580872	CHEMBL3804530	Inhibition of FGFR3 in human RT112 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.6	CHEMBL2742	Homo sapiens	IC50	nM	0.6
	16594889	CHEMBL3812429	Inhibition of human FGFR3 (442 to 771 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	93.0	CHEMBL2742	Homo sapiens	Activity	%	93.0
	16614477	CHEMBL3816607	Inhibition of human FGFR3 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-8.0	CHEMBL2742	Homo sapiens	INH	%	-8.0
	16618218	CHEMBL3816336	Inhibition of recombinant human His-tagged cytoplasmic FGFR3 (399 to 806 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	16621508	CHEMBL3820493	Inhibition of FGFR3 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL2742	Homo sapiens	IC50	nM	30000.0
	16622215	CHEMBL3820493	Inhibition of FGFR3 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.6	CHEMBL2742	Homo sapiens	IC50	nM	15.6
	16653337	CHEMBL3830173	Inhibition of recombinant human FGFR3 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	=	IC50	nM	2.0	CHEMBL2742	Homo sapiens	IC50	nM	2.0
	16671136	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(NC(=O)Nc2cccc3c(Nc4cc(OC)cc(OC)c4)ncnc23)cc(OC)c1		CHEMBL3943655	=	Inhibition	%	13.7	CHEMBL2742	Homo sapiens	INH	%	13.7
	16671137	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cccc(Oc5ccccc5)c4)cccc23)cc(OC)c1		CHEMBL3973156	=	Inhibition	%	18.1	CHEMBL2742	Homo sapiens	INH	%	18.1
	16671138	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(C)cc4C)cccc23)cc(OC)c1		CHEMBL3952368	=	Inhibition	%	13.0	CHEMBL2742	Homo sapiens	INH	%	13.0
	16671139	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(C)c(C)c4)cccc23)cc(OC)c1		CHEMBL3981155	=	Inhibition	%	17.0	CHEMBL2742	Homo sapiens	INH	%	17.0
	16671140	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccccc4Cl)cccc23)cc(OC)c1		CHEMBL3925791	=	Inhibition	%	8.9	CHEMBL2742	Homo sapiens	INH	%	8.9
	16671141	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cccc(Cl)c4Cl)cccc23)cc(OC)c1		CHEMBL3953416	=	Inhibition	%	12.4	CHEMBL2742	Homo sapiens	INH	%	12.4
	16671142	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cc(Cl)cc(Cl)c4)cccc23)cc(OC)c1		CHEMBL3934679	=	Inhibition	%	10.6	CHEMBL2742	Homo sapiens	INH	%	10.6
	16671143	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cc(Cl)c(Cl)cc4Cl)cccc23)cc(OC)c1		CHEMBL3962166	=	Inhibition	%	8.1	CHEMBL2742	Homo sapiens	INH	%	8.1
	16671144	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cc(F)cc(F)c4)cccc23)cc(OC)c1		CHEMBL3907784	=	Inhibition	%	11.9	CHEMBL2742	Homo sapiens	INH	%	11.9
	16671145	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cccc23)cc(OC)c1		CHEMBL3935740	=	Inhibition	%	12.6	CHEMBL2742	Homo sapiens	INH	%	12.6
	16671146	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(F)cc4C(F)(F)F)cccc23)cc(OC)c1		CHEMBL3912014	=	Inhibition	%	10.1	CHEMBL2742	Homo sapiens	INH	%	10.1
	16671147	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cccc23)cc(OC)c1		CHEMBL3981962	=	Inhibition	%	18.2	CHEMBL2742	Homo sapiens	INH	%	18.2
	16671148	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc([N+](=O)[O-])cc4)cccc23)cc(OC)c1		CHEMBL3920959	=	Inhibition	%	9.6	CHEMBL2742	Homo sapiens	INH	%	9.6
	16671149	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(C(F)(F)F)cc4[N+](=O)[O-])cccc23)cc(OC)c1		CHEMBL3910364	=	Inhibition	%	10.1	CHEMBL2742	Homo sapiens	INH	%	10.1
	16671150	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc5c(c4)OCCO5)cccc23)cc(OC)c1		CHEMBL3936980	=	Inhibition	%	10.6	CHEMBL2742	Homo sapiens	INH	%	10.6
	16671151	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cccc(C)c4C)cccc23)cc(OC)c1		CHEMBL3901923	=	Inhibition	%	11.1	CHEMBL2742	Homo sapiens	INH	%	11.1
	16671152	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cc(C)cc(C)c4)cccc23)cc(OC)c1		CHEMBL3938885	=	Inhibition	%	13.8	CHEMBL2742	Homo sapiens	INH	%	13.8
	16671153	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cccc(Cc5ccccc5)c4)cccc23)cc(OC)c1		CHEMBL3910944	=	Inhibition	%	8.0	CHEMBL2742	Homo sapiens	INH	%	8.0
	16671154	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(Cl)cc4)cccc23)cc(OC)c1		CHEMBL3947680	=	Inhibition	%	14.8	CHEMBL2742	Homo sapiens	INH	%	14.8
	16671155	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(Cl)cc4Cl)cccc23)cc(OC)c1		CHEMBL3919890	=	Inhibition	%	11.2	CHEMBL2742	Homo sapiens	INH	%	11.2
	16671156	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(Cl)c(Cl)c4)cccc23)cc(OC)c1		CHEMBL3951422	=	Inhibition	%	12.0	CHEMBL2742	Homo sapiens	INH	%	12.0
	16671157	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(F)cc4F)cccc23)cc(OC)c1		CHEMBL3980358	=	Inhibition	%	11.6	CHEMBL2742	Homo sapiens	INH	%	11.6
	16671158	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(C(F)(F)F)cc4)cccc23)cc(OC)c1		CHEMBL3942678	=	Inhibition	%	17.7	CHEMBL2742	Homo sapiens	INH	%	17.7
	16671159	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4ccc(C(F)(F)F)cc4Cl)cccc23)cc(OC)c1		CHEMBL3972295	=	Inhibition	%	12.0	CHEMBL2742	Homo sapiens	INH	%	12.0
	16671160	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)Nc4cccc(C(F)(F)F)c4F)cccc23)cc(OC)c1		CHEMBL3971215	=	Inhibition	%	8.5	CHEMBL2742	Homo sapiens	INH	%	8.5
	16671161	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	CCOC(=O)c1ccc(NC(=O)Nc2cccc3c(Nc4cc(OC)cc(OC)c4)ncnc23)cc1		CHEMBL3900062	=	Inhibition	%	8.2	CHEMBL2742	Homo sapiens	INH	%	8.2
	16671162	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	Inhibition	%	99.9	CHEMBL2742	Homo sapiens	INH	%	99.9
	16671163	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)cccc23)cc(OC)c1		CHEMBL3933670	=	Inhibition	%	12.5	CHEMBL2742	Homo sapiens	INH	%	12.5
	16671164	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)c4cccc(N5CCN(C)CC5)c4)cccc23)cc(OC)c1		CHEMBL3918047	=	Inhibition	%	16.8	CHEMBL2742	Homo sapiens	INH	%	16.8
	16671165	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)c4ccc(CN(C)C)cc4)cccc23)cc(OC)c1		CHEMBL3967611	=	Inhibition	%	12.5	CHEMBL2742	Homo sapiens	INH	%	12.5
	16671166	CHEMBL3855404	Inhibition of human FGFR3 kinase domain (436 to 806 residues) assessed as reduction in ULight-poly GT substrate phosphorylation at 10 uM after 1 hr in presence of ATP by TR-FRET assay	B	COc1cc(Nc2ncnc3c(NC(=O)c4cc(=O)c5ccccc5o4)cccc23)cc(OC)c1		CHEMBL3938003	=	Inhibition	%	18.6	CHEMBL2742	Homo sapiens	INH	%	18.6
	16737937	CHEMBL3856654	Inhibition of recombinant human FGFR3 expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	72.0	CHEMBL2742	Homo sapiens	Activity	%	72.0
	16760012	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	=	IC50	nM	230.0	CHEMBL2742	Homo sapiens	IC50	nM	230.0
	16760013	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1ccc2cc(C(=O)c3cnn(-c4ccc5nc(C)[nH]c5c4)c3N)[nH]c2c1		CHEMBL3895337	=	IC50	nM	180.0	CHEMBL2742	Homo sapiens	IC50	nM	180.0
	16760014	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
	16760015	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	68.0	CHEMBL2742	Homo sapiens	IC50	nM	68.0
	16760016	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	130.0	CHEMBL2742	Homo sapiens	IC50	nM	130.0
	16760017	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	3.5	CHEMBL2742	Homo sapiens	IC50	nM	3.5
	16760018	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5cc(CN6CCOCC6)ccc5[nH]4)c3N)cc2[nH]1		CHEMBL3891894	=	IC50	nM	4.4	CHEMBL2742	Homo sapiens	IC50	nM	4.4
	16760019	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(=O)[nH]c2c1		CHEMBL3952373	>	IC50	nM	50000.0	CHEMBL2742	Homo sapiens	IC50	nM	50000.0
	16760020	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3959997	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
	16760021	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]ccc2c1		CHEMBL3941474	=	IC50	nM	270.0	CHEMBL2742	Homo sapiens	IC50	nM	270.0
	16760022	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	79.0	CHEMBL2742	Homo sapiens	IC50	nM	79.0
	16760023	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	22.0	CHEMBL2742	Homo sapiens	IC50	nM	22.0
	16760024	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2nc[nH]c2c1		CHEMBL3934547	=	IC50	nM	120.0	CHEMBL2742	Homo sapiens	IC50	nM	120.0
	16760025	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3cc(CN4CCOCC4)ccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3984621	=	IC50	nM	4.0	CHEMBL2742	Homo sapiens	IC50	nM	4.0
	16760026	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccccc1Cl		CHEMBL3956001	=	IC50	nM	4800.0	CHEMBL2742	Homo sapiens	IC50	nM	4800.0
	16760027	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3976548	=	IC50	nM	25.0	CHEMBL2742	Homo sapiens	IC50	nM	25.0
	16760028	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2ccc3ncccc3c2)cnn1-c1cc(O)ccc1Cl		CHEMBL3947281	=	IC50	nM	720.0	CHEMBL2742	Homo sapiens	IC50	nM	720.0
	16760029	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3o2)cnn1-c1cc(O)ccc1Cl		CHEMBL3981956	=	IC50	nM	940.0	CHEMBL2742	Homo sapiens	IC50	nM	940.0
	16760030	CHEMBL3861872	Inhibition of human FGFR3 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cccc(C(=O)c2cnn(-c3cc(O)ccc3Cl)c2N)c1		CHEMBL3905685	=	IC50	nM	7400.0	CHEMBL2742	Homo sapiens	IC50	nM	7400.0
Active	16760158	CHEMBL3861902	Binding affinity to wild type human partial length FGFR3 expressed in bacterial system at 100 nM by KINOMEscan panel assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479		Activity			CHEMBL2742	Homo sapiens	Activity		
	16867364	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	=	IC50	nM	245.47	CHEMBL2742	Homo sapiens	pIC50		6.61
	16867365	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	=	IC50	nM	371.54	CHEMBL2742	Homo sapiens	pIC50		6.43
	16867366	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	=	IC50	nM	2290.87	CHEMBL2742	Homo sapiens	pIC50		5.64
	16867367	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	=	IC50	nM	2137.96	CHEMBL2742	Homo sapiens	pIC50		5.67
	16867368	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	=	IC50	nM	2884.03	CHEMBL2742	Homo sapiens	pIC50		5.54
	16867369	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	=	IC50	nM	229.09	CHEMBL2742	Homo sapiens	pIC50		6.64
	16867370	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	=	IC50	nM	81.28	CHEMBL2742	Homo sapiens	pIC50		7.09
	16867371	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	=	IC50	nM	707.95	CHEMBL2742	Homo sapiens	pIC50		6.15
	16867372	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	=	IC50	nM	2754.23	CHEMBL2742	Homo sapiens	pIC50		5.56
	16867373	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	=	IC50	nM	1905.46	CHEMBL2742	Homo sapiens	pIC50		5.72
	16867374	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	=	IC50	nM	2187.76	CHEMBL2742	Homo sapiens	pIC50		5.66
	16867375	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867376	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	=	IC50	nM	295.12	CHEMBL2742	Homo sapiens	pIC50		6.53
	16867377	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	=	IC50	nM	977.24	CHEMBL2742	Homo sapiens	pIC50		6.01
	16867378	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	=	IC50	nM	138.04	CHEMBL2742	Homo sapiens	pIC50		6.86
	16867379	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	=	IC50	nM	1047.13	CHEMBL2742	Homo sapiens	pIC50		5.98
	16867380	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16867381	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867382	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867383	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867384	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	707.95	CHEMBL2742	Homo sapiens	pIC50		6.15
	16867385	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	=	IC50	nM	134.9	CHEMBL2742	Homo sapiens	pIC50		6.87
	16867386	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	=	IC50	nM	8128.31	CHEMBL2742	Homo sapiens	pIC50		5.09
	16867387	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	=	IC50	nM	79.43	CHEMBL2742	Homo sapiens	pIC50		7.1
	16867388	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	=	IC50	nM	245.47	CHEMBL2742	Homo sapiens	pIC50		6.61
	16867389	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	=	IC50	nM	5888.44	CHEMBL2742	Homo sapiens	pIC50		5.23
	16867390	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	=	IC50	nM	4570.88	CHEMBL2742	Homo sapiens	pIC50		5.34
	16867391	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867392	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16867393	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	=	IC50	nM	2511.89	CHEMBL2742	Homo sapiens	pIC50		5.6
	16867394	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16867395	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	=	IC50	nM	181.97	CHEMBL2742	Homo sapiens	pIC50		6.74
	16867396	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	=	IC50	nM	776.25	CHEMBL2742	Homo sapiens	pIC50		6.11
	16867397	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	=	IC50	nM	85.11	CHEMBL2742	Homo sapiens	pIC50		7.07
	16867398	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	=	IC50	nM	151.36	CHEMBL2742	Homo sapiens	pIC50		6.82
	16867399	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	=	IC50	nM	275.42	CHEMBL2742	Homo sapiens	pIC50		6.56
	16867400	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	=	IC50	nM	407.38	CHEMBL2742	Homo sapiens	pIC50		6.39
	16867401	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16867402	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	=	IC50	nM	588.84	CHEMBL2742	Homo sapiens	pIC50		6.23
	16867403	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	=	IC50	nM	281.84	CHEMBL2742	Homo sapiens	pIC50		6.55
	16867404	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	=	IC50	nM	676.08	CHEMBL2742	Homo sapiens	pIC50		6.17
	16867405	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867406	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	=	IC50	nM	1778.28	CHEMBL2742	Homo sapiens	pIC50		5.75
	16867407	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	=	IC50	nM	107.15	CHEMBL2742	Homo sapiens	pIC50		6.97
	16867408	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	2089.3	CHEMBL2742	Homo sapiens	pIC50		5.68
	16867409	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16867410	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	=	IC50	nM	707.95	CHEMBL2742	Homo sapiens	pIC50		6.15
	16867411	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	=	IC50	nM	794.33	CHEMBL2742	Homo sapiens	pIC50		6.1
	16867412	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	=	IC50	nM	6760.83	CHEMBL2742	Homo sapiens	pIC50		5.17
	16867413	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	=	IC50	nM	128.82	CHEMBL2742	Homo sapiens	pIC50		6.89
	16867414	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	=	IC50	nM	9120.11	CHEMBL2742	Homo sapiens	pIC50		5.04
	16867415	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16867416	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	=	IC50	nM	112.2	CHEMBL2742	Homo sapiens	pIC50		6.95
	16867417	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	=	IC50	nM	7762.47	CHEMBL2742	Homo sapiens	pIC50		5.11
	16867418	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	=	IC50	nM	1230.27	CHEMBL2742	Homo sapiens	pIC50		5.91
	16867419	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	=	IC50	nM	1949.84	CHEMBL2742	Homo sapiens	pIC50		5.71
	16867420	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16867421	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	1122.02	CHEMBL2742	Homo sapiens	pIC50		5.95
	16867422	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16867423	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	=	IC50	nM	977.24	CHEMBL2742	Homo sapiens	pIC50		6.01
	16867424	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	=	IC50	nM	1698.24	CHEMBL2742	Homo sapiens	pIC50		5.77
	16867425	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	=	IC50	nM	151.36	CHEMBL2742	Homo sapiens	pIC50		6.82
	16867426	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	=	IC50	nM	776.25	CHEMBL2742	Homo sapiens	pIC50		6.11
	16867427	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	=	IC50	nM	1380.38	CHEMBL2742	Homo sapiens	pIC50		5.86
	16867428	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	=	IC50	nM	275.42	CHEMBL2742	Homo sapiens	pIC50		6.56
	16867429	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	=	IC50	nM	812.83	CHEMBL2742	Homo sapiens	pIC50		6.09
	16867430	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	=	IC50	nM	5128.61	CHEMBL2742	Homo sapiens	pIC50		5.29
	16867431	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	=	IC50	nM	158.49	CHEMBL2742	Homo sapiens	pIC50		6.8
	16867432	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	933.25	CHEMBL2742	Homo sapiens	pIC50		6.03
	16867433	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	=	IC50	nM	851.14	CHEMBL2742	Homo sapiens	pIC50		6.07
	16867434	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	=	IC50	nM	776.25	CHEMBL2742	Homo sapiens	pIC50		6.11
	16867435	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	=	IC50	nM	380.19	CHEMBL2742	Homo sapiens	pIC50		6.42
	16867436	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	=	IC50	nM	74.13	CHEMBL2742	Homo sapiens	pIC50		7.13
	16867437	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	=	IC50	nM	128.82	CHEMBL2742	Homo sapiens	pIC50		6.89
	16867438	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	=	IC50	nM	173.78	CHEMBL2742	Homo sapiens	pIC50		6.76
	16867439	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	=	IC50	nM	269.15	CHEMBL2742	Homo sapiens	pIC50		6.57
	16867440	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	=	IC50	nM	125.89	CHEMBL2742	Homo sapiens	pIC50		6.9
	16867441	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	=	IC50	nM	263.03	CHEMBL2742	Homo sapiens	pIC50		6.58
	16867442	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	=	IC50	nM	67.61	CHEMBL2742	Homo sapiens	pIC50		7.17
	16867443	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	=	IC50	nM	131.83	CHEMBL2742	Homo sapiens	pIC50		6.88
	16867444	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867445	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	=	IC50	nM	758.58	CHEMBL2742	Homo sapiens	pIC50		6.12
	16867446	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	=	IC50	nM	85.11	CHEMBL2742	Homo sapiens	pIC50		7.07
	16867447	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921618	=	IC50	nM	13.49	CHEMBL2742	Homo sapiens	pIC50		7.87
	16867448	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16867449	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16867450	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	=	IC50	nM	26.3	CHEMBL2742	Homo sapiens	pIC50		7.58
	16867451	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16867452	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	=	IC50	nM	125.89	CHEMBL2742	Homo sapiens	pIC50		6.9
	16867453	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	=	IC50	nM	120.23	CHEMBL2742	Homo sapiens	pIC50		6.92
	16867454	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	=	IC50	nM	1737.8	CHEMBL2742	Homo sapiens	pIC50		5.76
	16867455	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16867456	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867457	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	=	IC50	nM	645.65	CHEMBL2742	Homo sapiens	pIC50		6.19
	16867458	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	=	IC50	nM	16.98	CHEMBL2742	Homo sapiens	pIC50		7.77
	16867459	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	=	IC50	nM	2089.3	CHEMBL2742	Homo sapiens	pIC50		5.68
	16867460	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867461	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16867462	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	15.85	CHEMBL2742	Homo sapiens	pIC50		7.8
	16867463	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	=	IC50	nM	67.61	CHEMBL2742	Homo sapiens	pIC50		7.17
	16867464	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	=	IC50	nM	72.44	CHEMBL2742	Homo sapiens	pIC50		7.14
	16867465	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	=	IC50	nM	1513.56	CHEMBL2742	Homo sapiens	pIC50		5.82
	16867466	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	=	IC50	nM	81.28	CHEMBL2742	Homo sapiens	pIC50		7.09
	16867467	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16867468	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	=	IC50	nM	32.36	CHEMBL2742	Homo sapiens	pIC50		7.49
	16867469	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	=	IC50	nM	79.43	CHEMBL2742	Homo sapiens	pIC50		7.1
	16867470	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	=	IC50	nM	6165.95	CHEMBL2742	Homo sapiens	pIC50		5.21
	16867471	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	=	IC50	nM	54.95	CHEMBL2742	Homo sapiens	pIC50		7.26
	16867472	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	=	IC50	nM	26.3	CHEMBL2742	Homo sapiens	pIC50		7.58
	16867473	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	=	IC50	nM	251.19	CHEMBL2742	Homo sapiens	pIC50		6.6
	16867474	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	=	IC50	nM	371.54	CHEMBL2742	Homo sapiens	pIC50		6.43
	16867475	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	=	IC50	nM	257.04	CHEMBL2742	Homo sapiens	pIC50		6.59
	16867476	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	16.98	CHEMBL2742	Homo sapiens	pIC50		7.77
	16867477	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16867478	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16867479	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	=	IC50	nM	5754.4	CHEMBL2742	Homo sapiens	pIC50		5.24
	16867480	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	=	IC50	nM	263.03	CHEMBL2742	Homo sapiens	pIC50		6.58
	16867481	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	16.22	CHEMBL2742	Homo sapiens	pIC50		7.79
	16867482	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867483	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	=	IC50	nM	125.89	CHEMBL2742	Homo sapiens	pIC50		6.9
	16867484	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	=	IC50	nM	1659.59	CHEMBL2742	Homo sapiens	pIC50		5.78
	16867485	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16867486	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	=	IC50	nM	16.22	CHEMBL2742	Homo sapiens	pIC50		7.79
	16867487	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	=	IC50	nM	22.39	CHEMBL2742	Homo sapiens	pIC50		7.65
	16867488	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867489	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	=	IC50	nM	2754.23	CHEMBL2742	Homo sapiens	pIC50		5.56
	16867490	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	=	IC50	nM	426.58	CHEMBL2742	Homo sapiens	pIC50		6.37
	16867491	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	=	IC50	nM	131.83	CHEMBL2742	Homo sapiens	pIC50		6.88
	16867492	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	=	IC50	nM	87.1	CHEMBL2742	Homo sapiens	pIC50		7.06
	16867493	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	=	IC50	nM	380.19	CHEMBL2742	Homo sapiens	pIC50		6.42
	16867494	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	=	IC50	nM	12.3	CHEMBL2742	Homo sapiens	pIC50		7.91
	16867495	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	=	IC50	nM	199.53	CHEMBL2742	Homo sapiens	pIC50		6.7
	16867496	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	=	IC50	nM	83.18	CHEMBL2742	Homo sapiens	pIC50		7.08
	16867497	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3928646	=	IC50	nM	213.8	CHEMBL2742	Homo sapiens	pIC50		6.67
	16867498	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3931381	=	IC50	nM	2137.96	CHEMBL2742	Homo sapiens	pIC50		5.67
	16867499	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3938610	=	IC50	nM	2290.87	CHEMBL2742	Homo sapiens	pIC50		5.64
	16867500	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)N2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923808	=	IC50	nM	2344.23	CHEMBL2742	Homo sapiens	pIC50		5.63
	16867501	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3890896	=	IC50	nM	134.9	CHEMBL2742	Homo sapiens	pIC50		6.87
	16867502	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986607	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16867503	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3902581	=	IC50	nM	1380.38	CHEMBL2742	Homo sapiens	pIC50		5.86
	16867504	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	=	IC50	nM	81.28	CHEMBL2742	Homo sapiens	pIC50		7.09
	16867505	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892025	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867506	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935912	=	IC50	nM	478.63	CHEMBL2742	Homo sapiens	pIC50		6.32
	16867507	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	=	IC50	nM	316.23	CHEMBL2742	Homo sapiens	pIC50		6.5
	16867508	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897858	=	IC50	nM	851.14	CHEMBL2742	Homo sapiens	pIC50		6.07
	16867509	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896104	=	IC50	nM	29.51	CHEMBL2742	Homo sapiens	pIC50		7.53
	16867510	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893398	=	IC50	nM	33.11	CHEMBL2742	Homo sapiens	pIC50		7.48
	16867511	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	=	IC50	nM	120.23	CHEMBL2742	Homo sapiens	pIC50		6.92
	16867512	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	=	IC50	nM	489.78	CHEMBL2742	Homo sapiens	pIC50		6.31
	16867513	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867514	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	=	IC50	nM	724.44	CHEMBL2742	Homo sapiens	pIC50		6.14
	16867515	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	=	IC50	nM	34.67	CHEMBL2742	Homo sapiens	pIC50		7.46
	16867516	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	=	IC50	nM	549.54	CHEMBL2742	Homo sapiens	pIC50		6.26
	16867517	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867518	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	=	IC50	nM	407.38	CHEMBL2742	Homo sapiens	pIC50		6.39
	16867519	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	=	IC50	nM	138.04	CHEMBL2742	Homo sapiens	pIC50		6.86
	16867520	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867521	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	74.13	CHEMBL2742	Homo sapiens	pIC50		7.13
	16867522	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	=	IC50	nM	199.53	CHEMBL2742	Homo sapiens	pIC50		6.7
	16867523	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	26.92	CHEMBL2742	Homo sapiens	pIC50		7.57
	16867524	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	=	IC50	nM	741.31	CHEMBL2742	Homo sapiens	pIC50		6.13
	16867525	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867526	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	=	IC50	nM	25.12	CHEMBL2742	Homo sapiens	pIC50		7.6
	16867527	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	=	IC50	nM	141.25	CHEMBL2742	Homo sapiens	pIC50		6.85
	16867528	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	=	IC50	nM	75.86	CHEMBL2742	Homo sapiens	pIC50		7.12
	16867529	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	=	IC50	nM	776.25	CHEMBL2742	Homo sapiens	pIC50		6.11
	16867530	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	=	IC50	nM	4265.8	CHEMBL2742	Homo sapiens	pIC50		5.37
	16867531	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	=	IC50	nM	489.78	CHEMBL2742	Homo sapiens	pIC50		6.31
	16867532	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	=	IC50	nM	54.95	CHEMBL2742	Homo sapiens	pIC50		7.26
	16867533	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	=	IC50	nM	25.7	CHEMBL2742	Homo sapiens	pIC50		7.59
	16867534	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	=	IC50	nM	275.42	CHEMBL2742	Homo sapiens	pIC50		6.56
	16867535	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16867536	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	=	IC50	nM	51.29	CHEMBL2742	Homo sapiens	pIC50		7.29
	16867537	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	=	IC50	nM	478.63	CHEMBL2742	Homo sapiens	pIC50		6.32
	16867538	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	=	IC50	nM	2089.3	CHEMBL2742	Homo sapiens	pIC50		5.68
	16867539	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	=	IC50	nM	10.23	CHEMBL2742	Homo sapiens	pIC50		7.99
	16867540	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	=	IC50	nM	245.47	CHEMBL2742	Homo sapiens	pIC50		6.61
	16867541	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	=	IC50	nM	257.04	CHEMBL2742	Homo sapiens	pIC50		6.59
	16867542	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	=	IC50	nM	151.36	CHEMBL2742	Homo sapiens	pIC50		6.82
	16867543	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16867544	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16867545	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	=	IC50	nM	630.96	CHEMBL2742	Homo sapiens	pIC50		6.2
	16867546	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	=	IC50	nM	208.93	CHEMBL2742	Homo sapiens	pIC50		6.68
	16867547	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	=	IC50	nM	2818.38	CHEMBL2742	Homo sapiens	pIC50		5.55
	16867548	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	=	IC50	nM	275.42	CHEMBL2742	Homo sapiens	pIC50		6.56
	16867549	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867550	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	=	IC50	nM	5370.32	CHEMBL2742	Homo sapiens	pIC50		5.27
	16867551	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	=	IC50	nM	851.14	CHEMBL2742	Homo sapiens	pIC50		6.07
	16867552	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	=	IC50	nM	41.69	CHEMBL2742	Homo sapiens	pIC50		7.38
	16867553	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	=	IC50	nM	7585.78	CHEMBL2742	Homo sapiens	pIC50		5.12
	16867554	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	=	IC50	nM	707.95	CHEMBL2742	Homo sapiens	pIC50		6.15
	16867555	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	=	IC50	nM	1047.13	CHEMBL2742	Homo sapiens	pIC50		5.98
	16867556	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867557	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	=	IC50	nM	67.61	CHEMBL2742	Homo sapiens	pIC50		7.17
	16867558	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	=	IC50	nM	269.15	CHEMBL2742	Homo sapiens	pIC50		6.57
	16867559	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16867560	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	=	IC50	nM	114.82	CHEMBL2742	Homo sapiens	pIC50		6.94
	16867561	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	=	IC50	nM	12.02	CHEMBL2742	Homo sapiens	pIC50		7.92
	16867562	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	=	IC50	nM	23.44	CHEMBL2742	Homo sapiens	pIC50		7.63
	16867563	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	=	IC50	nM	15.49	CHEMBL2742	Homo sapiens	pIC50		7.81
	16867564	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	=	IC50	nM	389.05	CHEMBL2742	Homo sapiens	pIC50		6.41
	16867565	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	=	IC50	nM	309.03	CHEMBL2742	Homo sapiens	pIC50		6.51
	16867566	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	229.09	CHEMBL2742	Homo sapiens	pIC50		6.64
	16867567	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	=	IC50	nM	28.18	CHEMBL2742	Homo sapiens	pIC50		7.55
	16867568	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	=	IC50	nM	794.33	CHEMBL2742	Homo sapiens	pIC50		6.1
	16867569	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915533	=	IC50	nM	109.65	CHEMBL2742	Homo sapiens	pIC50		6.96
	16867570	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	=	IC50	nM	67.61	CHEMBL2742	Homo sapiens	pIC50		7.17
	16867571	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C3C[C@@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3976183	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16867572	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967011	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16867573	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	=	IC50	nM	42.66	CHEMBL2742	Homo sapiens	pIC50		7.37
	16867574	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	=	IC50	nM	323.59	CHEMBL2742	Homo sapiens	pIC50		6.49
	16867575	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3922285	=	IC50	nM	141.25	CHEMBL2742	Homo sapiens	pIC50		6.85
	16867576	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925008	=	IC50	nM	72.44	CHEMBL2742	Homo sapiens	pIC50		7.14
	16867577	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	=	IC50	nM	23.44	CHEMBL2742	Homo sapiens	pIC50		7.63
	16867578	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16867579	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	=	IC50	nM	25.7	CHEMBL2742	Homo sapiens	pIC50		7.59
	16867580	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939439	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16867581	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C[Si](C)(C)C)c4)nc3c2)c1		CHEMBL3898601	=	IC50	nM	1548.82	CHEMBL2742	Homo sapiens	pIC50		5.81
	16867582	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901357	=	IC50	nM	158.49	CHEMBL2742	Homo sapiens	pIC50		6.8
	16867583	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3957643	=	IC50	nM	338.84	CHEMBL2742	Homo sapiens	pIC50		6.47
	16867584	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	=	IC50	nM	87.1	CHEMBL2742	Homo sapiens	pIC50		7.06
	16867585	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981706	=	IC50	nM	1621.81	CHEMBL2742	Homo sapiens	pIC50		5.79
	16867586	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3979314	=	IC50	nM	2691.53	CHEMBL2742	Homo sapiens	pIC50		5.57
	16867587	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985678	=	IC50	nM	104.71	CHEMBL2742	Homo sapiens	pIC50		6.98
	16867588	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969381	=	IC50	nM	56.23	CHEMBL2742	Homo sapiens	pIC50		7.25
	16867589	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968361	=	IC50	nM	741.31	CHEMBL2742	Homo sapiens	pIC50		6.13
	16867590	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867591	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	=	IC50	nM	13.18	CHEMBL2742	Homo sapiens	pIC50		7.88
	16867592	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	=	IC50	nM	181.97	CHEMBL2742	Homo sapiens	pIC50		6.74
	16867593	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	=	IC50	nM	9.55	CHEMBL2742	Homo sapiens	pIC50		8.02
	16867594	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	=	IC50	nM	85.11	CHEMBL2742	Homo sapiens	pIC50		7.07
	16867595	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	=	IC50	nM	288.4	CHEMBL2742	Homo sapiens	pIC50		6.54
	16867596	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	=	IC50	nM	134.9	CHEMBL2742	Homo sapiens	pIC50		6.87
	16867597	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	=	IC50	nM	316.23	CHEMBL2742	Homo sapiens	pIC50		6.5
	16867598	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	=	IC50	nM	1174.9	CHEMBL2742	Homo sapiens	pIC50		5.93
	16867599	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	=	IC50	nM	1621.81	CHEMBL2742	Homo sapiens	pIC50		5.79
	16867600	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	=	IC50	nM	8317.64	CHEMBL2742	Homo sapiens	pIC50		5.08
	16867601	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	=	IC50	nM	416.87	CHEMBL2742	Homo sapiens	pIC50		6.38
	16867602	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	165.96	CHEMBL2742	Homo sapiens	pIC50		6.78
	16867603	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867604	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	=	IC50	nM	933.25	CHEMBL2742	Homo sapiens	pIC50		6.03
	16867605	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	=	IC50	nM	11.48	CHEMBL2742	Homo sapiens	pIC50		7.94
	16867606	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	=	IC50	nM	269.15	CHEMBL2742	Homo sapiens	pIC50		6.57
	16867607	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	=	IC50	nM	51.29	CHEMBL2742	Homo sapiens	pIC50		7.29
	16867608	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	=	IC50	nM	22.39	CHEMBL2742	Homo sapiens	pIC50		7.65
	16867609	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	=	IC50	nM	2570.4	CHEMBL2742	Homo sapiens	pIC50		5.59
	16867610	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	=	IC50	nM	1584.89	CHEMBL2742	Homo sapiens	pIC50		5.8
	16867611	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	=	IC50	nM	1548.82	CHEMBL2742	Homo sapiens	pIC50		5.81
	16867612	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	=	IC50	nM	549.54	CHEMBL2742	Homo sapiens	pIC50		6.26
	16867613	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	=	IC50	nM	416.87	CHEMBL2742	Homo sapiens	pIC50		6.38
	16867614	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	=	IC50	nM	676.08	CHEMBL2742	Homo sapiens	pIC50		6.17
	16867615	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16867616	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	=	IC50	nM	2344.23	CHEMBL2742	Homo sapiens	pIC50		5.63
	16867617	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	=	IC50	nM	93.33	CHEMBL2742	Homo sapiens	pIC50		7.03
	16867618	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	=	IC50	nM	234.42	CHEMBL2742	Homo sapiens	pIC50		6.63
	16867619	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	=	IC50	nM	3235.94	CHEMBL2742	Homo sapiens	pIC50		5.49
	16867620	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	=	IC50	nM	190.55	CHEMBL2742	Homo sapiens	pIC50		6.72
	16867621	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16867622	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16867623	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	=	IC50	nM	4466.84	CHEMBL2742	Homo sapiens	pIC50		5.35
	16867624	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	=	IC50	nM	3890.45	CHEMBL2742	Homo sapiens	pIC50		5.41
	16867625	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	=	IC50	nM	269.15	CHEMBL2742	Homo sapiens	pIC50		6.57
	16867626	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16867627	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	=	IC50	nM	42.66	CHEMBL2742	Homo sapiens	pIC50		7.37
	16867628	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	=	IC50	nM	13.8	CHEMBL2742	Homo sapiens	pIC50		7.86
	16867629	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	=	IC50	nM	14.13	CHEMBL2742	Homo sapiens	pIC50		7.85
	16867630	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	=	IC50	nM	141.25	CHEMBL2742	Homo sapiens	pIC50		6.85
	16867631	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	=	IC50	nM	26.92	CHEMBL2742	Homo sapiens	pIC50		7.57
	16867632	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	=	IC50	nM	426.58	CHEMBL2742	Homo sapiens	pIC50		6.37
	16867633	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	=	IC50	nM	138.04	CHEMBL2742	Homo sapiens	pIC50		6.86
	16867634	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	=	IC50	nM	61.66	CHEMBL2742	Homo sapiens	pIC50		7.21
	16867635	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	=	IC50	nM	11.48	CHEMBL2742	Homo sapiens	pIC50		7.94
	16867636	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	=	IC50	nM	1737.8	CHEMBL2742	Homo sapiens	pIC50		5.76
	16867637	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	=	IC50	nM	20.42	CHEMBL2742	Homo sapiens	pIC50		7.69
	16867638	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	=	IC50	nM	64.57	CHEMBL2742	Homo sapiens	pIC50		7.19
	16867639	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16867640	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	=	IC50	nM	251.19	CHEMBL2742	Homo sapiens	pIC50		6.6
	16867641	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	=	IC50	nM	1258.93	CHEMBL2742	Homo sapiens	pIC50		5.9
	16867642	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	=	IC50	nM	489.78	CHEMBL2742	Homo sapiens	pIC50		6.31
	16867643	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	=	IC50	nM	154.88	CHEMBL2742	Homo sapiens	pIC50		6.81
	16867644	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	=	IC50	nM	812.83	CHEMBL2742	Homo sapiens	pIC50		6.09
	16867645	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	=	IC50	nM	812.83	CHEMBL2742	Homo sapiens	pIC50		6.09
	16867646	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	=	IC50	nM	144.54	CHEMBL2742	Homo sapiens	pIC50		6.84
	16867647	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	=	IC50	nM	204.17	CHEMBL2742	Homo sapiens	pIC50		6.69
	16867648	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	=	IC50	nM	45.71	CHEMBL2742	Homo sapiens	pIC50		7.34
	16867649	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	=	IC50	nM	186.21	CHEMBL2742	Homo sapiens	pIC50		6.73
	16867650	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	=	IC50	nM	11.22	CHEMBL2742	Homo sapiens	pIC50		7.95
	16867651	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	=	IC50	nM	2454.71	CHEMBL2742	Homo sapiens	pIC50		5.61
	16867652	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	=	IC50	nM	8.318	CHEMBL2742	Homo sapiens	pIC50		8.08
	16867653	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	93.33	CHEMBL2742	Homo sapiens	pIC50		7.03
	16867654	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16867655	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	912.01	CHEMBL2742	Homo sapiens	pIC50		6.04
	16867656	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	=	IC50	nM	14.79	CHEMBL2742	Homo sapiens	pIC50		7.83
	16867657	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16867658	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	=	IC50	nM	95.5	CHEMBL2742	Homo sapiens	pIC50		7.02
	16867659	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	=	IC50	nM	1047.13	CHEMBL2742	Homo sapiens	pIC50		5.98
	16867660	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	=	IC50	nM	1995.26	CHEMBL2742	Homo sapiens	pIC50		5.7
	16867661	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	=	IC50	nM	8.71	CHEMBL2742	Homo sapiens	pIC50		8.06
	16867662	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	165.96	CHEMBL2742	Homo sapiens	pIC50		6.78
	16867663	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	=	IC50	nM	158.49	CHEMBL2742	Homo sapiens	pIC50		6.8
	16867664	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	=	IC50	nM	56.23	CHEMBL2742	Homo sapiens	pIC50		7.25
	16867665	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	=	IC50	nM	50.12	CHEMBL2742	Homo sapiens	pIC50		7.3
	16867666	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16867667	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	=	IC50	nM	151.36	CHEMBL2742	Homo sapiens	pIC50		6.82
	16867668	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	=	IC50	nM	40.74	CHEMBL2742	Homo sapiens	pIC50		7.39
	16867669	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	=	IC50	nM	194.98	CHEMBL2742	Homo sapiens	pIC50		6.71
	16867670	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	=	IC50	nM	398.11	CHEMBL2742	Homo sapiens	pIC50		6.4
	16867671	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	=	IC50	nM	316.23	CHEMBL2742	Homo sapiens	pIC50		6.5
	16867672	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	=	IC50	nM	12.59	CHEMBL2742	Homo sapiens	pIC50		7.9
	16867673	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	=	IC50	nM	44.67	CHEMBL2742	Homo sapiens	pIC50		7.35
	16867674	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16867675	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	=	IC50	nM	125.89	CHEMBL2742	Homo sapiens	pIC50		6.9
	16867676	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	=	IC50	nM	18.2	CHEMBL2742	Homo sapiens	pIC50		7.74
	16867677	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	=	IC50	nM	1148.15	CHEMBL2742	Homo sapiens	pIC50		5.94
	16867678	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	=	IC50	nM	87.1	CHEMBL2742	Homo sapiens	pIC50		7.06
	16867679	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	=	IC50	nM	7.762	CHEMBL2742	Homo sapiens	pIC50		8.11
	16867680	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	=	IC50	nM	147.91	CHEMBL2742	Homo sapiens	pIC50		6.83
	16867681	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	=	IC50	nM	19.95	CHEMBL2742	Homo sapiens	pIC50		7.7
	16867682	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	=	IC50	nM	57.54	CHEMBL2742	Homo sapiens	pIC50		7.24
	16867683	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	=	IC50	nM	83.18	CHEMBL2742	Homo sapiens	pIC50		7.08
	16867684	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	=	IC50	nM	32.36	CHEMBL2742	Homo sapiens	pIC50		7.49
	16867685	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	=	IC50	nM	12.59	CHEMBL2742	Homo sapiens	pIC50		7.9
	16867686	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	=	IC50	nM	107.15	CHEMBL2742	Homo sapiens	pIC50		6.97
	16867687	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	=	IC50	nM	239.88	CHEMBL2742	Homo sapiens	pIC50		6.62
	16867688	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16867689	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	=	IC50	nM	537.03	CHEMBL2742	Homo sapiens	pIC50		6.27
	16867690	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	=	IC50	nM	389.05	CHEMBL2742	Homo sapiens	pIC50		6.41
	16867691	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	=	IC50	nM	645.65	CHEMBL2742	Homo sapiens	pIC50		6.19
	16867692	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	=	IC50	nM	173.78	CHEMBL2742	Homo sapiens	pIC50		6.76
	16867693	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867694	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	=	IC50	nM	7.943	CHEMBL2742	Homo sapiens	pIC50		8.1
	16867695	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16867696	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	=	IC50	nM	70.79	CHEMBL2742	Homo sapiens	pIC50		7.15
	16867697	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16867698	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	457.09	CHEMBL2742	Homo sapiens	pIC50		6.34
	16867699	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	=	IC50	nM	97.72	CHEMBL2742	Homo sapiens	pIC50		7.01
	16867700	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	=	IC50	nM	26.3	CHEMBL2742	Homo sapiens	pIC50		7.58
	16867701	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	=	IC50	nM	50.12	CHEMBL2742	Homo sapiens	pIC50		7.3
	16867702	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	=	IC50	nM	42.66	CHEMBL2742	Homo sapiens	pIC50		7.37
	16867703	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	=	IC50	nM	6.457	CHEMBL2742	Homo sapiens	pIC50		8.19
	16867704	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	=	IC50	nM	26.3	CHEMBL2742	Homo sapiens	pIC50		7.58
	16867705	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	=	IC50	nM	144.54	CHEMBL2742	Homo sapiens	pIC50		6.84
	16867706	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	=	IC50	nM	114.82	CHEMBL2742	Homo sapiens	pIC50		6.94
	16867707	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	=	IC50	nM	63.1	CHEMBL2742	Homo sapiens	pIC50		7.2
	16867708	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	=	IC50	nM	89.13	CHEMBL2742	Homo sapiens	pIC50		7.05
	16867709	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	=	IC50	nM	33.11	CHEMBL2742	Homo sapiens	pIC50		7.48
	16867710	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	=	IC50	nM	213.8	CHEMBL2742	Homo sapiens	pIC50		6.67
	16867711	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	=	IC50	nM	95.5	CHEMBL2742	Homo sapiens	pIC50		7.02
	16867712	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	=	IC50	nM	66.07	CHEMBL2742	Homo sapiens	pIC50		7.18
	16867713	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16867714	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	=	IC50	nM	45.71	CHEMBL2742	Homo sapiens	pIC50		7.34
	16867715	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	=	IC50	nM	74.13	CHEMBL2742	Homo sapiens	pIC50		7.13
	16867716	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	=	IC50	nM	20.89	CHEMBL2742	Homo sapiens	pIC50		7.68
	16867717	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	=	IC50	nM	257.04	CHEMBL2742	Homo sapiens	pIC50		6.59
	16867718	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	=	IC50	nM	812.83	CHEMBL2742	Homo sapiens	pIC50		6.09
	16867719	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	=	IC50	nM	23.44	CHEMBL2742	Homo sapiens	pIC50		7.63
	16867720	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	=	IC50	nM	18.2	CHEMBL2742	Homo sapiens	pIC50		7.74
	16867721	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	=	IC50	nM	10.23	CHEMBL2742	Homo sapiens	pIC50		7.99
	16867722	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	=	IC50	nM	1412.54	CHEMBL2742	Homo sapiens	pIC50		5.85
	16867723	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	=	IC50	nM	660.69	CHEMBL2742	Homo sapiens	pIC50		6.18
	16867724	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	=	IC50	nM	3630.78	CHEMBL2742	Homo sapiens	pIC50		5.44
	16867725	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	=	IC50	nM	263.03	CHEMBL2742	Homo sapiens	pIC50		6.58
	16867726	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16867727	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16867728	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	=	IC50	nM	42.66	CHEMBL2742	Homo sapiens	pIC50		7.37
	16867729	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	=	IC50	nM	14.79	CHEMBL2742	Homo sapiens	pIC50		7.83
	16867730	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	=	IC50	nM	169.82	CHEMBL2742	Homo sapiens	pIC50		6.77
	16867731	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16867732	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	=	IC50	nM	162.18	CHEMBL2742	Homo sapiens	pIC50		6.79
	16867733	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	=	IC50	nM	43.65	CHEMBL2742	Homo sapiens	pIC50		7.36
	16867734	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	=	IC50	nM	13.49	CHEMBL2742	Homo sapiens	pIC50		7.87
	16867735	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16867736	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	=	IC50	nM	8.128	CHEMBL2742	Homo sapiens	pIC50		8.09
	16867737	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	=	IC50	nM	501.19	CHEMBL2742	Homo sapiens	pIC50		6.3
	16867738	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16867739	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	=	IC50	nM	79.43	CHEMBL2742	Homo sapiens	pIC50		7.1
	16867740	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	=	IC50	nM	85.11	CHEMBL2742	Homo sapiens	pIC50		7.07
	16867741	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	=	IC50	nM	63.1	CHEMBL2742	Homo sapiens	pIC50		7.2
	16867742	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	=	IC50	nM	85.11	CHEMBL2742	Homo sapiens	pIC50		7.07
	16867743	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	=	IC50	nM	616.6	CHEMBL2742	Homo sapiens	pIC50		6.21
	16867744	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	=	IC50	nM	602.56	CHEMBL2742	Homo sapiens	pIC50		6.22
	16867745	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867746	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	=	IC50	nM	50.12	CHEMBL2742	Homo sapiens	pIC50		7.3
	16867747	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	=	IC50	nM	64.57	CHEMBL2742	Homo sapiens	pIC50		7.19
	16867748	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	=	IC50	nM	21.38	CHEMBL2742	Homo sapiens	pIC50		7.67
	16867749	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	=	IC50	nM	489.78	CHEMBL2742	Homo sapiens	pIC50		6.31
	16867750	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	=	IC50	nM	19.95	CHEMBL2742	Homo sapiens	pIC50		7.7
	16867751	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	=	IC50	nM	524.81	CHEMBL2742	Homo sapiens	pIC50		6.28
	16867752	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	=	IC50	nM	123.03	CHEMBL2742	Homo sapiens	pIC50		6.91
	16867753	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	=	IC50	nM	229.09	CHEMBL2742	Homo sapiens	pIC50		6.64
	16867754	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	=	IC50	nM	1318.26	CHEMBL2742	Homo sapiens	pIC50		5.88
	16867755	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	=	IC50	nM	575.44	CHEMBL2742	Homo sapiens	pIC50		6.24
	16867756	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	=	IC50	nM	87.1	CHEMBL2742	Homo sapiens	pIC50		7.06
	16867757	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867758	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	=	IC50	nM	97.72	CHEMBL2742	Homo sapiens	pIC50		7.01
	16867759	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	=	IC50	nM	15.49	CHEMBL2742	Homo sapiens	pIC50		7.81
	16867760	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	=	IC50	nM	15.49	CHEMBL2742	Homo sapiens	pIC50		7.81
	16867761	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	=	IC50	nM	18.2	CHEMBL2742	Homo sapiens	pIC50		7.74
	16867762	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	=	IC50	nM	7.762	CHEMBL2742	Homo sapiens	pIC50		8.11
	16867763	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	=	IC50	nM	11.48	CHEMBL2742	Homo sapiens	pIC50		7.94
	16867764	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	=	IC50	nM	1071.52	CHEMBL2742	Homo sapiens	pIC50		5.97
	16867765	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	=	IC50	nM	190.55	CHEMBL2742	Homo sapiens	pIC50		6.72
	16867766	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	=	IC50	nM	251.19	CHEMBL2742	Homo sapiens	pIC50		6.6
	16867767	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16867768	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	=	IC50	nM	16.6	CHEMBL2742	Homo sapiens	pIC50		7.78
	16867769	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	=	IC50	nM	165.96	CHEMBL2742	Homo sapiens	pIC50		6.78
	16867770	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	=	IC50	nM	117.49	CHEMBL2742	Homo sapiens	pIC50		6.93
	16867771	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	=	IC50	nM	67.61	CHEMBL2742	Homo sapiens	pIC50		7.17
	16867772	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	=	IC50	nM	44.67	CHEMBL2742	Homo sapiens	pIC50		7.35
	16867773	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	>	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16867774	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	=	IC50	nM	54.95	CHEMBL2742	Homo sapiens	pIC50		7.26
	16867775	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	=	IC50	nM	371.54	CHEMBL2742	Homo sapiens	pIC50		6.43
	16867776	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	=	IC50	nM	363.08	CHEMBL2742	Homo sapiens	pIC50		6.44
	16867777	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	=	IC50	nM	52.48	CHEMBL2742	Homo sapiens	pIC50		7.28
	16867778	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	=	IC50	nM	52.48	CHEMBL2742	Homo sapiens	pIC50		7.28
	16867779	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	=	IC50	nM	77.62	CHEMBL2742	Homo sapiens	pIC50		7.11
	16867780	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	=	IC50	nM	5370.32	CHEMBL2742	Homo sapiens	pIC50		5.27
	16867781	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	=	IC50	nM	28.84	CHEMBL2742	Homo sapiens	pIC50		7.54
	16867782	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	=	IC50	nM	131.83	CHEMBL2742	Homo sapiens	pIC50		6.88
	16867783	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	=	IC50	nM	251.19	CHEMBL2742	Homo sapiens	pIC50		6.6
	16867784	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	=	IC50	nM	74.13	CHEMBL2742	Homo sapiens	pIC50		7.13
	16867785	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	=	IC50	nM	117.49	CHEMBL2742	Homo sapiens	pIC50		6.93
	16867786	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	=	IC50	nM	199.53	CHEMBL2742	Homo sapiens	pIC50		6.7
	16867787	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16867788	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	=	IC50	nM	28.84	CHEMBL2742	Homo sapiens	pIC50		7.54
	16867789	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	=	IC50	nM	5.37	CHEMBL2742	Homo sapiens	pIC50		8.27
	16867790	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	=	IC50	nM	245.47	CHEMBL2742	Homo sapiens	pIC50		6.61
	16867791	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	=	IC50	nM	128.82	CHEMBL2742	Homo sapiens	pIC50		6.89
	16867792	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	=	IC50	nM	269.15	CHEMBL2742	Homo sapiens	pIC50		6.57
	16867793	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16867794	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	=	IC50	nM	112.2	CHEMBL2742	Homo sapiens	pIC50		6.95
	16867795	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	=	IC50	nM	114.82	CHEMBL2742	Homo sapiens	pIC50		6.94
	16867796	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	=	IC50	nM	295.12	CHEMBL2742	Homo sapiens	pIC50		6.53
	16867797	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	=	IC50	nM	128.82	CHEMBL2742	Homo sapiens	pIC50		6.89
	16867798	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	=	IC50	nM	660.69	CHEMBL2742	Homo sapiens	pIC50		6.18
	16867799	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	=	IC50	nM	30.2	CHEMBL2742	Homo sapiens	pIC50		7.52
	16867800	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	=	IC50	nM	263.03	CHEMBL2742	Homo sapiens	pIC50		6.58
	16867801	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	=	IC50	nM	162.18	CHEMBL2742	Homo sapiens	pIC50		6.79
	16867802	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	=	IC50	nM	741.31	CHEMBL2742	Homo sapiens	pIC50		6.13
	16867803	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16867804	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	=	IC50	nM	630.96	CHEMBL2742	Homo sapiens	pIC50		6.2
	16867805	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	489.78	CHEMBL2742	Homo sapiens	pIC50		6.31
	16867806	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	=	IC50	nM	831.76	CHEMBL2742	Homo sapiens	pIC50		6.08
	16867807	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	=	IC50	nM	41.69	CHEMBL2742	Homo sapiens	pIC50		7.38
	16867808	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	=	IC50	nM	1122.02	CHEMBL2742	Homo sapiens	pIC50		5.95
	16867809	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867810	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	=	IC50	nM	204.17	CHEMBL2742	Homo sapiens	pIC50		6.69
	16867811	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	154.88	CHEMBL2742	Homo sapiens	pIC50		6.81
	16867812	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	=	IC50	nM	2511.89	CHEMBL2742	Homo sapiens	pIC50		5.6
	16867813	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16867814	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	=	IC50	nM	269.15	CHEMBL2742	Homo sapiens	pIC50		6.57
	16867815	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	=	IC50	nM	204.17	CHEMBL2742	Homo sapiens	pIC50		6.69
	16867816	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	=	IC50	nM	3467.37	CHEMBL2742	Homo sapiens	pIC50		5.46
	16867817	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867818	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867819	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	2951.21	CHEMBL2742	Homo sapiens	pIC50		5.53
	16867820	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867821	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	=	IC50	nM	346.74	CHEMBL2742	Homo sapiens	pIC50		6.46
	16867822	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	=	IC50	nM	109.65	CHEMBL2742	Homo sapiens	pIC50		6.96
	16867823	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	123.03	CHEMBL2742	Homo sapiens	pIC50		6.91
	16867824	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	=	IC50	nM	154.88	CHEMBL2742	Homo sapiens	pIC50		6.81
	16867825	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	=	IC50	nM	95.5	CHEMBL2742	Homo sapiens	pIC50		7.02
	16867826	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	74.13	CHEMBL2742	Homo sapiens	pIC50		7.13
	16867827	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867828	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	54.95	CHEMBL2742	Homo sapiens	pIC50		7.26
	16867829	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	=	IC50	nM	81.28	CHEMBL2742	Homo sapiens	pIC50		7.09
	16867830	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	104.71	CHEMBL2742	Homo sapiens	pIC50		6.98
	16867831	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867832	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	=	IC50	nM	257.04	CHEMBL2742	Homo sapiens	pIC50		6.59
	16867833	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	=	IC50	nM	398.11	CHEMBL2742	Homo sapiens	pIC50		6.4
	16867834	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16867835	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	190.55	CHEMBL2742	Homo sapiens	pIC50		6.72
	16867836	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	=	IC50	nM	40.74	CHEMBL2742	Homo sapiens	pIC50		7.39
	16867837	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16867838	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	=	IC50	nM	9.12	CHEMBL2742	Homo sapiens	pIC50		8.04
	16867839	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	=	IC50	nM	512.86	CHEMBL2742	Homo sapiens	pIC50		6.29
	16867840	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	=	IC50	nM	21.38	CHEMBL2742	Homo sapiens	pIC50		7.67
	16867841	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	=	IC50	nM	22.39	CHEMBL2742	Homo sapiens	pIC50		7.65
	16867842	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	=	IC50	nM	87.1	CHEMBL2742	Homo sapiens	pIC50		7.06
	16867843	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	=	IC50	nM	4466.84	CHEMBL2742	Homo sapiens	pIC50		5.35
	16867844	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	=	IC50	nM	724.44	CHEMBL2742	Homo sapiens	pIC50		6.14
	16867845	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	=	IC50	nM	64.57	CHEMBL2742	Homo sapiens	pIC50		7.19
	16867846	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	=	IC50	nM	1318.26	CHEMBL2742	Homo sapiens	pIC50		5.88
	16867847	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16867848	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	=	IC50	nM	7079.46	CHEMBL2742	Homo sapiens	pIC50		5.15
	16867849	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	=	IC50	nM	112.2	CHEMBL2742	Homo sapiens	pIC50		6.95
	16867850	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	=	IC50	nM	524.81	CHEMBL2742	Homo sapiens	pIC50		6.28
	16867851	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	=	IC50	nM	457.09	CHEMBL2742	Homo sapiens	pIC50		6.34
	16867852	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	=	IC50	nM	1202.26	CHEMBL2742	Homo sapiens	pIC50		5.92
	16867853	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	=	IC50	nM	1230.27	CHEMBL2742	Homo sapiens	pIC50		5.91
	16867854	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	=	IC50	nM	95.5	CHEMBL2742	Homo sapiens	pIC50		7.02
	16867855	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16867856	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	1023.29	CHEMBL2742	Homo sapiens	pIC50		5.99
	16867857	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	=	IC50	nM	2570.4	CHEMBL2742	Homo sapiens	pIC50		5.59
	16867858	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	=	IC50	nM	2630.27	CHEMBL2742	Homo sapiens	pIC50		5.58
	16867859	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	=	IC50	nM	512.86	CHEMBL2742	Homo sapiens	pIC50		6.29
	16867860	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16867861	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	=	IC50	nM	36.31	CHEMBL2742	Homo sapiens	pIC50		7.44
	16867862	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867863	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	6.166	CHEMBL2742	Homo sapiens	pIC50		8.21
	16867864	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16867865	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	11.48	CHEMBL2742	Homo sapiens	pIC50		7.94
	16867866	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	=	IC50	nM	93.33	CHEMBL2742	Homo sapiens	pIC50		7.03
	16867867	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	=	IC50	nM	1778.28	CHEMBL2742	Homo sapiens	pIC50		5.75
	16867868	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	=	IC50	nM	8128.31	CHEMBL2742	Homo sapiens	pIC50		5.09
	16867869	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	=	IC50	nM	1698.24	CHEMBL2742	Homo sapiens	pIC50		5.77
	16867870	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867871	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	=	IC50	nM	23.44	CHEMBL2742	Homo sapiens	pIC50		7.63
	16867872	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867873	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	52.48	CHEMBL2742	Homo sapiens	pIC50		7.28
	16867874	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	=	IC50	nM	416.87	CHEMBL2742	Homo sapiens	pIC50		6.38
	16867875	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16867876	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	=	IC50	nM	79.43	CHEMBL2742	Homo sapiens	pIC50		7.1
	16867877	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	=	IC50	nM	34.67	CHEMBL2742	Homo sapiens	pIC50		7.46
	16867878	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	=	IC50	nM	72.44	CHEMBL2742	Homo sapiens	pIC50		7.14
	16867879	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	=	IC50	nM	48.98	CHEMBL2742	Homo sapiens	pIC50		7.31
	16867880	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16867881	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	=	IC50	nM	436.52	CHEMBL2742	Homo sapiens	pIC50		6.36
	16867882	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	=	IC50	nM	309.03	CHEMBL2742	Homo sapiens	pIC50		6.51
	16867883	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16867884	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	=	IC50	nM	295.12	CHEMBL2742	Homo sapiens	pIC50		6.53
	16867885	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	=	IC50	nM	61.66	CHEMBL2742	Homo sapiens	pIC50		7.21
	16867886	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16867887	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	=	IC50	nM	18.62	CHEMBL2742	Homo sapiens	pIC50		7.73
	16867888	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	=	IC50	nM	181.97	CHEMBL2742	Homo sapiens	pIC50		6.74
	16867889	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	=	IC50	nM	204.17	CHEMBL2742	Homo sapiens	pIC50		6.69
	16867890	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16867891	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16867892	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	=	IC50	nM	70.79	CHEMBL2742	Homo sapiens	pIC50		7.15
	16867893	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	=	IC50	nM	36.31	CHEMBL2742	Homo sapiens	pIC50		7.44
	16867894	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	=	IC50	nM	9.333	CHEMBL2742	Homo sapiens	pIC50		8.03
	16867895	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	=	IC50	nM	575.44	CHEMBL2742	Homo sapiens	pIC50		6.24
	16867896	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	=	IC50	nM	1318.26	CHEMBL2742	Homo sapiens	pIC50		5.88
	16867897	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16867898	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	=	IC50	nM	10.72	CHEMBL2742	Homo sapiens	pIC50		7.97
	16867899	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	=	IC50	nM	19.05	CHEMBL2742	Homo sapiens	pIC50		7.72
	16867900	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16867901	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	=	IC50	nM	2.455	CHEMBL2742	Homo sapiens	pIC50		8.61
	16867902	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	=	IC50	nM	5888.44	CHEMBL2742	Homo sapiens	pIC50		5.23
	16867903	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1		CHEMBL3953771	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16867904	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16867905	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16867906	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	323.59	CHEMBL2742	Homo sapiens	pIC50		6.49
	16867907	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	=	IC50	nM	776.25	CHEMBL2742	Homo sapiens	pIC50		6.11
	16867908	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	2.344	CHEMBL2742	Homo sapiens	pIC50		8.63
	16867909	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	=	IC50	nM	58.88	CHEMBL2742	Homo sapiens	pIC50		7.23
	16867910	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	=	IC50	nM	467.74	CHEMBL2742	Homo sapiens	pIC50		6.33
	16867911	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	=	IC50	nM	75.86	CHEMBL2742	Homo sapiens	pIC50		7.12
	16867912	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	=	IC50	nM	616.6	CHEMBL2742	Homo sapiens	pIC50		6.21
	16867913	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	=	IC50	nM	134.9	CHEMBL2742	Homo sapiens	pIC50		6.87
	16867914	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	=	IC50	nM	218.78	CHEMBL2742	Homo sapiens	pIC50		6.66
	16867915	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	=	IC50	nM	72.44	CHEMBL2742	Homo sapiens	pIC50		7.14
	16867916	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	=	IC50	nM	141.25	CHEMBL2742	Homo sapiens	pIC50		6.85
	16867917	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	141.25	CHEMBL2742	Homo sapiens	pIC50		6.85
	16867918	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	=	IC50	nM	1698.24	CHEMBL2742	Homo sapiens	pIC50		5.77
	16867919	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	=	IC50	nM	102.33	CHEMBL2742	Homo sapiens	pIC50		6.99
	16867920	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	=	IC50	nM	213.8	CHEMBL2742	Homo sapiens	pIC50		6.67
	16867921	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	=	IC50	nM	1122.02	CHEMBL2742	Homo sapiens	pIC50		5.95
	16867922	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	=	IC50	nM	891.25	CHEMBL2742	Homo sapiens	pIC50		6.05
	16867923	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	=	IC50	nM	2.455	CHEMBL2742	Homo sapiens	pIC50		8.61
	16867924	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	=	IC50	nM	23.44	CHEMBL2742	Homo sapiens	pIC50		7.63
	16867925	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	=	IC50	nM	8709.64	CHEMBL2742	Homo sapiens	pIC50		5.06
	16867926	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	=	IC50	nM	1621.81	CHEMBL2742	Homo sapiens	pIC50		5.79
	16867927	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	=	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16867928	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	=	IC50	nM	29.51	CHEMBL2742	Homo sapiens	pIC50		7.53
	16867929	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	=	IC50	nM	575.44	CHEMBL2742	Homo sapiens	pIC50		6.24
	16867930	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	=	IC50	nM	295.12	CHEMBL2742	Homo sapiens	pIC50		6.53
	16867931	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	=	IC50	nM	933.25	CHEMBL2742	Homo sapiens	pIC50		6.03
	16867932	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	=	IC50	nM	158.49	CHEMBL2742	Homo sapiens	pIC50		6.8
	16867933	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	=	IC50	nM	5.37	CHEMBL2742	Homo sapiens	pIC50		8.27
	16867934	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	=	IC50	nM	72.44	CHEMBL2742	Homo sapiens	pIC50		7.14
	16867935	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	=	IC50	nM	501.19	CHEMBL2742	Homo sapiens	pIC50		6.3
	16867936	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	=	IC50	nM	117.49	CHEMBL2742	Homo sapiens	pIC50		6.93
	16867937	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	=	IC50	nM	32.36	CHEMBL2742	Homo sapiens	pIC50		7.49
	16867938	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	=	IC50	nM	2398.83	CHEMBL2742	Homo sapiens	pIC50		5.62
	16867939	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	=	IC50	nM	676.08	CHEMBL2742	Homo sapiens	pIC50		6.17
	16867940	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	>	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16867941	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	=	IC50	nM	1548.82	CHEMBL2742	Homo sapiens	pIC50		5.81
	16867942	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	=	IC50	nM	93.33	CHEMBL2742	Homo sapiens	pIC50		7.03
	16867943	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	>	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16867944	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	=	IC50	nM	21.88	CHEMBL2742	Homo sapiens	pIC50		7.66
	16867945	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	=	IC50	nM	1995.26	CHEMBL2742	Homo sapiens	pIC50		5.7
	16867946	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	=	IC50	nM	794.33	CHEMBL2742	Homo sapiens	pIC50		6.1
	16867947	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	=	IC50	nM	154.88	CHEMBL2742	Homo sapiens	pIC50		6.81
	16867948	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	=	IC50	nM	0.389	CHEMBL2742	Homo sapiens	pIC50		9.41
	16867949	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	0.3802	CHEMBL2742	Homo sapiens	pIC50		9.42
	16867950	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16867951	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16867952	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	=	IC50	nM	24.55	CHEMBL2742	Homo sapiens	pIC50		7.61
	16867953	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	=	IC50	nM	4570.88	CHEMBL2742	Homo sapiens	pIC50		5.34
	16867954	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	173.78	CHEMBL2742	Homo sapiens	pIC50		6.76
	16867955	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867956	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	=	IC50	nM	1659.59	CHEMBL2742	Homo sapiens	pIC50		5.78
	16867957	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	=	IC50	nM	56.23	CHEMBL2742	Homo sapiens	pIC50		7.25
	16867958	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867959	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867960	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867961	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867962	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	=	IC50	nM	1230.27	CHEMBL2742	Homo sapiens	pIC50		5.91
	16867963	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	=	IC50	nM	1949.84	CHEMBL2742	Homo sapiens	pIC50		5.71
	16867964	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	=	IC50	nM	7244.36	CHEMBL2742	Homo sapiens	pIC50		5.14
	16867965	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	=	IC50	nM	1949.84	CHEMBL2742	Homo sapiens	pIC50		5.71
	16867966	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867967	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	=	IC50	nM	707.95	CHEMBL2742	Homo sapiens	pIC50		6.15
	16867968	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867969	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	=	IC50	nM	9772.37	CHEMBL2742	Homo sapiens	pIC50		5.01
	16867970	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	=	IC50	nM	2818.38	CHEMBL2742	Homo sapiens	pIC50		5.55
	16867971	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	=	IC50	nM	134.9	CHEMBL2742	Homo sapiens	pIC50		6.87
	16867972	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	=	IC50	nM	58.88	CHEMBL2742	Homo sapiens	pIC50		7.23
	16867973	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	=	IC50	nM	7585.78	CHEMBL2742	Homo sapiens	pIC50		5.12
	16867974	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	=	IC50	nM	6025.6	CHEMBL2742	Homo sapiens	pIC50		5.22
	16867975	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	=	IC50	nM	4677.35	CHEMBL2742	Homo sapiens	pIC50		5.33
	16867976	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	=	IC50	nM	275.42	CHEMBL2742	Homo sapiens	pIC50		6.56
	16867977	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867978	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867979	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	=	IC50	nM	977.24	CHEMBL2742	Homo sapiens	pIC50		6.01
	16867980	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867981	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	=	IC50	nM	5888.44	CHEMBL2742	Homo sapiens	pIC50		5.23
	16867982	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	=	IC50	nM	8128.31	CHEMBL2742	Homo sapiens	pIC50		5.09
	16867983	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	=	IC50	nM	3890.45	CHEMBL2742	Homo sapiens	pIC50		5.41
	16867984	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	=	IC50	nM	9332.54	CHEMBL2742	Homo sapiens	pIC50		5.03
	16867985	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867986	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	=	IC50	nM	8709.64	CHEMBL2742	Homo sapiens	pIC50		5.06
	16867987	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	=	IC50	nM	2238.72	CHEMBL2742	Homo sapiens	pIC50		5.65
	16867988	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	=	IC50	nM	8912.51	CHEMBL2742	Homo sapiens	pIC50		5.05
	16867989	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	=	IC50	nM	8128.31	CHEMBL2742	Homo sapiens	pIC50		5.09
	16867990	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867991	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	=	IC50	nM	154.88	CHEMBL2742	Homo sapiens	pIC50		6.81
	16867992	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	=	IC50	nM	812.83	CHEMBL2742	Homo sapiens	pIC50		6.09
	16867993	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	=	IC50	nM	2344.23	CHEMBL2742	Homo sapiens	pIC50		5.63
	16867994	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	=	IC50	nM	8912.51	CHEMBL2742	Homo sapiens	pIC50		5.05
	16867995	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	=	IC50	nM	1230.27	CHEMBL2742	Homo sapiens	pIC50		5.91
	16867996	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	=	IC50	nM	707.95	CHEMBL2742	Homo sapiens	pIC50		6.15
	16867997	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867998	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16867999	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868000	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868001	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868002	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868003	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868004	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868005	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868006	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	=	IC50	nM	5754.4	CHEMBL2742	Homo sapiens	pIC50		5.24
	16868007	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868008	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868009	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868010	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868011	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868012	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868013	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868014	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868015	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868016	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	=	IC50	nM	9549.93	CHEMBL2742	Homo sapiens	pIC50		5.02
	16868017	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868018	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	5370.32	CHEMBL2742	Homo sapiens	pIC50		5.27
	16868019	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868020	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868021	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868022	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868023	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868024	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868025	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868026	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868027	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868028	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868029	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868030	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868031	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868032	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868033	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868034	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868035	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868036	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868037	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868038	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868039	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868040	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868041	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868042	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	5888.44	CHEMBL2742	Homo sapiens	pIC50		5.23
	16868043	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	4677.35	CHEMBL2742	Homo sapiens	pIC50		5.33
	16868044	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868045	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868046	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868047	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868048	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868049	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868050	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868051	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	=	IC50	nM	7079.46	CHEMBL2742	Homo sapiens	pIC50		5.15
	16868052	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	=	IC50	nM	5248.07	CHEMBL2742	Homo sapiens	pIC50		5.28
	16868053	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	=	IC50	nM	5495.41	CHEMBL2742	Homo sapiens	pIC50		5.26
	16868054	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	=	IC50	nM	8709.64	CHEMBL2742	Homo sapiens	pIC50		5.06
	16868055	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	5370.32	CHEMBL2742	Homo sapiens	pIC50		5.27
	16868056	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868057	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868058	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868059	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868060	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868061	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868062	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868063	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868064	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	=	IC50	nM	5495.41	CHEMBL2742	Homo sapiens	pIC50		5.26
	16868065	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868066	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	5128.61	CHEMBL2742	Homo sapiens	pIC50		5.29
	16868067	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868068	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868069	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868070	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868071	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868072	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868073	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868074	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868075	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868076	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868077	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868078	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868079	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868080	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868081	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921618	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868082	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868083	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868084	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868085	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868086	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868087	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868088	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868089	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868090	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868091	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868092	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868093	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868094	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868095	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868096	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	<=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868097	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868098	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868099	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868100	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868101	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868102	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868103	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868104	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868105	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868106	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868107	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868108	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868109	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868110	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	9772.37	CHEMBL2742	Homo sapiens	pIC50		5.01
	16868111	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	=	IC50	nM	9332.54	CHEMBL2742	Homo sapiens	pIC50		5.03
	16868112	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868113	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	=	IC50	nM	5248.07	CHEMBL2742	Homo sapiens	pIC50		5.28
	16868114	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868115	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868116	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868117	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868118	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868119	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868120	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868121	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868122	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868123	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868124	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868125	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868126	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868127	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868128	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868129	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	=	IC50	nM	9772.37	CHEMBL2742	Homo sapiens	pIC50		5.01
	16868130	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868131	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3928646	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868132	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3931381	=	IC50	nM	5248.07	CHEMBL2742	Homo sapiens	pIC50		5.28
	16868133	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3938610	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868134	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)N2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923808	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868135	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3890896	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868136	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986607	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868137	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3902581	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868138	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868139	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892025	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868140	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935912	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868141	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868142	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897858	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868143	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896104	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868144	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893398	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868145	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868146	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868147	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868148	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868149	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868150	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868151	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868152	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868153	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868154	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868155	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	7762.47	CHEMBL2742	Homo sapiens	pIC50		5.11
	16868156	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	=	IC50	nM	8317.64	CHEMBL2742	Homo sapiens	pIC50		5.08
	16868157	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868158	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868159	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868160	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868161	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868162	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868163	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868164	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868165	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868166	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868167	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868168	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868169	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868170	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868171	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	=	IC50	nM	9549.93	CHEMBL2742	Homo sapiens	pIC50		5.02
	16868172	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868173	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868174	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868175	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868176	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868177	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868178	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868179	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868180	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	<	IC50	nM	3019.95	CHEMBL2742	Homo sapiens	pIC50		5.52
	16868181	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868182	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868183	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868184	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868185	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868186	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868187	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868188	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868189	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868190	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868191	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868192	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868193	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868194	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868195	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868196	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868197	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	<=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868198	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868199	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868200	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	6760.83	CHEMBL2742	Homo sapiens	pIC50		5.17
	16868201	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868202	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868203	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915533	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868204	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868205	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C3C[C@@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3976183	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868206	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967011	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868207	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868208	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	=	IC50	nM	7943.28	CHEMBL2742	Homo sapiens	pIC50		5.1
	16868209	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3922285	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868210	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925008	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868211	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	<=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868212	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868213	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868214	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939439	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868215	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C[Si](C)(C)C)c4)nc3c2)c1		CHEMBL3898601	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868216	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901357	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868217	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3957643	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868218	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868219	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981706	=	IC50	nM	7762.47	CHEMBL2742	Homo sapiens	pIC50		5.11
	16868220	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3979314	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868221	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985678	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868222	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969381	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868223	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968361	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868224	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868225	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868226	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868227	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	=	IC50	nM	6918.31	CHEMBL2742	Homo sapiens	pIC50		5.16
	16868228	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868229	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868230	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868231	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868232	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868233	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868234	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868235	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868236	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868237	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868238	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868239	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	=	IC50	nM	8128.31	CHEMBL2742	Homo sapiens	pIC50		5.09
	16868240	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	=	IC50	nM	7079.46	CHEMBL2742	Homo sapiens	pIC50		5.15
	16868241	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868242	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868243	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868244	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868245	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868246	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868247	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868248	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868249	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868250	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868251	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868252	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	=	IC50	nM	6456.54	CHEMBL2742	Homo sapiens	pIC50		5.19
	16868253	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868254	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868255	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868256	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868257	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868258	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868259	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	=	IC50	nM	9549.93	CHEMBL2742	Homo sapiens	pIC50		5.02
	16868260	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	=	IC50	nM	7762.47	CHEMBL2742	Homo sapiens	pIC50		5.11
	16868261	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868262	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	=	IC50	nM	7413.1	CHEMBL2742	Homo sapiens	pIC50		5.13
	16868263	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	=	IC50	nM	7943.28	CHEMBL2742	Homo sapiens	pIC50		5.1
	16868264	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868265	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868266	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868267	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868268	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868269	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	=	IC50	nM	6918.31	CHEMBL2742	Homo sapiens	pIC50		5.16
	16868270	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868271	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868272	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868273	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868274	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	=	IC50	nM	6025.6	CHEMBL2742	Homo sapiens	pIC50		5.22
	16868275	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	=	IC50	nM	6165.95	CHEMBL2742	Homo sapiens	pIC50		5.21
	16868276	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868277	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868278	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868279	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868280	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868281	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868282	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868283	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	=	IC50	nM	7079.46	CHEMBL2742	Homo sapiens	pIC50		5.15
	16868284	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868285	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868286	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868287	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868288	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868289	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	3162.28	CHEMBL2742	Homo sapiens	pIC50		5.5
	16868290	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	=	IC50	nM	7762.47	CHEMBL2742	Homo sapiens	pIC50		5.11
	16868291	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868292	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868293	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868294	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868295	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	=	IC50	nM	7762.47	CHEMBL2742	Homo sapiens	pIC50		5.11
	16868296	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	4365.16	CHEMBL2742	Homo sapiens	pIC50		5.36
	16868297	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868298	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868299	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868300	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868301	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868302	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868303	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868304	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868305	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868306	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868307	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868308	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868309	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868310	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868311	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868312	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868313	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868314	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	<=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868315	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868316	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868317	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868318	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868319	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868320	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868321	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868322	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868323	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868324	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868325	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868326	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868327	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868328	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868329	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868330	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868331	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868332	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	5128.61	CHEMBL2742	Homo sapiens	pIC50		5.29
	16868333	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868334	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	=	IC50	nM	6309.57	CHEMBL2742	Homo sapiens	pIC50		5.2
	16868335	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868336	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868337	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868338	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868339	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868340	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868341	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868342	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868343	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868344	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	=	IC50	nM	9772.37	CHEMBL2742	Homo sapiens	pIC50		5.01
	16868345	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868346	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868347	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	=	IC50	nM	7413.1	CHEMBL2742	Homo sapiens	pIC50		5.13
	16868348	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	=	IC50	nM	6165.95	CHEMBL2742	Homo sapiens	pIC50		5.21
	16868349	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868350	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868351	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868352	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868353	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868354	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868355	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	=	IC50	nM	7079.46	CHEMBL2742	Homo sapiens	pIC50		5.15
	16868356	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868357	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868358	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868359	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868360	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868361	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868362	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868363	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868364	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868365	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868366	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868367	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868368	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868369	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	4570.88	CHEMBL2742	Homo sapiens	pIC50		5.34
	16868370	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868371	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868372	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	=	IC50	nM	7244.36	CHEMBL2742	Homo sapiens	pIC50		5.14
	16868373	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868374	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868375	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868376	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868377	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868378	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868379	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	=	IC50	nM	6760.83	CHEMBL2742	Homo sapiens	pIC50		5.17
	16868380	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868381	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868382	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868383	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868384	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868385	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868386	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868387	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868388	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868389	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868390	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868391	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868392	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868393	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868394	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	=	IC50	nM	9332.54	CHEMBL2742	Homo sapiens	pIC50		5.03
	16868395	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868396	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	=	IC50	nM	9120.11	CHEMBL2742	Homo sapiens	pIC50		5.04
	16868397	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868398	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868399	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868400	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	=	IC50	nM	7943.28	CHEMBL2742	Homo sapiens	pIC50		5.1
	16868401	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868402	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868403	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868404	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868405	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868406	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868407	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868408	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868409	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868410	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868411	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868412	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868413	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868414	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868415	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868416	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868417	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868418	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868419	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868420	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868421	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868422	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868423	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868424	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868425	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868426	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868427	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868428	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868429	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868430	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868431	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868432	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868433	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868434	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868435	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868436	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868437	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868438	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868439	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	9549.93	CHEMBL2742	Homo sapiens	pIC50		5.02
	16868440	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868441	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868442	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868443	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868444	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868445	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	5248.07	CHEMBL2742	Homo sapiens	pIC50		5.28
	16868446	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868447	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	<=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868448	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868449	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868450	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868451	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868452	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868453	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	5754.4	CHEMBL2742	Homo sapiens	pIC50		5.24
	16868454	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868455	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868456	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868457	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	7244.36	CHEMBL2742	Homo sapiens	pIC50		5.14
	16868458	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868459	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868460	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	6165.95	CHEMBL2742	Homo sapiens	pIC50		5.21
	16868461	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868462	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	7244.36	CHEMBL2742	Homo sapiens	pIC50		5.14
	16868463	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868464	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	7079.46	CHEMBL2742	Homo sapiens	pIC50		5.15
	16868465	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868466	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868467	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868468	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868469	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	8912.51	CHEMBL2742	Homo sapiens	pIC50		5.05
	16868470	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868471	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	5888.44	CHEMBL2742	Homo sapiens	pIC50		5.23
	16868472	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868473	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868474	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868475	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	=	IC50	nM	7585.78	CHEMBL2742	Homo sapiens	pIC50		5.12
	16868476	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868477	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868478	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868479	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868480	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868481	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	5623.41	CHEMBL2742	Homo sapiens	pIC50		5.25
	16868482	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868483	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868484	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868485	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868486	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868487	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868488	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	<=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868489	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	2570.4	CHEMBL2742	Homo sapiens	pIC50		5.59
	16868490	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	7244.36	CHEMBL2742	Homo sapiens	pIC50		5.14
	16868491	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868492	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868493	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868494	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868495	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868496	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868497	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	8317.64	CHEMBL2742	Homo sapiens	pIC50		5.08
	16868498	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	2041.74	CHEMBL2742	Homo sapiens	pIC50		5.69
	16868499	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	2454.71	CHEMBL2742	Homo sapiens	pIC50		5.61
	16868500	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868501	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868502	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868503	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868504	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	8317.64	CHEMBL2742	Homo sapiens	pIC50		5.08
	16868505	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868506	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868507	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	2754.23	CHEMBL2742	Homo sapiens	pIC50		5.56
	16868508	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868509	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868510	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868511	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868512	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868513	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868514	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	2344.23	CHEMBL2742	Homo sapiens	pIC50		5.63
	16868515	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868516	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868517	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868518	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868519	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868520	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868521	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868522	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868523	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868524	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868525	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868526	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868527	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868528	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868529	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868530	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868531	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868532	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868533	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868534	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868535	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868536	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868537	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1		CHEMBL3953771	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868538	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868539	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	4168.69	CHEMBL2742	Homo sapiens	pIC50		5.38
	16868540	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	7244.36	CHEMBL2742	Homo sapiens	pIC50		5.14
	16868541	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868542	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	6606.93	CHEMBL2742	Homo sapiens	pIC50		5.18
	16868543	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868544	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868545	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868546	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868547	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868548	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868549	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868550	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868551	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	4677.35	CHEMBL2742	Homo sapiens	pIC50		5.33
	16868552	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868553	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868554	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868555	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868556	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868557	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868558	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868559	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868560	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868561	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868562	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868563	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868564	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868565	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868566	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868567	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868568	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868569	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868570	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868571	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868572	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868573	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868574	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868575	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868576	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868577	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868578	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868579	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868580	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868581	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868582	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868583	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	9772.37	CHEMBL2742	Homo sapiens	pIC50		5.01
	16868584	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868585	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868586	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868587	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	=	IC50	nM	9332.54	CHEMBL2742	Homo sapiens	pIC50		5.03
	16868588	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	3630.78	CHEMBL2742	Homo sapiens	pIC50		5.44
	16868589	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868590	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868591	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868592	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868593	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868594	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868595	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868596	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868597	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868598	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868599	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868600	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868601	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868602	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868603	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868604	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868605	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868606	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868607	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868608	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868609	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868610	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868611	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868612	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868613	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868614	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868615	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868616	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868617	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868618	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868619	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868620	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868621	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868622	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868623	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868624	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868625	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868626	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868627	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868628	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868629	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868630	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16868631	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16871216	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	5.012	CHEMBL2742	Homo sapiens	pIC50		8.3
	16871217	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	0.5129	CHEMBL2742	Homo sapiens	pIC50		9.29
	16871218	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3928646	=	IC50	nM	1.905	CHEMBL2742	Homo sapiens	pIC50		8.72
	16871219	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3931381	=	IC50	nM	5.129	CHEMBL2742	Homo sapiens	pIC50		8.29
	16871220	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COCCNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3938610	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16871221	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3890896	=	IC50	nM	1.514	CHEMBL2742	Homo sapiens	pIC50		8.82
	16871222	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986607	=	IC50	nM	2.884	CHEMBL2742	Homo sapiens	pIC50		8.54
	16871223	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3902581	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16871224	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC(=O)NCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892025	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16871225	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OCCO)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935912	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16871226	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897858	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16871227	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16871228	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16871229	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	1.349	CHEMBL2742	Homo sapiens	pIC50		8.87
	16871230	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC(O)CN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915533	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16871231	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967011	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16871232	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3922285	=	IC50	nM	0.8128	CHEMBL2742	Homo sapiens	pIC50		9.09
	16871233	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925008	=	IC50	nM	1.514	CHEMBL2742	Homo sapiens	pIC50		8.82
	16871234	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	=	IC50	nM	0.6166	CHEMBL2742	Homo sapiens	pIC50		9.21
	16871235	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939439	=	IC50	nM	1.585	CHEMBL2742	Homo sapiens	pIC50		8.8
	16871236	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2C[C@@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901357	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16871237	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3957643	=	IC50	nM	6.166	CHEMBL2742	Homo sapiens	pIC50		8.21
	16871238	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981706	=	IC50	nM	26.92	CHEMBL2742	Homo sapiens	pIC50		7.57
	16871239	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985678	=	IC50	nM	0.7079	CHEMBL2742	Homo sapiens	pIC50		9.15
	16871240	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968361	=	IC50	nM	7.079	CHEMBL2742	Homo sapiens	pIC50		8.15
	16871241	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	3.631	CHEMBL2742	Homo sapiens	pIC50		8.44
	16871242	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16871243	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	0.8913	CHEMBL2742	Homo sapiens	pIC50		9.05
	16871244	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	=	IC50	nM	151.36	CHEMBL2742	Homo sapiens	pIC50		6.82
	16871245	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	pIC50		9.0
	16871246	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1cc(OC)cc(OC)c1Cl		CHEMBL3922418	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16871247	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	CCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3890126	=	IC50	nM	8.128	CHEMBL2742	Homo sapiens	pIC50		8.09
	16871248	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969061	=	IC50	nM	16.98	CHEMBL2742	Homo sapiens	pIC50		7.77
	16871249	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc1OC		CHEMBL3913051	=	IC50	nM	616.6	CHEMBL2742	Homo sapiens	pIC50		6.21
	16871250	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910393	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16871251	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951316	=	IC50	nM	2.884	CHEMBL2742	Homo sapiens	pIC50		8.54
	16871252	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3955800	=	IC50	nM	0.5129	CHEMBL2742	Homo sapiens	pIC50		9.29
	16871253	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962736	=	IC50	nM	0.6457	CHEMBL2742	Homo sapiens	pIC50		9.19
	16871254	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967645	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16871255	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925286	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16871256	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3927947	=	IC50	nM	1.349	CHEMBL2742	Homo sapiens	pIC50		8.87
	16871257	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982740	=	IC50	nM	0.6166	CHEMBL2742	Homo sapiens	pIC50		9.21
	16871258	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985332	=	IC50	nM	3.631	CHEMBL2742	Homo sapiens	pIC50		8.44
	16871259	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963649	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16871260	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3932112	=	IC50	nM	0.8913	CHEMBL2742	Homo sapiens	pIC50		9.05
	16871261	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3955685	=	IC50	nM	151.36	CHEMBL2742	Homo sapiens	pIC50		6.82
	16871262	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3898322	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16871263	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944340	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	pIC50		9.0
	16871264	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934596	=	IC50	nM	1.995	CHEMBL2742	Homo sapiens	pIC50		8.7
	16871265	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	CCN(CC)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932832	=	IC50	nM	1905.46	CHEMBL2742	Homo sapiens	pIC50		5.72
	16871327	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	181.97	CHEMBL2742	Homo sapiens	pIC50		6.74
	16871328	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	=	IC50	nM	37.15	CHEMBL2742	Homo sapiens	pIC50		7.43
	16871329	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16871330	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16871331	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3928646	=	IC50	nM	26.3	CHEMBL2742	Homo sapiens	pIC50		7.58
	16871332	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3931381	=	IC50	nM	346.74	CHEMBL2742	Homo sapiens	pIC50		6.46
	16871333	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COCCNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3938610	=	IC50	nM	128.82	CHEMBL2742	Homo sapiens	pIC50		6.89
	16871334	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)N2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923808	=	IC50	nM	346.74	CHEMBL2742	Homo sapiens	pIC50		6.46
	16871335	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3890896	=	IC50	nM	2.692	CHEMBL2742	Homo sapiens	pIC50		8.57
	16871336	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986607	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16871337	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3902581	=	IC50	nM	229.09	CHEMBL2742	Homo sapiens	pIC50		6.64
	16871338	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892025	=	IC50	nM	158.49	CHEMBL2742	Homo sapiens	pIC50		6.8
	16871339	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935912	=	IC50	nM	26.3	CHEMBL2742	Homo sapiens	pIC50		7.58
	16871340	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897858	=	IC50	nM	19.95	CHEMBL2742	Homo sapiens	pIC50		7.7
	16871341	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896104	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16871342	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893398	=	IC50	nM	0.8913	CHEMBL2742	Homo sapiens	pIC50		9.05
	16871343	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	8.71	CHEMBL2742	Homo sapiens	pIC50		8.06
	16871344	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16871345	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	6.31	CHEMBL2742	Homo sapiens	pIC50		8.2
	16871346	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915533	=	IC50	nM	6.166	CHEMBL2742	Homo sapiens	pIC50		8.21
	16871347	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967011	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16871348	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3922285	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16871349	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925008	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16871350	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939439	=	IC50	nM	0.8913	CHEMBL2742	Homo sapiens	pIC50		9.05
	16871351	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901357	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16871352	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3957643	=	IC50	nM	21.88	CHEMBL2742	Homo sapiens	pIC50		7.66
	16871353	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981706	=	IC50	nM	120.23	CHEMBL2742	Homo sapiens	pIC50		6.92
	16871354	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985678	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16871355	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969381	=	IC50	nM	0.5888	CHEMBL2742	Homo sapiens	pIC50		9.23
	16871356	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968361	=	IC50	nM	48.98	CHEMBL2742	Homo sapiens	pIC50		7.31
	16871357	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	12.02	CHEMBL2742	Homo sapiens	pIC50		7.92
	16871358	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	1.288	CHEMBL2742	Homo sapiens	pIC50		8.89
	16871359	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	=	IC50	nM	0.6761	CHEMBL2742	Homo sapiens	pIC50		9.17
	16871360	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3961923	=	IC50	nM	0.4571	CHEMBL2742	Homo sapiens	pIC50		9.34
	16871361	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	=	IC50	nM	0.389	CHEMBL2742	Homo sapiens	pIC50		9.41
	16871362	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	0.912	CHEMBL2742	Homo sapiens	pIC50		9.04
	16871363	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1cc(OC)cc(OC)c1Cl		CHEMBL3922418	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16871364	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	CCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3890126	=	IC50	nM	53.7	CHEMBL2742	Homo sapiens	pIC50		7.27
	16871365	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969061	=	IC50	nM	141.25	CHEMBL2742	Homo sapiens	pIC50		6.85
	16871366	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910393	=	IC50	nM	181.97	CHEMBL2742	Homo sapiens	pIC50		6.74
	16871367	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948698	=	IC50	nM	37.15	CHEMBL2742	Homo sapiens	pIC50		7.43
	16871368	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951316	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16871369	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903768	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16871370	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3955800	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16871371	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962736	=	IC50	nM	0.5754	CHEMBL2742	Homo sapiens	pIC50		9.24
	16871372	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967645	=	IC50	nM	8.71	CHEMBL2742	Homo sapiens	pIC50		8.06
	16871373	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925286	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16871374	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3927947	=	IC50	nM	6.31	CHEMBL2742	Homo sapiens	pIC50		8.2
	16871375	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985332	=	IC50	nM	12.02	CHEMBL2742	Homo sapiens	pIC50		7.92
	16871376	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3932112	=	IC50	nM	1.288	CHEMBL2742	Homo sapiens	pIC50		8.89
	16871377	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3958312	=	IC50	nM	0.6761	CHEMBL2742	Homo sapiens	pIC50		9.17
	16871378	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3898322	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16871379	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944340	=	IC50	nM	0.912	CHEMBL2742	Homo sapiens	pIC50		9.04
	16871380	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934596	=	IC50	nM	0.7943	CHEMBL2742	Homo sapiens	pIC50		9.1
	16871409	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16871411	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16871413	CHEMBL3880350	Inhibition of recombinant human N-terminal His6-tagged FGFR3 expressed in insect Sf21 cells using Btn-Flt3 as substrate after 3 hrs by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	0.6457	CHEMBL2742	Homo sapiens	pIC50		9.19
	16871415	CHEMBL3880352	Inhibition of TEL-fused FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 72 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	0.5754	CHEMBL2742	Homo sapiens	pIC50		9.24
	16872659	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	=	IC50	nM	1.862	CHEMBL2742	Homo sapiens	pIC50		8.73
	16872660	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16872661	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16872662	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	=	IC50	nM	7.079	CHEMBL2742	Homo sapiens	pIC50		8.15
	16872663	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16872664	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16872665	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	pIC50		9.0
	16872666	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872667	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872668	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	=	IC50	nM	2.818	CHEMBL2742	Homo sapiens	pIC50		8.55
	16872669	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	=	IC50	nM	54.95	CHEMBL2742	Homo sapiens	pIC50		7.26
	16872670	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	=	IC50	nM	602.56	CHEMBL2742	Homo sapiens	pIC50		6.22
	16872671	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	=	IC50	nM	3.548	CHEMBL2742	Homo sapiens	pIC50		8.45
	16872672	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	=	IC50	nM	7.413	CHEMBL2742	Homo sapiens	pIC50		8.13
	16872673	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	=	IC50	nM	1.122	CHEMBL2742	Homo sapiens	pIC50		8.95
	16872674	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	=	IC50	nM	1.38	CHEMBL2742	Homo sapiens	pIC50		8.86
	16872675	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	=	IC50	nM	2.818	CHEMBL2742	Homo sapiens	pIC50		8.55
	16872676	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	=	IC50	nM	40.74	CHEMBL2742	Homo sapiens	pIC50		7.39
	16872677	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16872678	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	=	IC50	nM	758.58	CHEMBL2742	Homo sapiens	pIC50		6.12
	16872679	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	0.9772	CHEMBL2742	Homo sapiens	pIC50		9.01
	16872680	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	=	IC50	nM	0.7943	CHEMBL2742	Homo sapiens	pIC50		9.1
	16872681	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	=	IC50	nM	165.96	CHEMBL2742	Homo sapiens	pIC50		6.78
	16872682	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	=	IC50	nM	1.072	CHEMBL2742	Homo sapiens	pIC50		8.97
	16872683	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	=	IC50	nM	5.129	CHEMBL2742	Homo sapiens	pIC50		8.29
	16872684	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	=	IC50	nM	58.88	CHEMBL2742	Homo sapiens	pIC50		7.23
	16872685	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	=	IC50	nM	29.51	CHEMBL2742	Homo sapiens	pIC50		7.53
	16872686	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	=	IC50	nM	83.18	CHEMBL2742	Homo sapiens	pIC50		7.08
	16872687	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	=	IC50	nM	0.912	CHEMBL2742	Homo sapiens	pIC50		9.04
	16872688	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	=	IC50	nM	6.31	CHEMBL2742	Homo sapiens	pIC50		8.2
	16872689	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	0.871	CHEMBL2742	Homo sapiens	pIC50		9.06
	16872690	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	=	IC50	nM	0.7079	CHEMBL2742	Homo sapiens	pIC50		9.15
	16872691	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	=	IC50	nM	2.042	CHEMBL2742	Homo sapiens	pIC50		8.69
	16872692	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16872693	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16872694	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	=	IC50	nM	4.467	CHEMBL2742	Homo sapiens	pIC50		8.35
	16872695	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	=	IC50	nM	1.122	CHEMBL2742	Homo sapiens	pIC50		8.95
	16872696	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872697	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	=	IC50	nM	3.548	CHEMBL2742	Homo sapiens	pIC50		8.45
	16872698	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	=	IC50	nM	8.511	CHEMBL2742	Homo sapiens	pIC50		8.07
	16872699	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	=	IC50	nM	6.166	CHEMBL2742	Homo sapiens	pIC50		8.21
	16872700	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	=	IC50	nM	676.08	CHEMBL2742	Homo sapiens	pIC50		6.17
	16872701	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	=	IC50	nM	51.29	CHEMBL2742	Homo sapiens	pIC50		7.29
	16872702	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	=	IC50	nM	1.175	CHEMBL2742	Homo sapiens	pIC50		8.93
	16872703	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	6.761	CHEMBL2742	Homo sapiens	pIC50		8.17
	16872704	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	2.884	CHEMBL2742	Homo sapiens	pIC50		8.54
	16872705	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	=	IC50	nM	2.089	CHEMBL2742	Homo sapiens	pIC50		8.68
	16872706	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	=	IC50	nM	16.98	CHEMBL2742	Homo sapiens	pIC50		7.77
	16872707	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	=	IC50	nM	44.67	CHEMBL2742	Homo sapiens	pIC50		7.35
	16872708	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	=	IC50	nM	1.318	CHEMBL2742	Homo sapiens	pIC50		8.88
	16872709	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16872710	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	=	IC50	nM	1.622	CHEMBL2742	Homo sapiens	pIC50		8.79
	16872711	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	=	IC50	nM	1.95	CHEMBL2742	Homo sapiens	pIC50		8.71
	16872712	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	=	IC50	nM	870.96	CHEMBL2742	Homo sapiens	pIC50		6.06
	16872713	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	=	IC50	nM	1.738	CHEMBL2742	Homo sapiens	pIC50		8.76
	16872714	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16872715	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	=	IC50	nM	1.862	CHEMBL2742	Homo sapiens	pIC50		8.73
	16872716	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16872717	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	=	IC50	nM	1.259	CHEMBL2742	Homo sapiens	pIC50		8.9
	16872718	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	=	IC50	nM	1.288	CHEMBL2742	Homo sapiens	pIC50		8.89
	16872719	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16872720	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	=	IC50	nM	4.266	CHEMBL2742	Homo sapiens	pIC50		8.37
	16872721	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	=	IC50	nM	2.239	CHEMBL2742	Homo sapiens	pIC50		8.65
	16872722	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872723	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	=	IC50	nM	2.239	CHEMBL2742	Homo sapiens	pIC50		8.65
	16872724	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	=	IC50	nM	2.57	CHEMBL2742	Homo sapiens	pIC50		8.59
	16872725	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	=	IC50	nM	11.75	CHEMBL2742	Homo sapiens	pIC50		7.93
	16872726	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	=	IC50	nM	0.8511	CHEMBL2742	Homo sapiens	pIC50		9.07
	16872727	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	1.23	CHEMBL2742	Homo sapiens	pIC50		8.91
	16872728	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16872729	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872730	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16872731	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16872732	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	=	IC50	nM	1.318	CHEMBL2742	Homo sapiens	pIC50		8.88
	16872733	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	=	IC50	nM	1.259	CHEMBL2742	Homo sapiens	pIC50		8.9
	16872734	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	=	IC50	nM	12.59	CHEMBL2742	Homo sapiens	pIC50		7.9
	16872735	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	=	IC50	nM	1.622	CHEMBL2742	Homo sapiens	pIC50		8.79
	16872736	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	=	IC50	nM	2.692	CHEMBL2742	Homo sapiens	pIC50		8.57
	16872737	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	=	IC50	nM	0.7943	CHEMBL2742	Homo sapiens	pIC50		9.1
	16872738	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	=	IC50	nM	1.259	CHEMBL2742	Homo sapiens	pIC50		8.9
	16872739	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	=	IC50	nM	501.19	CHEMBL2742	Homo sapiens	pIC50		6.3
	16872740	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	=	IC50	nM	4.365	CHEMBL2742	Homo sapiens	pIC50		8.36
	16872741	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16872742	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921618	=	IC50	nM	0.4467	CHEMBL2742	Homo sapiens	pIC50		9.35
	16872743	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16872744	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16872745	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	=	IC50	nM	3.548	CHEMBL2742	Homo sapiens	pIC50		8.45
	16872746	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	=	IC50	nM	3.631	CHEMBL2742	Homo sapiens	pIC50		8.44
	16872747	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	=	IC50	nM	4.677	CHEMBL2742	Homo sapiens	pIC50		8.33
	16872748	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16872749	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16872750	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	=	IC50	nM	0.7244	CHEMBL2742	Homo sapiens	pIC50		9.14
	16872751	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	=	IC50	nM	309.03	CHEMBL2742	Homo sapiens	pIC50		6.51
	16872752	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16872753	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	=	IC50	nM	1.514	CHEMBL2742	Homo sapiens	pIC50		8.82
	16872754	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	=	IC50	nM	194.98	CHEMBL2742	Homo sapiens	pIC50		6.71
	16872755	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16872756	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	=	IC50	nM	6.31	CHEMBL2742	Homo sapiens	pIC50		8.2
	16872757	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872758	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	=	IC50	nM	1.175	CHEMBL2742	Homo sapiens	pIC50		8.93
	16872759	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	=	IC50	nM	1.479	CHEMBL2742	Homo sapiens	pIC50		8.83
	16872760	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16872761	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	=	IC50	nM	3.631	CHEMBL2742	Homo sapiens	pIC50		8.44
	16872762	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	=	IC50	nM	3.981	CHEMBL2742	Homo sapiens	pIC50		8.4
	16872763	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	=	IC50	nM	3.631	CHEMBL2742	Homo sapiens	pIC50		8.44
	16872764	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16872765	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	=	IC50	nM	208.93	CHEMBL2742	Homo sapiens	pIC50		6.68
	16872766	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16872767	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16872768	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	=	IC50	nM	7.413	CHEMBL2742	Homo sapiens	pIC50		8.13
	16872769	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	=	IC50	nM	1.445	CHEMBL2742	Homo sapiens	pIC50		8.84
	16872770	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	=	IC50	nM	1.905	CHEMBL2742	Homo sapiens	pIC50		8.72
	16872771	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	2.089	CHEMBL2742	Homo sapiens	pIC50		8.68
	16872772	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	=	IC50	nM	2.754	CHEMBL2742	Homo sapiens	pIC50		8.56
	16872773	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	=	IC50	nM	2.344	CHEMBL2742	Homo sapiens	pIC50		8.63
	16872774	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	=	IC50	nM	478.63	CHEMBL2742	Homo sapiens	pIC50		6.32
	16872775	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	=	IC50	nM	18.62	CHEMBL2742	Homo sapiens	pIC50		7.73
	16872776	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16872777	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	=	IC50	nM	32.36	CHEMBL2742	Homo sapiens	pIC50		7.49
	16872778	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872779	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	=	IC50	nM	4.571	CHEMBL2742	Homo sapiens	pIC50		8.34
	16872780	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	=	IC50	nM	1.445	CHEMBL2742	Homo sapiens	pIC50		8.84
	16872781	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16872782	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	=	IC50	nM	3.467	CHEMBL2742	Homo sapiens	pIC50		8.46
	16872783	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	=	IC50	nM	776.25	CHEMBL2742	Homo sapiens	pIC50		6.11
	16872784	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16872785	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16872786	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	=	IC50	nM	3.311	CHEMBL2742	Homo sapiens	pIC50		8.48
	16872787	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	=	IC50	nM	0.6457	CHEMBL2742	Homo sapiens	pIC50		9.19
	16872788	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872789	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	=	IC50	nM	2.089	CHEMBL2742	Homo sapiens	pIC50		8.68
	16872790	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	=	IC50	nM	4.677	CHEMBL2742	Homo sapiens	pIC50		8.33
	16872791	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	=	IC50	nM	7.413	CHEMBL2742	Homo sapiens	pIC50		8.13
	16872792	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	=	IC50	nM	0.9772	CHEMBL2742	Homo sapiens	pIC50		9.01
	16872793	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	=	IC50	nM	2.818	CHEMBL2742	Homo sapiens	pIC50		8.55
	16872794	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	=	IC50	nM	2.089	CHEMBL2742	Homo sapiens	pIC50		8.68
	16872795	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872796	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	=	IC50	nM	144.54	CHEMBL2742	Homo sapiens	pIC50		6.84
	16872797	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16872798	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16872799	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	=	IC50	nM	50.12	CHEMBL2742	Homo sapiens	pIC50		7.3
	16872800	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16872801	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	=	IC50	nM	3.311	CHEMBL2742	Homo sapiens	pIC50		8.48
	16872802	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	=	IC50	nM	10.72	CHEMBL2742	Homo sapiens	pIC50		7.97
	16872803	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	=	IC50	nM	30.2	CHEMBL2742	Homo sapiens	pIC50		7.52
	16872804	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	1.66	CHEMBL2742	Homo sapiens	pIC50		8.78
	16872805	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	=	IC50	nM	3.09	CHEMBL2742	Homo sapiens	pIC50		8.51
	16872806	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872807	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872808	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	=	IC50	nM	51.29	CHEMBL2742	Homo sapiens	pIC50		7.29
	16872809	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	=	IC50	nM	0.5888	CHEMBL2742	Homo sapiens	pIC50		9.23
	16872810	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	=	IC50	nM	1.995	CHEMBL2742	Homo sapiens	pIC50		8.7
	16872811	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	=	IC50	nM	1.288	CHEMBL2742	Homo sapiens	pIC50		8.89
	16872812	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	=	IC50	nM	9.12	CHEMBL2742	Homo sapiens	pIC50		8.04
	16872813	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	=	IC50	nM	245.47	CHEMBL2742	Homo sapiens	pIC50		6.61
	16872814	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16872815	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16872816	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16872817	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872818	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16872819	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	=	IC50	nM	0.871	CHEMBL2742	Homo sapiens	pIC50		9.06
	16872820	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	=	IC50	nM	1.862	CHEMBL2742	Homo sapiens	pIC50		8.73
	16872821	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16872822	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872823	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	=	IC50	nM	9.12	CHEMBL2742	Homo sapiens	pIC50		8.04
	16872824	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	=	IC50	nM	15.85	CHEMBL2742	Homo sapiens	pIC50		7.8
	16872825	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872826	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872827	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	=	IC50	nM	1.318	CHEMBL2742	Homo sapiens	pIC50		8.88
	16872828	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	=	IC50	nM	8.511	CHEMBL2742	Homo sapiens	pIC50		8.07
	16872829	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16872830	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	=	IC50	nM	64.57	CHEMBL2742	Homo sapiens	pIC50		7.19
	16872831	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16872832	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	=	IC50	nM	416.87	CHEMBL2742	Homo sapiens	pIC50		6.38
	16872833	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	=	IC50	nM	5.623	CHEMBL2742	Homo sapiens	pIC50		8.25
	16872834	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	=	IC50	nM	104.71	CHEMBL2742	Homo sapiens	pIC50		6.98
	16872835	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16872836	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	=	IC50	nM	107.15	CHEMBL2742	Homo sapiens	pIC50		6.97
	16872837	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	=	IC50	nM	21.88	CHEMBL2742	Homo sapiens	pIC50		7.66
	16872838	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16872839	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	=	IC50	nM	53.7	CHEMBL2742	Homo sapiens	pIC50		7.27
	16872840	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	=	IC50	nM	4.786	CHEMBL2742	Homo sapiens	pIC50		8.32
	16872841	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	=	IC50	nM	1.445	CHEMBL2742	Homo sapiens	pIC50		8.84
	16872842	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16872843	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	=	IC50	nM	2.692	CHEMBL2742	Homo sapiens	pIC50		8.57
	16872844	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16872845	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	=	IC50	nM	1.148	CHEMBL2742	Homo sapiens	pIC50		8.94
	16872846	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16872847	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	=	IC50	nM	1.549	CHEMBL2742	Homo sapiens	pIC50		8.81
	16872848	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	=	IC50	nM	2.455	CHEMBL2742	Homo sapiens	pIC50		8.61
	16872849	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872850	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	=	IC50	nM	1.072	CHEMBL2742	Homo sapiens	pIC50		8.97
	16872851	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	=	IC50	nM	10.72	CHEMBL2742	Homo sapiens	pIC50		7.97
	16872852	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	=	IC50	nM	0.871	CHEMBL2742	Homo sapiens	pIC50		9.06
	16872853	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	=	IC50	nM	6.457	CHEMBL2742	Homo sapiens	pIC50		8.19
	16872854	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	=	IC50	nM	5.623	CHEMBL2742	Homo sapiens	pIC50		8.25
	16872855	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	=	IC50	nM	2.138	CHEMBL2742	Homo sapiens	pIC50		8.67
	16872856	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16872857	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16872858	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	=	IC50	nM	1.862	CHEMBL2742	Homo sapiens	pIC50		8.73
	16872859	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	6.457	CHEMBL2742	Homo sapiens	pIC50		8.19
	16872860	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	=	IC50	nM	1.349	CHEMBL2742	Homo sapiens	pIC50		8.87
	16872861	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16872862	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16872863	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16872864	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	=	IC50	nM	2.138	CHEMBL2742	Homo sapiens	pIC50		8.67
	16872865	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	=	IC50	nM	0.8913	CHEMBL2742	Homo sapiens	pIC50		9.05
	16872866	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	=	IC50	nM	0.9772	CHEMBL2742	Homo sapiens	pIC50		9.01
	16872867	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	=	IC50	nM	4.898	CHEMBL2742	Homo sapiens	pIC50		8.31
	16872868	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	=	IC50	nM	83.18	CHEMBL2742	Homo sapiens	pIC50		7.08
	16872869	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	=	IC50	nM	56.23	CHEMBL2742	Homo sapiens	pIC50		7.25
	16872870	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	=	IC50	nM	323.59	CHEMBL2742	Homo sapiens	pIC50		6.49
	16872871	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16872872	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16872873	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	=	IC50	nM	7.943	CHEMBL2742	Homo sapiens	pIC50		8.1
	16872874	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	=	IC50	nM	4.266	CHEMBL2742	Homo sapiens	pIC50		8.37
	16872875	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	=	IC50	nM	5.37	CHEMBL2742	Homo sapiens	pIC50		8.27
	16872876	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16872877	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	=	IC50	nM	1.549	CHEMBL2742	Homo sapiens	pIC50		8.81
	16872878	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	=	IC50	nM	204.17	CHEMBL2742	Homo sapiens	pIC50		6.69
	16872879	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16872880	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	=	IC50	nM	2.884	CHEMBL2742	Homo sapiens	pIC50		8.54
	16872881	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	=	IC50	nM	4.786	CHEMBL2742	Homo sapiens	pIC50		8.32
	16872882	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16872883	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16872884	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872885	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	=	IC50	nM	10.23	CHEMBL2742	Homo sapiens	pIC50		7.99
	16872886	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	=	IC50	nM	1.148	CHEMBL2742	Homo sapiens	pIC50		8.94
	16872887	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	=	IC50	nM	1.95	CHEMBL2742	Homo sapiens	pIC50		8.71
	16872888	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	=	IC50	nM	8.318	CHEMBL2742	Homo sapiens	pIC50		8.08
	16872889	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	=	IC50	nM	1.318	CHEMBL2742	Homo sapiens	pIC50		8.88
	16872890	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16872891	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16872892	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	=	IC50	nM	158.49	CHEMBL2742	Homo sapiens	pIC50		6.8
	16872893	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	=	IC50	nM	398.11	CHEMBL2742	Homo sapiens	pIC50		6.4
	16872894	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	=	IC50	nM	8.511	CHEMBL2742	Homo sapiens	pIC50		8.07
	16872895	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	=	IC50	nM	4.898	CHEMBL2742	Homo sapiens	pIC50		8.31
	16872896	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	=	IC50	nM	3.89	CHEMBL2742	Homo sapiens	pIC50		8.41
	16872897	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	=	IC50	nM	2.884	CHEMBL2742	Homo sapiens	pIC50		8.54
	16872898	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	=	IC50	nM	2.754	CHEMBL2742	Homo sapiens	pIC50		8.56
	16872899	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	=	IC50	nM	1.585	CHEMBL2742	Homo sapiens	pIC50		8.8
	16872900	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16872901	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872902	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	=	IC50	nM	4.266	CHEMBL2742	Homo sapiens	pIC50		8.37
	16872903	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	=	IC50	nM	2.951	CHEMBL2742	Homo sapiens	pIC50		8.53
	16872904	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	=	IC50	nM	12.59	CHEMBL2742	Homo sapiens	pIC50		7.9
	16872905	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16872906	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	=	IC50	nM	4.898	CHEMBL2742	Homo sapiens	pIC50		8.31
	16872907	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	=	IC50	nM	2.138	CHEMBL2742	Homo sapiens	pIC50		8.67
	16872908	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16872909	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16872910	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	=	IC50	nM	30.9	CHEMBL2742	Homo sapiens	pIC50		7.51
	16872911	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16872912	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	=	IC50	nM	2.818	CHEMBL2742	Homo sapiens	pIC50		8.55
	16872913	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	=	IC50	nM	14.45	CHEMBL2742	Homo sapiens	pIC50		7.84
	16872914	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	=	IC50	nM	14.45	CHEMBL2742	Homo sapiens	pIC50		7.84
	16872915	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16872916	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	=	IC50	nM	6.761	CHEMBL2742	Homo sapiens	pIC50		8.17
	16872917	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3961923	=	IC50	nM	2.884	CHEMBL2742	Homo sapiens	pIC50		8.54
	16872918	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	=	IC50	nM	2.692	CHEMBL2742	Homo sapiens	pIC50		8.57
	16872919	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16872920	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16872921	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	=	IC50	nM	19.05	CHEMBL2742	Homo sapiens	pIC50		7.72
	16872922	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16872923	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	2.818	CHEMBL2742	Homo sapiens	pIC50		8.55
	16872924	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	2.344	CHEMBL2742	Homo sapiens	pIC50		8.63
	16872925	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	4.266	CHEMBL2742	Homo sapiens	pIC50		8.37
	16872926	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	=	IC50	nM	1.38	CHEMBL2742	Homo sapiens	pIC50		8.86
	16872927	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	=	IC50	nM	4.467	CHEMBL2742	Homo sapiens	pIC50		8.35
	16872928	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	=	IC50	nM	0.7079	CHEMBL2742	Homo sapiens	pIC50		9.15
	16872929	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16872930	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	=	IC50	nM	8.71	CHEMBL2742	Homo sapiens	pIC50		8.06
	16872931	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16872932	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	2.089	CHEMBL2742	Homo sapiens	pIC50		8.68
	16872933	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16872934	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16872935	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	=	IC50	nM	0.8511	CHEMBL2742	Homo sapiens	pIC50		9.07
	16872936	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	=	IC50	nM	1.622	CHEMBL2742	Homo sapiens	pIC50		8.79
	16872937	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	=	IC50	nM	1.318	CHEMBL2742	Homo sapiens	pIC50		8.88
	16872938	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	=	IC50	nM	10.72	CHEMBL2742	Homo sapiens	pIC50		7.97
	16872939	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	=	IC50	nM	4.169	CHEMBL2742	Homo sapiens	pIC50		8.38
	16872940	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	=	IC50	nM	5.129	CHEMBL2742	Homo sapiens	pIC50		8.29
	16872941	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16872942	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	=	IC50	nM	1.622	CHEMBL2742	Homo sapiens	pIC50		8.79
	16872943	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	=	IC50	nM	2.692	CHEMBL2742	Homo sapiens	pIC50		8.57
	16872944	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	=	IC50	nM	1.023	CHEMBL2742	Homo sapiens	pIC50		8.99
	16872945	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	=	IC50	nM	5.754	CHEMBL2742	Homo sapiens	pIC50		8.24
	16872946	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	=	IC50	nM	4.266	CHEMBL2742	Homo sapiens	pIC50		8.37
	16872947	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	=	IC50	nM	22.91	CHEMBL2742	Homo sapiens	pIC50		7.64
	16872948	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872949	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	=	IC50	nM	0.8128	CHEMBL2742	Homo sapiens	pIC50		9.09
	16872950	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872951	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	=	IC50	nM	2.754	CHEMBL2742	Homo sapiens	pIC50		8.56
	16872952	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	=	IC50	nM	2.63	CHEMBL2742	Homo sapiens	pIC50		8.58
	16872953	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	=	IC50	nM	2.754	CHEMBL2742	Homo sapiens	pIC50		8.56
	16872954	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16872955	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16872956	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16872957	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	=	IC50	nM	1.479	CHEMBL2742	Homo sapiens	pIC50		8.83
	16872958	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16872959	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	=	IC50	nM	13.49	CHEMBL2742	Homo sapiens	pIC50		7.87
	16872960	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	=	IC50	nM	6.026	CHEMBL2742	Homo sapiens	pIC50		8.22
	16872961	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16872962	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CNS(=O)(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933000	=	IC50	nM	2.692	CHEMBL2742	Homo sapiens	pIC50		8.57
	16872963	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	=	IC50	nM	7.943	CHEMBL2742	Homo sapiens	pIC50		8.1
	16872964	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16872965	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16872966	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872967	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	=	IC50	nM	0.8318	CHEMBL2742	Homo sapiens	pIC50		9.08
	16872968	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	=	IC50	nM	3.548	CHEMBL2742	Homo sapiens	pIC50		8.45
	16872969	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	33.88	CHEMBL2742	Homo sapiens	pIC50		7.47
	16872970	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	=	IC50	nM	4.786	CHEMBL2742	Homo sapiens	pIC50		8.32
	16872971	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	=	IC50	nM	6.31	CHEMBL2742	Homo sapiens	pIC50		8.2
	16872972	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16872973	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	=	IC50	nM	3.02	CHEMBL2742	Homo sapiens	pIC50		8.52
	16872974	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	=	IC50	nM	2.754	CHEMBL2742	Homo sapiens	pIC50		8.56
	16872975	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	=	IC50	nM	3.09	CHEMBL2742	Homo sapiens	pIC50		8.51
	16872976	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	=	IC50	nM	3.631	CHEMBL2742	Homo sapiens	pIC50		8.44
	16872977	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	=	IC50	nM	2.951	CHEMBL2742	Homo sapiens	pIC50		8.53
	16872978	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	=	IC50	nM	1.95	CHEMBL2742	Homo sapiens	pIC50		8.71
	16872979	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16872980	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	=	IC50	nM	4.786	CHEMBL2742	Homo sapiens	pIC50		8.32
	16872981	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16872982	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	=	IC50	nM	11.22	CHEMBL2742	Homo sapiens	pIC50		7.95
	16872983	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	=	IC50	nM	5.754	CHEMBL2742	Homo sapiens	pIC50		8.24
	16872984	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16872985	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16872986	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	=	IC50	nM	6.166	CHEMBL2742	Homo sapiens	pIC50		8.21
	16872987	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	=	IC50	nM	2.239	CHEMBL2742	Homo sapiens	pIC50		8.65
	16872988	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16872989	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	=	IC50	nM	60.26	CHEMBL2742	Homo sapiens	pIC50		7.22
	16872990	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16872991	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	=	IC50	nM	3.467	CHEMBL2742	Homo sapiens	pIC50		8.46
	16872992	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	=	IC50	nM	3.981	CHEMBL2742	Homo sapiens	pIC50		8.4
	16872993	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	=	IC50	nM	19.95	CHEMBL2742	Homo sapiens	pIC50		7.7
	16872994	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	=	IC50	nM	11.75	CHEMBL2742	Homo sapiens	pIC50		7.93
	16872995	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	=	IC50	nM	15.85	CHEMBL2742	Homo sapiens	pIC50		7.8
	16872996	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	=	IC50	nM	3.89	CHEMBL2742	Homo sapiens	pIC50		8.41
	16872997	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	=	IC50	nM	16.22	CHEMBL2742	Homo sapiens	pIC50		7.79
	16872998	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	=	IC50	nM	6.026	CHEMBL2742	Homo sapiens	pIC50		8.22
	16872999	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	=	IC50	nM	4.467	CHEMBL2742	Homo sapiens	pIC50		8.35
	16873000	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16873001	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	=	IC50	nM	2.57	CHEMBL2742	Homo sapiens	pIC50		8.59
	16873002	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16873003	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	=	IC50	nM	19.5	CHEMBL2742	Homo sapiens	pIC50		7.71
	16873004	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	=	IC50	nM	1.479	CHEMBL2742	Homo sapiens	pIC50		8.83
	16873005	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	=	IC50	nM	3.09	CHEMBL2742	Homo sapiens	pIC50		8.51
	16873006	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	5.754	CHEMBL2742	Homo sapiens	pIC50		8.24
	16873007	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	=	IC50	nM	3.548	CHEMBL2742	Homo sapiens	pIC50		8.45
	16873008	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	=	IC50	nM	13.8	CHEMBL2742	Homo sapiens	pIC50		7.86
	16873009	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16873010	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16873011	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16873012	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	=	IC50	nM	5.37	CHEMBL2742	Homo sapiens	pIC50		8.27
	16873013	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	=	IC50	nM	6.026	CHEMBL2742	Homo sapiens	pIC50		8.22
	16873014	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16873015	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16873016	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	=	IC50	nM	4.786	CHEMBL2742	Homo sapiens	pIC50		8.32
	16873017	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16873018	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16873019	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	=	IC50	nM	3.311	CHEMBL2742	Homo sapiens	pIC50		8.48
	16873020	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	=	IC50	nM	8.913	CHEMBL2742	Homo sapiens	pIC50		8.05
	16873021	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	=	IC50	nM	5.012	CHEMBL2742	Homo sapiens	pIC50		8.3
	16873022	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	=	IC50	nM	7.762	CHEMBL2742	Homo sapiens	pIC50		8.11
	16873023	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	=	IC50	nM	5.495	CHEMBL2742	Homo sapiens	pIC50		8.26
	16873024	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16873025	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	=	IC50	nM	53.7	CHEMBL2742	Homo sapiens	pIC50		7.27
	16873026	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16873027	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	=	IC50	nM	1.259	CHEMBL2742	Homo sapiens	pIC50		8.9
	16873028	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	=	IC50	nM	16.6	CHEMBL2742	Homo sapiens	pIC50		7.78
	16873029	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	=	IC50	nM	1.66	CHEMBL2742	Homo sapiens	pIC50		8.78
	16873030	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	=	IC50	nM	6.31	CHEMBL2742	Homo sapiens	pIC50		8.2
	16873031	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	=	IC50	nM	1.95	CHEMBL2742	Homo sapiens	pIC50		8.71
	16873032	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16873033	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16873034	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16873035	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	=	IC50	nM	19.05	CHEMBL2742	Homo sapiens	pIC50		7.72
	16873036	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C3CCN(C(C)=O)CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943610	=	IC50	nM	10.72	CHEMBL2742	Homo sapiens	pIC50		7.97
	16873037	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	=	IC50	nM	8.913	CHEMBL2742	Homo sapiens	pIC50		8.05
	16873038	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	=	IC50	nM	7.079	CHEMBL2742	Homo sapiens	pIC50		8.15
	16873039	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	=	IC50	nM	2.239	CHEMBL2742	Homo sapiens	pIC50		8.65
	16873040	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	=	IC50	nM	1.82	CHEMBL2742	Homo sapiens	pIC50		8.74
	16873041	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16873042	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951090	=	IC50	nM	9.12	CHEMBL2742	Homo sapiens	pIC50		8.04
	16873043	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16873044	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3949508	=	IC50	nM	10.23	CHEMBL2742	Homo sapiens	pIC50		7.99
	16873045	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901612	=	IC50	nM	3.981	CHEMBL2742	Homo sapiens	pIC50		8.4
	16873046	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16873047	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	pIC50		9.0
	16873048	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	=	IC50	nM	0.6166	CHEMBL2742	Homo sapiens	pIC50		9.21
	16873049	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	=	IC50	nM	2.344	CHEMBL2742	Homo sapiens	pIC50		8.63
	16873050	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	=	IC50	nM	3.715	CHEMBL2742	Homo sapiens	pIC50		8.43
	16873051	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	=	IC50	nM	8.913	CHEMBL2742	Homo sapiens	pIC50		8.05
	16873052	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16873053	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	=	IC50	nM	1.778	CHEMBL2742	Homo sapiens	pIC50		8.75
	16873054	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	=	IC50	nM	1.585	CHEMBL2742	Homo sapiens	pIC50		8.8
	16873055	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	=	IC50	nM	21.88	CHEMBL2742	Homo sapiens	pIC50		7.66
	16873056	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	=	IC50	nM	3.09	CHEMBL2742	Homo sapiens	pIC50		8.51
	16873057	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16873058	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	=	IC50	nM	8.128	CHEMBL2742	Homo sapiens	pIC50		8.09
	16873059	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	=	IC50	nM	5.129	CHEMBL2742	Homo sapiens	pIC50		8.29
	16873060	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	=	IC50	nM	5.129	CHEMBL2742	Homo sapiens	pIC50		8.29
	16873061	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	=	IC50	nM	3.981	CHEMBL2742	Homo sapiens	pIC50		8.4
	16873062	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16873063	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16873064	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	=	IC50	nM	4.786	CHEMBL2742	Homo sapiens	pIC50		8.32
	16873065	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16873066	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	=	IC50	nM	14.45	CHEMBL2742	Homo sapiens	pIC50		7.84
	16873067	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16873068	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	=	IC50	nM	2.455	CHEMBL2742	Homo sapiens	pIC50		8.61
	16873069	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16873070	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	=	IC50	nM	2.57	CHEMBL2742	Homo sapiens	pIC50		8.59
	16873071	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16873072	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	=	IC50	nM	2.188	CHEMBL2742	Homo sapiens	pIC50		8.66
	16873073	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	=	IC50	nM	1.23	CHEMBL2742	Homo sapiens	pIC50		8.91
	16873074	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	=	IC50	nM	0.4898	CHEMBL2742	Homo sapiens	pIC50		9.31
	16873075	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	=	IC50	nM	8.913	CHEMBL2742	Homo sapiens	pIC50		8.05
	16873076	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	=	IC50	nM	0.8318	CHEMBL2742	Homo sapiens	pIC50		9.08
	16873077	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	=	IC50	nM	5.888	CHEMBL2742	Homo sapiens	pIC50		8.23
	16873078	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16873079	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	=	IC50	nM	11.48	CHEMBL2742	Homo sapiens	pIC50		7.94
	16873080	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16873081	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	=	IC50	nM	22.39	CHEMBL2742	Homo sapiens	pIC50		7.65
	16873082	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	=	IC50	nM	0.955	CHEMBL2742	Homo sapiens	pIC50		9.02
	16873083	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	=	IC50	nM	20.42	CHEMBL2742	Homo sapiens	pIC50		7.69
	16873084	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	=	IC50	nM	7.244	CHEMBL2742	Homo sapiens	pIC50		8.14
	16873085	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	=	IC50	nM	7.586	CHEMBL2742	Homo sapiens	pIC50		8.12
	16873086	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	12.3	CHEMBL2742	Homo sapiens	pIC50		7.91
	16873087	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	=	IC50	nM	66.07	CHEMBL2742	Homo sapiens	pIC50		7.18
	16873088	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	=	IC50	nM	10.72	CHEMBL2742	Homo sapiens	pIC50		7.97
	16873089	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	=	IC50	nM	15.14	CHEMBL2742	Homo sapiens	pIC50		7.82
	16873090	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	=	IC50	nM	1.738	CHEMBL2742	Homo sapiens	pIC50		8.76
	16873091	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	=	IC50	nM	6.457	CHEMBL2742	Homo sapiens	pIC50		8.19
	16873092	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	=	IC50	nM	251.19	CHEMBL2742	Homo sapiens	pIC50		6.6
	16873093	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16873094	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	28.84	CHEMBL2742	Homo sapiens	pIC50		7.54
	16873095	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16873096	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	=	IC50	nM	19.95	CHEMBL2742	Homo sapiens	pIC50		7.7
	16873097	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	=	IC50	nM	1.862	CHEMBL2742	Homo sapiens	pIC50		8.73
	16873098	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	5.129	CHEMBL2742	Homo sapiens	pIC50		8.29
	16873099	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	=	IC50	nM	3.236	CHEMBL2742	Homo sapiens	pIC50		8.49
	16873100	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	=	IC50	nM	5.623	CHEMBL2742	Homo sapiens	pIC50		8.25
	16873101	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	9.772	CHEMBL2742	Homo sapiens	pIC50		8.01
	16873102	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	=	IC50	nM	0.7762	CHEMBL2742	Homo sapiens	pIC50		9.11
	16873103	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	9.333	CHEMBL2742	Homo sapiens	pIC50		8.03
	16873104	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16873105	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	1.995	CHEMBL2742	Homo sapiens	pIC50		8.7
	16873106	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	=	IC50	nM	346.74	CHEMBL2742	Homo sapiens	pIC50		6.46
	16873107	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3897783	=	IC50	nM	1.66	CHEMBL2742	Homo sapiens	pIC50		8.78
	16873108	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16873109	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	=	IC50	nM	3.311	CHEMBL2742	Homo sapiens	pIC50		8.48
	16873110	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16873111	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16873112	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	=	IC50	nM	34.67	CHEMBL2742	Homo sapiens	pIC50		7.46
	16873113	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	3.162	CHEMBL2742	Homo sapiens	pIC50		8.5
	16873114	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16873115	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	=	IC50	nM	25.12	CHEMBL2742	Homo sapiens	pIC50		7.6
	16873116	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	=	IC50	nM	7.943	CHEMBL2742	Homo sapiens	pIC50		8.1
	16873117	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16873118	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	=	IC50	nM	1.514	CHEMBL2742	Homo sapiens	pIC50		8.82
	16873119	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	=	IC50	nM	169.82	CHEMBL2742	Homo sapiens	pIC50		6.77
	16873120	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	=	IC50	nM	199.53	CHEMBL2742	Homo sapiens	pIC50		6.7
	16873121	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	=	IC50	nM	2.818	CHEMBL2742	Homo sapiens	pIC50		8.55
	16873122	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	=	IC50	nM	2.754	CHEMBL2742	Homo sapiens	pIC50		8.56
	16873123	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	4.571	CHEMBL2742	Homo sapiens	pIC50		8.34
	16873124	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	=	IC50	nM	288.4	CHEMBL2742	Homo sapiens	pIC50		6.54
	16873125	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	=	IC50	nM	4.467	CHEMBL2742	Homo sapiens	pIC50		8.35
	16873126	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	=	IC50	nM	47.86	CHEMBL2742	Homo sapiens	pIC50		7.32
	16873127	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	=	IC50	nM	57.54	CHEMBL2742	Homo sapiens	pIC50		7.24
	16873128	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	=	IC50	nM	34.67	CHEMBL2742	Homo sapiens	pIC50		7.46
	16873129	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	=	IC50	nM	38.02	CHEMBL2742	Homo sapiens	pIC50		7.42
	16873130	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	=	IC50	nM	12.59	CHEMBL2742	Homo sapiens	pIC50		7.9
	16873131	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	5.012	CHEMBL2742	Homo sapiens	pIC50		8.3
	16873132	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	162.18	CHEMBL2742	Homo sapiens	pIC50		6.79
	16873133	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	=	IC50	nM	251.19	CHEMBL2742	Homo sapiens	pIC50		6.6
	16873134	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	=	IC50	nM	10.23	CHEMBL2742	Homo sapiens	pIC50		7.99
	16873135	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	=	IC50	nM	8.511	CHEMBL2742	Homo sapiens	pIC50		8.07
	16873136	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	=	IC50	nM	4.266	CHEMBL2742	Homo sapiens	pIC50		8.37
	16873137	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	=	IC50	nM	5.012	CHEMBL2742	Homo sapiens	pIC50		8.3
	16873138	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16873139	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	10.96	CHEMBL2742	Homo sapiens	pIC50		7.96
	16873140	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	13.8	CHEMBL2742	Homo sapiens	pIC50		7.86
	16873141	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	5.623	CHEMBL2742	Homo sapiens	pIC50		8.25
	16873142	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	=	IC50	nM	31.62	CHEMBL2742	Homo sapiens	pIC50		7.5
	16873143	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	=	IC50	nM	12.59	CHEMBL2742	Homo sapiens	pIC50		7.9
	16873144	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	=	IC50	nM	218.78	CHEMBL2742	Homo sapiens	pIC50		6.66
	16873145	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16873146	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	7.079	CHEMBL2742	Homo sapiens	pIC50		8.15
	16873147	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	=	IC50	nM	6.457	CHEMBL2742	Homo sapiens	pIC50		8.19
	16873148	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	=	IC50	nM	194.98	CHEMBL2742	Homo sapiens	pIC50		6.71
	16873149	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16873150	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	pIC50		8.0
	16873151	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	=	IC50	nM	10.47	CHEMBL2742	Homo sapiens	pIC50		7.98
	16873152	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16873153	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	=	IC50	nM	1.096	CHEMBL2742	Homo sapiens	pIC50		8.96
	16873154	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16873155	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	=	IC50	nM	11.22	CHEMBL2742	Homo sapiens	pIC50		7.95
	16873156	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	3.311	CHEMBL2742	Homo sapiens	pIC50		8.48
	16873157	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	=	IC50	nM	7.762	CHEMBL2742	Homo sapiens	pIC50		8.11
	16873158	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	=	IC50	nM	66.07	CHEMBL2742	Homo sapiens	pIC50		7.18
	16873159	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	=	IC50	nM	9.12	CHEMBL2742	Homo sapiens	pIC50		8.04
	16873160	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	=	IC50	nM	6.166	CHEMBL2742	Homo sapiens	pIC50		8.21
	16873161	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	=	IC50	nM	2.042	CHEMBL2742	Homo sapiens	pIC50		8.69
	16873162	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	=	IC50	nM	28.18	CHEMBL2742	Homo sapiens	pIC50		7.55
	16873163	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	=	IC50	nM	54.95	CHEMBL2742	Homo sapiens	pIC50		7.26
	16873164	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	=	IC50	nM	95.5	CHEMBL2742	Homo sapiens	pIC50		7.02
	16873165	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	=	IC50	nM	34.67	CHEMBL2742	Homo sapiens	pIC50		7.46
	16873166	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	=	IC50	nM	21.88	CHEMBL2742	Homo sapiens	pIC50		7.66
	16873167	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	=	IC50	nM	3.467	CHEMBL2742	Homo sapiens	pIC50		8.46
	16873168	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	=	IC50	nM	4.571	CHEMBL2742	Homo sapiens	pIC50		8.34
	16873169	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	=	IC50	nM	7.413	CHEMBL2742	Homo sapiens	pIC50		8.13
	16873170	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16873171	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	=	IC50	nM	15.49	CHEMBL2742	Homo sapiens	pIC50		7.81
	16873172	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	=	IC50	nM	61.66	CHEMBL2742	Homo sapiens	pIC50		7.21
	16873173	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	=	IC50	nM	14.45	CHEMBL2742	Homo sapiens	pIC50		7.84
	16873174	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	=	IC50	nM	12.88	CHEMBL2742	Homo sapiens	pIC50		7.89
	16873175	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	=	IC50	nM	33.11	CHEMBL2742	Homo sapiens	pIC50		7.48
	16873176	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	=	IC50	nM	5.248	CHEMBL2742	Homo sapiens	pIC50		8.28
	16873177	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	=	IC50	nM	4.677	CHEMBL2742	Homo sapiens	pIC50		8.33
	16873178	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	=	IC50	nM	295.12	CHEMBL2742	Homo sapiens	pIC50		6.53
	16873179	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1		CHEMBL3953771	=	IC50	nM	20.89	CHEMBL2742	Homo sapiens	pIC50		7.68
	16873180	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	=	IC50	nM	18.62	CHEMBL2742	Homo sapiens	pIC50		7.73
	16873181	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	120.23	CHEMBL2742	Homo sapiens	pIC50		6.92
	16873182	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	29.51	CHEMBL2742	Homo sapiens	pIC50		7.53
	16873183	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	=	IC50	nM	33.11	CHEMBL2742	Homo sapiens	pIC50		7.48
	16873184	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	6.607	CHEMBL2742	Homo sapiens	pIC50		8.18
	16873185	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	=	IC50	nM	75.86	CHEMBL2742	Homo sapiens	pIC50		7.12
	16873186	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	=	IC50	nM	19.05	CHEMBL2742	Homo sapiens	pIC50		7.72
	16873187	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	=	IC50	nM	2.57	CHEMBL2742	Homo sapiens	pIC50		8.59
	16873188	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	=	IC50	nM	23.44	CHEMBL2742	Homo sapiens	pIC50		7.63
	16873189	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	=	IC50	nM	26.92	CHEMBL2742	Homo sapiens	pIC50		7.57
	16873190	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	=	IC50	nM	2.344	CHEMBL2742	Homo sapiens	pIC50		8.63
	16873191	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	=	IC50	nM	1.259	CHEMBL2742	Homo sapiens	pIC50		8.9
	16873192	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	=	IC50	nM	2.951	CHEMBL2742	Homo sapiens	pIC50		8.53
	16873193	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	18.2	CHEMBL2742	Homo sapiens	pIC50		7.74
	16873194	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	=	IC50	nM	22.39	CHEMBL2742	Homo sapiens	pIC50		7.65
	16873195	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	=	IC50	nM	1.413	CHEMBL2742	Homo sapiens	pIC50		8.85
	16873196	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	=	IC50	nM	3.802	CHEMBL2742	Homo sapiens	pIC50		8.42
	16873197	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	=	IC50	nM	75.86	CHEMBL2742	Homo sapiens	pIC50		7.12
	16873198	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	=	IC50	nM	114.82	CHEMBL2742	Homo sapiens	pIC50		6.94
	16873199	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	=	IC50	nM	19.05	CHEMBL2742	Homo sapiens	pIC50		7.72
	16873200	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	=	IC50	nM	25.7	CHEMBL2742	Homo sapiens	pIC50		7.59
	16873201	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	=	IC50	nM	177.83	CHEMBL2742	Homo sapiens	pIC50		6.75
	16873202	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	pIC50		7.0
	16873203	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	=	IC50	nM	72.44	CHEMBL2742	Homo sapiens	pIC50		7.14
	16873204	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	=	IC50	nM	18.62	CHEMBL2742	Homo sapiens	pIC50		7.73
	16873205	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	=	IC50	nM	13.18	CHEMBL2742	Homo sapiens	pIC50		7.88
	16873206	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	=	IC50	nM	11.48	CHEMBL2742	Homo sapiens	pIC50		7.94
	16873207	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	=	IC50	nM	25.12	CHEMBL2742	Homo sapiens	pIC50		7.6
	16873208	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	=	IC50	nM	9.333	CHEMBL2742	Homo sapiens	pIC50		8.03
	16873209	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	=	IC50	nM	1.585	CHEMBL2742	Homo sapiens	pIC50		8.8
	16873210	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	=	IC50	nM	27.54	CHEMBL2742	Homo sapiens	pIC50		7.56
	16873211	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	=	IC50	nM	15.14	CHEMBL2742	Homo sapiens	pIC50		7.82
	16873212	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	=	IC50	nM	51.29	CHEMBL2742	Homo sapiens	pIC50		7.29
	16873213	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	=	IC50	nM	16.98	CHEMBL2742	Homo sapiens	pIC50		7.77
	16873214	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	=	IC50	nM	19.05	CHEMBL2742	Homo sapiens	pIC50		7.72
	16873215	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	=	IC50	nM	11.75	CHEMBL2742	Homo sapiens	pIC50		7.93
	16873216	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	=	IC50	nM	4.898	CHEMBL2742	Homo sapiens	pIC50		8.31
	16873217	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	=	IC50	nM	91.2	CHEMBL2742	Homo sapiens	pIC50		7.04
	16873218	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16873219	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	=	IC50	nM	2.089	CHEMBL2742	Homo sapiens	pIC50		8.68
	16873220	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	=	IC50	nM	0.7943	CHEMBL2742	Homo sapiens	pIC50		9.1
	16873221	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	=	IC50	nM	83.18	CHEMBL2742	Homo sapiens	pIC50		7.08
	16873222	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	=	IC50	nM	26.92	CHEMBL2742	Homo sapiens	pIC50		7.57
	16873223	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	=	IC50	nM	3.388	CHEMBL2742	Homo sapiens	pIC50		8.47
	16873224	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	=	IC50	nM	2.399	CHEMBL2742	Homo sapiens	pIC50		8.62
	16873225	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	2.291	CHEMBL2742	Homo sapiens	pIC50		8.64
	16873226	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	=	IC50	nM	1.585	CHEMBL2742	Homo sapiens	pIC50		8.8
	16873227	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	=	IC50	nM	28.84	CHEMBL2742	Homo sapiens	pIC50		7.54
	16873228	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892005	=	IC50	nM	23.99	CHEMBL2742	Homo sapiens	pIC50		7.62
	16873229	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	=	IC50	nM	1.122	CHEMBL2742	Homo sapiens	pIC50		8.95
	16873230	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	=	IC50	nM	10.47	CHEMBL2742	Homo sapiens	pIC50		7.98
	16873231	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16873232	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	=	IC50	nM	371.54	CHEMBL2742	Homo sapiens	pIC50		6.43
	16873233	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	=	IC50	nM	39.81	CHEMBL2742	Homo sapiens	pIC50		7.4
	16873234	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	=	IC50	nM	3.311	CHEMBL2742	Homo sapiens	pIC50		8.48
	16873235	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899151	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16873236	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960877	=	IC50	nM	1.202	CHEMBL2742	Homo sapiens	pIC50		8.92
	16873237	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCC#N)c4)nc3c2)c1		CHEMBL3958209	=	IC50	nM	1.698	CHEMBL2742	Homo sapiens	pIC50		8.77
	16873238	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951253	=	IC50	nM	2.512	CHEMBL2742	Homo sapiens	pIC50		8.6
	16873239	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(c3nccc(OC)n3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948629	<	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16873240	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCOCC5)c4)nc3c2)c1		CHEMBL3913492	=	IC50	nM	3.09	CHEMBL2742	Homo sapiens	pIC50		8.51
	16873241	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
	16873242	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	=	IC50	nM	3981.07	CHEMBL2742	Homo sapiens	pIC50		5.4
	16873243	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	=	IC50	nM	1995.26	CHEMBL2742	Homo sapiens	pIC50		5.7
	16873244	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	=	IC50	nM	794.33	CHEMBL2742	Homo sapiens	pIC50		6.1
	16873245	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCN2Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946591	=	IC50	nM	46.77	CHEMBL2742	Homo sapiens	pIC50		7.33
	16873246	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	=	IC50	nM	17.38	CHEMBL2742	Homo sapiens	pIC50		7.76
	16873247	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	=	IC50	nM	17.78	CHEMBL2742	Homo sapiens	pIC50		7.75
	16873248	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	=	IC50	nM	181.97	CHEMBL2742	Homo sapiens	pIC50		6.74
	16873249	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	=	IC50	nM	4.074	CHEMBL2742	Homo sapiens	pIC50		8.39
	16873250	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	=	IC50	nM	380.19	CHEMBL2742	Homo sapiens	pIC50		6.42
	16873251	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	=	IC50	nM	43.65	CHEMBL2742	Homo sapiens	pIC50		7.36
	16873252	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16873253	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	=	IC50	nM	457.09	CHEMBL2742	Homo sapiens	pIC50		6.34
	16873254	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948043	=	IC50	nM	281.84	CHEMBL2742	Homo sapiens	pIC50		6.55
	16873255	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	=	IC50	nM	32.36	CHEMBL2742	Homo sapiens	pIC50		7.49
	16873256	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	=	IC50	nM	10.47	CHEMBL2742	Homo sapiens	pIC50		7.98
	16873257	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	=	IC50	nM	4.571	CHEMBL2742	Homo sapiens	pIC50		8.34
	16873258	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	=	IC50	nM	354.81	CHEMBL2742	Homo sapiens	pIC50		6.45
	16873259	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	=	IC50	nM	173.78	CHEMBL2742	Homo sapiens	pIC50		6.76
	16873260	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	=	IC50	nM	28.84	CHEMBL2742	Homo sapiens	pIC50		7.54
	16873261	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	=	IC50	nM	5.37	CHEMBL2742	Homo sapiens	pIC50		8.27
	16873262	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	=	IC50	nM	1.549	CHEMBL2742	Homo sapiens	pIC50		8.81
	16873263	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	=	IC50	nM	64.57	CHEMBL2742	Homo sapiens	pIC50		7.19
	16873264	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	=	IC50	nM	25.7	CHEMBL2742	Homo sapiens	pIC50		7.59
	16873265	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16873266	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	=	IC50	nM	44.67	CHEMBL2742	Homo sapiens	pIC50		7.35
	16873267	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	=	IC50	nM	123.03	CHEMBL2742	Homo sapiens	pIC50		6.91
	16873268	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	=	IC50	nM	147.91	CHEMBL2742	Homo sapiens	pIC50		6.83
	16873269	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	=	IC50	nM	144.54	CHEMBL2742	Homo sapiens	pIC50		6.84
	16873270	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	=	IC50	nM	467.74	CHEMBL2742	Homo sapiens	pIC50		6.33
	16873271	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	=	IC50	nM	275.42	CHEMBL2742	Homo sapiens	pIC50		6.56
	16873272	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	=	IC50	nM	51.29	CHEMBL2742	Homo sapiens	pIC50		7.29
	16873273	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	<	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16873274	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	=	IC50	nM	616.6	CHEMBL2742	Homo sapiens	pIC50		6.21
	16873275	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16873276	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	=	IC50	nM	13.8	CHEMBL2742	Homo sapiens	pIC50		7.86
	16873277	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	<	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	16873278	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	=	IC50	nM	61.66	CHEMBL2742	Homo sapiens	pIC50		7.21
	16873279	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	=	IC50	nM	123.03	CHEMBL2742	Homo sapiens	pIC50		6.91
	16873280	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	=	IC50	nM	17.38	CHEMBL2742	Homo sapiens	pIC50		7.76
	16873281	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	=	IC50	nM	43.65	CHEMBL2742	Homo sapiens	pIC50		7.36
	16873282	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	=	IC50	nM	223.87	CHEMBL2742	Homo sapiens	pIC50		6.65
	16873283	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(CNC(C)C)C(C)C)c1		CHEMBL3932123	=	IC50	nM	281.84	CHEMBL2742	Homo sapiens	pIC50		6.55
	16875825	CHEMBL3880339	Inhibition of human FGFR3 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	=	IC50	nM	31.62	CHEMBL2742	Homo sapiens	pIC50		7.5
	16875830	CHEMBL3880344	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	=	IC50	nM	2691.53	CHEMBL2742	Homo sapiens	pIC50		5.57
	16875831	CHEMBL3880345	Inhibition of FGFR3 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	<	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	pIC50		5.0
17467	17601341	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(C(N)=O)cn3)c3nccnc23)c1Cl		CHEMBL3653143	=	IC50	nM	74.0	CHEMBL2742	Homo sapiens	IC50	nM	74.0
220030	17608728	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(c2cccc(NC(=O)c3ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c4nccnc34)c2)CC1		CHEMBL3653093	=	IC50	nM	530.0	CHEMBL2742	Homo sapiens	IC50	nM	530.0
220031	17608729	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(C(N)=O)cc3)c3nccnc23)c1Cl		CHEMBL3653094	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
220032	17608730	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N4CCOCC4)cc3)c3nccnc23)c1Cl		CHEMBL3653095	=	IC50	nM	1300.0	CHEMBL2742	Homo sapiens	IC50	nM	1300.0
220033	17608731	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N4CCN(C(C)C)CC4)cc3)c3nccnc23)c1Cl		CHEMBL3653096	=	IC50	nM	58.0	CHEMBL2742	Homo sapiens	IC50	nM	58.0
220034	17608732	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C(C)C)CC4)cc3)c3nccnc23)c1Cl		CHEMBL3653097	=	IC50	nM	31.0	CHEMBL2742	Homo sapiens	IC50	nM	31.0
220035	17608733	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3nnc[nH]3)c3nccnc23)c1Cl		CHEMBL3653129	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
220036	17608734	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN4CCN(C)CC4)[nH]3)c3nccnc23)c1Cl		CHEMBL3653130	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
220037	17608735	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3nccnc23)c1Cl		CHEMBL3653131	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
220038	17608736	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(=O)[nH]c3)c3nccnc23)c1Cl		CHEMBL3653098	=	IC50	nM	530.0	CHEMBL2742	Homo sapiens	IC50	nM	530.0
220039	17608737	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(C(=O)N4CCN(C)CC4)cn3)c3nccnc23)c1Cl		CHEMBL3653099	=	IC50	nM	41.0	CHEMBL2742	Homo sapiens	IC50	nM	41.0
220040	17608738	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1Cl		CHEMBL3653100	=	IC50	nM	22.0	CHEMBL2742	Homo sapiens	IC50	nM	22.0
220041	17608739	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(c2ccc(NC(=O)c3ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c4nccnc34)cn2)CC1		CHEMBL3653101	=	IC50	nM	54.0	CHEMBL2742	Homo sapiens	IC50	nM	54.0
220042	17608740	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N(C)CCN(C)C)nc3)c3nccnc23)c1Cl		CHEMBL3653102	=	IC50	nM	270.0	CHEMBL2742	Homo sapiens	IC50	nM	270.0
220043	17608741	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCOCC4)nc3)c3nccnc23)c1Cl		CHEMBL3653103	=	IC50	nM	87.0	CHEMBL2742	Homo sapiens	IC50	nM	87.0
220044	17608742	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cncc5ccccc45)c4nccnc34)nc2)CC1		CHEMBL3653104	=	IC50	nM	1200.0	CHEMBL2742	Homo sapiens	IC50	nM	1200.0
220045	17608743	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CN1CCN(Cc2cnc(NC(=O)c3ccc(-c4cncc5ccccc45)c4nccnc34)[nH]2)CC1		CHEMBL3653105	=	IC50	nM	700.0	CHEMBL2742	Homo sapiens	IC50	nM	700.0
220046	17608744	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CN1CCN(Cc2cnc(NC(=O)c3ccc(-c4csc5ccccc45)c4nccnc34)[nH]2)CC1		CHEMBL3653106	=	IC50	nM	8100.0	CHEMBL2742	Homo sapiens	IC50	nM	8100.0
220047	17608745	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	Cc1cscc1-c1ccc(C(=O)Nc2ncc(CN3CCN(C)CC3)[nH]2)c2nccnc12		CHEMBL3653107	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
220048	17608746	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	Cc1cccc(C)c1-c1ccc(C(=O)Nc2ncc(CN3CCN(C)CC3)[nH]2)c2nccnc12		CHEMBL3653108	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
220049	17608747	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(Cc2cnc3c(-c4c(Cl)c(OC)cc(OC)c4Cl)ccc(C(=O)Nc4cccnc4)c3n2)CC1		CHEMBL3653109	=	IC50	nM	605.0	CHEMBL2742	Homo sapiens	IC50	nM	605.0
220050	17608748	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(Cc2cnc3c(C(=O)Nc4cccnc4)ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c3n2)CC1		CHEMBL3653110	=	IC50	nM	945.0	CHEMBL2742	Homo sapiens	IC50	nM	945.0
220051	17608749	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc[nH]3)c3ncc(N(C)CCN(C)C)nc23)c1Cl		CHEMBL3653132	=	IC50	nM	210.0	CHEMBL2742	Homo sapiens	IC50	nM	210.0
220052	17608750	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccccn3)c3ncc(N(C)CCN(C)C)nc23)c1Cl		CHEMBL3653111	=	IC50	nM	2550.0	CHEMBL2742	Homo sapiens	IC50	nM	2550.0
220053	17608751	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccccn3)c3nccnc23)c1F		CHEMBL3653112	=	IC50	nM	485.0	CHEMBL2742	Homo sapiens	IC50	nM	485.0
220054	17608752	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN4CCCC4)[nH]3)c3nccnc23)c1F		CHEMBL3653133	=	IC50	nM	7.0	CHEMBL2742	Homo sapiens	IC50	nM	7.0
220055	17608753	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(OC)cc(OC)c4F)c4nccnc34)nc2)CC1		CHEMBL3653113	=	IC50	nM	42.0	CHEMBL2742	Homo sapiens	IC50	nM	42.0
220056	17608754	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(C)cc(OC)c4C)c4nccnc34)nc2)CC1		CHEMBL3653114	=	IC50	nM	875.0	CHEMBL2742	Homo sapiens	IC50	nM	875.0
220057	17608755	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4c(C)c(OC)cc(C)c4Cl)c4nccnc34)nc2)CC1		CHEMBL3653115	=	IC50	nM	1050.0	CHEMBL2742	Homo sapiens	IC50	nM	1050.0
220058	17608756	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(C)c[n+]([O-])c4C)c4nccnc34)nc2)CC1		CHEMBL3653116	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
220059	17608757	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)cn3)c3nccnc23)c1Cl		CHEMBL3653117	=	IC50	nM	20.0	CHEMBL2742	Homo sapiens	IC50	nM	20.0
220060	17608758	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCNC(C)(C)C4)nc3)c3nccnc23)c1Cl		CHEMBL3653118	=	IC50	nM	139.0	CHEMBL2742	Homo sapiens	IC50	nM	139.0
220061	17608759	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nc(C)c(C)nc23)c1Cl		CHEMBL3653119	=	IC50	nM	14.0	CHEMBL2742	Homo sapiens	IC50	nM	14.0
220062	17608760	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1F		CHEMBL3674746	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
220063	17608761	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3nccnc23)c1F		CHEMBL3653135	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
220064	17608762	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN4CCOCC4)[nH]3)c3nccnc23)c1F		CHEMBL3653136	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
220065	17608763	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN(C)CC(N)=O)cn3)c3nccnc23)c1F		CHEMBL3653120	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
220066	17608764	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccn(CCN(C)C)c3)c3nccnc23)c1F		CHEMBL3653121	=	IC50	nM	265.0	CHEMBL2742	Homo sapiens	IC50	nM	265.0
220067	17608765	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1		CHEMBL3653122	=	IC50	nM	44.0	CHEMBL2742	Homo sapiens	IC50	nM	44.0
220068	17608766	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1F		CHEMBL3653123	=	IC50	nM	7.0	CHEMBL2742	Homo sapiens	IC50	nM	7.0
220069	17608767	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCS(=O)(=O)CC4)cn3)c3nccnc23)c1F		CHEMBL3653124	=	IC50	nM	32.0	CHEMBL2742	Homo sapiens	IC50	nM	32.0
220070	17608768	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3nccnc23)c1F		CHEMBL3653137	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
220071	17608769	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN4CCN(C)CC4)[nH]3)c3nccnc23)c1F		CHEMBL3653138	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
220072	17608770	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN4CCNC(=O)C4)[nH]3)c3nccnc23)c1F		CHEMBL3653139	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
220073	17608771	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCNCC4)cn3)c3ncccc23)c1Cl		CHEMBL3653125	=	IC50	nM	99.0	CHEMBL2742	Homo sapiens	IC50	nM	99.0
220074	17608772	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3ncccc23)c1Cl		CHEMBL3653140	=	IC50	nM	70.0	CHEMBL2742	Homo sapiens	IC50	nM	70.0
220075	17608773	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN(C)CCN(C)C)cn3)c3ncccc23)c1Cl		CHEMBL3653126	=	IC50	nM	245.0	CHEMBL2742	Homo sapiens	IC50	nM	245.0
220076	17608774	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3ncccc23)c1F		CHEMBL3653127	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
220077	17608775	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3ncccc23)c1F		CHEMBL3653141	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
220078	17608776	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3ncccc23)c1F		CHEMBL3653128	=	IC50	nM	51.0	CHEMBL2742	Homo sapiens	IC50	nM	51.0
220079	17608777	CHEMBL3705346	Kinase Assay: Protein kinase activity measured by the microfluidic caliper method.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3ncccc23)c1F		CHEMBL3653142	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
259353	17641881	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3690476	=	IC50	nM	13.5	CHEMBL2742	Homo sapiens	IC50	nM	13.5
259354	17641882	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690477	=	IC50	nM	295.0	CHEMBL2742	Homo sapiens	IC50	nM	295.0
259355	17641883	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(C5CCCO5)s4)ccn23)c1		CHEMBL3686060	=	IC50	nM	0.83	CHEMBL2742	Homo sapiens	IC50	nM	0.83
259356	17641884	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCOC(=O)C(C)(C)n1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3686061	=	IC50	nM	0.85	CHEMBL2742	Homo sapiens	IC50	nM	0.85
259357	17641885	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccccn4)ccn23)c1		CHEMBL3686062	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
259358	17641886	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(C5CCNCC5)c4)ccn23)c1		CHEMBL3686063	=	IC50	nM	0.57	CHEMBL2742	Homo sapiens	IC50	nM	0.57
259359	17641887	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(C(=O)O)n1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3686064	=	IC50	nM	1.15	CHEMBL2742	Homo sapiens	IC50	nM	1.15
259360	17641888	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CCC(n2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CC1		CHEMBL3686065	=	IC50	nM	0.545	CHEMBL2742	Homo sapiens	IC50	nM	0.545
259361	17641889	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(N5CCCCC5)nn4)ccn23)c1		CHEMBL3686066	=	IC50	nM	0.55	CHEMBL2742	Homo sapiens	IC50	nM	0.55
259362	17641890	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nc5c(s4)CCC5)ccn23)c1		CHEMBL3690373	=	IC50	nM	1.1	CHEMBL2742	Homo sapiens	IC50	nM	1.1
259363	17641891	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nccn1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690478	=	IC50	nM	225.0	CHEMBL2742	Homo sapiens	IC50	nM	225.0
259364	17641892	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N=C(/C=C/CN)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690374	=	IC50	nM	4.0	CHEMBL2742	Homo sapiens	IC50	nM	4.0
259365	17641893	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(C#Cc4cccnc4)ccn23)c1		CHEMBL3690376	=	IC50	nM	10.4	CHEMBL2742	Homo sapiens	IC50	nM	10.4
259366	17641894	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CCN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)nn2)CC1		CHEMBL3690377	=	IC50	nM	1.1	CHEMBL2742	Homo sapiens	IC50	nM	1.1
259367	17641895	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1C#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690378	=	IC50	nM	4.46	CHEMBL2742	Homo sapiens	IC50	nM	4.46
259368	17641896	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)CC#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690379	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
259369	17641897	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N=C(C/C=C(\N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1)N1CCOCC1		CHEMBL3690380	=	IC50	nM	0.64	CHEMBL2742	Homo sapiens	IC50	nM	0.64
259370	17641898	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(C#Cc4ccsc4)ccn23)c1		CHEMBL3690381	=	IC50	nM	24.2	CHEMBL2742	Homo sapiens	IC50	nM	24.2
259371	17641899	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(C(F)(F)F)s4)ccn23)c1		CHEMBL3690382	=	IC50	nM	3.96	CHEMBL2742	Homo sapiens	IC50	nM	3.96
259372	17641900	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(O)C#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690383	=	IC50	nM	13.3	CHEMBL2742	Homo sapiens	IC50	nM	13.3
259373	17641901	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(C#CCCO)ccn23)c1		CHEMBL3690384	=	IC50	nM	24.7	CHEMBL2742	Homo sapiens	IC50	nM	24.7
259374	17641902	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(-c4cccnn4)ccn23)c1		CHEMBL3690385	=	IC50	nM	7.36	CHEMBL2742	Homo sapiens	IC50	nM	7.36
259375	17641903	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ccc(-c2ccn3c(-c4cncc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3690386	=	IC50	nM	6.29	CHEMBL2742	Homo sapiens	IC50	nM	6.29
259376	17641904	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(CCN5CCCCC5)s4)ccn23)c1		CHEMBL3690387	=	IC50	nM	0.704	CHEMBL2742	Homo sapiens	IC50	nM	0.704
259377	17641905	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(-c4nncs4)ccn23)c1		CHEMBL3690389	=	IC50	nM	8.0	CHEMBL2742	Homo sapiens	IC50	nM	8.0
259378	17641906	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(Nc1cccc(-c2cnc3cc(Cl)ccn23)c1)NC1CC1		CHEMBL3690390	=	IC50	nM	545.0	CHEMBL2742	Homo sapiens	IC50	nM	545.0
259379	17641907	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(C#CCO)ccn23)c1		CHEMBL3690391	=	IC50	nM	16.9	CHEMBL2742	Homo sapiens	IC50	nM	16.9
259380	17641908	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(=O)n2nc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)sc2n1		CHEMBL3690392	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
259381	17641909	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(Nc1cccc(-c2cnc3cc(-c4ccc(F)cc4)ccn23)c1)NC1CC1		CHEMBL3690393	=	IC50	nM	21.8	CHEMBL2742	Homo sapiens	IC50	nM	21.8
259382	17641910	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(C#CC4CC4)ccn23)c1		CHEMBL3690394	=	IC50	nM	16.7	CHEMBL2742	Homo sapiens	IC50	nM	16.7
259383	17641911	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnccn4)ccn23)c1		CHEMBL3690395	=	IC50	nM	9.26	CHEMBL2742	Homo sapiens	IC50	nM	9.26
259384	17641912	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(Cl)ccn23)c1		CHEMBL3690396	=	IC50	nM	80.0	CHEMBL2742	Homo sapiens	IC50	nM	80.0
259385	17641913	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)N1CC(/N=C/C(C=N)c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)C1		CHEMBL3690397	=	IC50	nM	0.613	CHEMBL2742	Homo sapiens	IC50	nM	0.613
259386	17641914	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(Cl)nn4)ccn23)c1		CHEMBL3639892	=	IC50	nM	3.5	CHEMBL2742	Homo sapiens	IC50	nM	3.5
259387	17641915	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccncn4)ccn23)c1		CHEMBL3690398	=	IC50	nM	3.05	CHEMBL2742	Homo sapiens	IC50	nM	3.05
259388	17641916	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3690399	=	IC50	nM	37.5	CHEMBL2742	Homo sapiens	IC50	nM	37.5
259389	17641917	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)C1CCN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)nn2)CC1		CHEMBL3690400	=	IC50	nM	0.82	CHEMBL2742	Homo sapiens	IC50	nM	0.82
259390	17641918	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(C5CNC5)c4)ccn23)c1		CHEMBL3690401	=	IC50	nM	0.807	CHEMBL2742	Homo sapiens	IC50	nM	0.807
259391	17641919	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CCCC(/N=C/C(C=N)c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)C1		CHEMBL3690402	=	IC50	nM	0.61	CHEMBL2742	Homo sapiens	IC50	nM	0.61
259392	17641920	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(C)OC(=O)N1CCCC(n2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)C1		CHEMBL3690403	=	IC50	nM	1.3	CHEMBL2742	Homo sapiens	IC50	nM	1.3
259393	17641921	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(C5CCCNC5)c4)ccn23)c1		CHEMBL3690404	=	IC50	nM	0.612	CHEMBL2742	Homo sapiens	IC50	nM	0.612
259394	17641922	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CC(n2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)C1		CHEMBL3690405	=	IC50	nM	1.05	CHEMBL2742	Homo sapiens	IC50	nM	1.05
259395	17641923	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cncnc4)ccn23)c1		CHEMBL3690406	=	IC50	nM	27.0	CHEMBL2742	Homo sapiens	IC50	nM	27.0
259396	17641924	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)c1sccc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690407	=	IC50	nM	10.3	CHEMBL2742	Homo sapiens	IC50	nM	10.3
259397	17641925	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCN1CCC(/N=C/C(C=N)c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)C1		CHEMBL3690408	=	IC50	nM	0.582	CHEMBL2742	Homo sapiens	IC50	nM	0.582
259398	17641926	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(C5CCNC5)c4)ccn23)c1		CHEMBL3690409	=	IC50	nM	0.603	CHEMBL2742	Homo sapiens	IC50	nM	0.603
259399	17641927	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(C(F)(F)F)n4)ccn23)c1		CHEMBL3690410	=	IC50	nM	38.4	CHEMBL2742	Homo sapiens	IC50	nM	38.4
259400	17641928	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(C5CCOC5)c4)ccn23)c1		CHEMBL3690411	=	IC50	nM	0.542	CHEMBL2742	Homo sapiens	IC50	nM	0.542
259401	17641929	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cc(OC)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690412	=	IC50	nM	22.0	CHEMBL2742	Homo sapiens	IC50	nM	22.0
259402	17641930	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(N5CCCCC5)nc4)ccn23)c1		CHEMBL3690413	=	IC50	nM	2.25	CHEMBL2742	Homo sapiens	IC50	nM	2.25
259403	17641931	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3690414	=	IC50	nM	1.74	CHEMBL2742	Homo sapiens	IC50	nM	1.74
259404	17641932	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(=O)[nH]n4)ccn23)c1		CHEMBL3690415	=	IC50	nM	2.45	CHEMBL2742	Homo sapiens	IC50	nM	2.45
259405	17641933	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nc5c(s4)CNCC5)ccn23)c1		CHEMBL3690416	=	IC50	nM	0.675	CHEMBL2742	Homo sapiens	IC50	nM	0.675
259406	17641934	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(C)OC(=O)N1CCc2nc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)sc2C1		CHEMBL3690417	=	IC50	nM	1.25	CHEMBL2742	Homo sapiens	IC50	nM	1.25
259407	17641935	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cc(C#Cc2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3690419	=	IC50	nM	4.6	CHEMBL2742	Homo sapiens	IC50	nM	4.6
259408	17641936	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	C/N=C/C(C(=N)CN)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690420	=	IC50	nM	34.1	CHEMBL2742	Homo sapiens	IC50	nM	34.1
259409	17641937	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690421	=	IC50	nM	15.0	CHEMBL2742	Homo sapiens	IC50	nM	15.0
259410	17641938	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690422	=	IC50	nM	23.5	CHEMBL2742	Homo sapiens	IC50	nM	23.5
259411	17641939	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(F)cn4)ccn23)c1		CHEMBL3690423	=	IC50	nM	14.5	CHEMBL2742	Homo sapiens	IC50	nM	14.5
259412	17641940	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690424	=	IC50	nM	4.12	CHEMBL2742	Homo sapiens	IC50	nM	4.12
259413	17641941	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ccc1=O		CHEMBL3690425	=	IC50	nM	3.7	CHEMBL2742	Homo sapiens	IC50	nM	3.7
259414	17641942	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ncc(C#Cc2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1C		CHEMBL3690427	=	IC50	nM	4.95	CHEMBL2742	Homo sapiens	IC50	nM	4.95
259415	17641943	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CCC(O)(C#Cc2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)CC1		CHEMBL3690428	=	IC50	nM	7.74	CHEMBL2742	Homo sapiens	IC50	nM	7.74
259416	17641944	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(NCCO)nn4)ccn23)c1		CHEMBL3690430	=	IC50	nM	0.569	CHEMBL2742	Homo sapiens	IC50	nM	0.569
259417	17641945	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCN(CC)CCNC(=O)C(C)(C)/N=C/C(C=N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690431	=	IC50	nM	2.8	CHEMBL2742	Homo sapiens	IC50	nM	2.8
259418	17641946	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNC(=O)C(C)(C)/N=C/C(C=N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690432	=	IC50	nM	1.25	CHEMBL2742	Homo sapiens	IC50	nM	1.25
259419	17641947	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)C(=O)C(C)(C)/N=C/C(C=N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690433	=	IC50	nM	0.74	CHEMBL2742	Homo sapiens	IC50	nM	0.74
259420	17641948	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(C(=O)NC1CC1)n1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3690434	=	IC50	nM	1.1	CHEMBL2742	Homo sapiens	IC50	nM	1.1
259421	17641949	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(/N=C/C(C=N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1)C(N)=O		CHEMBL3690435	=	IC50	nM	1.45	CHEMBL2742	Homo sapiens	IC50	nM	1.45
259422	17641950	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC1CCN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)nn2)CC1		CHEMBL3690438	=	IC50	nM	0.535	CHEMBL2742	Homo sapiens	IC50	nM	0.535
259423	17641951	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1ncc(-c2cnc3cc(Cl)ccn23)s1		CHEMBL3690479	=	IC50	nM	1150.0	CHEMBL2742	Homo sapiens	IC50	nM	1150.0
259424	17641952	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CCC(Nc2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)nn2)CC1		CHEMBL3690439	=	IC50	nM	0.73	CHEMBL2742	Homo sapiens	IC50	nM	0.73
259425	17641953	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc2ncc(-c3cccc(NC(=O)NCC(F)(F)F)c3)n2cc1C		CHEMBL3690440	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	IC50	nM	100.0
259426	17641954	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cccnc4)ccn23)c1		CHEMBL3690441	=	IC50	nM	2.79	CHEMBL2742	Homo sapiens	IC50	nM	2.79
259427	17641955	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN1CCN(c2ncc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CC1		CHEMBL3690442	=	IC50	nM	3.75	CHEMBL2742	Homo sapiens	IC50	nM	3.75
259428	17641956	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COCCNc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3690443	=	IC50	nM	0.89	CHEMBL2742	Homo sapiens	IC50	nM	0.89
259429	17641957	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(CO)Nc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3690444	=	IC50	nM	0.447	CHEMBL2742	Homo sapiens	IC50	nM	0.447
259430	17641958	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(N5CCC5)nn4)ccn23)c1		CHEMBL3690445	=	IC50	nM	0.715	CHEMBL2742	Homo sapiens	IC50	nM	0.715
259431	17641959	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccncc4)ccn23)c1		CHEMBL3690446	=	IC50	nM	1.54	CHEMBL2742	Homo sapiens	IC50	nM	1.54
259432	17641960	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nccnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690447	=	IC50	nM	78.9	CHEMBL2742	Homo sapiens	IC50	nM	78.9
259433	17641961	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3690448	=	IC50	nM	4.89	CHEMBL2742	Homo sapiens	IC50	nM	4.89
259434	17641962	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1ccc(C#Cc2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690449	=	IC50	nM	6.28	CHEMBL2742	Homo sapiens	IC50	nM	6.28
259435	17641963	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnc(N5CC(F)(F)C5)nc4)ccn23)c1		CHEMBL3690450	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
259436	17641964	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccnnc4)ccn23)c1		CHEMBL3690451	=	IC50	nM	7.87	CHEMBL2742	Homo sapiens	IC50	nM	7.87
259437	17641965	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3690452	=	IC50	nM	8.3	CHEMBL2742	Homo sapiens	IC50	nM	8.3
259438	17641966	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cncc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690453	=	IC50	nM	12.4	CHEMBL2742	Homo sapiens	IC50	nM	12.4
259439	17641967	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690454	=	IC50	nM	0.84	CHEMBL2742	Homo sapiens	IC50	nM	0.84
259440	17641968	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(CO)cn4)ccn23)c1		CHEMBL3690455	=	IC50	nM	0.94	CHEMBL2742	Homo sapiens	IC50	nM	0.94
259441	17641969	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3690456	=	IC50	nM	9.04	CHEMBL2742	Homo sapiens	IC50	nM	9.04
259442	17641970	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C1CN(c2ncc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CCN1		CHEMBL3690457	=	IC50	nM	4.75	CHEMBL2742	Homo sapiens	IC50	nM	4.75
259443	17641971	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C1CN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)nn2)CCN1		CHEMBL3690458	=	IC50	nM	0.53	CHEMBL2742	Homo sapiens	IC50	nM	0.53
259444	17641972	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(F)cn4)ccn23)c1		CHEMBL3690459	=	IC50	nM	1.75	CHEMBL2742	Homo sapiens	IC50	nM	1.75
259445	17641973	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3690460	=	IC50	nM	1.3	CHEMBL2742	Homo sapiens	IC50	nM	1.3
259446	17641974	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690461	=	IC50	nM	2.55	CHEMBL2742	Homo sapiens	IC50	nM	2.55
259447	17641975	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCOc1cccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690462	=	IC50	nM	4.19	CHEMBL2742	Homo sapiens	IC50	nM	4.19
259448	17641976	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cncc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690463	=	IC50	nM	14.0	CHEMBL2742	Homo sapiens	IC50	nM	14.0
259449	17641977	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690464	=	IC50	nM	2.8	CHEMBL2742	Homo sapiens	IC50	nM	2.8
259450	17641978	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3690465	=	IC50	nM	4.82	CHEMBL2742	Homo sapiens	IC50	nM	4.82
259451	17641979	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cc(F)ccn4)ccn23)c1		CHEMBL3690466	=	IC50	nM	3.7	CHEMBL2742	Homo sapiens	IC50	nM	3.7
259452	17641980	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cccnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690467	=	IC50	nM	22.8	CHEMBL2742	Homo sapiens	IC50	nM	22.8
259453	17641981	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1C		CHEMBL3690480	=	IC50	nM	13.5	CHEMBL2742	Homo sapiens	IC50	nM	13.5
259454	17641982	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4c[nH]c(=O)cn4)ccn23)c1		CHEMBL3690468	=	IC50	nM	6.2	CHEMBL2742	Homo sapiens	IC50	nM	6.2
259455	17641983	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690469	=	IC50	nM	1.39	CHEMBL2742	Homo sapiens	IC50	nM	1.39
259456	17641984	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cccc(CCO)c4)ccn23)c1		CHEMBL3690470	=	IC50	nM	2.68	CHEMBL2742	Homo sapiens	IC50	nM	2.68
259457	17641985	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3690471	=	IC50	nM	1.3	CHEMBL2742	Homo sapiens	IC50	nM	1.3
259458	17641986	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(N5CCC(O)CC5)n4)ccn23)c1		CHEMBL3690472	=	IC50	nM	18.5	CHEMBL2742	Homo sapiens	IC50	nM	18.5
259459	17641987	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690473	=	IC50	nM	6.35	CHEMBL2742	Homo sapiens	IC50	nM	6.35
259460	17641988	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(CCO)cc4)ccn23)c1		CHEMBL3690474	=	IC50	nM	0.89	CHEMBL2742	Homo sapiens	IC50	nM	0.89
259461	17641989	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)c1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3690475	=	IC50	nM	0.61	CHEMBL2742	Homo sapiens	IC50	nM	0.61
259462	17641990	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)Nc1cccc(-c2cnc3cc(Cl)ccn23)c1		CHEMBL3690481	=	IC50	nM	92.7	CHEMBL2742	Homo sapiens	IC50	nM	92.7
259463	17641991	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)c1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690482	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
259464	17641992	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1CCc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690483	=	IC50	nM	86.2	CHEMBL2742	Homo sapiens	IC50	nM	86.2
259465	17641993	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(CCO)cn4)ccn23)c1		CHEMBL3690484	=	IC50	nM	0.704	CHEMBL2742	Homo sapiens	IC50	nM	0.704
259466	17641994	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(-c4cnn(C5CNC5)c4)ccn23)c1		CHEMBL3690485	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
259467	17641995	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690486	=	IC50	nM	0.789	CHEMBL2742	Homo sapiens	IC50	nM	0.789
259468	17641996	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cccnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690487	=	IC50	nM	65.7	CHEMBL2742	Homo sapiens	IC50	nM	65.7
259469	17641997	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cc(Cl)cnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690502	=	IC50	nM	91.7	CHEMBL2742	Homo sapiens	IC50	nM	91.7
259470	17641998	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690499	=	IC50	nM	17.1	CHEMBL2742	Homo sapiens	IC50	nM	17.1
259471	17641999	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(=O)n(CCO)n4)ccn23)c1		CHEMBL3690488	=	IC50	nM	2.68	CHEMBL2742	Homo sapiens	IC50	nM	2.68
259472	17642000	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cncc(-c2cnc3cc(-c4cnn(C5CCNCC5)c4)ccn23)c1		CHEMBL3690506	=	IC50	nM	0.93	CHEMBL2742	Homo sapiens	IC50	nM	0.93
259473	17642001	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(OC5CCNCC5)nn4)ccn23)c1		CHEMBL3690489	=	IC50	nM	2.3	CHEMBL2742	Homo sapiens	IC50	nM	2.3
259474	17642002	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1ncccc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690505	=	IC50	nM	44.0	CHEMBL2742	Homo sapiens	IC50	nM	44.0
259475	17642003	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(Cl)nnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690494	=	IC50	nM	60.0	CHEMBL2742	Homo sapiens	IC50	nM	60.0
259476	17642004	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nnc1Cl		CHEMBL3690493	=	IC50	nM	3.55	CHEMBL2742	Homo sapiens	IC50	nM	3.55
259477	17642005	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cnc(Cl)nc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3639893	=	IC50	nM	34.9	CHEMBL2742	Homo sapiens	IC50	nM	34.9
259478	17642006	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(=O)N1CCN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CC1		CHEMBL3690501	=	IC50	nM	0.56	CHEMBL2742	Homo sapiens	IC50	nM	0.56
259479	17642007	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)CCCOc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3690500	=	IC50	nM	2.4	CHEMBL2742	Homo sapiens	IC50	nM	2.4
259480	17642008	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(OC5CCCNC5)nn4)ccn23)c1		CHEMBL3690490	=	IC50	nM	1.66	CHEMBL2742	Homo sapiens	IC50	nM	1.66
259481	17642009	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(C)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690512	=	IC50	nM	50.3	CHEMBL2742	Homo sapiens	IC50	nM	50.3
259482	17642010	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3690491	=	IC50	nM	0.71	CHEMBL2742	Homo sapiens	IC50	nM	0.71
259483	17642011	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cncnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690497	=	IC50	nM	34.5	CHEMBL2742	Homo sapiens	IC50	nM	34.5
259484	17642012	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(N5CCCC(O)C5)nn4)ccn23)c1		CHEMBL3690492	=	IC50	nM	0.484	CHEMBL2742	Homo sapiens	IC50	nM	0.484
259485	17642013	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cnc1N(C)C(=O)OC(C)(C)C		CHEMBL3690504	=	IC50	nM	2.88	CHEMBL2742	Homo sapiens	IC50	nM	2.88
259486	17642014	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccnn4)ccn23)c1		CHEMBL3690498	=	IC50	nM	17.9	CHEMBL2742	Homo sapiens	IC50	nM	17.9
259487	17642015	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNc1ncc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cc1C		CHEMBL3690513	=	IC50	nM	2.48	CHEMBL2742	Homo sapiens	IC50	nM	2.48
259488	17642016	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3690514	=	IC50	nM	22.8	CHEMBL2742	Homo sapiens	IC50	nM	22.8
259489	17642017	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1cccc(-c2cnc3cc(C#Cc4cncn4C)ccn23)c1		CHEMBL3694657	=	IC50	nM	28.8	CHEMBL2742	Homo sapiens	IC50	nM	28.8
259490	17642018	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3694723	=	IC50	nM	9.44	CHEMBL2742	Homo sapiens	IC50	nM	9.44
259491	17642019	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1cccc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3694672	=	IC50	nM	97.3	CHEMBL2742	Homo sapiens	IC50	nM	97.3
259492	17642020	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1cccc(-c2cnc3cc(-c4ncc(F)c(N)n4)ccn23)c1		CHEMBL3690515	=	IC50	nM	29.4	CHEMBL2742	Homo sapiens	IC50	nM	29.4
259493	17642021	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(F)c(NCCO)n4)ccn23)c1		CHEMBL3690516	=	IC50	nM	19.0	CHEMBL2742	Homo sapiens	IC50	nM	19.0
259494	17642022	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1C#Cc1ccn2c(-c3cccc(NC(=O)NC4CC4)c3)cnc2c1		CHEMBL3694718	=	IC50	nM	48.0	CHEMBL2742	Homo sapiens	IC50	nM	48.0
259495	17642023	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N#Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3690517	=	IC50	nM	3.05	CHEMBL2742	Homo sapiens	IC50	nM	3.05
259496	17642024	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N#Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3690517	=	IC50	nM	3.05	CHEMBL2742	Homo sapiens	IC50	nM	3.05
259497	17642025	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NC5CC5)c4)cnc3c2)ncc1F		CHEMBL3690518	=	IC50	nM	34.9	CHEMBL2742	Homo sapiens	IC50	nM	34.9
259498	17642026	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)Nc1cccc(-c2cnc3cc(-c4ncc(F)c(N)n4)ccn23)c1		CHEMBL3690519	=	IC50	nM	5.76	CHEMBL2742	Homo sapiens	IC50	nM	5.76
259499	17642027	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3690495	=	IC50	nM	4.2	CHEMBL2742	Homo sapiens	IC50	nM	4.2
259500	17642028	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cncc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3690520	=	IC50	nM	6.97	CHEMBL2742	Homo sapiens	IC50	nM	6.97
259501	17642029	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nnc(-c2ccn3c(-c4cccc(NC(N)=O)c4)cnc3c2)o1		CHEMBL3694717	=	IC50	nM	26.5	CHEMBL2742	Homo sapiens	IC50	nM	26.5
259502	17642030	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(Nc1cccc(-c2cnc3cc(-c4ncccn4)ccn23)c1)NC1CC1		CHEMBL3690511	=	IC50	nM	210.0	CHEMBL2742	Homo sapiens	IC50	nM	210.0
259503	17642031	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)Nc1cccc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3694724	=	IC50	nM	35.3	CHEMBL2742	Homo sapiens	IC50	nM	35.3
259504	17642032	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)Nc1cccc(-c2cnc3cc(-c4nncs4)ccn23)c1		CHEMBL3694661	=	IC50	nM	4.89	CHEMBL2742	Homo sapiens	IC50	nM	4.89
259505	17642033	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COCCc1nnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)s1		CHEMBL3694708	=	IC50	nM	0.643	CHEMBL2742	Homo sapiens	IC50	nM	0.643
259506	17642034	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1C#Cc1ccn2c(-c3cncc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3694658	=	IC50	nM	4100.0	CHEMBL2742	Homo sapiens	IC50	nM	4100.0
259507	17642035	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1C#Cc1ccn2c(-c3cc(NC(=O)NCC(F)(F)F)ccc3F)cnc2c1		CHEMBL3694716	=	IC50	nM	8.2	CHEMBL2742	Homo sapiens	IC50	nM	8.2
259508	17642036	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)c1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3690521	=	IC50	nM	15.1	CHEMBL2742	Homo sapiens	IC50	nM	15.1
259509	17642037	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1Cl		CHEMBL3690522	=	IC50	nM	59.8	CHEMBL2742	Homo sapiens	IC50	nM	59.8
259510	17642038	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(C)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3690503	=	IC50	nM	3.45	CHEMBL2742	Homo sapiens	IC50	nM	3.45
259511	17642039	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(N)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690523	=	IC50	nM	9.2	CHEMBL2742	Homo sapiens	IC50	nM	9.2
259512	17642040	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ccc1F		CHEMBL3690524	=	IC50	nM	3.75	CHEMBL2742	Homo sapiens	IC50	nM	3.75
259513	17642041	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3690525	=	IC50	nM	3.93	CHEMBL2742	Homo sapiens	IC50	nM	3.93
259514	17642042	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(NC5CC5)s4)ccn23)c1		CHEMBL3694646	=	IC50	nM	4.6	CHEMBL2742	Homo sapiens	IC50	nM	4.6
259515	17642043	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690526	=	IC50	nM	13.3	CHEMBL2742	Homo sapiens	IC50	nM	13.3
259516	17642044	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690496	=	IC50	nM	7.86	CHEMBL2742	Homo sapiens	IC50	nM	7.86
259517	17642045	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3690527	=	IC50	nM	5.83	CHEMBL2742	Homo sapiens	IC50	nM	5.83
259518	17642046	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnc(N)nc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690528	=	IC50	nM	23.0	CHEMBL2742	Homo sapiens	IC50	nM	23.0
259519	17642047	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)Nc1cccc(-c2cnc3cc(-c4ccc(F)cc4)ccn23)c1		CHEMBL3690507	=	IC50	nM	2.28	CHEMBL2742	Homo sapiens	IC50	nM	2.28
259520	17642048	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3690529	=	IC50	nM	44.0	CHEMBL2742	Homo sapiens	IC50	nM	44.0
259521	17642049	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1C#Cc1ccn2c(-c3cccc(NC(N)=O)c3)cnc2c1		CHEMBL3694660	=	IC50	nM	9.65	CHEMBL2742	Homo sapiens	IC50	nM	9.65
259522	17642050	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(Nc1cccc(-c2cnc3cc(-c4nncs4)ccn23)c1)NC1CC1		CHEMBL3690510	=	IC50	nM	43.0	CHEMBL2742	Homo sapiens	IC50	nM	43.0
259523	17642051	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1C(F)(F)F		CHEMBL3690530	=	IC50	nM	3.91	CHEMBL2742	Homo sapiens	IC50	nM	3.91
259524	17642052	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1ncc(C(F)(F)F)c(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690531	=	IC50	nM	92.0	CHEMBL2742	Homo sapiens	IC50	nM	92.0
259525	17642053	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(F)c(NC5CC5)n4)ccn23)c1		CHEMBL3690532	=	IC50	nM	26.0	CHEMBL2742	Homo sapiens	IC50	nM	26.0
259526	17642054	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1nccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690533	=	IC50	nM	11.5	CHEMBL2742	Homo sapiens	IC50	nM	11.5
259527	17642055	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NCCNc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3690534	=	IC50	nM	55.5	CHEMBL2742	Homo sapiens	IC50	nM	55.5
259528	17642056	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncn1		CHEMBL3690535	=	IC50	nM	4.2	CHEMBL2742	Homo sapiens	IC50	nM	4.2
259529	17642057	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cc(=O)[nH]cn4)ccn23)c1		CHEMBL3690536	=	IC50	nM	9.5	CHEMBL2742	Homo sapiens	IC50	nM	9.5
259530	17642058	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(CCO)s4)ccn23)c1		CHEMBL3694656	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
259531	17642059	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cc(NC(=O)NCC(F)(F)F)ccc4F)cnc3c2)ncc1F		CHEMBL3694701	=	IC50	nM	34.0	CHEMBL2742	Homo sapiens	IC50	nM	34.0
259532	17642060	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nnc(-c2ccn3c(-c4cccc(NC(=O)NC5CC5)c4)cnc3c2)o1		CHEMBL3690509	=	IC50	nM	230.0	CHEMBL2742	Homo sapiens	IC50	nM	230.0
259533	17642061	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)c1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690537	=	IC50	nM	7.56	CHEMBL2742	Homo sapiens	IC50	nM	7.56
259534	17642062	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(N5CCNCC5)n4)ccn23)c1		CHEMBL3694662	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
259535	17642063	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ccc(NC(=O)NCC(F)(F)F)cc1-c1cnc2cc(C#Cc3cncn3C)ccn12		CHEMBL3694715	=	IC50	nM	42.0	CHEMBL2742	Homo sapiens	IC50	nM	42.0
259536	17642064	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(/C=C/c4ccccn4)ccn23)c1		CHEMBL3690538	=	IC50	nM	2.18	CHEMBL2742	Homo sapiens	IC50	nM	2.18
259537	17642065	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(/C=C/c4ccccn4)ccn23)c1		CHEMBL3690538	=	IC50	nM	6.7	CHEMBL2742	Homo sapiens	IC50	nM	6.7
259538	17642066	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1ncc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cc1C		CHEMBL3690539	=	IC50	nM	5.9	CHEMBL2742	Homo sapiens	IC50	nM	5.9
259539	17642067	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1ccnc1/C=C/c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690540	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
259540	17642068	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(O)n4)ccn23)c1		CHEMBL3690541	=	IC50	nM	82.0	CHEMBL2742	Homo sapiens	IC50	nM	82.0
259541	17642069	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1ccnc1C#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3694674	=	IC50	nM	4.8	CHEMBL2742	Homo sapiens	IC50	nM	4.8
259542	17642070	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)n1ccnc1C#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3694659	=	IC50	nM	8.66	CHEMBL2742	Homo sapiens	IC50	nM	8.66
259543	17642071	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nc(NC5CCC5)ncc4C(F)(F)F)ccn23)c1		CHEMBL3690542	=	IC50	nM	520.0	CHEMBL2742	Homo sapiens	IC50	nM	520.0
259544	17642072	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(C(F)(F)F)c(NC5CCC5)n4)ccn23)c1		CHEMBL3690543	=	IC50	nM	380.0	CHEMBL2742	Homo sapiens	IC50	nM	380.0
259545	17642073	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(O)c1cccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3694709	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
259546	17642074	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(C)OC(=O)NC1CN(c2ccnc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)n2)C1		CHEMBL3690544	=	IC50	nM	16.1	CHEMBL2742	Homo sapiens	IC50	nM	16.1
259547	17642075	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cc(N2CCN(CCO)CC2)n1		CHEMBL3690545	=	IC50	nM	6.5	CHEMBL2742	Homo sapiens	IC50	nM	6.5
259548	17642076	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1ccnc1C#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3694674	=	IC50	nM	7.2	CHEMBL2742	Homo sapiens	IC50	nM	7.2
259549	17642077	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1ccc(NC(=O)NCC(F)(F)F)cc1-c1cnc2cc(-c3ncc(F)c(N)n3)ccn12		CHEMBL3694675	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
259550	17642078	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1cncc1/C=C/c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690508	=	IC50	nM	4.6	CHEMBL2742	Homo sapiens	IC50	nM	4.6
259551	17642079	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC1CN(c2ccnc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)n2)C1		CHEMBL3690547	=	IC50	nM	24.0	CHEMBL2742	Homo sapiens	IC50	nM	24.0
259552	17642080	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3690549	=	IC50	nM	9.28	CHEMBL2742	Homo sapiens	IC50	nM	9.28
259553	17642081	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N(C)C		CHEMBL3690550	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
259554	17642082	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(N5CCC5)n4)ccn23)c1		CHEMBL3690551	=	IC50	nM	24.0	CHEMBL2742	Homo sapiens	IC50	nM	24.0
259555	17642083	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cn1c(CO)cnc1C#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3694714	=	IC50	nM	3.7	CHEMBL2742	Homo sapiens	IC50	nM	3.7
259556	17642084	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(C#Cc4nccn4CCO)ccn23)c1		CHEMBL3694655	=	IC50	nM	4.4	CHEMBL2742	Homo sapiens	IC50	nM	4.4
259557	17642085	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(OC2CCCC2)cc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3694676	=	IC50	nM	200.0	CHEMBL2742	Homo sapiens	IC50	nM	200.0
259558	17642086	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COCCOc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ncc(F)c(N)n4)ccn23)c1		CHEMBL3694677	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
259559	17642087	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(C)OC(=O)NCC1CCN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CC1		CHEMBL3694707	=	IC50	nM	4.2	CHEMBL2742	Homo sapiens	IC50	nM	4.2
259560	17642088	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(N5CC(O)C5)n4)ccn23)c1		CHEMBL3690553	=	IC50	nM	24.0	CHEMBL2742	Homo sapiens	IC50	nM	24.0
259561	17642089	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N#Cc1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3694649	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
259562	17642090	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690554	=	IC50	nM	0.99	CHEMBL2742	Homo sapiens	IC50	nM	0.99
259563	17642091	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CSc1nc(N)cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690555	=	IC50	nM	1.3	CHEMBL2742	Homo sapiens	IC50	nM	1.3
259564	17642092	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(/C=C/CO)ccn23)c1		CHEMBL3690556	=	IC50	nM	7.7	CHEMBL2742	Homo sapiens	IC50	nM	7.7
259565	17642093	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1N		CHEMBL3694703	=	IC50	nM	24.0	CHEMBL2742	Homo sapiens	IC50	nM	24.0
259566	17642094	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3694702	=	IC50	nM	5.2	CHEMBL2742	Homo sapiens	IC50	nM	5.2
259567	17642095	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N#Cc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3694650	=	IC50	nM	1.65	CHEMBL2742	Homo sapiens	IC50	nM	1.65
259568	17642096	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)c1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690557	=	IC50	nM	1.1	CHEMBL2742	Homo sapiens	IC50	nM	1.1
259569	17642097	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nc(N)cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690558	=	IC50	nM	1.5	CHEMBL2742	Homo sapiens	IC50	nM	1.5
259570	17642098	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NC(=O)c1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3690559	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
259571	17642099	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(C(F)(F)F)n1		CHEMBL3690560	=	IC50	nM	3.5	CHEMBL2742	Homo sapiens	IC50	nM	3.5
259572	17642100	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(=O)N1CC(n2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)C1		CHEMBL3690561	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
259573	17642101	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(-n5ccnc5)n4)ccn23)c1		CHEMBL3690562	=	IC50	nM	0.46	CHEMBL2742	Homo sapiens	IC50	nM	0.46
259574	17642102	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)c1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(C(F)(F)F)n1		CHEMBL3690563	=	IC50	nM	17.0	CHEMBL2742	Homo sapiens	IC50	nM	17.0
259575	17642103	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCCCOC(=O)Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694704	=	IC50	nM	30.0	CHEMBL2742	Homo sapiens	IC50	nM	30.0
259576	17642104	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCOC(=O)Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694705	=	IC50	nM	17.0	CHEMBL2742	Homo sapiens	IC50	nM	17.0
259577	17642105	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)S(=O)(=O)n1ccnc1-c1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690565	=	IC50	nM	3.2	CHEMBL2742	Homo sapiens	IC50	nM	3.2
259578	17642106	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(C5CN(CCO)C5)c4)ccn23)c1		CHEMBL3690566	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
259579	17642107	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(SC)n1		CHEMBL3690567	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
259580	17642108	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nc2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)ccc2s1		CHEMBL3690568	=	IC50	nM	2.1	CHEMBL2742	Homo sapiens	IC50	nM	2.1
259581	17642109	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)COC(=O)Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694666	=	IC50	nM	26.0	CHEMBL2742	Homo sapiens	IC50	nM	26.0
259582	17642110	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNC(=O)c1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690569	=	IC50	nM	3.0	CHEMBL2742	Homo sapiens	IC50	nM	3.0
259583	17642111	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(N5CCN(CCO)CC5)n4)ccn23)c1		CHEMBL3694663	=	IC50	nM	9.1	CHEMBL2742	Homo sapiens	IC50	nM	9.1
259584	17642112	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)s1		CHEMBL3639935	=	IC50	nM	0.54	CHEMBL2742	Homo sapiens	IC50	nM	0.54
259585	17642113	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nccc(C(=O)N5CCOCC5)n4)ccn23)c1		CHEMBL3690570	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
259586	17642114	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CNC(=O)c1cc(C)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690571	=	IC50	nM	19.0	CHEMBL2742	Homo sapiens	IC50	nM	19.0
259587	17642115	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(C(=O)N5CCOCC5)cn4)ccn23)c1		CHEMBL3690572	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
259588	17642116	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cn2nc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)sc2n1		CHEMBL3690574	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
259589	17642117	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(C(C)C)n1		CHEMBL3690575	=	IC50	nM	2.8	CHEMBL2742	Homo sapiens	IC50	nM	2.8
259590	17642118	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1OCCO		CHEMBL3694706	=	IC50	nM	4.2	CHEMBL2742	Homo sapiens	IC50	nM	4.2
259591	17642119	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCOC(=O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3694679	=	IC50	nM	4.6	CHEMBL2742	Homo sapiens	IC50	nM	4.6
259592	17642120	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cc(C(F)(F)F)ncn4)ccn23)c1		CHEMBL3690576	=	IC50	nM	3.4	CHEMBL2742	Homo sapiens	IC50	nM	3.4
259593	17642121	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1cccc(-c2cnc3cc(-c4ccc(F)c(C)n4)ccn23)c1		CHEMBL3690577	=	IC50	nM	17.0	CHEMBL2742	Homo sapiens	IC50	nM	17.0
259594	17642122	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cc(C(F)(F)F)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3694711	=	IC50	nM	19.0	CHEMBL2742	Homo sapiens	IC50	nM	19.0
259595	17642123	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1C(=O)O		CHEMBL3694669	=	IC50	nM	2.6	CHEMBL2742	Homo sapiens	IC50	nM	2.6
259596	17642124	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ccc1C(F)(F)F		CHEMBL3690579	=	IC50	nM	44.0	CHEMBL2742	Homo sapiens	IC50	nM	44.0
259597	17642125	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1CO		CHEMBL3694720	=	IC50	nM	5.4	CHEMBL2742	Homo sapiens	IC50	nM	5.4
259598	17642126	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)c1nccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690581	=	IC50	nM	75.0	CHEMBL2742	Homo sapiens	IC50	nM	75.0
259599	17642127	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1C(F)(F)F		CHEMBL3690582	=	IC50	nM	2.5	CHEMBL2742	Homo sapiens	IC50	nM	2.5
259600	17642128	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1cccc(-c2cnc3cc(-c4ncc(C(F)(F)F)c(N)n4)ccn23)c1		CHEMBL3690583	=	IC50	nM	0.88	CHEMBL2742	Homo sapiens	IC50	nM	0.88
259601	17642129	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(C(F)(F)F)n1		CHEMBL3690585	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
259602	17642130	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cc(C(F)(F)F)n1		CHEMBL3690586	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
259603	17642131	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CS(=O)(=O)Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694671	=	IC50	nM	14.0	CHEMBL2742	Homo sapiens	IC50	nM	14.0
259604	17642132	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ncc(F)c(N)n4)ccn23)c1		CHEMBL3694683	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
259605	17642133	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(Nc5cccnc5)s4)ccn23)c1		CHEMBL3694681	=	IC50	nM	0.99	CHEMBL2742	Homo sapiens	IC50	nM	0.99
259606	17642134	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(NC5CC5)s4)ccn23)c1		CHEMBL3694646	=	IC50	nM	0.5	CHEMBL2742	Homo sapiens	IC50	nM	0.5
259607	17642135	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COC(=O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3694682	=	IC50	nM	8.5	CHEMBL2742	Homo sapiens	IC50	nM	8.5
259608	17642136	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCNC(=O)Nc1cccc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3690587	=	IC50	nM	23.0	CHEMBL2742	Homo sapiens	IC50	nM	23.0
259609	17642137	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCOc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3690588	=	IC50	nM	48.0	CHEMBL2742	Homo sapiens	IC50	nM	48.0
259610	17642138	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(CCN5CCCC5)s4)ccn23)c1		CHEMBL3690589	=	IC50	nM	6.1	CHEMBL2742	Homo sapiens	IC50	nM	6.1
259611	17642139	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)c1cnc(N)nc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3690590	=	IC50	nM	0.83	CHEMBL2742	Homo sapiens	IC50	nM	0.83
259612	17642140	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)c1ccnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3690591	=	IC50	nM	410.0	CHEMBL2742	Homo sapiens	IC50	nM	410.0
259613	17642141	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(C(F)(F)F)cn4)ccn23)c1		CHEMBL3690592	=	IC50	nM	16.6	CHEMBL2742	Homo sapiens	IC50	nM	16.6
259614	17642142	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cc(C(F)(F)F)n1		CHEMBL3690593	=	IC50	nM	7.4	CHEMBL2742	Homo sapiens	IC50	nM	7.4
259615	17642143	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CCN(CC)CCc1nnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)s1		CHEMBL3690594	=	IC50	nM	4.3	CHEMBL2742	Homo sapiens	IC50	nM	4.3
259616	17642144	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COCc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(N)n1		CHEMBL3694722	=	IC50	nM	83.0	CHEMBL2742	Homo sapiens	IC50	nM	83.0
259617	17642145	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)c1cc(N)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3694712	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
259618	17642146	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CN(C)Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3694654	=	IC50	nM	2.0	CHEMBL2742	Homo sapiens	IC50	nM	2.0
259619	17642147	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(C(=O)O)cn4)ccn23)c1		CHEMBL3694721	=	IC50	nM	8.1	CHEMBL2742	Homo sapiens	IC50	nM	8.1
259620	17642148	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cn2nc(-c3ccn4c(-c5cc(NC(=O)NCC(F)(F)F)cc(OC(C)C)c5)cnc4c3)sc2n1		CHEMBL3694645	=	IC50	nM	0.96	CHEMBL2742	Homo sapiens	IC50	nM	0.96
259621	17642149	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ncc(F)c(N)n4)ccn23)c1		CHEMBL3694648	=	IC50	nM	36.0	CHEMBL2742	Homo sapiens	IC50	nM	36.0
259622	17642150	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(CO)cn4)ccn23)c1		CHEMBL3694668	=	IC50	nM	9.4	CHEMBL2742	Homo sapiens	IC50	nM	9.4
259623	17642151	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3694670	=	IC50	nM	3.8	CHEMBL2742	Homo sapiens	IC50	nM	3.8
259624	17642152	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cc(NC(=O)NCC(F)(F)F)cc(C(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694652	=	IC50	nM	58.3	CHEMBL2742	Homo sapiens	IC50	nM	58.3
259625	17642153	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COCc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(N)n1		CHEMBL3694722	=	IC50	nM	0.99	CHEMBL2742	Homo sapiens	IC50	nM	0.99
259626	17642154	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(C)(O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3694651	=	IC50	nM	2.8	CHEMBL2742	Homo sapiens	IC50	nM	2.8
259627	17642155	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(=O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3694684	=	IC50	nM	5.2	CHEMBL2742	Homo sapiens	IC50	nM	5.2
259628	17642156	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(F)(F)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1		CHEMBL3694685	=	IC50	nM	3.7	CHEMBL2742	Homo sapiens	IC50	nM	3.7
259629	17642157	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1CN1CCC1		CHEMBL3694653	=	IC50	nM	2.24	CHEMBL2742	Homo sapiens	IC50	nM	2.24
259630	17642158	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)cc(C(F)(F)F)c1		CHEMBL3694688	=	IC50	nM	270.0	CHEMBL2742	Homo sapiens	IC50	nM	270.0
259631	17642159	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(CO)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694687	=	IC50	nM	78.0	CHEMBL2742	Homo sapiens	IC50	nM	78.0
259632	17642160	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694690	=	IC50	nM	93.0	CHEMBL2742	Homo sapiens	IC50	nM	93.0
259633	17642161	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(Cl)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694689	=	IC50	nM	21.0	CHEMBL2742	Homo sapiens	IC50	nM	21.0
259634	17642162	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	N#Cc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694691	=	IC50	nM	17.0	CHEMBL2742	Homo sapiens	IC50	nM	17.0
259635	17642163	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	COCc1cc(N)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3694713	=	IC50	nM	5.6	CHEMBL2742	Homo sapiens	IC50	nM	5.6
259636	17642164	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cc(Cl)cc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694692	=	IC50	nM	5.5	CHEMBL2742	Homo sapiens	IC50	nM	5.5
259637	17642165	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(-c2cnc3cc(-c4ncccn4)ccn23)cc(C(F)(F)F)c1		CHEMBL3694693	=	IC50	nM	110.0	CHEMBL2742	Homo sapiens	IC50	nM	110.0
259638	17642166	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(F)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694647	=	IC50	nM	5.1	CHEMBL2742	Homo sapiens	IC50	nM	5.1
259639	17642167	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(F)cc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3694694	=	IC50	nM	4.4	CHEMBL2742	Homo sapiens	IC50	nM	4.4
259640	17642168	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(O)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694695	=	IC50	nM	55.0	CHEMBL2742	Homo sapiens	IC50	nM	55.0
259641	17642169	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(Br)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694686	=	IC50	nM	39.0	CHEMBL2742	Homo sapiens	IC50	nM	39.0
259642	17642170	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Nc1nc(-c2ccn3c(-c4cc(F)cc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F		CHEMBL3694696	=	IC50	nM	1.3	CHEMBL2742	Homo sapiens	IC50	nM	1.3
259643	17642171	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	Cc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694697	=	IC50	nM	39.0	CHEMBL2742	Homo sapiens	IC50	nM	39.0
259644	17642172	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	CC(=O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N		CHEMBL3694698	=	IC50	nM	2.2	CHEMBL2742	Homo sapiens	IC50	nM	2.2
259645	17642173	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	O=C(NCC(F)(F)F)Nc1cc(Cl)cc(-c2cnc3cc(-c4ncccn4)ccn23)c1		CHEMBL3694699	=	IC50	nM	8.2	CHEMBL2742	Homo sapiens	IC50	nM	8.2
259646	17642174	CHEMBL3705512	In Vitro Kinase Inhibition Assay: Enzymes (from Upstate) were prepared at 2× final concentration in 1× kinase assay buffer (Table 1). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin −DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty pl of 5× detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode. Kinase Assay buffers were:A: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.	B	NCc1cc(NC(=O)NCC(F)(F)F)cc(-c2cnc3cc(-c4ccnc(C(F)(F)F)n4)ccn23)c1		CHEMBL3694667	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
261805	17644333	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(c2cccc(NC(=O)c3ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c4nccnc34)c2)CC1		CHEMBL3653093	=	IC50	nM	530.0	CHEMBL2742	Homo sapiens	IC50	nM	530.0
261806	17644334	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(C(N)=O)cc3)c3nccnc23)c1Cl		CHEMBL3653094	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
261807	17644335	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N4CCOCC4)cc3)c3nccnc23)c1Cl		CHEMBL3653095	=	IC50	nM	1300.0	CHEMBL2742	Homo sapiens	IC50	nM	1300.0
261808	17644336	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(C(N)=O)cn3)c3nccnc23)c1Cl		CHEMBL3653143	=	IC50	nM	74.0	CHEMBL2742	Homo sapiens	IC50	nM	74.0
261809	17644337	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N4CCN(C(C)C)CC4)cc3)c3nccnc23)c1Cl		CHEMBL3653096	=	IC50	nM	58.0	CHEMBL2742	Homo sapiens	IC50	nM	58.0
261810	17644338	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C(C)C)CC4)cc3)c3nccnc23)c1Cl		CHEMBL3653097	=	IC50	nM	31.0	CHEMBL2742	Homo sapiens	IC50	nM	31.0
261811	17644339	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3nnc[nH]3)c3nccnc23)c1Cl		CHEMBL3653129	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
261812	17644340	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN4CCN(C)CC4)[nH]3)c3nccnc23)c1Cl		CHEMBL3653130	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
261813	17644341	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3nccnc23)c1Cl		CHEMBL3653131	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
261814	17644342	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(=O)[nH]c3)c3nccnc23)c1Cl		CHEMBL3653098	=	IC50	nM	530.0	CHEMBL2742	Homo sapiens	IC50	nM	530.0
261815	17644343	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(C(=O)N4CCN(C)CC4)cn3)c3nccnc23)c1Cl		CHEMBL3653099	=	IC50	nM	41.0	CHEMBL2742	Homo sapiens	IC50	nM	41.0
261816	17644344	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1Cl		CHEMBL3653100	=	IC50	nM	22.0	CHEMBL2742	Homo sapiens	IC50	nM	22.0
261817	17644345	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(c2ccc(NC(=O)c3ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c4nccnc34)cn2)CC1		CHEMBL3653101	=	IC50	nM	54.0	CHEMBL2742	Homo sapiens	IC50	nM	54.0
261818	17644346	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N(C)CCN(C)C)nc3)c3nccnc23)c1Cl		CHEMBL3653102	=	IC50	nM	270.0	CHEMBL2742	Homo sapiens	IC50	nM	270.0
261819	17644347	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCOCC4)nc3)c3nccnc23)c1Cl		CHEMBL3653103	=	IC50	nM	87.0	CHEMBL2742	Homo sapiens	IC50	nM	87.0
261820	17644348	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cncc5ccccc45)c4nccnc34)nc2)CC1		CHEMBL3653104	=	IC50	nM	1200.0	CHEMBL2742	Homo sapiens	IC50	nM	1200.0
261821	17644349	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CN1CCN(Cc2cnc(NC(=O)c3ccc(-c4cncc5ccccc45)c4nccnc34)[nH]2)CC1		CHEMBL3653105	=	IC50	nM	700.0	CHEMBL2742	Homo sapiens	IC50	nM	700.0
261822	17644350	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CN1CCN(Cc2cnc(NC(=O)c3ccc(-c4csc5ccccc45)c4nccnc34)[nH]2)CC1		CHEMBL3653106	=	IC50	nM	8100.0	CHEMBL2742	Homo sapiens	IC50	nM	8100.0
261823	17644351	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	Cc1cscc1-c1ccc(C(=O)Nc2ncc(CN3CCN(C)CC3)[nH]2)c2nccnc12		CHEMBL3653107	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
261824	17644352	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	Cc1cccc(C)c1-c1ccc(C(=O)Nc2ncc(CN3CCN(C)CC3)[nH]2)c2nccnc12		CHEMBL3653108	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
261825	17644353	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(Cc2cnc3c(-c4c(Cl)c(OC)cc(OC)c4Cl)ccc(C(=O)Nc4cccnc4)c3n2)CC1		CHEMBL3653109	=	IC50	nM	605.0	CHEMBL2742	Homo sapiens	IC50	nM	605.0
261826	17644354	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(Cc2cnc3c(C(=O)Nc4cccnc4)ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c3n2)CC1		CHEMBL3653110	=	IC50	nM	945.0	CHEMBL2742	Homo sapiens	IC50	nM	945.0
261827	17644355	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc[nH]3)c3ncc(N(C)CCN(C)C)nc23)c1Cl		CHEMBL3653132	=	IC50	nM	210.0	CHEMBL2742	Homo sapiens	IC50	nM	210.0
261828	17644356	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccccn3)c3ncc(N(C)CCN(C)C)nc23)c1Cl		CHEMBL3653111	=	IC50	nM	2550.0	CHEMBL2742	Homo sapiens	IC50	nM	2550.0
261829	17644357	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccccn3)c3nccnc23)c1F		CHEMBL3653112	=	IC50	nM	485.0	CHEMBL2742	Homo sapiens	IC50	nM	485.0
261830	17644358	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN4CCCC4)[nH]3)c3nccnc23)c1F		CHEMBL3653133	=	IC50	nM	7.0	CHEMBL2742	Homo sapiens	IC50	nM	7.0
261831	17644359	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(OC)cc(OC)c4F)c4nccnc34)nc2)CC1		CHEMBL3653113	=	IC50	nM	42.0	CHEMBL2742	Homo sapiens	IC50	nM	42.0
261832	17644360	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(C)cc(OC)c4C)c4nccnc34)nc2)CC1		CHEMBL3653114	=	IC50	nM	875.0	CHEMBL2742	Homo sapiens	IC50	nM	875.0
261833	17644361	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4c(C)c(OC)cc(C)c4Cl)c4nccnc34)nc2)CC1		CHEMBL3653115	=	IC50	nM	1050.0	CHEMBL2742	Homo sapiens	IC50	nM	1050.0
261834	17644362	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(C)c[n+]([O-])c4C)c4nccnc34)nc2)CC1		CHEMBL3653116	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
261835	17644363	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)cn3)c3nccnc23)c1Cl		CHEMBL3653117	=	IC50	nM	20.0	CHEMBL2742	Homo sapiens	IC50	nM	20.0
261836	17644364	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCNC(C)(C)C4)nc3)c3nccnc23)c1Cl		CHEMBL3653118	=	IC50	nM	139.0	CHEMBL2742	Homo sapiens	IC50	nM	139.0
261837	17644365	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nc(C)c(C)nc23)c1Cl		CHEMBL3653119	=	IC50	nM	14.0	CHEMBL2742	Homo sapiens	IC50	nM	14.0
261838	17644366	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN4CCNCC4)cn3)c3nccnc23)c1F		CHEMBL3653134	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
261839	17644367	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3nccnc23)c1F		CHEMBL3653135	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
261840	17644368	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN4CCOCC4)[nH]3)c3nccnc23)c1F		CHEMBL3653136	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
261841	17644369	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN(C)CC(N)=O)cn3)c3nccnc23)c1F		CHEMBL3653120	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
261842	17644370	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccn(CCN(C)C)c3)c3nccnc23)c1F		CHEMBL3653121	=	IC50	nM	265.0	CHEMBL2742	Homo sapiens	IC50	nM	265.0
261843	17644371	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1		CHEMBL3653122	=	IC50	nM	44.0	CHEMBL2742	Homo sapiens	IC50	nM	44.0
261844	17644372	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1F		CHEMBL3653123	=	IC50	nM	7.0	CHEMBL2742	Homo sapiens	IC50	nM	7.0
261845	17644373	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCS(=O)(=O)CC4)cn3)c3nccnc23)c1F		CHEMBL3653124	=	IC50	nM	32.0	CHEMBL2742	Homo sapiens	IC50	nM	32.0
261846	17644374	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3nccnc23)c1F		CHEMBL3653137	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
261847	17644375	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN4CCN(C)CC4)[nH]3)c3nccnc23)c1F		CHEMBL3653138	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
261848	17644376	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN4CCNC(=O)C4)[nH]3)c3nccnc23)c1F		CHEMBL3653139	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
261849	17644377	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCNCC4)cn3)c3ncccc23)c1Cl		CHEMBL3653125	=	IC50	nM	99.0	CHEMBL2742	Homo sapiens	IC50	nM	99.0
261850	17644378	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3ncccc23)c1Cl		CHEMBL3653140	=	IC50	nM	70.0	CHEMBL2742	Homo sapiens	IC50	nM	70.0
261851	17644379	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN(C)CCN(C)C)cn3)c3ncccc23)c1Cl		CHEMBL3653126	=	IC50	nM	245.0	CHEMBL2742	Homo sapiens	IC50	nM	245.0
261852	17644380	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3ncccc23)c1F		CHEMBL3653127	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
261853	17644381	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(F)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3ncccc23)c1F		CHEMBL3653141	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
261854	17644382	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3ncccc23)c1F		CHEMBL3653128	=	IC50	nM	51.0	CHEMBL2742	Homo sapiens	IC50	nM	51.0
261855	17644383	CHEMBL3705405	LanthaScreen TR-FRET Assay: The assay has been run at room temperature on a liquid handling robot. To the assay plates containing 50 mL compound or control solutions, 4.5 uL of solution A (50 mM Tris-HCl pH7.4, 2.0m MDTT, 0.05% Tween20, 0.02 mM Na3VO4) including a generic concentration of 2.0 uM ATP was added per well, followed by 4.5 uL of solution B (0.5% BSA) including a generic concentration of 50 nM poly(EAY) to give 9.05 uL of a reaction volume with final concentrations of 2.0 uM ATP, 50 nM poly(EAY), 25 mM Tris-HCl pH7.4, 1.0 mM DTT, 0.025% Tween20, 0.01 mM Na3VO4, 0.025% BSA as well as specific concentration of the respective enzyme and individual concentrations of divalent cations: (FGFR-3-K650E) 0.2 nM GST-FGR-3-K650E, 3.0 mM MgCl2, (KIT) 36.6 nM GST-KIT, 10 mM MnCl2, (RET) 0.11 nM GST-Xa-RET, 1.0 mM MnCl2, 10 mM MgCl2, (LCK) 3.3 nM His-LCK, 10 mM MnCl2. (KDR) 0.38 nM GST-KDR, 10 mM MgCl2, 1.0 mM MnCl2, (PDGFaV561D) 4.4 nM GST-PDGFRaV561D, 10 mM MnCl2.	B	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ncc(CN(C)C)[nH]3)c3ncccc23)c1F		CHEMBL3653142	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
262918	17645410	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=CC=CC5N4)c3N)ccc2[nH]1		CHEMBL3676312	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
262919	17645411	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(O)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676313	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
262920	17645412	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCNCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676314	=	IC50	nM	38.0	CHEMBL2742	Homo sapiens	IC50	nM	38.0
262921	17645413	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCCN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676315	=	IC50	nM	5.4	CHEMBL2742	Homo sapiens	IC50	nM	5.4
262922	17645414	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OC6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676316	=	IC50	nM	6.7	CHEMBL2742	Homo sapiens	IC50	nM	6.7
262923	17645415	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(F)c(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676317	=	IC50	nM	500.0	CHEMBL2742	Homo sapiens	IC50	nM	500.0
262924	17645416	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(F)cc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676318	=	IC50	nM	360.0	CHEMBL2742	Homo sapiens	IC50	nM	360.0
262925	17645417	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccc(C(F)(F)F)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676319	=	IC50	nM	50000.0	CHEMBL2742	Homo sapiens	IC50	nM	50000.0
262926	17645418	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCCC(F)(F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676320	=	IC50	nM	3.1	CHEMBL2742	Homo sapiens	IC50	nM	3.1
262927	17645419	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)NCC(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676321	=	IC50	nM	210.0	CHEMBL2742	Homo sapiens	IC50	nM	210.0
262928	17645420	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(C(F)(F)F)cn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676322	=	IC50	nM	350.0	CHEMBL2742	Homo sapiens	IC50	nM	350.0
262929	17645421	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CO)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676323	=	IC50	nM	77.0	CHEMBL2742	Homo sapiens	IC50	nM	77.0
262930	17645422	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCCN6CCN(C)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676324	=	IC50	nM	46.0	CHEMBL2742	Homo sapiens	IC50	nM	46.0
262931	17645423	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCC6(C)COC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676325	=	IC50	nM	3.7	CHEMBL2742	Homo sapiens	IC50	nM	3.7
262932	17645424	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCN(CCOC)Cc1ccc2cc(C(=O)C3C=NN(c4ccc5[nH]c(C)nc5c4)C3N)[nH]c2c1		CHEMBL3676326	=	IC50	nM	34.0	CHEMBL2742	Homo sapiens	IC50	nM	34.0
262933	17645425	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	C#CCN(C)Cc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3676327	=	IC50	nM	70.0	CHEMBL2742	Homo sapiens	IC50	nM	70.0
262934	17645426	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOC[C@@H]6C)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676328	=	IC50	nM	5.4	CHEMBL2742	Homo sapiens	IC50	nM	5.4
262935	17645427	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	=	IC50	nM	110.0	CHEMBL2742	Homo sapiens	IC50	nM	110.0
262936	17645428	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ncccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676330	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
262937	17645429	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(I)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676331	=	IC50	nM	210.0	CHEMBL2742	Homo sapiens	IC50	nM	210.0
262938	17645430	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676332	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
262939	17645431	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C(C)C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676333	=	IC50	nM	190.0	CHEMBL2742	Homo sapiens	IC50	nM	190.0
262940	17645432	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Cc6ccccc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676334	=	IC50	nM	180.0	CHEMBL2742	Homo sapiens	IC50	nM	180.0
262941	17645433	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6=C(C(F)(F)F)CCC=C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676335	=	IC50	nM	580.0	CHEMBL2742	Homo sapiens	IC50	nM	580.0
262942	17645434	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	C#Cc1cccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc12		CHEMBL3676336	=	IC50	nM	320.0	CHEMBL2742	Homo sapiens	IC50	nM	320.0
262943	17645435	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2c(F)cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3676337	=	IC50	nM	360.0	CHEMBL2742	Homo sapiens	IC50	nM	360.0
262944	17645436	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCCCOc1ccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2c1		CHEMBL3681236	=	IC50	nM	160.0	CHEMBL2742	Homo sapiens	IC50	nM	160.0
262945	17645437	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(NS(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681237	=	IC50	nM	43.0	CHEMBL2742	Homo sapiens	IC50	nM	43.0
262946	17645438	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(N7CCOCC7)nc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681238	=	IC50	nM	82.0	CHEMBL2742	Homo sapiens	IC50	nM	82.0
262947	17645439	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCCCc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681239	=	IC50	nM	400.0	CHEMBL2742	Homo sapiens	IC50	nM	400.0
262948	17645440	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cnn(C)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681240	=	IC50	nM	60.0	CHEMBL2742	Homo sapiens	IC50	nM	60.0
262949	17645441	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ncccc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681241	=	IC50	nM	130.0	CHEMBL2742	Homo sapiens	IC50	nM	130.0
262950	17645442	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(C6CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681242	=	IC50	nM	82.0	CHEMBL2742	Homo sapiens	IC50	nM	82.0
262951	17645443	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccccc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681243	=	IC50	nM	800.0	CHEMBL2742	Homo sapiens	IC50	nM	800.0
262952	17645444	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	=	IC50	nM	230.0	CHEMBL2742	Homo sapiens	IC50	nM	230.0
262953	17645445	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cncc(S(C)(=O)=O)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681245	=	IC50	nM	86.0	CHEMBL2742	Homo sapiens	IC50	nM	86.0
262954	17645446	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccnn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681246	=	IC50	nM	27.0	CHEMBL2742	Homo sapiens	IC50	nM	27.0
262955	17645447	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCOc1ccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2c1		CHEMBL3681247	=	IC50	nM	45.0	CHEMBL2742	Homo sapiens	IC50	nM	45.0
262956	17645448	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(OCC6CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681248	=	IC50	nM	370.0	CHEMBL2742	Homo sapiens	IC50	nM	370.0
262957	17645449	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc6c(cc5[nH]4)OC(F)(F)O6)c3N)ccc2[nH]1		CHEMBL3681249	=	IC50	nM	670.0	CHEMBL2742	Homo sapiens	IC50	nM	670.0
262958	17645450	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(F)cn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681250	=	IC50	nM	94.0	CHEMBL2742	Homo sapiens	IC50	nM	94.0
262959	17645451	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Cl)c(OCC6CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681251	=	IC50	nM	90.0	CHEMBL2742	Homo sapiens	IC50	nM	90.0
262960	17645452	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2ccc(-n3ncc(C(=O)c4[nH]c5ccccc5c4F)c3N)cc2[nH]1		CHEMBL3681262	=	IC50	nM	380.0	CHEMBL2742	Homo sapiens	IC50	nM	380.0
262961	17645453	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C(C)C)CC6)c(C(F)(F)F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681263	=	IC50	nM	77.0	CHEMBL2742	Homo sapiens	IC50	nM	77.0
262962	17645454	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=CC(C#N)=CC5N4)c3N)ccc2[nH]1		CHEMBL3681264	=	IC50	nM	32.0	CHEMBL2742	Homo sapiens	IC50	nM	32.0
262963	17645455	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6=CCNCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681265	=	IC50	nM	15.0	CHEMBL2742	Homo sapiens	IC50	nM	15.0
262964	17645456	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCNCC6)c(F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681266	=	IC50	nM	68.0	CHEMBL2742	Homo sapiens	IC50	nM	68.0
262965	17645457	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C(C)C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681267	=	IC50	nM	65.0	CHEMBL2742	Homo sapiens	IC50	nM	65.0
262966	17645458	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-c6cccnc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681268	=	IC50	nM	160.0	CHEMBL2742	Homo sapiens	IC50	nM	160.0
262967	17645459	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-c6ccc(O)nc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681269	=	IC50	nM	140.0	CHEMBL2742	Homo sapiens	IC50	nM	140.0
262968	17645460	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(C6CCN(C)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681270	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
262969	17645461	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6C(C)CCC6C)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681271	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
262970	17645462	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCCC(F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681272	=	IC50	nM	30.0	CHEMBL2742	Homo sapiens	IC50	nM	30.0
262971	17645463	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CN1CCC(c2ccc3[nH]c(C(=O)c4cnn(-c5ccc6[nH]c(C(F)F)nc6c5)c4N)cc3c2)CC1		CHEMBL3681273	=	IC50	nM	130.0	CHEMBL2742	Homo sapiens	IC50	nM	130.0
262972	17645464	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C7CCCC7)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681274	=	IC50	nM	41.0	CHEMBL2742	Homo sapiens	IC50	nM	41.0
262973	17645465	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(Br)c[nH]4)c3N)ccc2[nH]1		CHEMBL3681275	=	IC50	nM	2100.0	CHEMBL2742	Homo sapiens	IC50	nM	2100.0
262974	17645466	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc[nH]4)c3N)ccc2[nH]1		CHEMBL3681276	=	IC50	nM	5500.0	CHEMBL2742	Homo sapiens	IC50	nM	5500.0
262975	17645467	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(-c5cccc(F)c5)c[nH]4)c3N)ccc2[nH]1		CHEMBL3681277	=	IC50	nM	9800.0	CHEMBL2742	Homo sapiens	IC50	nM	9800.0
262976	17645468	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	3.5	CHEMBL2742	Homo sapiens	IC50	nM	3.5
262977	17645469	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NCCN6CCOCC6)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681279	=	IC50	nM	190.0	CHEMBL2742	Homo sapiens	IC50	nM	190.0
262978	17645470	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCN(C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681280	=	IC50	nM	35.0	CHEMBL2742	Homo sapiens	IC50	nM	35.0
262979	17645471	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCNc1cccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc12		CHEMBL3681281	=	IC50	nM	26.0	CHEMBL2742	Homo sapiens	IC50	nM	26.0
262980	17645472	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NC(CO)CO)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681282	=	IC50	nM	5.6	CHEMBL2742	Homo sapiens	IC50	nM	5.6
262981	17645473	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NCCc6ccncc6)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681283	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
262982	17645474	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(N6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681284	=	IC50	nM	1.6	CHEMBL2742	Homo sapiens	IC50	nM	1.6
262983	17645475	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCOCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681285	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
262984	17645476	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(C(F)(F)F)nc2c1		CHEMBL3681286	=	IC50	nM	280.0	CHEMBL2742	Homo sapiens	IC50	nM	280.0
262985	17645477	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	79.0	CHEMBL2742	Homo sapiens	IC50	nM	79.0
262986	17645478	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(Cc3ccccc3)nc2c1		CHEMBL3681288	=	IC50	nM	920.0	CHEMBL2742	Homo sapiens	IC50	nM	920.0
262987	17645479	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2c([nH]1)CCC(n1ncc(C(=O)c3cc4cc(CN5CCN(S(C)(=O)=O)CC5)ccc4[nH]3)c1N)=C2		CHEMBL3681289	=	IC50	nM	36.0	CHEMBL2742	Homo sapiens	IC50	nM	36.0
262988	17645480	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCNCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3639801	=	IC50	nM	130.0	CHEMBL2742	Homo sapiens	IC50	nM	130.0
262989	17645481	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CC(=O)N1CCN(Cc2ccc3cc(C(=O)c4cnn(-c5ccc6[nH]c(C)nc6c5)c4N)[nH]c3c2)CC1		CHEMBL3681290	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
262990	17645482	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCN(C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681291	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
262991	17645483	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681292	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
262992	17645484	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(F)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681293	=	IC50	nM	190.0	CHEMBL2742	Homo sapiens	IC50	nM	190.0
262993	17645485	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c([nH]4)=CC(CN4CCOCC4)C(F)C=5)c3N)ccc2[nH]1		CHEMBL3681294	=	IC50	nM	19.0	CHEMBL2742	Homo sapiens	IC50	nM	19.0
262994	17645486	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)O)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681295	=	IC50	nM	8.4	CHEMBL2742	Homo sapiens	IC50	nM	8.4
262995	17645487	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1cc(OC)c2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681296	=	IC50	nM	80.0	CHEMBL2742	Homo sapiens	IC50	nM	80.0
262996	17645488	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681297	=	IC50	nM	79.0	CHEMBL2742	Homo sapiens	IC50	nM	79.0
262997	17645489	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1cc(C)c2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681298	=	IC50	nM	140.0	CHEMBL2742	Homo sapiens	IC50	nM	140.0
262998	17645490	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(C)(C)C)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681299	=	IC50	nM	950.0	CHEMBL2742	Homo sapiens	IC50	nM	950.0
262999	17645491	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Oc6ccccc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681300	=	IC50	nM	380.0	CHEMBL2742	Homo sapiens	IC50	nM	380.0
263000	17645492	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CSc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681301	=	IC50	nM	77.0	CHEMBL2742	Homo sapiens	IC50	nM	77.0
263001	17645493	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(F)c(C(F)(F)F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681302	=	IC50	nM	180.0	CHEMBL2742	Homo sapiens	IC50	nM	180.0
263002	17645494	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1cc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2cc1Cl		CHEMBL3681303	=	IC50	nM	29.0	CHEMBL2742	Homo sapiens	IC50	nM	29.0
263003	17645495	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCc6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681304	=	IC50	nM	250.0	CHEMBL2742	Homo sapiens	IC50	nM	250.0
263004	17645496	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(OC(C)C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681305	=	IC50	nM	1300.0	CHEMBL2742	Homo sapiens	IC50	nM	1300.0
263005	17645497	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc6c(cc5[nH]4)OCCO6)c3N)ccc2[nH]1		CHEMBL3681306	=	IC50	nM	100.0	CHEMBL2742	Homo sapiens	IC50	nM	100.0
263006	17645498	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C(C)(C)C)cc(C(C)(C)C)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681307	=	IC50	nM	94.0	CHEMBL2742	Homo sapiens	IC50	nM	94.0
263007	17645499	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-n6ccnc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681308	=	IC50	nM	110.0	CHEMBL2742	Homo sapiens	IC50	nM	110.0
263008	17645500	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(SC(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681309	=	IC50	nM	370.0	CHEMBL2742	Homo sapiens	IC50	nM	370.0
263009	17645501	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	130.0	CHEMBL2742	Homo sapiens	IC50	nM	130.0
263010	17645502	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OC6COC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681315	=	IC50	nM	90.0	CHEMBL2742	Homo sapiens	IC50	nM	90.0
263011	17645503	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681316	=	IC50	nM	120.0	CHEMBL2742	Homo sapiens	IC50	nM	120.0
263012	17645504	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	68.0	CHEMBL2742	Homo sapiens	IC50	nM	68.0
263013	17645505	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(Br)c(Br)[nH]4)c3N)ccc2[nH]1		CHEMBL3681318	=	IC50	nM	1400.0	CHEMBL2742	Homo sapiens	IC50	nM	1400.0
263014	17645506	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(-c5cccnc5)c(-c5cccnc5)[nH]4)c3N)ccc2[nH]1		CHEMBL3681319	=	IC50	nM	1800.0	CHEMBL2742	Homo sapiens	IC50	nM	1800.0
263015	17645507	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Cl)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681252	=	IC50	nM	370.0	CHEMBL2742	Homo sapiens	IC50	nM	370.0
263016	17645508	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc5cc[nH]c5c4)c3N)ccc2[nH]1		CHEMBL3681253	=	IC50	nM	7900.0	CHEMBL2742	Homo sapiens	IC50	nM	7900.0
263017	17645509	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681254	=	IC50	nM	330.0	CHEMBL2742	Homo sapiens	IC50	nM	330.0
263018	17645510	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(F)cc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681255	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
263019	17645511	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1ccc(-c2ccc3cc(C(=O)c4cnn(-c5ccc6[nH]c(C)nc6c5)c4N)[nH]c3c2)cn1		CHEMBL3681256	=	IC50	nM	210.0	CHEMBL2742	Homo sapiens	IC50	nM	210.0
263020	17645512	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ncc(Cl)cc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681257	=	IC50	nM	260.0	CHEMBL2742	Homo sapiens	IC50	nM	260.0
263021	17645513	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccs6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681258	=	IC50	nM	350.0	CHEMBL2742	Homo sapiens	IC50	nM	350.0
263022	17645514	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=C(C(=O)N6CCC(F)(F)C6)C=CC5N4)c3N)ccc2[nH]1		CHEMBL3681259	=	IC50	nM	260.0	CHEMBL2742	Homo sapiens	IC50	nM	260.0
263023	17645515	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CC(C)OC(C)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681260	=	IC50	nM	880.0	CHEMBL2742	Homo sapiens	IC50	nM	880.0
263024	17645516	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CC[C@H](F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681261	=	IC50	nM	4000.0	CHEMBL2742	Homo sapiens	IC50	nM	4000.0
263025	17645517	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccc(-c2c[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)c2)cc1		CHEMBL3681313	=	IC50	nM	3180.0	CHEMBL2742	Homo sapiens	IC50	nM	3180.0
263026	17645518	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4nc5ccccc5s4)c3N)ccc2[nH]1		CHEMBL3681310	=	IC50	nM	82.0	CHEMBL2742	Homo sapiens	IC50	nM	82.0
263027	17645519	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc(F)cc4)c3N)ccc2[nH]1		CHEMBL3681311	=	IC50	nM	320.0	CHEMBL2742	Homo sapiens	IC50	nM	320.0
263028	17645520	CHEMBL3705410	Enzyme Inhibition Assay: The FGFR3-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR3 enzyme (Calm Biosciences, cat. 08-135). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cccc(Cl)c4)c3N)ccc2[nH]1		CHEMBL3681312	=	IC50	nM	230.0	CHEMBL2742	Homo sapiens	IC50	nM	230.0
274889	17657189	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(F)cc4)ccn23)c1		CHEMBL3647337	=	IC50	nM	3.3	CHEMBL2742	Homo sapiens	IC50	nM	3.3
274890	17657190	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1nnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)o1		CHEMBL3647339	=	IC50	nM	15.8	CHEMBL2742	Homo sapiens	IC50	nM	15.8
274891	17657191	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1nnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)s1		CHEMBL3647338	=	IC50	nM	0.78	CHEMBL2742	Homo sapiens	IC50	nM	0.78
274892	17657192	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	N=C(S)OC(=N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3647340	=	IC50	nM	22.2	CHEMBL2742	Homo sapiens	IC50	nM	22.2
274893	17657193	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	CN(N)/N=C(\N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3647341	=	IC50	nM	16.4	CHEMBL2742	Homo sapiens	IC50	nM	16.4
274894	17657194	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cn1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c1		CHEMBL3647342	=	IC50	nM	0.49	CHEMBL2742	Homo sapiens	IC50	nM	0.49
274895	17657195	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1c(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nnn1C		CHEMBL3647343	=	IC50	nM	0.79	CHEMBL2742	Homo sapiens	IC50	nM	0.79
274896	17657196	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nncs4)ccn23)c1		CHEMBL3647344	=	IC50	nM	1.9	CHEMBL2742	Homo sapiens	IC50	nM	1.9
274897	17657197	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	CC#Cc1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1		CHEMBL3647345	=	IC50	nM	18.3	CHEMBL2742	Homo sapiens	IC50	nM	18.3
274898	17657198	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1nsc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1		CHEMBL3647346	=	IC50	nM	4.74	CHEMBL2742	Homo sapiens	IC50	nM	4.74
274899	17657199	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1cn(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3647350	=	IC50	nM	2.18	CHEMBL2742	Homo sapiens	IC50	nM	2.18
274900	17657200	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnn(CCO)c4)ccn23)c1		CHEMBL3647347	=	IC50	nM	0.704	CHEMBL2742	Homo sapiens	IC50	nM	0.704
274901	17657201	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)c(C)n1C		CHEMBL3647349	=	IC50	nM	1.24	CHEMBL2742	Homo sapiens	IC50	nM	1.24
274902	17657202	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	NCCn1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1		CHEMBL3647353	=	IC50	nM	1.6	CHEMBL2742	Homo sapiens	IC50	nM	1.6
274903	17657203	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1ccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nn1		CHEMBL3647351	=	IC50	nM	2.6	CHEMBL2742	Homo sapiens	IC50	nM	2.6
274904	17657204	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncns4)ccn23)c1		CHEMBL3647352	=	IC50	nM	3.3	CHEMBL2742	Homo sapiens	IC50	nM	3.3
274905	17657205	CHEMBL3705596	In Vitro Kinase Inhibitory Activity Assay: Enzymes (from Upstate) were prepared at 2x final concentration in 1x kinase assay buffer (as described below). Enzymes were then incubated with test compounds, biotinylated Flt3 substrate (biotin-DNEYFYV) (Cell Signalling Technology Inc.) and ATP. The reaction was allowed to proceed for 3 hours (FGFR3) or 2.5 hrs (PDGFR-beta) at room temperature on a plate shaker at 900 rpm before being stopped with 20 μl of 35 mM EDTA, pH 8 (FGFR3) or 55 mM EDTA, pH 8 (PDGFR-beta). Twenty μl of 5x detection mix (50 mM HEPES pH 7.5, 0.1% BSA, 2 nM Eu-anti-pY (PY20) (PerkinElmer) 15 nM SA-XL665 (Cisbio) for FGFR3 and 50 mM HEPES, pH 7.5, 0.5 M KF, 0.1% BSA, 11.34 nM Eu-anti-pY (PT66) (PerkinElmer), 94 nM SA-XL665 (Cisbio) for PDGFR-beta) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 900 rpm. The plate was then read on a Packard Fusion plate reader in TRF mode.	B	Cc1nnc(-c2ccn3c(-c4cncc(NC(=O)NCC(F)(F)F)c4)cnc3c2)o1		CHEMBL3647348	=	IC50	nM	31.0	CHEMBL2742	Homo sapiens	IC50	nM	31.0
278149	17660494	CHEMBL3706134	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR3 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR3 protein (Cama Biosciences, Inc., 08-135) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 uL of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration 011000 nM and ATP (Promega Corporation, V9102) in a final concentration of 16.7 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 2 hours (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 pt of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at room temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cc2)CC1		CHEMBL3686864	=	IC50	nM	7.9	CHEMBL2742	Homo sapiens	IC50	nM	7.9
278150	17660495	CHEMBL3706134	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR3 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR3 protein (Cama Biosciences, Inc., 08-135) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 uL of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration 011000 nM and ATP (Promega Corporation, V9102) in a final concentration of 16.7 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 2 hours (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 pt of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at room temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3686883	=	IC50	nM	6.0	CHEMBL2742	Homo sapiens	IC50	nM	6.0
278151	17660496	CHEMBL3706134	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR3 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR3 protein (Cama Biosciences, Inc., 08-135) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 uL of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration 011000 nM and ATP (Promega Corporation, V9102) in a final concentration of 16.7 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 2 hours (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 pt of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at room temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3686884	=	IC50	nM	5.4	CHEMBL2742	Homo sapiens	IC50	nM	5.4
304745	17685606	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701238	=	IC50	nM	0.5	CHEMBL2742	Homo sapiens	IC50	nM	0.5
304746	17685607	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C#CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701239	=	IC50	nM	0.2	CHEMBL2742	Homo sapiens	IC50	nM	0.2
304747	17685608	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C=CC(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701241	=	IC50	nM	0.3	CHEMBL2742	Homo sapiens	IC50	nM	0.3
304748	17685609	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)C#CC(C)(C)O)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701262	=	IC50	nM	0.5	CHEMBL2742	Homo sapiens	IC50	nM	0.5
304749	17685610	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C=CC(=O)N1CC(N2C=C(C#Cc3cc(OC)cc(OC)c3)C3C(N)=NC=NC32)C1		CHEMBL3701266	=	IC50	nM	0.1	CHEMBL2742	Homo sapiens	IC50	nM	0.1
304750	17685611	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701267	=	IC50	nM	0.7	CHEMBL2742	Homo sapiens	IC50	nM	0.7
304751	17685612	CHEMBL3705583	Inhibition Assay: Purified recombinant human FGFR3 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR3 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR3 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR3 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN4CC[C@H](O)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701274	=	IC50	nM	0.7	CHEMBL2742	Homo sapiens	IC50	nM	0.7
347373	17723910	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3963485	=	IC50	nM	24.8	CHEMBL2742	Homo sapiens	IC50	nM	24.8
347374	17723911	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3963485	=	IC50	nM	29.4	CHEMBL2742	Homo sapiens	IC50	nM	29.4
347375	17723912	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4111992	=	IC50	nM	46.6	CHEMBL2742	Homo sapiens	IC50	nM	46.6
347376	17723913	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4111992	=	IC50	nM	24.8	CHEMBL2742	Homo sapiens	IC50	nM	24.8
347377	17723914	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3979989	=	IC50	nM	12.1	CHEMBL2742	Homo sapiens	IC50	nM	12.1
347378	17723915	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3979989	=	IC50	nM	28.5	CHEMBL2742	Homo sapiens	IC50	nM	28.5
347379	17723916	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4106638	=	IC50	nM	10.4	CHEMBL2742	Homo sapiens	IC50	nM	10.4
347380	17723917	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4106638	=	IC50	nM	17.7	CHEMBL2742	Homo sapiens	IC50	nM	17.7
347381	17723918	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CNCC(N)=O		CHEMBL3930278	=	IC50	nM	63.9	CHEMBL2742	Homo sapiens	IC50	nM	63.9
347382	17723919	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3969781	=	IC50	nM	8.3	CHEMBL2742	Homo sapiens	IC50	nM	8.3
347383	17723920	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1		CHEMBL3901861	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
347384	17723921	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3929808	=	IC50	nM	14.0	CHEMBL2742	Homo sapiens	IC50	nM	14.0
347385	17723922	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(CN4CCNC(=O)C4)n4ncnc(N)c34)sc12		CHEMBL3914307	=	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
347386	17723923	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC[C@](C)(N)C1		CHEMBL3938823	=	IC50	nM	2.5	CHEMBL2742	Homo sapiens	IC50	nM	2.5
347387	17723924	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC[C@](C)(N)C1		CHEMBL3985178	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
347388	17723925	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1		CHEMBL3915403	=	IC50	nM	9.4	CHEMBL2742	Homo sapiens	IC50	nM	9.4
347389	17723926	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3892887	=	IC50	nM	3.3	CHEMBL2742	Homo sapiens	IC50	nM	3.3
347390	17723927	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3924399	=	IC50	nM	2.8	CHEMBL2742	Homo sapiens	IC50	nM	2.8
347391	17723928	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3924399	=	IC50	nM	2.7	CHEMBL2742	Homo sapiens	IC50	nM	2.7
347392	17723929	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1		CHEMBL3901861	=	IC50	nM	26.1	CHEMBL2742	Homo sapiens	IC50	nM	26.1
347393	17723930	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCCO)c(CN4CCNC(=O)C4)n4ncnc(N)c34)sc12		CHEMBL3923490	=	IC50	nM	13.0	CHEMBL2742	Homo sapiens	IC50	nM	13.0
347394	17723931	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCCO)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3895503	=	IC50	nM	4.7	CHEMBL2742	Homo sapiens	IC50	nM	4.7
347395	17723932	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCCCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3932448	=	IC50	nM	41.9	CHEMBL2742	Homo sapiens	IC50	nM	41.9
347396	17723933	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3907995	=	IC50	nM	5.7	CHEMBL2742	Homo sapiens	IC50	nM	5.7
347397	17723934	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC4CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3909132	=	IC50	nM	5.2	CHEMBL2742	Homo sapiens	IC50	nM	5.2
347398	17723935	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COC4CCC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3979384	=	IC50	nM	4.9	CHEMBL2742	Homo sapiens	IC50	nM	4.9
347399	17723936	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COC(C)C)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3918062	=	IC50	nM	12.6	CHEMBL2742	Homo sapiens	IC50	nM	12.6
347400	17723937	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3984301	=	IC50	nM	9.7	CHEMBL2742	Homo sapiens	IC50	nM	9.7
347401	17723938	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(F)(F)F)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3889953	=	IC50	nM	2.5	CHEMBL2742	Homo sapiens	IC50	nM	2.5
347402	17723939	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCCN)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3958993	=	IC50	nM	6.4	CHEMBL2742	Homo sapiens	IC50	nM	6.4
347403	17723940	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COC(=O)COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3938826	=	IC50	nM	13.3	CHEMBL2742	Homo sapiens	IC50	nM	13.3
347404	17723941	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(=O)O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3962751	=	IC50	nM	52.3	CHEMBL2742	Homo sapiens	IC50	nM	52.3
347405	17723942	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(N)=O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3926373	=	IC50	nM	7.2	CHEMBL2742	Homo sapiens	IC50	nM	7.2
347406	17723943	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(N)=O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3954008	=	IC50	nM	10.5	CHEMBL2742	Homo sapiens	IC50	nM	10.5
347407	17723944	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COc4ccccc4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3917388	=	IC50	nM	65.4	CHEMBL2742	Homo sapiens	IC50	nM	65.4
347408	17723945	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CNCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3948716	=	IC50	nM	9.8	CHEMBL2742	Homo sapiens	IC50	nM	9.8
347409	17723946	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN(C)C)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3911960	=	IC50	nM	34.6	CHEMBL2742	Homo sapiens	IC50	nM	34.6
347410	17723947	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCNCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3939941	=	IC50	nM	18.8	CHEMBL2742	Homo sapiens	IC50	nM	18.8
347411	17723948	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCCO)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3905236	=	IC50	nM	4.9	CHEMBL2742	Homo sapiens	IC50	nM	4.9
347412	17723949	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCCC(O)C4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3929725	=	IC50	nM	7.9	CHEMBL2742	Homo sapiens	IC50	nM	7.9
347413	17723950	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCC(O)CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3906882	=	IC50	nM	7.2	CHEMBL2742	Homo sapiens	IC50	nM	7.2
347414	17723951	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCC(O)C4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3980564	=	IC50	nM	18.4	CHEMBL2742	Homo sapiens	IC50	nM	18.4
347415	17723952	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCN(CC)Cc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3897866	=	IC50	nM	32.4	CHEMBL2742	Homo sapiens	IC50	nM	32.4
347416	17723953	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC4CCC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3969060	=	IC50	nM	6.1	CHEMBL2742	Homo sapiens	IC50	nM	6.1
347417	17723954	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCCC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3907380	=	IC50	nM	9.7	CHEMBL2742	Homo sapiens	IC50	nM	9.7
347418	17723955	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC4CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3930377	=	IC50	nM	8.1	CHEMBL2742	Homo sapiens	IC50	nM	8.1
347419	17723956	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC4CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3952635	=	IC50	nM	3.4	CHEMBL2742	Homo sapiens	IC50	nM	3.4
347420	17723957	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(=O)O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3924925	=	IC50	nM	45.4	CHEMBL2742	Homo sapiens	IC50	nM	45.4
347421	17723958	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN[C@H]4CCNC4=O)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3905636	=	IC50	nM	3.9	CHEMBL2742	Homo sapiens	IC50	nM	3.9
347422	17723959	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3921263	=	IC50	nM	7.0	CHEMBL2742	Homo sapiens	IC50	nM	7.0
347423	17723960	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)O)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3944881	=	IC50	nM	2.5	CHEMBL2742	Homo sapiens	IC50	nM	2.5
347424	17723961	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3957859	=	IC50	nM	6.8	CHEMBL2742	Homo sapiens	IC50	nM	6.8
347425	17723962	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN[C@@H]4CCNC4=O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL4108692	=	IC50	nM	2.0	CHEMBL2742	Homo sapiens	IC50	nM	2.0
347426	17723963	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3949626	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
347427	17723964	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CN4CCN(C=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3974164	=	IC50	nM	9.8	CHEMBL2742	Homo sapiens	IC50	nM	9.8
347428	17723965	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3954561	=	IC50	nM	6.8	CHEMBL2742	Homo sapiens	IC50	nM	6.8
347429	17723966	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COC(=O)c1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCNCC1		CHEMBL3983205	=	IC50	nM	77.9	CHEMBL2742	Homo sapiens	IC50	nM	77.9
347430	17723967	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(-c4cnco4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3951786	=	IC50	nM	0.9	CHEMBL2742	Homo sapiens	IC50	nM	0.9
347431	17723968	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3924079	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
347432	17723969	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3934668	=	IC50	nM	2.9	CHEMBL2742	Homo sapiens	IC50	nM	2.9
347433	17723970	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCN(C=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3968059	=	IC50	nM	3.1	CHEMBL2742	Homo sapiens	IC50	nM	3.1
347434	17723971	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3938513	=	IC50	nM	3.7	CHEMBL2742	Homo sapiens	IC50	nM	3.7
347435	17723972	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCNC(=O)C4)n4ncnc(N)c34)sc12		CHEMBL3976573	=	IC50	nM	9.4	CHEMBL2742	Homo sapiens	IC50	nM	9.4
347436	17723973	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(C#N)n4ncnc(N)c34)sc12		CHEMBL3950723	=	IC50	nM	42.7	CHEMBL2742	Homo sapiens	IC50	nM	42.7
347437	17723974	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C#N		CHEMBL3890365	=	IC50	nM	58.1	CHEMBL2742	Homo sapiens	IC50	nM	58.1
347438	17723975	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(C#N)n4ncnc(N)c34)sc12		CHEMBL3897839	=	IC50	nM	5.4	CHEMBL2742	Homo sapiens	IC50	nM	5.4
347439	17723976	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CNC(C)=O)n4ncnc(N)c34)sc12		CHEMBL3929322	=	IC50	nM	0.7	CHEMBL2742	Homo sapiens	IC50	nM	0.7
347440	17723977	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(C(C)(C)O)n4ncnc(N)c34)sc12		CHEMBL3892430	=	IC50	nM	12.2	CHEMBL2742	Homo sapiens	IC50	nM	12.2
347441	17723978	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(C(C)(C)O)n4ncnc(N)c34)sc12		CHEMBL3920417	=	IC50	nM	1.4	CHEMBL2742	Homo sapiens	IC50	nM	1.4
347442	17723979	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(C)n4ncnc(N)c34)sc12		CHEMBL3919371	=	IC50	nM	19.8	CHEMBL2742	Homo sapiens	IC50	nM	19.8
347443	17723980	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(C)n4ncnc(N)c34)sc12		CHEMBL3943773	=	IC50	nM	1.4	CHEMBL2742	Homo sapiens	IC50	nM	1.4
347444	17723981	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(C)n4ncnc(N)c34)sc12		CHEMBL3906839	=	IC50	nM	3.8	CHEMBL2742	Homo sapiens	IC50	nM	3.8
347445	17723982	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(C)n4ncnc(N)c34)sc12		CHEMBL3906839	=	IC50	nM	2.0	CHEMBL2742	Homo sapiens	IC50	nM	2.0
347446	17723983	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3933729	=	IC50	nM	17.9	CHEMBL2742	Homo sapiens	IC50	nM	17.9
347447	17723984	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3937124	=	IC50	nM	0.2	CHEMBL2742	Homo sapiens	IC50	nM	0.2
347448	17723985	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3911335	=	IC50	nM	0.5	CHEMBL2742	Homo sapiens	IC50	nM	0.5
347449	17723986	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3911335	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
347450	17723987	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1Cl		CHEMBL3916756	=	IC50	nM	2.1	CHEMBL2742	Homo sapiens	IC50	nM	2.1
347451	17723988	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(C)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3948076	=	IC50	nM	16.5	CHEMBL2742	Homo sapiens	IC50	nM	16.5
347452	17723989	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(Cl)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3925756	=	IC50	nM	26.0	CHEMBL2742	Homo sapiens	IC50	nM	26.0
347453	17723990	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CO		CHEMBL3953385	=	IC50	nM	6.8	CHEMBL2742	Homo sapiens	IC50	nM	6.8
347454	17723991	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC1=O		CHEMBL3967890	=	IC50	nM	28.1	CHEMBL2742	Homo sapiens	IC50	nM	28.1
347455	17723992	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(C)O		CHEMBL3889482	=	IC50	nM	11.0	CHEMBL2742	Homo sapiens	IC50	nM	11.0
347456	17723993	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(O)C1CC1		CHEMBL3976970	=	IC50	nM	31.1	CHEMBL2742	Homo sapiens	IC50	nM	31.1
347457	17723994	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@H]1CCNC1=O		CHEMBL3938754	=	IC50	nM	8.7	CHEMBL2742	Homo sapiens	IC50	nM	8.7
347458	17723995	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1(C)C		CHEMBL3933274	=	IC50	nM	28.7	CHEMBL2742	Homo sapiens	IC50	nM	28.7
347459	17723996	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCC(O)CC1		CHEMBL3896327	=	IC50	nM	26.5	CHEMBL2742	Homo sapiens	IC50	nM	26.5
347460	17723997	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCS(=O)(=O)CC1		CHEMBL3914178	=	IC50	nM	36.9	CHEMBL2742	Homo sapiens	IC50	nM	36.9
347461	17723998	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC(F)(F)C1		CHEMBL3945043	=	IC50	nM	39.8	CHEMBL2742	Homo sapiens	IC50	nM	39.8
347462	17723999	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N[C@@H]1CCNC1=O		CHEMBL4112606	=	IC50	nM	7.1	CHEMBL2742	Homo sapiens	IC50	nM	7.1
347463	17724000	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCNC(=O)C1		CHEMBL3921890	=	IC50	nM	17.4	CHEMBL2742	Homo sapiens	IC50	nM	17.4
347464	17724001	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)NCCO		CHEMBL3949665	=	IC50	nM	7.7	CHEMBL2742	Homo sapiens	IC50	nM	7.7
347465	17724002	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N(C)C		CHEMBL3969794	=	IC50	nM	9.6	CHEMBL2742	Homo sapiens	IC50	nM	9.6
347466	17724003	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CNC(=O)C1		CHEMBL3934358	=	IC50	nM	5.3	CHEMBL2742	Homo sapiens	IC50	nM	5.3
347467	17724004	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCS(=O)(=O)C1		CHEMBL3977038	=	IC50	nM	4.5	CHEMBL2742	Homo sapiens	IC50	nM	4.5
347468	17724005	CHEMBL3887675	Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 ul of a solution of the above FGFR-3 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 16.7 uM; final concentration in the 5 ul assay volume=10 uM) and substrate (0.8 uM; final concentration in the 5 ul assay volume=0.5 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22° C. The concentration of FGFR-3 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCC(O)CC1		CHEMBL3981692	=	IC50	nM	24.6	CHEMBL2742	Homo sapiens	IC50	nM	24.6
431430	17791538	CHEMBL3889040	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	33.9	CHEMBL2742	Homo sapiens	IC50	nM	33.9
435234	17795195	CHEMBL3889132	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3961994	=	IC50	nM	1980.0	CHEMBL2742	Homo sapiens	IC50	nM	1980.0
435235	17795196	CHEMBL3889132	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	2000.0	CHEMBL2742	Homo sapiens	IC50	nM	2000.0
	17979922	CHEMBL3998329	Inhibition of recombinant GST fused FGFR3 (unknown origin) using poly(EY) 4:1 as substrate in presence of [gamma-32P]ATP after 10 mins by scintillation counting method	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
	17979941	CHEMBL3998336	Inhibition of recombinant human FGFR3 in presence of ATP	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
	17979947	CHEMBL3998341	Inhibition of recombinant FGFR3 (unknown origin) using biotinylated peptide substrate GGGGQDGKDYIVLPI in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
	17979958	CHEMBL3998352	Inhibition of FGFR3 (unknown origin)	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	22.0	CHEMBL2742	Homo sapiens	IC50	nM	22.0
	17979959	CHEMBL3998352	Inhibition of FGFR3 (unknown origin)	B	C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1		CHEMBL4065323	=	IC50	nM	93.0	CHEMBL2742	Homo sapiens	IC50	nM	93.0
	17979960	CHEMBL3998352	Inhibition of FGFR3 (unknown origin)	B	C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4092990	=	IC50	nM	41.0	CHEMBL2742	Homo sapiens	IC50	nM	41.0
	17979978	CHEMBL3998363	Inhibition of human N-terminal GST-tagged FGFR3 cytoplasmic domain (436 to 806 end residues) expressed in baculovirus expression system using CSKtide as substrate after 90 mins	B	C=CC(=O)Nc1ccccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4090527	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
	17990985	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990986	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(NCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061383	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990987	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1c(C)cccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4091534	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990988	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(C)ccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4077138	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990989	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1ccc(C)cc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4099268	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990990	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1ccccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4082818	=	IC50	nM	1200.0	CHEMBL2742	Homo sapiens	IC50	nM	1200.0
	17990991	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4060935	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990992	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4067483	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990993	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OCC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4086040	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990994	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OC(C)C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4084175	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990995	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4102146	=	IC50	nM	4300.0	CHEMBL2742	Homo sapiens	IC50	nM	4300.0
	17990996	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4073826	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990997	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C(F)(F)F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4094408	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990998	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4065231	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17990999	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(Cl)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4086669	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991000	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(C(F)(F)F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4103091	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991001	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	CCC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4078819	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991002	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OC(C)c2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4070060	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991003	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)ccc(OC)c2Cl)cn1		CHEMBL4091031	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991004	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)cc(OC)c2Cl)cn1		CHEMBL4082121	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991005	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)cccc2Cl)cn1		CHEMBL4060226	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991006	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cccc(OC)c2Cl)cn1		CHEMBL4071593	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991007	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)ccc2Cl)cn1		CHEMBL4098624	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991008	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)cc(OC)c2)cn1		CHEMBL4097713	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991009	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2ccccc2Cl)cn1		CHEMBL4079677	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991010	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cccc(OC)c2)cn1		CHEMBL4089981	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	17991011	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	243.5	CHEMBL2742	Homo sapiens	IC50	nM	243.5
	17991012	CHEMBL4000068	Inhibition of His-tagged cytoplasmic recombinant human FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	6.0	CHEMBL2742	Homo sapiens	IC50	nM	6.0
	18002355	CHEMBL4002767	Inhibition of recombinant FGFR3 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
	18002373	CHEMBL4002767	Inhibition of recombinant FGFR3 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	9.4	CHEMBL2742	Homo sapiens	IC50	nM	9.4
	18064119	CHEMBL4013818	Inhibition of human FGFR3 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)NCc1cccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4101091	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18064120	CHEMBL4013818	Inhibition of human FGFR3 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4065736	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18064121	CHEMBL4013818	Inhibition of human FGFR3 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4093349	=	IC50	nM	820.0	CHEMBL2742	Homo sapiens	IC50	nM	820.0
	18064122	CHEMBL4013818	Inhibition of human FGFR3 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4103536	=	IC50	nM	269.0	CHEMBL2742	Homo sapiens	IC50	nM	269.0
	18064295	CHEMBL4013850	Inhibition of human FGFR3 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
Active	18064337	CHEMBL4013892	Time dependent inhibition of human FGFR3 preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509		TDI			CHEMBL2742	Homo sapiens	TDI		
	18064341	CHEMBL4013896	Irreversible inhibition of human FGFR3 preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Kinact	/s	0.00097	CHEMBL2742	Homo sapiens	Kinact	/s	0.00097
	18064345	CHEMBL4013900	Ratio of Kinact to Ki for human FGFR3	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Ratio	/uM/s	0.46	CHEMBL2742	Homo sapiens	Ratio	/uM/s	0.46
	18064369	CHEMBL4013818	Inhibition of human FGFR3 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	4.1	CHEMBL2742	Homo sapiens	IC50	nM	4.1
	18064379	CHEMBL4013896	Irreversible inhibition of human FGFR3 preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Ki	nM	2.2	CHEMBL2742	Homo sapiens	Ki	nM	2.2
	18085845	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(=O)Nc1ccccc1-c1ncc(N[C@@H](CO)c2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL4062871	=	IC50	nM	3653.5	CHEMBL2742	Homo sapiens	IC50	nM	3653.5
	18085846	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3C(F)(F)F)cc12		CHEMBL4092280	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085847	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3F)cc12		CHEMBL4071491	=	IC50	nM	430.5	CHEMBL2742	Homo sapiens	IC50	nM	430.5
	18085848	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc4cc[nH]c34)cc12		CHEMBL4060706	=	IC50	nM	560.7	CHEMBL2742	Homo sapiens	IC50	nM	560.7
	18085849	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc4cccnc34)cc12		CHEMBL4082577	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085850	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccnc3)cc12		CHEMBL4064545	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085851	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3)cc12		CHEMBL4086068	=	IC50	nM	279.9	CHEMBL2742	Homo sapiens	IC50	nM	279.9
	18085852	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccs3)cc12		CHEMBL4102447	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085853	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccsc3)cc12		CHEMBL4078176	=	IC50	nM	969.7	CHEMBL2742	Homo sapiens	IC50	nM	969.7
	18085854	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccco3)cc12		CHEMBL4083543	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085855	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccoc3)cc12		CHEMBL4101542	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085912	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3CO)cc12		CHEMBL4084547	=	IC50	nM	250.5	CHEMBL2742	Homo sapiens	IC50	nM	250.5
	18085913	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3C(N)=O)cc12		CHEMBL4094883	=	IC50	nM	388.0	CHEMBL2742	Homo sapiens	IC50	nM	388.0
	18085914	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3O)cc12		CHEMBL4073545	=	IC50	nM	8.0	CHEMBL2742	Homo sapiens	IC50	nM	8.0
	18085915	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1ccccc1-c1ncc(N[C@@H](CO)c2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL4082023	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085916	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(O)c3)cc12		CHEMBL4100031	=	IC50	nM	433.8	CHEMBL2742	Homo sapiens	IC50	nM	433.8
	18085917	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	73.1	CHEMBL2742	Homo sapiens	IC50	nM	73.1
	18085918	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	5.5	CHEMBL2742	Homo sapiens	IC50	nM	5.5
	18085919	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ncc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4082721	=	IC50	nM	93.9	CHEMBL2742	Homo sapiens	IC50	nM	93.9
	18085920	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	23.0	CHEMBL2742	Homo sapiens	IC50	nM	23.0
	18085921	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C1Cc2cc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)ccc2N1		CHEMBL4077119	=	IC50	nM	591.5	CHEMBL2742	Homo sapiens	IC50	nM	591.5
	18085922	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(=O)Nc1ccc(-c2cc(N[C@@H](CO)c3ccccc3)cnc2-c2cc(Cl)ccc2O)cc1		CHEMBL4063010	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085923	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3[nH]ccc3c2)c1)c1ccccc1		CHEMBL4075768	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085924	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4091460	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085925	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](C)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4101681	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085926	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NCCO)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4100109	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085927	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NCCCO)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4068491	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085928	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NC[C@H](O)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4095830	=	IC50	nM	401.5	CHEMBL2742	Homo sapiens	IC50	nM	401.5
	18085929	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(O)c(-c2ncc(N[C@@H](CO)c3ccccc3)cc2-c2ccc3[nH]nc(C)c3c2)c1		CHEMBL4084388	=	IC50	nM	22.8	CHEMBL2742	Homo sapiens	IC50	nM	22.8
	18085930	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(C(C)C)ccc3O)cc12		CHEMBL4102355	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18085931	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	27.5	CHEMBL2742	Homo sapiens	IC50	nM	27.5
	18085932	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	15.9	CHEMBL2742	Homo sapiens	IC50	nM	15.9
	18085933	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(F)c3O)cc12		CHEMBL4076118	=	IC50	nM	35.3	CHEMBL2742	Homo sapiens	IC50	nM	35.3
	18085934	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)c(F)cc3O)cc12		CHEMBL4074407	=	IC50	nM	27.6	CHEMBL2742	Homo sapiens	IC50	nM	27.6
	18085935	CHEMBL4018627	Inhibition of recombinant human FGFR3 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)cc(F)c3O)cc12		CHEMBL4077448	=	IC50	nM	58.4	CHEMBL2742	Homo sapiens	IC50	nM	58.4
	18086081	CHEMBL4018688	Inhibition of FGFR3 in human RT112 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	27.0	CHEMBL2742	Homo sapiens	IC50	nM	27.0
	18086082	CHEMBL4018688	Inhibition of FGFR3 in human RT112 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	122.5	CHEMBL2742	Homo sapiens	IC50	nM	122.5
	18114352	CHEMBL4025142	Inhibition of human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	18114353	CHEMBL4025141	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	89.0	CHEMBL2742	Homo sapiens	Activity	%	89.0
	18140422	CHEMBL4031013	Inhibiton of human FGFR3 at 30 uM	B	CCCOc1ccc(/C=N/n2c(S)nnc2-c2ccncc2)cc1		CHEMBL4081879	=	Inhibition	%	55.0	CHEMBL2742	Homo sapiens	INH	%	55.0
	18149652	CHEMBL4033345	Inhibition of human FGFR3 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561	>	Inhibition	%	96.0	CHEMBL2742	Homo sapiens	INH	%	96.0
	18172173	CHEMBL4038031	Inhibition of cytoplasmic recombinant human His-tagged FGFR3 (399 to 806 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	=	IC50	nM	40.2	CHEMBL2742	Homo sapiens	IC50	nM	40.2
Not Active	18203434	CHEMBL4043791	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	18203435	CHEMBL4043791	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	18203436	CHEMBL4043791	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	18203443	CHEMBL4043790	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM pretreated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	18203444	CHEMBL4043790	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM pretreated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	18203445	CHEMBL4043790	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM pretreated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	18203495	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	5.99	CHEMBL2742	Homo sapiens	IC50	nM	5.99
	18203496	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1ccc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)cc1		CHEMBL4100258	=	IC50	nM	5.09	CHEMBL2742	Homo sapiens	IC50	nM	5.09
	18203497	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1ccccc1Nc1ncc2c(n1)N(C1CCN(C(=O)/C=C/CN(C)C)CC1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4077029	=	IC50	nM	11.6	CHEMBL2742	Homo sapiens	IC50	nM	11.6
	18203498	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	IC50	nM	5.07	CHEMBL2742	Homo sapiens	IC50	nM	5.07
	18203499	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cccc(F)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4079538	=	IC50	nM	7.04	CHEMBL2742	Homo sapiens	IC50	nM	7.04
	18203500	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cccc(C)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4103795	=	IC50	nM	7.12	CHEMBL2742	Homo sapiens	IC50	nM	7.12
	18203501	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cccc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)c1		CHEMBL4068733	=	IC50	nM	7.15	CHEMBL2742	Homo sapiens	IC50	nM	7.15
	18203502	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041	=	IC50	nM	5.38	CHEMBL2742	Homo sapiens	IC50	nM	5.38
	18203503	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCOCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4060079	=	IC50	nM	16.3	CHEMBL2742	Homo sapiens	IC50	nM	16.3
	18203504	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCCCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4088313	=	IC50	nM	11.1	CHEMBL2742	Homo sapiens	IC50	nM	11.1
	18203505	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCOC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096738	=	IC50	nM	20.5	CHEMBL2742	Homo sapiens	IC50	nM	20.5
	18203506	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC(C)C)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4069509	=	IC50	nM	12.9	CHEMBL2742	Homo sapiens	IC50	nM	12.9
	18203507	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(N(C)C)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4084614	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	uM	1.0
	18203508	CHEMBL4043779	Inhibition of human recombinant His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N(C1CCN(C(=O)/C=C/CN(C)C)CC1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4092354	=	IC50	nM	7.59	CHEMBL2742	Homo sapiens	IC50	nM	7.59
	18203665	CHEMBL4043952	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	1.7	CHEMBL2742	Homo sapiens	Activity	%	1.7
	18203666	CHEMBL4043953	Inhibition of human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	1.8	CHEMBL2742	Homo sapiens	Activity	%	1.8
Not Active	18203988	CHEMBL4044272	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced FGFR3 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Not Active	18203989	CHEMBL4044272	Inhibition of FGFR3 in human FGFR3-amplified SW780 cells assessed as decrease in FGF-induced FGFR3 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	18248593	CHEMBL4053876	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	9.0	CHEMBL2742	Homo sapiens	INH	%	9.0
	18253815	CHEMBL4055192	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	18253816	CHEMBL4055192	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	82.0	CHEMBL2742	Homo sapiens	Activity	%	82.0
	18265791	CHEMBL4057241	Inhibition of FGFR3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	14.0	CHEMBL2742	Homo sapiens	INH	%	14.0
	18265792	CHEMBL4057242	Inhibition of FGFR3 K650E mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	52.0	CHEMBL2742	Homo sapiens	INH	%	52.0
	18265793	CHEMBL4057243	Inhibition of FGFR3 K650M mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	68.3	CHEMBL2742	Homo sapiens	INH	%	68.3
	18266051	CHEMBL4057501	Inhibition of FGFR3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.3	CHEMBL2742	Homo sapiens	INH	%	-0.3
	18266052	CHEMBL4057502	Inhibition of FGFR3 K650E mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-1.7	CHEMBL2742	Homo sapiens	INH	%	-1.7
	18266053	CHEMBL4057503	Inhibition of FGFR3 K650M mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	6.3	CHEMBL2742	Homo sapiens	INH	%	6.3
	18282096	CHEMBL4120051	Inhibition of recombinant His-tagged FGFR3 human cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-1.8	CHEMBL2742	Homo sapiens	INH	%	-1.8
	18282415	CHEMBL4120051	Inhibition of recombinant His-tagged FGFR3 human cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-9.3	CHEMBL2742	Homo sapiens	INH	%	-9.3
	18282697	CHEMBL4120282	Inhibition of FGFR3 K650E mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	52.0	CHEMBL2742	Homo sapiens	INH	%	52.0
	18282801	CHEMBL4120386	Inhibition of FGFR3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	14.0	CHEMBL2742	Homo sapiens	INH	%	14.0
	18282877	CHEMBL4120462	Inhibition of FGFR3 K650M mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	68.3	CHEMBL2742	Homo sapiens	INH	%	68.3
	18282924	CHEMBL4120509	Inhibition of FGFR3 K650E mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	55.3	CHEMBL2742	Homo sapiens	INH	%	55.3
	18283028	CHEMBL4120613	Inhibition of FGFR3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	6.3	CHEMBL2742	Homo sapiens	INH	%	6.3
	18283091	CHEMBL4120676	Inhibition of FGFR3 K650M mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	64.0	CHEMBL2742	Homo sapiens	INH	%	64.0
	18283148	CHEMBL4120733	Inhibition of FGFR3 K650E mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	12.0	CHEMBL2742	Homo sapiens	INH	%	12.0
	18283194	CHEMBL4120779	Inhibition of FGFR3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-8.7	CHEMBL2742	Homo sapiens	INH	%	-8.7
	18283306	CHEMBL4120891	Inhibition of FGFR3 K650M mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	12.3	CHEMBL2742	Homo sapiens	INH	%	12.3
	18333465	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4172184	=	IC50	nM	4500.0	CHEMBL2742	Homo sapiens	IC50	uM	4.5
	18333466	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4061296	=	IC50	nM	51000.0	CHEMBL2742	Homo sapiens	IC50	uM	51.0
	18333467	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1cc(F)cc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4163123	>	IC50	nM	100000.0	CHEMBL2742	Homo sapiens	IC50	uM	100.0
	18333468	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1F		CHEMBL4171043	>	IC50	nM	100000.0	CHEMBL2742	Homo sapiens	IC50	uM	100.0
	18333469	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1ccc(F)c(-c2ccc3cn[nH]c3c2)c1F		CHEMBL4173432	>	IC50	nM	100000.0	CHEMBL2742	Homo sapiens	IC50	uM	100.0
	18333470	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Oc1ccc(-c2ccc3cn[nH]c3c2)c(F)c1		CHEMBL4162722	>	IC50	nM	100000.0	CHEMBL2742	Homo sapiens	IC50	uM	100.0
Not Determined	18333471	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1F		CHEMBL4169984		IC50			CHEMBL2742	Homo sapiens	IC50		
Not Determined	18333472	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Cc1cc(O)ccc1-c1ccc2cn[nH]c2c1		CHEMBL4159347		IC50			CHEMBL2742	Homo sapiens	IC50		
Not Determined	18333473	CHEMBL4136631	Inhibition of recombinant human His-tagged FGFR3 cytoplasmic domain (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Cc1cc(-c2ccc3cn[nH]c3c2)ccc1O		CHEMBL4171437		IC50			CHEMBL2742	Homo sapiens	IC50		
	18333478	CHEMBL4136635	Inhibition of FGFR3 (unknown origin)	A	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	22.0	CHEMBL2742	Homo sapiens	IC50	nM	22.0
	18379917	CHEMBL4145818	Inhibition of FGFR3 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-3.14	CHEMBL2742	Homo sapiens	INH	%	-3.14
	18379969	CHEMBL4145870	Inhibition of FGFR3 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.25	CHEMBL2742	Homo sapiens	IC50	nM	9.25
	18431330	CHEMBL4155782	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	-4.9	CHEMBL2742	Homo sapiens	INH	%	-4.9
	18440207	CHEMBL4157031	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	59.0	CHEMBL2742	Homo sapiens	Activity	%	59.0
	18440208	CHEMBL4157032	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	94.0	CHEMBL2742	Homo sapiens	Activity	%	94.0
	18463750	CHEMBL4181166	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	7.0	CHEMBL2742	Homo sapiens	INH	%	7.0
	18484647	CHEMBL4185810	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	89.0	CHEMBL2742	Homo sapiens	Activity	%	89.0
	18484648	CHEMBL4185811	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	95.0	CHEMBL2742	Homo sapiens	Activity	%	95.0
	18484984	CHEMBL4185810	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	73.0	CHEMBL2742	Homo sapiens	Activity	%	73.0
	18484985	CHEMBL4185811	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	93.0	CHEMBL2742	Homo sapiens	Activity	%	93.0
	18489514	CHEMBL4187255	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	85.0	CHEMBL2742	Homo sapiens	Activity	%	85.0
	18507788	CHEMBL4190974	Inhibition of recombinant human FGFR3 (447 to 761 residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	5.0	CHEMBL2742	Homo sapiens	INH	%	5.0
	18653633	CHEMBL4230087	Inhibition of FGFR3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	52.0	CHEMBL2742	Homo sapiens	INH	%	52.0
	18653634	CHEMBL4230087	Inhibition of FGFR3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	34.0	CHEMBL2742	Homo sapiens	INH	%	34.0
	18655524	CHEMBL4230711	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	18655525	CHEMBL4230710	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	18663910	CHEMBL4232894	Inhibition of partial length human FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	80.0	CHEMBL2742	Homo sapiens	Activity	%	80.0
	18664007	CHEMBL4232991	Binding affinity to partial length human FGFR3 (R442 to S771 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2742	Homo sapiens	Kd	uM	5.0
	18665422	CHEMBL4233325	Inhibition of FGFR3 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	18674670	CHEMBL4235357	Inhibition of FGFR3 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2742	Homo sapiens	Ki	nM	2000.0
	18674671	CHEMBL4235357	Inhibition of FGFR3 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2742	Homo sapiens	Ki	nM	2000.0
	18674672	CHEMBL4235357	Inhibition of FGFR3 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL2742	Homo sapiens	Ki	nM	10000.0
	18745392	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	O=Cc1ccc2cccc(C(=O)Nc3ccc(C(F)(F)F)cn3)c2n1		CHEMBL4277111	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	18745393	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	O=[N+]([O-])c1ccc(Cl)nc1Nc1ncc(C(F)(F)F)cc1Cl		CHEMBL4294665	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	18745394	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	C=CC(=O)Nc1ccccc1C(=O)Nc1cc(CCc2cc(OC)cc(OC)c2)[nH]n1		CHEMBL4284069	=	IC50	nM	1.7	CHEMBL2742	Homo sapiens	IC50	nM	1.7
	18745395	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CC(C)COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(C#N)c(N[C@H]2[C@@H](C(N)=O)[C@@H]3C=C[C@H]2C3)n1		CHEMBL4279514	=	IC50	nM	3500.0	CHEMBL2742	Homo sapiens	IC50	nM	3500.0
	18745396	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	85.0	CHEMBL2742	Homo sapiens	IC50	nM	85.0
	18745397	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL2403844	=	IC50	nM	8000.0	CHEMBL2742	Homo sapiens	IC50	nM	8000.0
	18745398	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	780.0	CHEMBL2742	Homo sapiens	IC50	nM	780.0
	18745399	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	5.2	CHEMBL2742	Homo sapiens	IC50	nM	5.2
	18745400	CHEMBL4262865	Inhibition of phosphorylated FGFR3 (411 to 806 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
	18751109	CHEMBL4263805	Inhibition of FGFR3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	8.0	CHEMBL2742	Homo sapiens	INH	%	8.0
	18751603	CHEMBL4264300	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	60.0	CHEMBL2742	Homo sapiens	Activity	%	60.0
	18751604	CHEMBL4264299	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	89.0	CHEMBL2742	Homo sapiens	Activity	%	89.0
	18761512	CHEMBL4266565	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	15.0	CHEMBL2742	Homo sapiens	INH	%	15.0
	18761783	CHEMBL4266565	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	18.0	CHEMBL2742	Homo sapiens	INH	%	18.0
	18761946	CHEMBL4266565	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-4.0	CHEMBL2742	Homo sapiens	INH	%	-4.0
	18763069	CHEMBL4266866	Inhibition of FGFR3 (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	14.42	CHEMBL2742	Homo sapiens	INH	%	14.42
	18763100	CHEMBL4266897	Inhibition of FGFR3 (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	81.62	CHEMBL2742	Homo sapiens	INH	%	81.62
	18786381	CHEMBL4271712	Inhibition of recombinant FGFR3 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	=	IC50	nM	10.6	CHEMBL2742	Homo sapiens	IC50	nM	10.6
	18786400	CHEMBL4271731	Inhibition of FGFR3 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	237.5	CHEMBL2742	Homo sapiens	IC50	nM	237.5
	18786403	CHEMBL4271734	Inhibition of human N-terminal GST-tagged FGFR3 (436 to 806 residues) cytoplasmic domain expressed in baculovirus expression system after 60 mins by off-chip mobility shift assay	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCO)cc21		CHEMBL4294625	=	IC50	nM	0.5	CHEMBL2742	Homo sapiens	IC50	nM	0.5
Not Active	18847317	CHEMBL4304903	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	18857968	CHEMBL4307814	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	18857969	CHEMBL4307815	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	79.0	CHEMBL2742	Homo sapiens	Activity	%	79.0
	18885088	CHEMBL4313069	Inhibition of human FGFR3 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	IC50	nM	15.0	CHEMBL2742	Homo sapiens	IC50	nM	15.0
	18885089	CHEMBL4313069	Inhibition of human FGFR3 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	=	IC50	nM	12.5	CHEMBL2742	Homo sapiens	IC50	nM	12.5
	18885090	CHEMBL4313069	Inhibition of human FGFR3 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	3.4	CHEMBL2742	Homo sapiens	IC50	nM	3.4
	18892619	CHEMBL4314682	Inhibition of recombinant human FGFR3 (447 to 761 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	94.5	CHEMBL2742	Homo sapiens	Activity	%	94.5
	18919406	CHEMBL4322766	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FGFR3 (unknown origin) (436 to 806 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	409.0	CHEMBL2742	Homo sapiens	Kd	nM	409.0
	18919594	CHEMBL4322766	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FGFR3 (unknown origin) (436 to 806 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	848.0	CHEMBL2742	Homo sapiens	Kd	nM	848.0
	18930926	CHEMBL4325586	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	COc1cc(NC(=O)c2ccc(C)c(C#Cc3cncc4ccccc34)c2)cc(OC)c1		CHEMBL4475726	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18930927	CHEMBL4325586	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	18930948	CHEMBL4325606	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	2.3	CHEMBL2742	Homo sapiens	INH	%	2.3
	18930972	CHEMBL4325630	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	18937933	CHEMBL4327697	Inhibition of human FGFR3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	96.44	CHEMBL2742	Homo sapiens	Activity	%	96.44
	18937934	CHEMBL4327697	Inhibition of human FGFR3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.77	CHEMBL2742	Homo sapiens	Activity	%	93.77
	18938537	CHEMBL4328057	Inhibition of human FGFR3 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2742	Homo sapiens	Activity	%	65.0
	18938915	CHEMBL4328421	Inhibition of human FGFR3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	16.7	CHEMBL2742	Homo sapiens	IC50	10'-8M	1.67
	18958885	CHEMBL4333404	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	18958886	CHEMBL4333405	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	96.0	CHEMBL2742	Homo sapiens	Activity	%	96.0
	18964297	CHEMBL4335086	Inhibition of recombinant human FGFR3 (447 to 761 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	107.0	CHEMBL2742	Homo sapiens	Activity	%	107.0
	18964298	CHEMBL4335086	Inhibition of recombinant human FGFR3 (447 to 761 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	106.0	CHEMBL2742	Homo sapiens	Activity	%	106.0
	18971903	CHEMBL4336913	Inhibition of recombinant human FGFR3 (447 to 761 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	50.0	CHEMBL2742	Homo sapiens	Activity	%	50.0
	18985721	CHEMBL4340020	Inhibition of FGFR3 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	18989204	CHEMBL4340721	Inhibition of recombinant human wild-type N-terminal GST-His6-fused FGFR3 C-terminal domain (R397 to T806 residues) expressed in Sf9 insect cells using TRK-C derived peptide as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	6300.0	CHEMBL2742	Homo sapiens	IC50	uM	6.3
	19021584	CHEMBL4347807	Inhibition of recombinant human FGFR3 at 20 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	36.0	CHEMBL2742	Homo sapiens	INH	%	36.0
	19021585	CHEMBL4347808	Inhibition of recombinant human FGFR3 at 200 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	65.0	CHEMBL2742	Homo sapiens	INH	%	65.0
Not Active	19039778	CHEMBL4351864	Inhibition of recombinant human FGFR3 (447 to 761 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	19041113	CHEMBL4352374	Inhibition of human FGFR3 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	19052184	CHEMBL4355251	Inhibition of FGFR3 (unknown origin)	B	Cc1ccc2c(c1)nc(CCN1C(=O)c3cccc4cccc(c34)C1=O)n2-c1ccncc1		CHEMBL4558162	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	19059587	CHEMBL4357888	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	19059588	CHEMBL4357889	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	19090158	CHEMBL4365732	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	19090159	CHEMBL4365733	Inhibition of human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	81.0	CHEMBL2742	Homo sapiens	Activity	%	81.0
	19091930	CHEMBL4366404	Inhibition of human FGFR3 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-7.49	CHEMBL2742	Homo sapiens	INH	%	-7.49
	19099846	CHEMBL4368283	Inhibition of recombinant His-tagged FGFR3 C582S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cccc(F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4102146	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	19099847	CHEMBL4368283	Inhibition of recombinant His-tagged FGFR3 C582S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4065231	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	19099848	CHEMBL4368283	Inhibition of recombinant His-tagged FGFR3 C582S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cccc(C(F)(F)F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4094408	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	19099849	CHEMBL4368283	Inhibition of recombinant His-tagged FGFR3 C582S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
	19099850	CHEMBL4368283	Inhibition of recombinant His-tagged FGFR3 C582S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4514636	=	Inhibition	%	10.0	CHEMBL2742	Homo sapiens	INH	%	10.0
Active	19114573	CHEMBL4371374	Inhibition of FGFR3 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	19114574	CHEMBL4371347	Inhibition of FGFR3 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	19130918	CHEMBL4374886	Inhibition of wild type His-tagged human FGFR3 (455 to 763 residues) expressed in Sf9 insect cells by ELISA	B	Nc1ccc2nccnc2c1	Outside typical range	CHEMBL3353658	=	IC50	nM	120000.0	CHEMBL2742	Homo sapiens	IC50	uM	120.0
	19130919	CHEMBL4374886	Inhibition of wild type His-tagged human FGFR3 (455 to 763 residues) expressed in Sf9 insect cells by ELISA	B	Cn1cc(-c2cnc3ccc(Cl)cc3n2)cn1		CHEMBL4551715	=	IC50	nM	6500.0	CHEMBL2742	Homo sapiens	IC50	uM	6.5
	19130920	CHEMBL4374886	Inhibition of wild type His-tagged human FGFR3 (455 to 763 residues) expressed in Sf9 insect cells by ELISA	B	COc1ccc(CNc2ccc3ncc(-c4cnn(C)c4)nc3c2)c(OC)c1		CHEMBL4513608	=	IC50	nM	330.0	CHEMBL2742	Homo sapiens	IC50	uM	0.33
	19130921	CHEMBL4374886	Inhibition of wild type His-tagged human FGFR3 (455 to 763 residues) expressed in Sf9 insect cells by ELISA	B	COc1cc(Nc2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1		CHEMBL4449692	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	uM	0.012
	19130922	CHEMBL4374886	Inhibition of wild type His-tagged human FGFR3 (455 to 763 residues) expressed in Sf9 insect cells by ELISA	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	3.0	CHEMBL2742	Homo sapiens	IC50	uM	0.003
	19144802	CHEMBL4377818	Inhibition of recombinant human FGFR3 (447 to 761 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	28.0	CHEMBL2742	Homo sapiens	INH	%	28.0
	19147854	CHEMBL4379328	Inhibition of recombinant human FGFR3 (447 to 761 residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	19159415	CHEMBL4382519	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	19.0	CHEMBL2742	Homo sapiens	Activity	%	19.0
	19159416	CHEMBL4382520	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	15.0	CHEMBL2742	Homo sapiens	Activity	%	15.0
	19159835	CHEMBL4382847	Inhibition of recombinant FGFR3 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	=	IC50	nM	9.4	CHEMBL2742	Homo sapiens	IC50	nM	9.4
Active	19159869	CHEMBL4382875	Inhibition of FGFR3 phosphorylation in human UMUC14 cells at 1 to 100 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	19159870	CHEMBL4382876	Inhibition of FGFR3 in human UMUC14 cells assessed as reduction in PLCgamma phosphorylation at 1 to 100 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
Active	19159871	CHEMBL4382877	Inhibition of FGFR3 in human UMUC14 cells assessed as reduction in ERK phosphorylation at 1 to 100 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	19161577	CHEMBL4383423	Inhibition of wild type C-terminal FLAG-tagged human TEL fused FGFR3 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	73.0	CHEMBL2742	Homo sapiens	GI50	uM	0.073
	19181031	CHEMBL4387242	Inhibition of recombinant human His-tagged FGFR3 catalytic domain (399 to 806 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	19181257	CHEMBL4387242	Inhibition of recombinant human His-tagged FGFR3 catalytic domain (399 to 806 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	1.5	CHEMBL2742	Homo sapiens	INH	%	1.5
	19191591	CHEMBL4389239	Inhibition of human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	53.0	CHEMBL2742	Homo sapiens	INH	%	53.0
	19191592	CHEMBL4389238	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	46.0	CHEMBL2742	Homo sapiens	INH	%	46.0
	19191901	CHEMBL4389715	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	83.0	CHEMBL2742	Homo sapiens	INH	%	83.0
	19191902	CHEMBL4389716	Inhibition of human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2742	Homo sapiens	INH	%	100.0
	19199880	CHEMBL4391342	Binding affinity to human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	40.0	CHEMBL2742	Homo sapiens	Activity	%	40.0
	19199881	CHEMBL4391341	Binding affinity to wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	54.0	CHEMBL2742	Homo sapiens	Activity	%	54.0
	19225465	CHEMBL4395885	Inhibition of human recombinant FGFR3 at 1 uM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 90 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	64.45	CHEMBL2742	Homo sapiens	INH	%	64.45
	19236743	CHEMBL4398816	Inhibition of FGFR3 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL2742	Homo sapiens	INH	%	25.0
	19237279	CHEMBL4398957	Inhibition of FGFR3 (unknown origin) at 10 uM using peptide as substrate incubated for 10 mins by caliper assay relative to control	B	O=C(Nc1nc(NCc2ccc(Cl)cc2)c2nc[nH]c2n1)c1ccccc1		CHEMBL4474543	=	Inhibition	%	26.0	CHEMBL2742	Homo sapiens	INH	%	26.0
	19245593	CHEMBL4400500	Inhibition of human FGFR3 wild-type using FL-peptide substrate measured after 50 mins in presence of ATP by mobility shift assay	B	C[C@H](Nc1c(-c2nc3c(F)cc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4529789	=	IC50	nM	0.48	CHEMBL2742	Homo sapiens	IC50	nM	0.48
	19245594	CHEMBL4400500	Inhibition of human FGFR3 wild-type using FL-peptide substrate measured after 50 mins in presence of ATP by mobility shift assay	B	C[C@@H](Nc1c(-c2nc3cc(C(F)(F)F)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1cocn1		CHEMBL4447174	=	IC50	nM	933.4	CHEMBL2742	Homo sapiens	IC50	nM	933.4
	19245595	CHEMBL4400500	Inhibition of human FGFR3 wild-type using FL-peptide substrate measured after 50 mins in presence of ATP by mobility shift assay	B	C[C@H]1CN(c2ccc3nc(-c4c(N[C@@H](C)c5ncccn5)c5nn(C)cc5[nH]c4=O)[nH]c3c2)C[C@@H](C)O1		CHEMBL4443370	=	IC50	nM	0.3731	CHEMBL2742	Homo sapiens	IC50	nM	0.3731
	19245596	CHEMBL4400500	Inhibition of human FGFR3 wild-type using FL-peptide substrate measured after 50 mins in presence of ATP by mobility shift assay	B	C[C@H](Nc1c(-c2nc3cnc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4577380	=	IC50	nM	0.4113	CHEMBL2742	Homo sapiens	IC50	nM	0.4113
	19245597	CHEMBL4400500	Inhibition of human FGFR3 wild-type using FL-peptide substrate measured after 50 mins in presence of ATP by mobility shift assay	B	CC(C)[C@H](Nc1c(-c2nc3ccc(N4CCN(C)CC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ccccn1		CHEMBL4461304	=	IC50	nM	1.061	CHEMBL2742	Homo sapiens	IC50	nM	1.061
	19245598	CHEMBL4400500	Inhibition of human FGFR3 wild-type using FL-peptide substrate measured after 50 mins in presence of ATP by mobility shift assay	B	CC[C@H](Nc1c(-c2nc3cc(C)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4568760	=	IC50	nM	0.9714	CHEMBL2742	Homo sapiens	IC50	nM	0.9714
	19245599	CHEMBL4400501	Inhibition of human FGFR3 V555M mutant using FL-peptide substrate measured after 45 mins in presence of ATP by mobility shift assay	B	C[C@H](Nc1c(-c2nc3c(F)cc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4529789	=	IC50	nM	0.41	CHEMBL2742	Homo sapiens	IC50	nM	0.41
	19245600	CHEMBL4400501	Inhibition of human FGFR3 V555M mutant using FL-peptide substrate measured after 45 mins in presence of ATP by mobility shift assay	B	C[C@@H](Nc1c(-c2nc3cc(C(F)(F)F)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1cocn1		CHEMBL4447174	=	IC50	nM	254.3	CHEMBL2742	Homo sapiens	IC50	nM	254.3
	19245601	CHEMBL4400501	Inhibition of human FGFR3 V555M mutant using FL-peptide substrate measured after 45 mins in presence of ATP by mobility shift assay	B	C[C@H]1CN(c2ccc3nc(-c4c(N[C@@H](C)c5ncccn5)c5nn(C)cc5[nH]c4=O)[nH]c3c2)C[C@@H](C)O1		CHEMBL4443370	=	IC50	nM	0.4081	CHEMBL2742	Homo sapiens	IC50	nM	0.4081
	19245602	CHEMBL4400501	Inhibition of human FGFR3 V555M mutant using FL-peptide substrate measured after 45 mins in presence of ATP by mobility shift assay	B	C[C@H](Nc1c(-c2nc3cnc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4577380	=	IC50	nM	0.212	CHEMBL2742	Homo sapiens	IC50	nM	0.212
	19245603	CHEMBL4400501	Inhibition of human FGFR3 V555M mutant using FL-peptide substrate measured after 45 mins in presence of ATP by mobility shift assay	B	CC(C)[C@H](Nc1c(-c2nc3ccc(N4CCN(C)CC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ccccn1		CHEMBL4461304	=	IC50	nM	0.2885	CHEMBL2742	Homo sapiens	IC50	nM	0.2885
	19245604	CHEMBL4400501	Inhibition of human FGFR3 V555M mutant using FL-peptide substrate measured after 45 mins in presence of ATP by mobility shift assay	B	CC[C@H](Nc1c(-c2nc3cc(C)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4568760	=	IC50	nM	0.2645	CHEMBL2742	Homo sapiens	IC50	nM	0.2645
	19245611	CHEMBL4400503	Inhibition of wild-type FGFR3 (unknown origin) expressed in mouse NIH/3T3 cells overexpressing wild type FGFR3-TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@H](Nc1c(-c2nc3c(F)cc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4529789	=	IC50	nM	5.9	CHEMBL2742	Homo sapiens	IC50	nM	5.9
	19245612	CHEMBL4400503	Inhibition of wild-type FGFR3 (unknown origin) expressed in mouse NIH/3T3 cells overexpressing wild type FGFR3-TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@@H](Nc1c(-c2nc3cc(C(F)(F)F)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1cocn1		CHEMBL4447174	=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	19245613	CHEMBL4400503	Inhibition of wild-type FGFR3 (unknown origin) expressed in mouse NIH/3T3 cells overexpressing wild type FGFR3-TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@H]1CN(c2ccc3nc(-c4c(N[C@@H](C)c5ncccn5)c5nn(C)cc5[nH]c4=O)[nH]c3c2)C[C@@H](C)O1		CHEMBL4443370	=	IC50	nM	11.14	CHEMBL2742	Homo sapiens	IC50	nM	11.136
	19245614	CHEMBL4400503	Inhibition of wild-type FGFR3 (unknown origin) expressed in mouse NIH/3T3 cells overexpressing wild type FGFR3-TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@H](Nc1c(-c2nc3cnc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4577380	=	IC50	nM	5.896	CHEMBL2742	Homo sapiens	IC50	nM	5.896
	19245615	CHEMBL4400503	Inhibition of wild-type FGFR3 (unknown origin) expressed in mouse NIH/3T3 cells overexpressing wild type FGFR3-TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	CC(C)[C@H](Nc1c(-c2nc3ccc(N4CCN(C)CC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ccccn1		CHEMBL4461304	=	IC50	nM	26.66	CHEMBL2742	Homo sapiens	IC50	nM	26.665
	19245616	CHEMBL4400503	Inhibition of wild-type FGFR3 (unknown origin) expressed in mouse NIH/3T3 cells overexpressing wild type FGFR3-TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	CC[C@H](Nc1c(-c2nc3cc(C)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4568760	=	IC50	nM	17.41	CHEMBL2742	Homo sapiens	IC50	nM	17.405
	19245617	CHEMBL4400504	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse NIH/3T3 cells overexpressing FGFR3-V555M mutant TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@H](Nc1c(-c2nc3c(F)cc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4529789	=	IC50	nM	6.96	CHEMBL2742	Homo sapiens	IC50	nM	6.96
	19245618	CHEMBL4400504	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse NIH/3T3 cells overexpressing FGFR3-V555M mutant TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@@H](Nc1c(-c2nc3cc(C(F)(F)F)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1cocn1		CHEMBL4447174	=	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	19245619	CHEMBL4400504	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse NIH/3T3 cells overexpressing FGFR3-V555M mutant TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@H]1CN(c2ccc3nc(-c4c(N[C@@H](C)c5ncccn5)c5nn(C)cc5[nH]c4=O)[nH]c3c2)C[C@@H](C)O1		CHEMBL4443370	=	IC50	nM	8.387	CHEMBL2742	Homo sapiens	IC50	nM	8.38653
	19245620	CHEMBL4400504	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse NIH/3T3 cells overexpressing FGFR3-V555M mutant TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	C[C@H](Nc1c(-c2nc3cnc(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4577380	=	IC50	nM	9.538	CHEMBL2742	Homo sapiens	IC50	nM	9.538
	19245621	CHEMBL4400504	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse NIH/3T3 cells overexpressing FGFR3-V555M mutant TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	CC(C)[C@H](Nc1c(-c2nc3ccc(N4CCN(C)CC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ccccn1		CHEMBL4461304	=	IC50	nM	29.14	CHEMBL2742	Homo sapiens	IC50	nM	29.135
	19245622	CHEMBL4400504	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse NIH/3T3 cells overexpressing FGFR3-V555M mutant TACC3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo assay	B	CC[C@H](Nc1c(-c2nc3cc(C)c(N4CCOCC4)cc3[nH]2)c(=O)[nH]c2cn(C)nc12)c1ncccn1		CHEMBL4568760	=	IC50	nM	13.87	CHEMBL2742	Homo sapiens	IC50	nM	13.8655
	19245624	CHEMBL4400608	Inhibition of human FGFR3 using Poly [E,Y] 4:1 substrate pre-incubated for 15 to 60 mins followed by ATP and [gamma33P]-ATP addition	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	1060.0	CHEMBL2742	Homo sapiens	IC50	uM	1.06
	19245628	CHEMBL4400604	Inhibition of N-terminal GST-fused human FGFR3 cytoplasmic domain (436 to 806(end) amino acids) using CSKtide substrate incubated for 90 mins	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
	19245632	CHEMBL4400600	Inhibition of N-terminal His6-tagged recombinant human FGFR3 (447 to 761 residues) incubated for 60 mins by time-resolved fluorescence kinase assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	3.0	CHEMBL2742	Homo sapiens	IC50	nM	3.0
	19245640	CHEMBL4400592	Inhibition of FGFR3 (unknown origin) using poly[Glu:Tyr] (4:1) substrate and ATP and [gamma33P]-ATP incubated for 30 mins	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	6.4	CHEMBL2742	Homo sapiens	IC50	nM	6.4
	19245645	CHEMBL4400587	Inhibition of human FGFR3 using poly[Glu:Tyr] (4:1) substrate and ATP and [gamma33P]-ATP	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	18.0	CHEMBL2742	Homo sapiens	IC50	nM	18.0
	19266426	CHEMBL4405376	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	19272026	CHEMBL4406971	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	62.0	CHEMBL2742	Homo sapiens	Activity	%	62.0
	19276178	CHEMBL4408181	Inhibition of recombinant human FGFR3 (447 to 761 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL2742	Homo sapiens	INH	%	0.0
	19295873	CHEMBL4412350	Inhibition of FGFR3 (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	94.2	CHEMBL2742	Homo sapiens	INH	%	94.2
	19295903	CHEMBL4412380	Inhibition of FGFR3 (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	82.0	CHEMBL2742	Homo sapiens	INH	%	82.0
	19295933	CHEMBL4412410	Inhibition of FGFR3 (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	52.3	CHEMBL2742	Homo sapiens	INH	%	52.3
	19319988	CHEMBL4417582	Inhibition of N-terminal GST tagged human FGFR3 cytoplasmic domain (436 to 806 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	15.75	CHEMBL2742	Homo sapiens	INH	%	15.75
	19371126	CHEMBL4424880	Inhibition of human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in baculovirus infected Sf21 insect cells using Poly (Glu4-Tyr) (4:1) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	19406184	CHEMBL4426418	Inhibition of human FGFR3 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359	=	IC50	nM	2.0	CHEMBL2742	Homo sapiens	IC50	nM	2.0
	19406215	CHEMBL4426418	Inhibition of human FGFR3 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	5.6	CHEMBL2742	Homo sapiens	IC50	nM	5.6
	19406225	CHEMBL4426440	Inhibition of human FGFR3	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
	20600530	CHEMBL4603482	Inhibition of recombinant His-tagged human FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2742	Homo sapiens	IC50	uM	100.0
	20600531	CHEMBL4603483	Inhibition of recombinant N-terminal His-tagged human FGFR3 K650E mutant (398 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2742	Homo sapiens	IC50	uM	100.0
	20609537	CHEMBL4605798	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	>	IC50	nM	9800.0	CHEMBL2742	Homo sapiens	IC50	uM	9.8
	20609538	CHEMBL4605798	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	430.0	CHEMBL2742	Homo sapiens	IC50	uM	0.43
	20609539	CHEMBL4605798	Inhibition of FGFR3 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	4900.0	CHEMBL2742	Homo sapiens	IC50	uM	4.9
	20711755	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)n1		CHEMBL4641667	=	IC50	nM	12.0	CHEMBL2742	Homo sapiens	IC50	nM	12.0
	20711756	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OC)c2)n1		CHEMBL4636935	=	IC50	nM	15.0	CHEMBL2742	Homo sapiens	IC50	nM	15.0
	20711757	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCC(=O)OCC)c2)n1		CHEMBL4644658	=	IC50	nM	62.0	CHEMBL2742	Homo sapiens	IC50	nM	62.0
	20711758	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCC(=O)O)c2)n1		CHEMBL4643652	=	IC50	nM	65.0	CHEMBL2742	Homo sapiens	IC50	nM	65.0
	20711759	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCCOC)c2)n1		CHEMBL4644695	=	IC50	nM	17.0	CHEMBL2742	Homo sapiens	IC50	nM	17.0
	20711760	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCCOCCOC)c2)n1		CHEMBL4638978	=	IC50	nM	21.0	CHEMBL2742	Homo sapiens	IC50	nM	21.0
	20711761	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCCN3CCOCC3)c2)n1		CHEMBL4645817	=	IC50	nM	4.1	CHEMBL2742	Homo sapiens	IC50	nM	4.1
	20711762	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCCN3CCN(C)CC3)c2)n1.Cl.Cl.Cl.Cl		CHEMBL4637057	=	IC50	nM	15.0	CHEMBL2742	Homo sapiens	IC50	nM	15.0
	20711763	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCN(C)CC3)c(OCCCN3CCOCC3)c2)n1		CHEMBL4637872	=	IC50	nM	63.0	CHEMBL2742	Homo sapiens	IC50	nM	63.0
	20711764	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1-c1cc(OC)cc(OC)c1		CHEMBL4635284	=	IC50	nM	4.1	CHEMBL2742	Homo sapiens	IC50	nM	4.1
	20711765	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1Cc1cc(OC)cc(OC)c1		CHEMBL4646707	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	20711766	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1CCc1cc(OC)cc(OC)c1		CHEMBL4634918	=	IC50	nM	2.8	CHEMBL2742	Homo sapiens	IC50	nM	2.8
	20711767	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(OC)cc(OC)c1		CHEMBL4642080	=	IC50	nM	4.3	CHEMBL2742	Homo sapiens	IC50	nM	4.3
	20711768	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(OC)ccc1OC		CHEMBL4647945	=	IC50	nM	54.0	CHEMBL2742	Homo sapiens	IC50	nM	54.0
	20711769	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cccc(OC)c1OC		CHEMBL4635626	=	IC50	nM	40.0	CHEMBL2742	Homo sapiens	IC50	nM	40.0
	20711770	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(O)cc(O)c1		CHEMBL4648279	=	IC50	nM	35.0	CHEMBL2742	Homo sapiens	IC50	nM	35.0
	20711771	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(C)cc(C)c1		CHEMBL4638231	=	IC50	nM	275.0	CHEMBL2742	Homo sapiens	IC50	nM	275.0
	20711772	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1nc(OC)cc(OC)n1		CHEMBL4635544	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
	20711773	CHEMBL4629238	Inhibition of N-terminal GST-tagged human FGFR3 cytoplasmic domain (436-806 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(OC)nc(OC)n1		CHEMBL4643533	=	IC50	nM	34.0	CHEMBL2742	Homo sapiens	IC50	nM	34.0
	20711793	CHEMBL4629240	Inhibition of human recombinant N-terminal His6 tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using FLT3 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by time resolved fluorescence assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	3.0	CHEMBL2742	Homo sapiens	IC50	nM	3.0
	20711822	CHEMBL4629246	Inhibition of FGFR3 (unknown origin) expressed in baculovirus infected insect cells using biotinylated-GGGGQDGKDYIVLPI peptide as substrate incubated for 1 to 4 hrs by TRF assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	9.0	CHEMBL2742	Homo sapiens	IC50	nM	9.0
	22392055	CHEMBL4667150	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) expressed in baculovirus expression system using Tyr 04 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL2742	Homo sapiens	INH	%	0.5
	22423611	CHEMBL4674381	Inhibition of human FGFR3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	101.04	CHEMBL2742	Homo sapiens	Activity	%	101.04
	22423612	CHEMBL4674381	Inhibition of human FGFR3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	102.37	CHEMBL2742	Homo sapiens	Activity	%	102.37
	22425194	CHEMBL4674897	Inhibition of human FGFR3 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	Nc1nc2[nH]c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c2c(=O)[nH]1		CHEMBL4790677	=	Inhibition	%	6.1	CHEMBL2742	Homo sapiens	INH	%	6.1
	22425195	CHEMBL4674897	Inhibition of human FGFR3 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccc(F)cc4)CC3)c(CN3CCN(Cc4ccc(F)cc4)CC3)c2c(=O)[nH]1		CHEMBL4742745	=	Inhibition	%	31.68	CHEMBL2742	Homo sapiens	INH	%	31.68
	22425196	CHEMBL4674897	Inhibition of human FGFR3 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4cccc(F)c4)CC3)c(CN3CCN(Cc4cccc(F)c4)CC3)c2c(=O)[nH]1		CHEMBL4786524	=	Inhibition	%	39.22	CHEMBL2742	Homo sapiens	INH	%	39.22
	22425197	CHEMBL4674897	Inhibition of human FGFR3 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4F)CC3)c(CN3CCN(Cc4ccccc4F)CC3)c2c(=O)[nH]1		CHEMBL4788342	=	Inhibition	%	39.95	CHEMBL2742	Homo sapiens	INH	%	39.95
	22425198	CHEMBL4674897	Inhibition of human FGFR3 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4)CC3)c(CN3CCN(Cc4ccccc4)CC3)c2c(=O)[nH]1		CHEMBL4787439	=	Inhibition	%	34.62	CHEMBL2742	Homo sapiens	INH	%	34.62
	22446620	CHEMBL4679674	Inhibition of His-tagged FGFR3 V555M mutant (unknown origin) expressed in insect cells using poly Glu-Tyr preincubated for 1 hr followed by substrate addition and measured after 1 hr by Lance Eu-W1024-antiphosphoTyrosine based TR-FRET assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4783926	=	IC50	nM	111.0	CHEMBL2742	Homo sapiens	IC50	nM	111.0
	22446621	CHEMBL4679674	Inhibition of His-tagged FGFR3 V555M mutant (unknown origin) expressed in insect cells using poly Glu-Tyr preincubated for 1 hr followed by substrate addition and measured after 1 hr by Lance Eu-W1024-antiphosphoTyrosine based TR-FRET assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4776177	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
	22446634	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2cc(Nc3cc(C)[nH]n3)nc(N3CCN(C)CC3)n2)cc1		CHEMBL4752618	=	GI50	nM	46.0	CHEMBL2742	Homo sapiens	GI50	nM	46.0
	22446635	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4793382	=	GI50	nM	1.4	CHEMBL2742	Homo sapiens	GI50	nM	1.4
	22446636	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1cccc(/C=C/c2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL4786744	=	GI50	nM	43.0	CHEMBL2742	Homo sapiens	GI50	nM	43.0
	22446637	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	GI50	nM	450.0	CHEMBL2742	Homo sapiens	GI50	nM	450.0
	22446638	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(C2CCN(c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)CC2)C1		CHEMBL4755567	=	GI50	nM	3.1	CHEMBL2742	Homo sapiens	GI50	nM	3.1
	22446639	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC2(CCN(c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)CC2)C1		CHEMBL4779534	=	GI50	nM	6.9	CHEMBL2742	Homo sapiens	GI50	nM	6.9
	22446640	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CC2(CCN(c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)CC2)C1		CHEMBL4783883	=	GI50	nM	8.0	CHEMBL2742	Homo sapiens	GI50	nM	8.0
	22446641	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C5COC5)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4791200	=	GI50	nM	11.0	CHEMBL2742	Homo sapiens	GI50	nM	11.0
	22446642	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4755774	=	GI50	nM	11.0	CHEMBL2742	Homo sapiens	GI50	nM	11.0
	22446643	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4783926	=	GI50	nM	19.0	CHEMBL2742	Homo sapiens	GI50	nM	19.0
	22446644	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)C1		CHEMBL4765110	=	GI50	nM	5.2	CHEMBL2742	Homo sapiens	GI50	nM	5.2
	22446645	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)C1		CHEMBL4746615	=	GI50	nM	9.3	CHEMBL2742	Homo sapiens	GI50	nM	9.3
	22446646	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)NC12CCC(/C=C/c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)(CC1)CC2		CHEMBL4777079	=	GI50	nM	40.0	CHEMBL2742	Homo sapiens	GI50	nM	40.0
	22446647	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(CCc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4752090	=	GI50	nM	66.0	CHEMBL2742	Homo sapiens	GI50	nM	66.0
	22446648	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cn(C(C)C)cn3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4760839	=	GI50	nM	4.9	CHEMBL2742	Homo sapiens	GI50	nM	4.9
	22446649	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3ncc(C(C)C)s3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4745451	=	GI50	nM	0.5	CHEMBL2742	Homo sapiens	GI50	nM	0.5
	22446650	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3ncc(C)s3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4764283	=	GI50	nM	0.7	CHEMBL2742	Homo sapiens	GI50	nM	0.7
	22446651	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C4COC4)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4744456	=	GI50	nM	0.6	CHEMBL2742	Homo sapiens	GI50	nM	0.6
	22446652	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(COC)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4777595	=	GI50	nM	1.3	CHEMBL2742	Homo sapiens	GI50	nM	1.3
	22446653	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(CC(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4761236	=	GI50	nM	0.6	CHEMBL2742	Homo sapiens	GI50	nM	0.6
	22446654	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4781569	=	GI50	nM	0.7	CHEMBL2742	Homo sapiens	GI50	nM	0.7
	22446655	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4756501	=	GI50	nM	0.6	CHEMBL2742	Homo sapiens	GI50	nM	0.6
	22446656	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4776177	=	GI50	nM	0.1	CHEMBL2742	Homo sapiens	GI50	nM	0.1
	22446657	CHEMBL4679677	Inhibition of FGFR3 V555M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(CC)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4748389	=	GI50	nM	0.2	CHEMBL2742	Homo sapiens	GI50	nM	0.2
	22446658	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2cc(Nc3cc(C)[nH]n3)nc(N3CCN(C)CC3)n2)cc1		CHEMBL4752618	=	GI50	nM	42.0	CHEMBL2742	Homo sapiens	GI50	nM	42.0
	22446659	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	GI50	nM	343.0	CHEMBL2742	Homo sapiens	GI50	nM	343.0
	22446660	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1cccc(/C=C/c2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL4786744	=	GI50	nM	26.0	CHEMBL2742	Homo sapiens	GI50	nM	26.0
	22446661	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4793382	=	GI50	nM	2.2	CHEMBL2742	Homo sapiens	GI50	nM	2.2
	22446662	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(C2CCN(c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)CC2)C1		CHEMBL4755567	=	GI50	nM	10.0	CHEMBL2742	Homo sapiens	GI50	nM	10.0
	22446663	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC2(CCN(c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)CC2)C1		CHEMBL4779534	=	GI50	nM	11.0	CHEMBL2742	Homo sapiens	GI50	nM	11.0
	22446664	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CC2(CCN(c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)CC2)C1		CHEMBL4783883	=	GI50	nM	10.0	CHEMBL2742	Homo sapiens	GI50	nM	10.0
	22446665	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C5COC5)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4791200	=	GI50	nM	63.0	CHEMBL2742	Homo sapiens	GI50	nM	63.0
	22446666	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C(C)C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4755774	=	GI50	nM	43.0	CHEMBL2742	Homo sapiens	GI50	nM	43.0
	22446667	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4783926	=	GI50	nM	46.0	CHEMBL2742	Homo sapiens	GI50	nM	46.0
	22446668	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)C1		CHEMBL4765110	=	GI50	nM	20.0	CHEMBL2742	Homo sapiens	GI50	nM	20.0
	22446669	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)C1		CHEMBL4746615	=	GI50	nM	16.0	CHEMBL2742	Homo sapiens	GI50	nM	16.0
	22446670	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)NC12CCC(/C=C/c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)(CC1)CC2		CHEMBL4777079	=	GI50	nM	158.0	CHEMBL2742	Homo sapiens	GI50	nM	158.0
	22446671	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(CCc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4752090	=	GI50	nM	55.0	CHEMBL2742	Homo sapiens	GI50	nM	55.0
	22446672	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cn(C(C)C)cn3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4760839	=	GI50	nM	7.3	CHEMBL2742	Homo sapiens	GI50	nM	7.3
	22446673	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3ncc(C(C)C)s3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4745451	=	GI50	nM	1.2	CHEMBL2742	Homo sapiens	GI50	nM	1.2
	22446674	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3ncc(C)s3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4764283	=	GI50	nM	1.2	CHEMBL2742	Homo sapiens	GI50	nM	1.2
	22446675	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C4COC4)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4744456	=	GI50	nM	5.8	CHEMBL2742	Homo sapiens	GI50	nM	5.8
	22446676	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(COC)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4777595	=	GI50	nM	3.4	CHEMBL2742	Homo sapiens	GI50	nM	3.4
	22446677	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(CC(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4761236	=	GI50	nM	0.6	CHEMBL2742	Homo sapiens	GI50	nM	0.6
	22446678	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4781569	=	GI50	nM	3.0	CHEMBL2742	Homo sapiens	GI50	nM	3.0
	22446679	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4756501	=	GI50	nM	4.0	CHEMBL2742	Homo sapiens	GI50	nM	4.0
	22446680	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4776177	=	GI50	nM	0.3	CHEMBL2742	Homo sapiens	GI50	nM	0.3
	22446681	CHEMBL4679678	Inhibition of wild type FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR3-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(CC)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4748389	=	GI50	nM	1.1	CHEMBL2742	Homo sapiens	GI50	nM	1.1
	22490076	CHEMBL4689523	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using biotinylated EQEDEPEGDYFEWLE peptide as substrate preincubated for 4 hrs followed by substrate addition and measured after 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2n[nH]c3ccc(N4CCn5cnc(C(F)(F)F)c5C4)nc23)cn1		CHEMBL4749593	<	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	22490077	CHEMBL4689523	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using biotinylated EQEDEPEGDYFEWLE peptide as substrate preincubated for 4 hrs followed by substrate addition and measured after 1 hr in presence of ATP by FRET assay	B	CC(C)C1C(=O)N(C)CCN1c1ccc2[nH]nc(-c3cnn(C)c3)c2n1		CHEMBL4753114	<	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	22490078	CHEMBL4689523	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using biotinylated EQEDEPEGDYFEWLE peptide as substrate preincubated for 4 hrs followed by substrate addition and measured after 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc3[nH]nc(-c4cnn(C)c4)c3n2)C(C2CC2)C1=O		CHEMBL4754734	<	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	22490079	CHEMBL4689523	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using biotinylated EQEDEPEGDYFEWLE peptide as substrate preincubated for 4 hrs followed by substrate addition and measured after 1 hr in presence of ATP by FRET assay	B	CC1CN(c2ccc3[nH]nc(-c4cnn(C)c4)c3n2)C(C)C(=O)N1C		CHEMBL4798507	<	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	22490080	CHEMBL4689523	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using biotinylated EQEDEPEGDYFEWLE peptide as substrate preincubated for 4 hrs followed by substrate addition and measured after 1 hr in presence of ATP by FRET assay	B	CC(C)C1C(=O)N(C)CCN1c1ccc2[nH]nc(-c3cnn(Cc4cccnc4)c3)c2n1		CHEMBL4740345	<	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	22490081	CHEMBL4689523	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using biotinylated EQEDEPEGDYFEWLE peptide as substrate preincubated for 4 hrs followed by substrate addition and measured after 1 hr in presence of ATP by FRET assay	B	CC(C)C1C(=O)N(C)CCN1c1ccc2[nH]nc(-c3cc4cnccc4s3)c2n1		CHEMBL4780804	<	IC50	nM	10.0	CHEMBL2742	Homo sapiens	IC50	nM	10.0
	22766972	CHEMBL4703351	Inhibition of FGFR3 (unknown origin) at 100 nM	B	C=CC(=O)Nc1cccc(C)c1Nc1cc(-c2cccnc2Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL4744686	=	Inhibition	%	-5.0	CHEMBL2742	Homo sapiens	INH	%	-5.0
	22802133	CHEMBL4711711	Inhibition of human partial length FGFR3 G697C mutant (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Activity	%	23.0	CHEMBL2742	Homo sapiens	Activity	%	23.0
	22802151	CHEMBL4711729	Inhibition of C-terminal NanoLuc-fused full length FGFR3 G6973C mutant (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816222	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=CS(=O)(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4785949	=	IC50	nM	1230.0	CHEMBL2742	Homo sapiens	IC50	uM	1.23
	22816223	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC#N)nc2)c1Cl		CHEMBL4750816	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816224	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NCC#N)nc2)c1Cl		CHEMBL4748301	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816225	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CC#N)nc2)c1Cl		CHEMBL4739914	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816226	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C#CCNc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4799486	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816227	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CCl)nc2)c1Cl		CHEMBL4763652	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816228	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)C3CO3)nc2)c1Cl		CHEMBL4740775	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816229	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=C(F)C(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4757810	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816230	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NCC=O)nc2)c1Cl		CHEMBL4742889	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816231	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=C(C#N)C(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4796512	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816232	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22816233	CHEMBL4714831	Inhibition of recombinant human His-tagged FGFR3 (399 to 806 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3908979	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22818104	CHEMBL4715327	Inhibition of recombinant human N-terminal His6-tagged FGFR3 (447 to 761 residues) expressed in Sf21 insect cells at 2 uM using poly (Glu,Tyr) (4:1) as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL2742	Homo sapiens	INH	%	50.0
	22822941	CHEMBL4716850	Inhibition of FGFR3 (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	uM	10.0
	22826327	CHEMBL4717512	Inhibition of N-terminal His6-tagged human FGFR3 (447 to 761 residues) expressed in Sf21 cells assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL2742	Homo sapiens	Activity	%	60.0
	22843743	CHEMBL4720729	Inhibition of human FGFR3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.42	CHEMBL2742	Homo sapiens	IC50	10^-9M	6.42
	22844095	CHEMBL4721081	Inhibition of human FGFR3 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	80.23	CHEMBL2742	Homo sapiens	Activity	%	80.23
	22844711	CHEMBL4721386	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	102.56	CHEMBL2742	Homo sapiens	Activity	%	102.56
	22849867	CHEMBL4723269	Inhibition of FGFR3 kinase domain (411 to 806) (unknown origin) using 5-FluoAhx-EEPLYWSFPAKKKCO-NH2 peptide as substrate in presence of ATP measured after 60 mins by caliper microfluidic mobility shift assay	A	COCCOc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3973674	>	IC50	nM	10000.0	CHEMBL2742	Homo sapiens	IC50	nM	10000.0
	22854896	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(Nc2ncc(CCc3c(F)c(OC)cc(OC)c3Cl)cn2)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL4746045	=	IC50	nM	1.6	CHEMBL2742	Homo sapiens	IC50	nM	1.6
	22854897	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(CCc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)c(F)c(OC)c1		CHEMBL4791437	=	IC50	nM	5.2	CHEMBL2742	Homo sapiens	IC50	nM	5.2
	22854898	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(Nc2ncc(CCc3c(F)c(OC)cc(OC)c3F)cn2)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL4763773	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
	22854899	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(Nc2ncc(CCc3c(Cl)c(OC)cc(OC)c3Cl)cn2)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL4750924	=	IC50	nM	4.3	CHEMBL2742	Homo sapiens	IC50	nM	4.3
	22854900	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(COc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)cc(OC)c1		CHEMBL4741510	=	IC50	nM	45.0	CHEMBL2742	Homo sapiens	IC50	nM	45.0
	22854901	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(OC)cc(OCc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)c1		CHEMBL4785244	=	IC50	nM	380.0	CHEMBL2742	Homo sapiens	IC50	nM	380.0
	22854902	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(OC)cc(C(=O)N(C)c2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)c1		CHEMBL4789040	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	22854903	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(CCc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)cc(OC)c1		CHEMBL4756275	=	IC50	nM	24.0	CHEMBL2742	Homo sapiens	IC50	nM	24.0
	22854904	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(CNc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)cc(OC)c1		CHEMBL4788946	=	IC50	nM	78.0	CHEMBL2742	Homo sapiens	IC50	nM	78.0
	22854905	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(OC)cc(C(=O)Nc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2)c1		CHEMBL4798679	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	22854906	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(OC)cc(C(=O)Nc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2NCCS(C)(=O)=O)c1		CHEMBL4782398	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
	22854907	CHEMBL4724596	Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(OC)cc(C(=O)Nc2cnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(OC)c3)nc2Nc2ccccc2)c1		CHEMBL4793847	=	IC50	nM	467.0	CHEMBL2742	Homo sapiens	IC50	nM	467.0
Not Active	22889511	CHEMBL4729030	Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2742	Homo sapiens	INH		
	22930971	CHEMBL4738761	Inhibition of FGFR3 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1		CHEMBL4757428	=	IC50	nM	146.0	CHEMBL2742	Homo sapiens	IC50	nM	146.0
	22930972	CHEMBL4738761	Inhibition of FGFR3 (unknown origin)	A	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	16.0	CHEMBL2742	Homo sapiens	IC50	nM	16.0
	22930973	CHEMBL4738761	Inhibition of FGFR3 (unknown origin)	A	COc1cccc(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1F		CHEMBL4779598	=	IC50	nM	86.0	CHEMBL2742	Homo sapiens	IC50	nM	86.0
	22930974	CHEMBL4738761	Inhibition of FGFR3 (unknown origin)	A	COc1ccc(F)c(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1		CHEMBL4748343	=	IC50	nM	208.0	CHEMBL2742	Homo sapiens	IC50	nM	208.0
	22950597	CHEMBL4766164	Inhibition of human recombinant FGFR3 (447 to 761 residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	120.0	CHEMBL2742	Homo sapiens	IC50	uM	0.12
	22952840	CHEMBL4766777	Inhibition of recombinant human FGFR3 (447 to 761 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	44.0	CHEMBL2742	Homo sapiens	Activity	%	44.0
	23122573	CHEMBL4804924	Inhibition of human FGFR3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	23122574	CHEMBL4804925	Inhibition of human FGFR3 G697C mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	93.0	CHEMBL2742	Homo sapiens	Activity	%	93.0
	23123268	CHEMBL4805512	Inhibition of human FGFR3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	23123269	CHEMBL4805513	Inhibition of human FGFR3 G697C mutant assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	23123622	CHEMBL4805866	Inhibition of DNA-tagged human FGFR3 G697C mutant assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	23123623	CHEMBL4805867	Inhibition of DNA-tagged human FGFR3 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	23124626	CHEMBL4806529	Inhibition of human FGFR3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL2742	Homo sapiens	Activity	%	98.0
	23124627	CHEMBL4806529	Inhibition of human FGFR3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL2742	Homo sapiens	Activity	%	99.0
	23124628	CHEMBL4806530	Inhibition of human FGFR3 G697C mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	95.0	CHEMBL2742	Homo sapiens	Activity	%	95.0
	23124629	CHEMBL4806530	Inhibition of human FGFR3 G697C mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2742	Homo sapiens	Activity	%	100.0
	23128110	CHEMBL4807845	Inhibition of FGFR3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL2742	Homo sapiens	Activity	%	50.0
	23128111	CHEMBL4807845	Inhibition of FGFR3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2742	Homo sapiens	Activity	%	75.0
	23128112	CHEMBL4807845	Inhibition of FGFR3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2742	Homo sapiens	Activity	%	75.0
	23149482	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4856613	=	IC50	nM	5.7	CHEMBL2742	Homo sapiens	IC50	nM	5.7
	23149483	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4847441	=	IC50	nM	2.2	CHEMBL2742	Homo sapiens	IC50	nM	2.2
	23149484	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1Cl		CHEMBL4863146	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
	23149485	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c(Cl)c(OC)c1Cl		CHEMBL4868291	=	IC50	nM	108.0	CHEMBL2742	Homo sapiens	IC50	nM	108.0
	23149486	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4863224	=	IC50	nM	1.4	CHEMBL2742	Homo sapiens	IC50	nM	1.4
	23149487	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4870179	=	IC50	nM	0.27	CHEMBL2742	Homo sapiens	IC50	nM	0.27
	23149488	CHEMBL4810139	Inhibition of human FGFR3 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4862823	=	IC50	nM	0.49	CHEMBL2742	Homo sapiens	IC50	nM	0.49
	23158838	CHEMBL4812090	Inhibition of FGFR3 (436 to 806 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	1.25	CHEMBL2742	Homo sapiens	INH	%	1.25
	23261805	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)Nc1cc(SC)ccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4879303	=	IC50	nM	79.0	CHEMBL2742	Homo sapiens	IC50	nM	79.0
	23261806	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)Nc1cc(S(C)(=O)=O)cc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4862742	=	IC50	nM	3874.0	CHEMBL2742	Homo sapiens	IC50	nM	3874.0
	23261807	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)Nc1cc(S(C)(=O)=O)ccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4877857	=	IC50	nM	102.0	CHEMBL2742	Homo sapiens	IC50	nM	102.0
	23261808	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)Nc1cc(S(N)(=O)=O)cc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4872856	=	IC50	nM	3915.0	CHEMBL2742	Homo sapiens	IC50	nM	3915.0
	23261809	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4514636	=	IC50	nM	2203.0	CHEMBL2742	Homo sapiens	IC50	nM	2203.0
	23261810	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	150.0	CHEMBL2742	Homo sapiens	IC50	nM	150.0
	23261811	CHEMBL4833171	Inhibition of FGFR3 (unknown origin)	A	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	1060.0	CHEMBL2742	Homo sapiens	IC50	nM	1060.0
	23265611	CHEMBL4834268	Inhibition of FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	490.0	CHEMBL2742	Homo sapiens	IC50	uM	0.49
	23265612	CHEMBL4834268	Inhibition of FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	1100.0	CHEMBL2742	Homo sapiens	IC50	uM	1.1
	23265613	CHEMBL4834268	Inhibition of FGFR3 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	>	IC50	nM	9400.0	CHEMBL2742	Homo sapiens	IC50	uM	9.4
	23284722	CHEMBL4838032	Inhibition of human N-terminal GST fusion tagged FGFR3 cytoplasmic domain (436 to 806 end residues) expressed in baculovirus infected Sf21 insect cells	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	=	IC50	nM	0.8	CHEMBL2742	Homo sapiens	IC50	nM	0.8
	23284723	CHEMBL4838033	Inhibition of human N-terminal GST fusion tagged FGFR3 cytoplasmic domain (460 to 802 end residues) expressed in baculovirus infected Sf21 insect cells	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	=	IC50	nM	1.4	CHEMBL2742	Homo sapiens	IC50	nM	1.4
	23284778	CHEMBL4838088	Inhibition of recombinant human FGFR3 (447 to 761 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL2742	Homo sapiens	INH	%	90.0
	23284809	CHEMBL4838113	Inhibition of FGFR3 (unknown origin)	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.0	CHEMBL2742	Homo sapiens	IC50	nM	1.0
	23284810	CHEMBL4838113	Inhibition of FGFR3 (unknown origin)	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	6.4	CHEMBL2742	Homo sapiens	IC50	nM	6.4
	23284811	CHEMBL4838113	Inhibition of FGFR3 (unknown origin)	B	CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21		CHEMBL4297522	=	IC50	nM	1.2	CHEMBL2742	Homo sapiens	IC50	nM	1.2
	23284812	CHEMBL4838113	Inhibition of FGFR3 (unknown origin)	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	3.0	CHEMBL2742	Homo sapiens	IC50	nM	3.0
	23284819	CHEMBL4838117	Inhibition of recombinant human FGFR3 in presence of ATP at Km concentration	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.8	CHEMBL2742	Homo sapiens	IC50	nM	1.8
	23297790	CHEMBL4841270	Inhibition of FGFR3 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL2742	Homo sapiens	IC50	nM	1000.0
Not Active	23317408	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	91.0	CHEMBL2742	Homo sapiens	% Control	%	91.0
Not Active	23317409	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	84.0	CHEMBL2742	Homo sapiens	% Control	%	84.0
Not Active	23317876	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL2742	Homo sapiens	% Control	%	96.0
Not Active	23317877	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	87.0	CHEMBL2742	Homo sapiens	% Control	%	87.0
Not Active	23318545	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	83.0	CHEMBL2742	Homo sapiens	% Control	%	83.0
Not Active	23318546	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	60.0	CHEMBL2742	Homo sapiens	% Control	%	60.0
Not Active	23319026	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23319027	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	97.0	CHEMBL2742	Homo sapiens	% Control	%	97.0
Not Active	23319663	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23319664	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	80.2	CHEMBL2742	Homo sapiens	% Control	%	80.2
Not Active	23320138	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	88.5	CHEMBL2742	Homo sapiens	% Control	%	88.5
Not Active	23320139	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	94.0	CHEMBL2742	Homo sapiens	% Control	%	94.0
Not Active	23320816	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	96.0	CHEMBL2742	Homo sapiens	% Control	%	96.0
Not Active	23320817	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23321284	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23321285	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23321914	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23321915	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	85.0	CHEMBL2742	Homo sapiens	% Control	%	85.0
Not Active	23322382	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23322383	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	99.0	CHEMBL2742	Homo sapiens	% Control	%	99.0
Not Active	23323071	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23323072	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	95.0	CHEMBL2742	Homo sapiens	% Control	%	95.0
Not Active	23323539	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23323540	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	93.0	CHEMBL2742	Homo sapiens	% Control	%	93.0
Not Active	23324011	CHEMBL4880630	FGFR3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	10.0	CHEMBL2742	Homo sapiens	% inhibition	%	10.0
Not Active	23324393	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	91.2	CHEMBL2742	Homo sapiens	% Control	%	91.2
Not Active	23324394	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23325028	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23325029	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23325496	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23325497	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	92.0	CHEMBL2742	Homo sapiens	% Control	%	92.0
Not Active	23326143	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	86.0	CHEMBL2742	Homo sapiens	% Control	%	86.0
Not Active	23326144	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23326611	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23326612	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23327311	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23327312	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23327779	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23327780	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	80.0	CHEMBL2742	Homo sapiens	% Control	%	80.0
Not Active	23328366	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	99.0	CHEMBL2742	Homo sapiens	% Control	%	99.0
Not Active	23328367	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23328834	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	92.0	CHEMBL2742	Homo sapiens	% Control	%	92.0
Not Active	23328835	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	97.0	CHEMBL2742	Homo sapiens	% Control	%	97.0
Not Active	23329345	CHEMBL4881052	FGFR3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	106.0	CHEMBL2742	Homo sapiens	% residual kinase activity	%	106.0
Not Active	23329780	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23329781	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23330248	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23330249	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23331004	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23331005	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23331472	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23331473	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	84.0	CHEMBL2742	Homo sapiens	% Control	%	84.0
Not Active	23331884	CHEMBL4881424	Bayer in-house kinase assay with FGER3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1	Non standard unit for type	CHEMBL3907057	>	IC50	µM	10.0	CHEMBL2742	Homo sapiens	IC50	µM	10.0
Not Active	23332059	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	95.6	CHEMBL2742	Homo sapiens	% Control	%	95.6
Not Active	23332060	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23332525	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	90.7	CHEMBL2742	Homo sapiens	% Control	%	90.7
Not Active	23332526	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23333243	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	96.4	CHEMBL2742	Homo sapiens	% Control	%	96.4
Not Active	23333244	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23333882	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	90.0	CHEMBL2742	Homo sapiens	% Control	%	90.0
Not Active	23333883	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	85.0	CHEMBL2742	Homo sapiens	% Control	%	85.0
Not Active	23334350	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	98.0	CHEMBL2742	Homo sapiens	% Control	%	98.0
Not Active	23334351	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23334894	CHEMBL4881518	FGFR3 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	12.0	CHEMBL2742	Homo sapiens	% inhibition	%	12.0
Not Active	23335329	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23335330	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23335797	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL2742	Homo sapiens	% Control	%	99.0
Not Active	23335798	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23336424	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	82.0	CHEMBL2742	Homo sapiens	% Control	%	82.0
Not Active	23336425	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	92.0	CHEMBL2742	Homo sapiens	% Control	%	92.0
Not Active	23336892	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	93.0	CHEMBL2742	Homo sapiens	% Control	%	93.0
Not Active	23336893	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	97.0	CHEMBL2742	Homo sapiens	% Control	%	97.0
Not Active	23337596	CHEMBL4881967	FGFR3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.5	CHEMBL2742	Homo sapiens	% Ctrl	%	95.5
Not Active	23337597	CHEMBL4881968	FGFR3 K650E Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	91.0	CHEMBL2742	Homo sapiens	% Ctrl	%	91.0
Not Active	23337973	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	94.0	CHEMBL2742	Homo sapiens	% Control	%	94.0
Not Active	23337974	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23338441	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23338442	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23339053	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23339054	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	96.0	CHEMBL2742	Homo sapiens	% Control	%	96.0
Not Active	23339521	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	80.0	CHEMBL2742	Homo sapiens	% Control	%	80.0
Not Active	23339522	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23340158	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23340159	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	91.0	CHEMBL2742	Homo sapiens	% Control	%	91.0
Not Active	23340626	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23340627	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	82.0	CHEMBL2742	Homo sapiens	% Control	%	82.0
Not Active	23341283	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23341284	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	98.0	CHEMBL2742	Homo sapiens	% Control	%	98.0
Not Active	23341751	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23341752	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	87.0	CHEMBL2742	Homo sapiens	% Control	%	87.0
Not Active	23342367	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	98.0	CHEMBL2742	Homo sapiens	% Control	%	98.0
Not Active	23342368	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23342835	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23342836	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23343465	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL2742	Homo sapiens	% Control	%	97.0
Not Active	23343466	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	92.0	CHEMBL2742	Homo sapiens	% Control	%	92.0
Not Active	23343933	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	93.0	CHEMBL2742	Homo sapiens	% Control	%	93.0
Not Active	23343934	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	82.0	CHEMBL2742	Homo sapiens	% Control	%	82.0
Not Active	23344571	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	84.0	CHEMBL2742	Homo sapiens	% Control	%	84.0
Not Active	23344572	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23345144	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23345145	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23345612	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23345613	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23346189	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	88.2	CHEMBL2742	Homo sapiens	% Control	%	88.2
Not Active	23346190	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23346658	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23346659	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23347263	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	85.4	CHEMBL2742	Homo sapiens	% Control	%	85.4
Not Active	23347264	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23347749	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	81.8	CHEMBL2742	Homo sapiens	% Control	%	81.8
Not Active	23347750	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23348328	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23348329	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23348796	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23348797	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23349383	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	90.0	CHEMBL2742	Homo sapiens	% Control	%	90.0
Not Active	23349384	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23350001	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23350002	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23350469	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23350470	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	90.0	CHEMBL2742	Homo sapiens	% Control	%	90.0
Not Active	23351074	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23351075	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23351542	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23351543	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL2742	Homo sapiens	% Control	%	90.0
Not Active	23352047	CHEMBL4882738	FGFR3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	9.377	CHEMBL2742	Homo sapiens	% Inhibition	%	9.3774
Not Active	23352048	CHEMBL4882739	FGFR3 K650E Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.431	CHEMBL2742	Homo sapiens	% Inhibition	%	3.431
Not Active	23352566	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	74.0	CHEMBL2742	Homo sapiens	% Control	%	74.0
Not Active	23352567	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	86.0	CHEMBL2742	Homo sapiens	% Control	%	86.0
Not Active	23353034	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23353035	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23353916	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23353917	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23354384	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23354385	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23355116	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23355117	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23355584	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23355585	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23356220	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23356221	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23356688	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23356689	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23357297	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	82.0	CHEMBL2742	Homo sapiens	% Control	%	82.0
Not Active	23357298	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23357944	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	83.0	CHEMBL2742	Homo sapiens	% Control	%	83.0
Not Active	23357945	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23358412	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	97.0	CHEMBL2742	Homo sapiens	% Control	%	97.0
Not Active	23358413	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23358998	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23358999	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	80.2	CHEMBL2742	Homo sapiens	% Control	%	80.2
Not Active	23359596	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23359597	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23360064	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23360065	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	79.0	CHEMBL2742	Homo sapiens	% Control	%	79.0
Not Active	23360649	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23360650	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23361117	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23361118	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23361690	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23361691	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	90.0	CHEMBL2742	Homo sapiens	% Control	%	90.0
Not Active	23362226	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23362227	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23362694	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23362695	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	76.0	CHEMBL2742	Homo sapiens	% Control	%	76.0
Not Active	23364336	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	95.0	CHEMBL2742	Homo sapiens	% Control	%	95.0
Not Active	23364337	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23364804	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23364805	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23365543	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	98.0	CHEMBL2742	Homo sapiens	% Control	%	98.0
Not Active	23365544	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23366086	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	98.0	CHEMBL2742	Homo sapiens	% Control	%	98.0
Not Active	23366087	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23366676	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23366677	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	87.0	CHEMBL2742	Homo sapiens	% Control	%	87.0
Not Active	23367144	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23367145	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23367573	CHEMBL4883926	FGF-R3 K650E ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	99.0	CHEMBL2742	Homo sapiens	% Residual activity with Skepinone-L	%	99.0
Not Active	23367574	CHEMBL4883927	FGF-R3 wt ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	102.0	CHEMBL2742	Homo sapiens	% Residual activity with Skepinone-L	%	102.0
Not Active	23368022	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23368023	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23368490	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	83.0	CHEMBL2742	Homo sapiens	% Control	%	83.0
Not Active	23368491	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23369089	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23369090	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23369557	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23369558	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23370067	CHEMBL4884311	FGFR3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	99.0	CHEMBL2742	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23370525	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	93.0	CHEMBL2742	Homo sapiens	% Control	%	93.0
Not Active	23370526	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	74.0	CHEMBL2742	Homo sapiens	% Control	%	74.0
Not Active	23370993	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	94.0	CHEMBL2742	Homo sapiens	% Control	%	94.0
Not Active	23370994	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	93.0	CHEMBL2742	Homo sapiens	% Control	%	93.0
Not Active	23371802	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23371803	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	86.0	CHEMBL2742	Homo sapiens	% Control	%	86.0
Not Active	23372270	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23372271	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	83.0	CHEMBL2742	Homo sapiens	% Control	%	83.0
	23372745	CHEMBL4884710	FGFR3(FGF3LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	23373154	CHEMBL4885001	FGFR3(FGF3LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
	23373515	CHEMBL4885292	FGFR3(FGF3LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2742	Homo sapiens	pIC50		6.0
Not Active	23374978	CHEMBL4885972	FGFR3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	1.5	CHEMBL2742	Homo sapiens	% Inhibition	%	1.5
Not Active	23375251	CHEMBL4886233	fibroblast growth factor receptor 3 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-2.0	CHEMBL2742	Homo sapiens	% inhibition	%	-2.0
Not Active	23375697	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23375698	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	79.0	CHEMBL2742	Homo sapiens	% Control	%	79.0
Not Active	23376165	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23376166	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	93.0	CHEMBL2742	Homo sapiens	% Control	%	93.0
Not Active	23376742	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	83.0	CHEMBL2742	Homo sapiens	% Control	%	83.0
Not Active	23376743	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23377211	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	97.0	CHEMBL2742	Homo sapiens	% Control	%	97.0
Not Active	23377212	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23378070	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	82.0	CHEMBL2742	Homo sapiens	% Control	%	82.0
Not Active	23378071	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	79.0	CHEMBL2742	Homo sapiens	% Control	%	79.0
Not Active	23378538	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL2742	Homo sapiens	% Control	%	92.0
Not Active	23378539	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	96.0	CHEMBL2742	Homo sapiens	% Control	%	96.0
Not Active	23379705	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23379706	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23380173	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23380174	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	98.0	CHEMBL2742	Homo sapiens	% Control	%	98.0
Not Active	23380867	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23380868	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23381515	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23381516	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23381983	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23381984	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23382607	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	78.0	CHEMBL2742	Homo sapiens	% Control	%	78.0
Not Active	23382608	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL2742	Homo sapiens	% Control	%	100.0
Not Active	23383075	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	71.0	CHEMBL2742	Homo sapiens	% Control	%	71.0
Not Active	23383076	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	89.0	CHEMBL2742	Homo sapiens	% Control	%	89.0
Not Active	23383792	CHEMBL4887429	FGFR3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL2742	Homo sapiens	% Ctrl	%	96.0
Not Active	23384276	CHEMBL4887871	FGFR3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-1.0	CHEMBL2742	Homo sapiens	% inhibition	%	-1.0
Not Active	23384990	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	88.0	CHEMBL2742	Homo sapiens	% Control	%	88.0
Not Active	23384991	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL2742	Homo sapiens	% Control	%	86.0
Not Active	23385457	CHEMBL4879714	KinomeScan assay: inhibition of FGFR3	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	90.0	CHEMBL2742	Homo sapiens	% Control	%	90.0
Not Active	23385458	CHEMBL4879715	KinomeScan assay: inhibition of FGFR3(G697C)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL2742	Homo sapiens	% Control	%	84.0
